nutrition or diet, Primary Sclerosing Cholangitis Literature

Primary Sclerosing Cholangitis Literature

Home Page

FAQ

PSC Partners

www Resources

Scientific Literature

Scientific Literature, nutrition or diet

Aagaard CS, Hoang TT, Vingsbo-Lundberg C, Dietrich J, Andersen P. Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis. J. Immunol. 183: 2659-2668 (2009).
Aanpreung P, Laohapansang M, Ruangtrakool R, Kimhan J. Neonatal cholestasis in Thai infants. J. Med. Assoc. Thai. 88 Suppl. 8: S9-S15 (2005).
Aasheim ET, Bjorkman S, Sovik TT, Engstrom M, Hanvold SE, Mala T, Olbers T, Bohmer T. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am. J. Clin. Nutr. 90: 15-22 (2009). *
Aasum E, Khalid AM, Gudbrandsen OA, How OJ, Berge RK, Larsen TS. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice. J. Mol. Cell. Cardiol. 44: 201-209 (2008).
Abad-Lacruz A, Fernandez-Banares F, Cabre E, Gil A, Esteve M, Gonzalez-Huix F, Xiol X, Gassull MA. The effect of total enteral tube feeding on the vitamin status of malnourished patients with inflammatory bowel disease. Int. J. Vitam. Nutr. Res. 58: 428-435 (1988).
Abba K, Sudarsanam TD, Grobler L, Volmink J. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst. Rev. 4: CD006086 (2008).
Abbate R, Gori AM, Martini F, Brunelli T, Filippini M, Francalanci I, Paniccia R, Prisco D, Gensini GF, Neri Serneri GG. n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production. Prostaglandins Leukot. Essent. Fatty Acids 54: 439-444 (1996).
Abbatecola AM, Cherubini A, Guralnik JM, Lacueva CA, Ruggiero C, Maggio M, Bandinella S, Paolisso G, Ferrucci L. Plasma polyunsaturated fatty acids and age-related physical performance decline. Rejuvenation Res. 12: 25-32 (2009).
Abbatecola AM, Evans W, Paolisso G. PUFA supplements and type 2 diabetes in the elderly. Curr. Pharm. Des. 15: 4126-4134 (2009).
Abbott J, Hart A, Morton AM, Dey P, Conway SP, Webb AK. Can health-related quality of life predict survival in adults with cystic fibrosis? Am. J. Respir. Crit. Care Med. 179: 54-58 (2009). *
Abbott J, Morton AM, Musson H, Conway SP, Etherington C, Gee L, Fitzjohn J, Kevin Webb A. Nutritional status, perceived body image and eating behaviours in adults with cystic fibrosis. Clin. Nutr. 26: 91-99 (2007).
Abdallah H, Leffler D, Dennis M, Kelly CP. Refractory celiac disease. Curr. Gastroenterol. Rep. 9: 401-405 (2007).
Abdel-Hamid NM, Faddah LM, Al-Rehany MA, Ali AH, Bakeet AA. New role of antinutritional factors, phytic acid and catechin in the treatment of CCl4 intoxication. Ann. Hepatol. 6: 262-266 (2007). *
Abdelmalek MF, Liu C, Shuster J, Nelson DR, Asal NR. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 4: 1162-1169 (2006).
Abdelmalek MF, Liu C, Valentine JF. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease. Am. J. Gastroenterol. 102: 1333-1334 (2007).
Abdelmalek MF, Sanderson SO, Angulo P, Soldevila-Pico C, Liu C, Peter J, Keach J, Cave M, Chen T, McClain CJ, Lindor KD. Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. Hepatology 50: 1818-1826 (2009). *
Abdelrazeq AS, Lund JN, Leveson SH. Implications of pouchitis on the functional results following stapled restorative proctocolectomy. Dis. Colon Rectum 48: 1700-1707 (2005). *
Abdukeyum GG, Owen AJ, McLennan PL. Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning. J. Nutr. 138: 1902-1909 (2008). *
Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am. J. Gastroenterol. 97: 2016-2021 (2002). *
Abdulkarim AS, Murray JA. Celiac disease. Curr. Treat. Options Gastroenterol. 5: 27-38 (2002).
Abdullah MA. Epidemiology of type I diabetes mellitus among Arab children. Saudi Med. J. 26: 911-917 (2005).
Abedin SA, Thorne JL, Battaglia S, Maguire O, Hornung L, Doherty AP, Mills IG, Campbell MJ. Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells. Carcinogenesis 30: 449-456 (2009). *
Abel EK. The rise and fall of celiac disease in the United States. J. Hist. Med. Allied Sci. 65: 81-105 (2010).
Abel S, Hundhausen C, Mentlein R, Schulte A, Berkhout TA, Broadway N, Hartmann D, Sedlacek R, Dietrich S, Muetze B, Schuster B, Kallen KJ, Saftig P, Rose-John S, Ludwig A. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172: 6362-6372 (2004). *
Abenavoli L, Proietti I, Leggio L, Ferrulli A, Vonghia L, Capizzi R, Rotoli M, Amerio PL, Gasbarrini G, Addolorato G. Cutaneous manifestations in celiac disease. World J. Gastroenterol. 12: 843-852 (2006). *
Aberle J, Fedderwitz I, Klages N, George E, Beil FU. Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet. Horm. Metab. Res. 39: 395-397 (2007).
Aberle J, Flitsch J, Beck NA, Mann O, Busch P, Peitsmeier P, Beil FU. Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes. Mol. Genet. Metab. 95: 188-191 (2008). *
Abete P, Testa G, Galizia G, Della-Morte D, Cacciatore F, Rengo F. PUFA for human health: diet or supplementation? Curr. Pharm. Des. 15: 4186-4190 (2009).
Abeywardena MY, Head RJ. Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc. Res. 52: 361-371 (2001). *
Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J. Hepatol. 51: 918-924 (2009).
Abiru N, Kawasaki E, Eguch K. Current knowledge of Japanese type 1 diabetic syndrome. Diabetes Metab. Res. Rev. 18: 357-366 (2002). *
Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, Couturier D, Amor B. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 108: 417-422 (1995). *
Abreu MT. The pathogenesis of inflammatory bowel disease: translational implications for clinicians. Curr. Gastroenterol. Rep. 4: 481-489 (2002).
Abu-Alshiekh NK, Kofahi SM, Nusair ZM. The use of sweat chloride test for screening cystic fibrosis among malnourished children suffering from frequent respiratory infections. Saudi Med. J. 30: 1526-1531 (2009).
Abu-Suboh Abadia M, Casellas F, Vilaseca J, Malagelada J. Response of first attack of inflammatory bowel disease requiring hospital admission to steroid therapy. Rev. Esp. Enferm. Dig. 96: 539-547 (2004).
AbuGhazaleh AA, Holmes LD, Jacobson BN, Kalscheur KF. Short communication: eicosatrienoic acid and docosatrienoic acid do not promote vaccenic acid accumulation in mixed ruminal cultures. J. Dairy Sci. 89: 4336-4339 (2006). *
Abumweis SS, Jones PJ. Cholesterol-lowering effect of plant sterols. Curr. Atheroscler. Rep. 10: 467-472 (2008).
Abuzakouk M, Barnes L, O'Gorman N, O'Grady A, Mohamed B, McKenna MJ, Freaney R, Feighery C. Dermatitis herpetiformis: no evidence of bone disease despite evidence of enteropathy. Dig. Dis. Sci. 52: 659-664 (2007). *
Acamovic T, Brooker JD. Biochemistry of plant secondary metabolites and their effects in animals. Proc. Nutr. Soc. 64: 403-412 (2005). *
Acar N, Berdeaux O, Juaneda P, Gregoire S, Cabaret S, Joffre C, Creuzot-Garcher CP, Bretillon L, Bron AM. Red blood cell plasmalogens and docosahexaenoic acid are independently reduced in primary open-angle glaucoma. Exp. Eye Res. 89: 840-853 (2009). *
Acar N, Bonhomme B, Joffre C, Bron AM, Creuzot-Garcher C, Bretillon L, Doly M, Chardigny JM. The retina is more susceptible than the brain and the liver to the incorporation of trans isomers of DHA in rats consuming trans isomers of alpha-linolenic acid. Reprod. Nutr. Dev. 46: 515-525 (2006). *
Accomando S, Cataldo F. The global village of celiac disease. Dig. Liver Dis. 36: 492-498 (2004).
Accomando S, Pellitteri V, Corsello G. Biochemical markers in celiac disease. Front. Biosci. (Schol. Ed.) 2: 313-317 (2010).
Accomando S, Pellitteri V, Corsello G. Natural polyphenols as anti-inflammatory agents. Front. Biosci. (Schol. Ed.) 2: 318-331 (2010).
Acheson DW, Luccioli S. Mucosal immune responses. Best Pract. Res. Clin. Gastroenterol. 18: 387-404 (2004).
Achneck HE, Pradhan SK, Kavic SM, Longo WE. Primary signet-ring cell carcinoma mimicking segmental Crohn's colitis. Dig. Liver Dis. 37: 537-541 (2005).
Acin-Perez R, Hoyos B, Zhao F, Vinogradov V, Fischman DA, Harris RA, Leitges M, Wongsiriroj N, Blaner WS, Manfredi G, Hammerling U. Control of oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial energy homoeostasis. FASEB J. Oct 7 [Epub ahead of print] (2009). *
Actis GC, Aimo G, Priolo G, Moscato D, Rizzetto M, Pagni R. Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. Inflamm. Bowel Dis. 4: 276-279 (1998). *
Actis GC, Fadda M, Pellicano R, David E, Rizzetto M, Sapino A. The 17-year single-center experience with the use of azathioprine to maintain remission in ulcerative colitis. Biomed. Pharmacother. 63: 362-365 (2009).
Actis GC, Pellicano R, Bugianesi E, Lagget M, Rizzetto M. Use of corticosteroids, immunomodulators, and infliximab at a third-level day-hospital service of gastro-hepatology. Minerva Gastroenterol. Dietol. 54: 239-242 (2008).
Actis GC, Pellicano R, Pinna-Pintor M, Rizzetto M. Inflammatory bowel disease: an overview. Minerva Gastroenterol. Dietol. 53: 231-232 (2007).
Actis GC, Pinna-Pintor M. An audit of the immunosuppressive management of ulcerative colitis. A retrospective chart review from a referral Day-Hospital of Gastro-enterology. Minerva Gastroenterol. Dietol. 48: 115-120 (2002).
Actis GC, Rossetti S, Rizzetto M, Fadda M, Palmo A. Need for hospital admission in patients with ulcerative colitis during maintenance with azathioprine. Minerva Gastroenterol. Dietol. 50: 97-101 (2004).
Adam O. Dietary fatty acids and immune reactions in synovial tissue. Eur. J. Med. Res. 8: 381-387 (2003).
Adam O. Ankylosing spondylitis and convenient nutrition. Wien. Med. Wochenschr. 158: 294-297 (2008).
Adam O, Beringer C, Kless T, Lemmen C, Adam A, Wiseman M, Adam P, Klimmek R, Forth W. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol. Int. 23: 27-36 (2003). *
Adam O, Fasse S, Ditrich O. Diet in rheumatic disease. Z. Rheumatol. 68: 549-558 (2009).
Adamo KB, Dent R, Langefeld CD, Cox M, Williams K, Carrick KM, Stuart JS, Sundseth SS, Harper ME, McPherson R, Tesson F. Peroxisome proliferator-activated receptor gamma 2 and acyl-CoA synthetase 5 polymorphisms influence diet response. Obesity (Silver Spring) 15: 1068-1075 (2007). *
Adamopoulos AB. Inflammatory bowel disease (IBD) and the liver. Annals of Gastroenterology 19: 146-151 (2006). *
Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D. Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agric. Food Chem. 54: 980-985 (2006).
Adamson AW, Dreesen TD, Tekle M, Tang C, Cho HP, Clarke SD, Gettys TW. A newly discovered member of the fatty acid desaturase gene family: a non-coding, antisense RNA gene to Delta5-desaturase. Prostaglandins Leukot. Essent. Fatty Acids 75: 97-106 (2006). *
Adamson AW, Suchankova G, Rufo C, Nakamura MT, Teran-Garcia M, Clarke SD, Gettys TW. Hepatocyte nuclear factor-4alpha contributes to carbohydrate-induced transcriptional activation of hepatic fatty acid synthase. Biochem. J. 399: 285-295 (2006). *
Adamzik M, Frey UH, Bitzer K, Jakob H, Baba HA, Schmieder RE, Schneider MP, Heusch G, Peters J, Siffert W. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men. Basic Res. Cardiol. 103: 598-610 (2008).
Addolorato G, Capristo E, Stefanini GF, Gasbarrini G. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand. J. Gastroenterol. 32: 1013-1021 (1997).
Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Vonghia L, Cardone S, Leso V, Miceli A, Gasbarrini G. Social phobia in coeliac disease. Scand. J. Gastroenterol. 43: 410-415 (2008). *
Addolorato G, Russell M, Albano E, Haber PS, Wands JR, Leggio L. Understanding and treating patients with alcoholic cirrhosis: an update. Alcohol Clin. Exp. Res. 33: 1136-1144 (2009).
Adhami E. Calculating the etiology of systemic lupus erythematosus. Med. Hypotheses 62: 237-246 (2004).
Adhi M, Farooq A, Hamid SA, Hasan R, Mamji S, Baloch AA. Sero-negative celiac disease with dermatitis herpetiformes: a case report. Cases J. 2: 7512 (2009). *
Adibhatla RM, Hatcher JF. Altered lipid metabolism in brain injury and disorders. Subcell. Biochem. 48: nihpa41041 (2008). *
Adibhatla RM, Hatcher JF. Altered lipid metabolism in brain injury and disorders. Subcell. Biochem. 49: 241-268 (2008). *
Adibi SA. Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G779-G788 (2003). *
Adolfsson O, Meydani SN, Russell RM. Yogurt and gut function. Am. J. Clin. Nutr. 80: 245-256 (2004). *
Adrych KJ, Marek IE, Kryszewski AJ. Adults celiac disease - the tip of the iceberg. Wiad. Lek. 59: 359-363 (2006).
Afman L, Muller M. Nutrigenomics: from molecular nutrition to prevention of disease. J. Am. Diet. Assoc. 106: 569-576 (2006).
Afzal NA, Davies S, Paintin M, Arnaud-Battandier F, Walker-Smith JA, Murch S, Heuschkel R, Fell J. Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig. Dis. Sci. 50: 1471-1475 (2005). *
Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, Davies S, Murch S, Derkx B, Heuschkel R, Fell JM. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment. Pharmacol. Ther. 20: 167-172 (2004). *
Agardh D. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin. Gastroenterol. Hepatol. 5: 1276-1281 (2007).
Agardh D, Lynch K, Brundin C, Ivarsson SA, Lernmark A, Cilio CM. Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease. Clin. Exp. Immunol. 144: 67-75 (2006). *
Agarwal N, Puri AS, Grover R. Non-diarrheal celiac disease: a report of 31 cases from Northern India. Indian J. Gastroenterol. 26: 122-126 (2007). *
Aggarwal P, Aggarwal A, Gupta S, Misra R. Osteopenia is common in adult male patients with active juvenile idiopathic arthritis. J. Rheumatol. 33: 1642-1645 (2006).
Aghdassi E, Wendland BE, Stapleton M, Raman M, Allard JP. Adequacy of nutritional intake in a Canadian population of patients with Crohn's disease. J. Am. Diet. Assoc. 107: 1575-1580 (2007). *
Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial. Am. J. Gastroenterol. 98: 348-353 (2003). *
Agostoni C. Role of long-chain polyunsaturated fatty acids in the first year of life. J. Pediatr. Gastroenterol. Nutr. 47 Suppl. 2: S41-S44 (2008). *
Agostoni C. Docosahexaenoic acid (DHA): from the maternal-fetal dyad to the complementary feeding period. Early Hum. Dev. Feb 2 [Epub ahead of print] (2010).
Agostoni C, Decsi T, Fewtrell M, Goulet O, Kolacek S, Koletzko B, Michaelsen KF, Moreno L, Puntis J, Rigo J, Shamir R, Szajewska H, Turck D, van Goudoever J; ESPGHAN Committee on Nutrition:. Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 46: 99-110 (2008). *
Agostoni C, Riva E, Giovannini M, Pinto F, Colombo C, Rise P, Galli C, Marangoni F. Maternal smoking habits are associated with differences in infants' long-chain polyunsaturated fatty acids in whole blood: a case-control study. Arch. Dis. Child. 93: 414-418 (2008).
Agrawal D, Rukkannagari S, Kethu S. Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease. Minerva Gastroenterol. Dietol. 53: 233-248 (2007).
Agte VV, Tarwadi KV. Combination of diabetes and cataract worsens the oxidative stress and micronutrient status in Indians. Nutrition 24: 617-624 (2008). *
Aguilar RP, Genta S, Oliveros L, Anzulovich A, Gimenez MS, S Sanchez S. Vitamin A deficiency injures liver parenchyma and alters the expression of hepatic extracellular matrix. J. Appl. Toxicol. 29: 214-222 (2009). *
Aguirre AL, Center SA, Randolph JF, Yeager AE, Keegan AM, Harvey HJ, Erb HN. Gallbladder disease in Shetland sheepdogs: 38 cases (1995-2005). J. Am. Vet. Med. Assoc. 231: 79-88 (2007).
Agundez JAG, Lozano L, Ladero JM, Sastre J, Cerdan FJ, Diaz-Rubio M, Benitez J. N-Acetyltransferase 2 (NAT2) genotype and colorectal carcinoma: risk variability according to tumour site? Scand. J. Gastroenterol. 35: 1087-1091 (2000). *
Ahlenstiel G, Rehermann B. Chapter 6. Hepatic NK, NKT, and T cells. In "Liver Immunology: Principles and Practice" (eds. Gershwin ME, Vierling JM, Manns MP), Humana Press Inc., Totowa, NJ, p. 71-82 (2007). *
Ahluwalia M, Gotlieb V, Damerla V, Saif MW. Aggressive Burkitt-like lymphoma of colon in a patient with prior celiac disease. Yale J. Biol. Med. 79: 173-175 (2006). *
Ahmad J, Slivka A. Hepatobiliary disease in inflammatory bowel disease. Gastroenterol. Clin. North Am. 31: 329-345 (2002).
Ahmad KA, Ahmann JR, Migas MC, Waheed A, Britton RS, Bacon BR, Sly WS, Fleming RE. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol. Dis. 29: 361-366 (2002). *
Ahmad SM, Haskell MJ, Raqib R, Stephensen CB. Men with low vitamin A stores respond adequately to primary yellow fever and secondary tetanus toxoid vaccination. J. Nutr. 138: 2276-2283 (2008). *
Ahmad SM, Haskell MJ, Raqib R, Stephensen CB. Markers of innate immune function are associated with vitamin A stores in men. J. Nutr. 139: 377-385 (2009). *
Ahmad SO, Park JH, Radel JD, Levant B. Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological study. Neurosci. Lett. 438: 303-307 (2008).
Ahmadi A, Polyak S, Draganov PV. Colorectal cancer surveillance in inflammatory bowel disease: the search continues. World J. Gastroenterol. 15: 61-66 (2009). *
Ahmed FE. Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases. Expert Rev. Mol. Diagn. 6: 345-363 (2006).
Ahmed FE. Gene-gene, gene-environment and multiple interactions in colorectal cancer. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 24: 1-101 (2006). *
Ahmed N, Corey M, Forstner G, Zielenski J, Tsui LC, Ellis L, Tullis E, Durie P. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 52: 1159-1164 (2003). *
Ahmed S, Leo MA, Lieber CS. Interactions between alcohol and beta-carotene in patients with alcoholic liver disease. Am. J. Clin. Nutr. 60: 430-436 (1994). *
Ahmed SF, Horrocks IA, Patterson T, Zaidi S, Ling SC, McGrogan P, Weaver LT. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. J. Pediatr. Gastroenterol. Nutr. 38: 276-280 (2004). *
Ahmed SF, Wong JS, McGrogan P. Improving growth in children with inflammatory bowel disease. Horm. Res. 68 Suppl. 5: S117-S121 (2007).
Ahn J, Flamm SL, Flamm SL. Autoimmune hepatitis. Curr. Treat. Options Gastroenterol. 8: 481-492 (2005).
Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Eng SM, Zhang Y, Garza C, Ambrosone CB. Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis 27: 1876-1882 (2006). *
Ahsan MK, Okuyama H, Hoshino Y, Oka SI, Masutani H, Yodoi J, Nakamura H. Thioredoxin-binding protein-2 deficiency enhances methionine-choline deficient diet-induced hepatic steatosis but inhibits steatohepatitis in mice. Antioxid. Redox Signal. May 18 [Epub ahead of print] (2009).
Ai ZL, Chen DF. The significance and effects of liver X receptor alpha in nonalcoholic fatty liver disease in rats. Zhonghua Gan Zang Bing Za Zhi 15: 127-130 (2007).
Aiga H, Matsuoka S, Kuroiwa C, Yamamoto S. Malnutrition among children in rural Malawian fish-farming households. Trans. R. Soc. Trop. Med. Hyg. 103: 827-833 (2009).
Aigner E, Strassburg CP, Strasser M, Pohla-Gubo G, Dietze O, Hutter J, Manns MP, Datz C. Transient autoimmune hepatitis induced by a thymoma. Am. J. Gastroenterol. 104: 1332-1334 (2009). *
Aigner E, Theurl I, Theurl M, Lederer D, Haufe H, Dietze O, Strasser M, Datz C, Weiss G. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am. J. Clin. Nutr. 87: 1374-1383 (2008). *
Aihara K, Azuma H, Matsumoto T. Vitamin D-vitamin D receptor system regulates antithrombogenicity in vivo. Clin. Calcium 16: 1173-1179 (2006).
Aikawa J, Moretto KD, Denes F, Yamazaki RK, Freitas FA, Hirabara SM, Tchaikovski O Jr, Kaelher MD, Brito GA, Curi R, Fernandes LC. Glucose metabolism by lymphocytes, macrophages, and tumor cells from Walker 256 tumor-bearing rats supplemented with fish oil for one generation. Cell. Biochem. Funct. 26: 874-880 (2008). *
Aiko S, Yoshizumi Y, Ishizuka T, Horio T, Sakano T, Kumano I, Kanai N, Maehara T. Enteral immuno-enhanced diets with arginine are safe and beneficial for patients early after esophageal cancer surgery. Dis. Esophagus 21: 619-627 (2008).
Ailhaud G, Guesnet P, Cunnane SC. An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development? Br. J. Nutr. 100: 461-470 (2008). *
Aires V, Hichami A, Boulay G, Khan NA. Activation of TRPC6 calcium channels by diacylglycerol (DAG)-containing arachidonic acid: a comparative study with DAG-containing docosahexaenoic acid. Biochimie 89: 926-937 (2007).
Aires V, Hichami A, Moutairou K, Khan NA. Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T-cells. Br. J. Pharmacol. 140: 1217-1226 (2003). *
Ait Ben Haddou E, Errabih I, Raissouni L, Elhassani M, Benomar A, Ouazzani H, Yahyaoui M. Interest of corticosteroids in neurological complications of celiac disease. Rev. Neurol. (Paris) 165: 1103-1106 (2009).
Aitola PT, Soppi ET, Halonen PJ, Laine ST, Matikainen MJ. The effect of proctocolectomy on serum antibody levels against cow's milk proteins in patients with chronic ulcerative colitis, with special reference to liver changes. Scand. J. Gastroenterol. 29: 646-650 (1994).
Ajmo JM, Liang X, Rogers CQ, Pennock B, You M. Resveratrol alleviates alcoholic fatty liver in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G833-G842 (2008). *
Akabas SR, Deckelbaum RJ. Summary of a workshop on n-3 fatty acids: current status of recommendations and future directions. Am. J. Clin. Nutr. 83: 1536S-1538S (2006). *
Akagawa M, Ito S, Toyoda K, Ishii Y, Tatsuda E, Shibata T, Yamaguchi S, Kawai Y, Ishino K, Kishi Y, Adachi T, Tsubata T, Takasaki Y, Hattori N, Matsuda T, Uchida K. Bispecific Abs against modified protein and DNA with oxidized lipids. Proc. Natl. Acad. Sci. U.S.A. 103: 6160-6165 (2006). *
Akagi S, Hiyama E, Imamura Y, Takesue Y, Matsuura Y, Yokoyama T. Interleukin-10 expression in intestine of Crohn disease. Int. J. Mol. Med. 5: 389-395 (2000).
Akagiri S, Naito Y, Ichikawa H, Mizushima K, Takagi T, Handa O, Kokura S, Yoshikawa T. A mouse model of metabolic syndrome; increase in visceral adipose tissue precedes the development of fatty liver and insulin resistance in high-fat diet-fed male KK/Ta mice. J. Clin. Biochem. Nutr. 42: 150-157 (2008). *
Akahoshi N, Kobayashi C, Ishizaki Y, Izumi T, Himi T, Suematsu M, Ishii I. Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. Hum. Mol. Genet. 17: 1994-2005 (2008). *
Akbar M, Calderon F, Wen Z, Kim HY. Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc. Natl. Acad. Sci. U.S.A. 102: 10858-10863 (2005). *
Akbiyik F, Cinar K, Demirpence E, Ozsullu T, Tunca R, Haziroglu R, Yurdaydin C, Uzunalimoglu O, Bozkaya H. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver. Eur. J. Clin. Invest. 34: 429-435 (2004).
Akcam M, Yildiz M, Yilmaz A, Artan R. Bone mineral density in response to two different regimes in rickets. Indian Pediatr. 43: 423-427 (2006). *
Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet. 115: 18-29 (2002).
Akerman PA, Jenkins RL, Bistrian BR. Preoperative nutrition assessment in liver transplantation. Nutrition 9: 350-356 (1993).
Akhavan A, Jackman SV, Costa G, Davies B, Wu T, Bond G, Abu-Elmagd K. Urogenital disorders associated with gut failure and intestinal transplantation. J. Urol. 178: 2067-2072 (2007).
Akinbami FO, Venugopalan P, Elnour IB, Nirmala V, Abiodun P, Azubuike JC. Pattern of chronic diarrhoea in children: a prospective analysis of causes, clinical features and outcome. Niger Postgrad. Med. J. 13: 53-56 (2006).
Akiyama S, Katsumata SI, Suzuki K, Nakaya Y, Ishimi Y, Uehara M. Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Biosci. Biotechnol. Biochem. 73: 2779-2782 (2009). *
Akman SA, Arikan C, Sozen G, Ozturk C, Yagci RV. Infliximab treatment of pediatric refractory Crohn's disease: a case report. Turk. J. Gastroenterol. 17: 133-136 (2006). *
Akobeng A, Thomas A. Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst. Rev. 3: CD005984 (2007). *
Akobeng A, Zachos M. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. Cochrane Database Syst. Rev. 1: CD003574 (2004). *
Akobeng AK. Review article: the evidence base for interventions used to maintain remission in Crohn's disease. Aliment. Pharmacol. Ther. 27: 11-18 (2008). *
Akobeng AK. Crohn's disease: current treatment options. Arch. Dis. Child. 93: 787-792 (2008).
Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast-feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch. Dis. Child. 91: 39-43 (2006).
Akobeng AK, Richmond K, Miller V, Thomas AG. Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn's disease. Clin. Nutr. 26: 51-56 (2007).
Akobeng AK, Thomas AG. Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment. Pharmacol. Ther. 27: 1044-1052 (2008). *
Akoglu B, Kindl P, Weber N, Trojan J, Caspary WF, Faust D. Polymorphisms in the methylenetetrahydrofolate reductase gene are determinant for vascular complications after liver transplantation. Eur. J. Clin. Nutr. 62: 430-435 (2008). *
Akoglu B, Schrott M, Bolouri H, Jaffari A, Kutschera E, Caspary WF, Faust D. The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study. Eur. J. Clin. Nutr. 62: 796-801 (2008). *
Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, Abraham SC. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin. Gastroenterol. Hepatol. 5: 1282-1290 (2007).
Al Khalidi H, Kandel G, Streutker CJ. Enteropathy with loss of enteroendocrine and Paneth cells in a patient with immune dysregulation: a case of adult autoimmune enteropathy. Hum. Pathol. 37: 373-376 (2006).
Al Senaidy AM. Serum vitamin A and beta-carotene levels in children with asthma. J. Asthma 46: 699-702 (2009).
Al-Attas OS, Al-Daghri NM, Al-Rubeaan KA, da Silva NF, Sabico SL, Kumar S, McTernan PG, Harte AL. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc. Diabetol. 8: 20 (2009).
Al-Ghonaium A. Stem cell transplantation for primary immunodeficiencies: King Faisal Specialist Hospital experience from 1993 to 2006. Bone Marrow Transplant. 42 Suppl. 1: S53-S56 (2008).
Al-Hasani H, Joost HG. Nutrition-/diet-induced changes in gene expression in white adipose tissue. Best Pract. Res. Clin. Endocrinol. Metab. 19: 589-603 (2005).
Al-Hathlol K, Al-Madani A, Al-Saif S, Abulaimoun B, Al-Tawil K, El-Demerdash A. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants. Singapore Med. J. 47: 147-151 (2006). *
Al-Mubarak L, Al-Khenaizan S, Al Goufi T. Cutaneous presentation of kwashiorkor due to infantile Crohn's disease. Eur. J. Pediatr. 169: 117-119 (2010).
Al-Nakkash L, Clarke LL, Rottinghaus GE, Chen YJ, Cooper K, Rubin LJ. Dietary genistein stimulates anion secretion across female murine intestine. J. Nutr. 136: 2785-2790 (2006). *
Al-Osaimi AM, Berg CL. Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature. Am. J. Gastroenterol. 97: S85 (2002). *
Al-Toma A, Verbeek W, Hadithi M, von Blomberg M, Mulder C. Survival in refractory coeliac disease and enteropathy associated T cell lymphoma: retrospective evaluation of single centre experience. Gut 56: 1373-1378 (2007). *
Al-toma A, Verbeek WH, Mulder CJ. The management of complicated celiac disease. Dig. Dis. 25: 230-236 (2007).
Al-Toma A, Verbeek WH, Mulder CJ. Update on the management of refractory coeliac disease. J. Gastrointestin. Liver Dis. 16: 57-63 (2007). *
Al-Zahrani AM, Al-Raddadi RM. Nutritional knowledge of primary health care physicians in Jeddah, Saudi Arabia. Saudi Med. J. 30: 284-287 (2009).
Alabbad SI, Ryckman J, Puligandla PS, Shaw K, Nguyen LT, Laberge JM. Use of transanastomotic feeding tubes during esophageal atresia repair. J. Pediatr. Surg. 44: 902-905 (2009).
Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann. Intern. Med. 142: 289-298 (2005). *
Alawneh K, Ashley C, Carlson JA. Neutrophilic myositis as a manifestation of celiac disease: a case report. Clin. Rheumatol. 27 Suppl. 1: 11-13 (2008). *
Alazmi WM, Fogel EL, Watkins JL, McHenry L, Sherman S, Lehman GA. The effect of biliary sphincterotomy on serum cholesterol level in postcholecystectomy patients: a pilot study. Can. J. Gastroenterol. 21: 81-84 (2007). *
Alba LM, Angulo P, Lindor KD. Primary sclerosing cholangitis. Minerva Gastroenterol. Dietol. 48: 99-113 (2002).
Albala BC, Jimenez RB, Perez B F, Liberman GC. Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance. Rev. Med. Chil. 134: 372-379 (2006).
Albala C, Villarroel A, Santos JL, Angel B, Lera L, Liberman C, Sanchez H, Perez-Bravo F. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Diabetes Res. Clin. Pract. 77: 245-250 (2007).
Albanese E, Dangour AD, Uauy R, Acosta D, Guerra M, Guerra SS, Huang Y, Jacob K, Llibre de Rodriguez J, Noriega LH, Salas A, Sosa AL, Sousa RM, Williams J, Ferri CP, Prince MJ. Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 Dementia Research Group population-based study. Am. J. Clin. Nutr. 90: 392-400 (2009). *
Albany C, Servetnyk Z. Disabling osteomalacia as the only presenting feature of celiac disease: a case report. Cases J. 2: 20 (2009). *
Albers R, Antoine JM, Bourdet-Sicard R, Calder PC, Gleeson M, Lesourd B, Samart�n S, Sanderson IR, Van Loo J, Vas Dias FW, Watzl B. Markers to measure immunomodulation in human nutrition intervention studies. Br. J. Nutr. 94: 452-481 (2005). *
Albers R, Bol M, Bleumink R, Willems AA, Pieters RH. Effects of supplementation with vitamins A, C, and E, selenium, and zinc on immune function in a murine sensitization model. Nutrition 19: 940-946 (2003). *
Albert CM. Dietary n-3 fatty acid intake and risk of sudden death and coronary artery disease. Curr. Treat. Options Cardiovasc. Med. 9: 71-77 (2007).
Albert NM. We are what we eat: women and diet for cardiovascular health. J. Cardiovasc. Nurs. 20: 451-460 (2005).
Alberti S, Schuster G, Parini P, Feltkamp D, Diczfalusy U, Rudling M, Angelin B, Bjorkhem I, Pettersson S, Gustafsson JA. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J. Clin. Invest. 107: 565-573 (2001). *
Albrecht C, Elliott JI, Sardini A, Litman T, Stieger B, Meier PJ, Higgins CF. Functional analysis of candidate ABC transporter proteins for sitosterol transport. Biochim. Biophys. Acta 1567: 133-142 (2002). *
Aldamiz-Echevarria L, Bilbao A, Andrade F, Elorz J, Prieto JA, Rodriguez-Soriano J. Fatty acid deficiency profile in children with food allergy managed with elimination diets. Acta Paediatr. 97: 1572-1576 (2008).
Aldamiz-Echevarria L, Prieto JA, Andrade F, Elorz J, Sojo A, Lage S, Sanjurjo P, Vazquez C, Rodriguez-Soriano J. Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy. Pediatr. Res. 66: 585-589 (2009).
Aldamiz-Echevarria L, Sanjurjo P, Elorz J, Prieto JA, Perez C, Andrade F, Rodriguez-Soriano J. Effect of docosahexaenoic acid administration on plasma lipid profile and metabolic parameters of children with methylmalonic acidaemia. J. Inherit. Metab. Dis. 29: 58-63 (2006). *
Aldhous MC, Meister D, Ghosh S. Modification of enteral diets in inflammatory bowel disease. Proc. Nutr. Soc. 60: 457-461 (2001). *
Aleksunes LM, Slitt AL, Maher JM, Dieter MZ, Knight TR, Goedken M, Cherrington NJ, Chan JY, Klaassen CD, Manautou JE. Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis. Cell Stress Chaperones 11: 356-363 (2006).
Aleman G, Torres N, Tovar AR. Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development. Rev. Invest. Clin. 56: 351-367 (2004).
Alempijevic T, Jovanovic I, Popovic D, Kovacevic N, Milutinovic AS, Krstic M. IGF-I as a marker of disease activity and nutritional status in patients with inflammatory bowel disease. Indian J. Gastroenterol. 27: 247-248 (2008).
Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, Aid S, Poumes-Ballihaut C, Champeil-Potokar G, Lavialle M. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod. Nutr. Dev. 44: 509-538 (2004).
Alex P, Ye M, Zachos NC, Sipes J, Nguyen T, Suhodrev M, Gonzales L, Arora Z, Zhang T, Centola M, Guggino SE, Li X. Clcn5 knockout mice exhibit novel immunomodulatory effects and are more susceptible to dextran sulfate sodium-induced colitis. J. Immunol. Feb 24 [Epub ahead of print] (2010).
Alexander LS, Qu A, Cutler SA, Mahajan A, Rothschild MF, Cai W, Dekkers JC, Stahl CH. A calcitonin receptor (CALCR) single nucleotide polymorphism is associated with growth performance and bone integrity in response to dietary phosphorus deficiency. J. Anim. Sci. Nov 20 [Epub ahead of print] (2009). *
Alexander RT, Woudenberg-Vrenken TE, Buurman J, Dijkman H, van der Eerden BC, van Leeuwen JP, Bindels RJ, Hoenderop JG. Klotho prevents renal calcium loss. J. Am. Soc. Nephrol. 20: 2371-2379 (2009).
Alfonso-Sanchez MA, Perez-Miranda AM, Garcia-Obregon S, Pena JA. An evolutionary approach to the high frequency of the Delta F508 CFTR mutation in European populations. Med. Hypotheses Jan 26 [Epub ahead of print] (2010).
Ali MM, Vaidya V. Vitamin D and cancer. J. Cancer Res. Ther. 3: 225-230 (2007). *
Ali S, Roberts PR. Nutrients with immune-modulating effects: what role should they play in the intensive care unit? Curr. Opin. Anaesthesiol. 19: 132-139 (2006).
Ali T, Lam D, Bronze MS, Humphrey MB. Osteoporosis in inflammatory bowel disease. Am. J. Med. 122: 599-604 (2009). *
Alibin CP, Kopilas MA, Anderson HD. Suppression of cardiac myocyte hypertrophy by conjugated linoleic acid: role of peroxisome proliferator-activated receptors alpha and gamma. J. Biol. Chem. 283: 10707-10715 (2008). *
Alic M. Is exposure to a patient with Crohn's disease an environmental factor for developing the disease. Gut 45: 631-632 (1999). *
Alkhouri N, Hupertz V, Mahajan L. Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease. Inflamm. Bowel Dis. 15: 803-806 (2009).
Allam G. Immunomodulatory effects of curcumin treatment on murine Schistosomiasis mansoni. Immunobiology 214: 712-727 (2009).
Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, Jalali P, Kandasamy T, Prayitno N, Sherman M, Guindi M, Ma DW, Heathcote JE. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J. Hepatol. 48: 300-307 (2008).
Allayee H, Baylin A, Hartiala J, Wijesuriya H, Mehrabian M, Lusis AJ, Campos H. Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am. J. Clin. Nutr. 88: 934-940 (2008). *
Allayee H, Roth N, Hodis HN. Polyunsaturated fatty acids and cardiovascular disease: implications for nutrigenetics. J. Nutrigenet. Nutrigenomics 2: 140-148 (2009).
Allen KJ, Cheah DM, Lee XL, Pettigrew-Buck NE, Vadolas J, Mercer JF, Ioannou PA, Williamson R. The potential of bone marrow stem cells to correct liver dysfunction in a mouse model of Wilson's disease. Cell Transplant. 13: 765-773 (2004).
Allen KJ, Cheah DM, Wright PF, Gazeas S, Pettigrew-Buck NE, Deal YH, Mercer JF, Williamson R. Liver cell transplantation leads to repopulation and functional correction in a mouse model of Wilson's disease. J. Gastroenterol. Hepatol. 19: 1283-1290 (2004). *
Allen LH. How common is vitamin B-12 deficiency? Am. J. Clin. Nutr. 89: 693S-696S (2009). *
Allen S, Britton J, Leonardi-Bee J. Association between antioxidant vitamins and asthma outcomes: systematic review and meta-analysis. Thorax 64: 610-619 (2009).
Allenspach K, Bergman PJ, Sauter S, Grone A, Doherr MG, Gaschen F. P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies. J. Comp. Pathol. 134: 1-7 (2006). *
Allenspach K, Steiner JM, Shah BN, Berghoff N, Ruaux C, Williams DA, Blum JW, Gaschen F. Evaluation of gastrointestinal permeability and mucosal absorptive capacity in dogs with chronic enteropathy. Am. J. Vet. Res. 67: 479-483 (2006).
Aller R, De Luis DA, Fernandez L, Calle F, Velayos B, Izaola O, Gonzalez Sagrado M, Conde R, Gonzalez JM. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease. Eur. Rev. Med. Pharmacol. Sci. 13: 357-364 (2009).
Aller R, de Luis DA, Fernandez L, Calle F, Velayos B, Olcoz JL, Izaola O, Sagrado MG, Conde R, Gonzalez JM. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. Dig. Dis. Sci. 53: 1088-1092 (2008). *
Alles N, Soysa NS, Hussain MA, Tomomatsu N, Saito H, Baron R, Morimoto N, Aoki K, Akiyoshi K, Ohya K. Polysaccharide nanogel delivery of a TNF-alpha and RANKL antagonist peptide allows systemic prevention of bone loss. Eur. J. Pharm. Sci. 37: 83-88 (2009).
Allez M, Mayer L. Regulatory T cells: peace keepers in the gut. Inflamm. Bowel Dis. 10: 666-676 (2004). *
Allgayer H, Dietrich CF. Celiac sprue and malignancies: analysis of risks and prevention strategies. Med. Klin. (Munich) 103: 561-568 (2008).
Allgayer H, Holtmeier W, Dietrich CF. Crohn's disease and cancer risk. Incidence/prevalence, clinical characteristics, and potential prevention strategies. Med. Klin. (Munich) 102: 727-733 (2007).
Allison C, Macfarlane GT. Influence of pH, nutrient availability, and growth rate on amine production by Bacteroides fragilis and Clostridium perfringens. Appl. Environ. Microbiol. 55: 2894-2898 (1989). *
Allison SP, Williams L, Sandhar B, Swaffield G, Newman GH, Bastow MD, Fox JE, Hardcastle JH. Supplementation of nutritional fluid and electrolyte balance by perfusion of an isolated small bowel loop in a patient with Crohn's disease. Clin. Nutr. 2: 107-111 (1983).
Allocca M, Crosignani A, Gritti A, Benetti A, Zuin M, Podda M, Battezzati PM. Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis. Aliment. Pharmacol. Ther. 25: 219-227 (2007). *
Allred CD, Talbert DR, Southard RC, Wang X, Kilgore MW. PPARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. J. Nutr. 138: 250-256 (2008). *
Almallah YZ, Ewen SW, El-Tahir A, Mowat NA, Brunt PW, Sinclair TS, Heys SD, Eremin O. Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ. J. Clin. Immunol. 20: 68-76 (2000). *
Almeida LB, Giudici KV, Jaime PC. Dietary intake and dyslipidemia arising from combination antiretroviral therapy for HIV infection: a systematic review. Arq. Bras. Endocrinol. Metabol. 53: 519-527 (2009).
Almendingen K, Fausa O, Hostmark AT, Bratlie J, Morkerid L, Aabakken L, Vatn MH. Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway. Eur. J. Nutr. 48: 129-136 (2009). *
Almendingen K, Hostmark AT, Fausa O, Mosdol A, Aabakken L, Vatn MH. Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids. Int. J. Cancer 120: 632-637 (2007). *
Almeras L, Eyles D, Benech P, Laffite D, Villard C, Patatian A, Boucraut J, Mackay-Sim A, McGrath J, Feron F. Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics 7: 769-780 (2007). *
Almqvist C, Garden F, Xuan W, Mihrshahi S, Leeder SR, Oddy W, Webb K, Marks GB; for the CAPS team. Omega-3 and omega-6 fatty acid exposure from early life does not affect atopy and asthma at age 5 years. J. Allergy Clin. Immunol. 119: 1438-1444 (2007). *
Alnounou M, Munoz SJ. Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf] Practical Gastroenterology April 2006: 92-100 (2006). *
Aloia JF, Patel M, Dimaano R, Li-Ng M, Talwar SA, Mikhail M, Pollack S, Yeh JK. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am. J. Clin. Nutr. 87: 1952-1958 (2008). *
Alonso N, Granada ML, Salinas I, Reverter JL, Flores L, Ojanguren I, Martinez-Caceres EM, Sanmarti A. Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis. Eur. J. Endocrinol. 157: 763-769 (2007). *
Alonso N, Martinez-Arconada MJ, Granada ML, Soldevila B, Canton A, Mate JL, Sanmarti A, Martinez-Caceres EM. Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis. Endocrine 35: 420-428 (2009).
Alonso N, Soldevila B, Sanmarti A, Pujol-Borrell R, Martinez-Caceres E. Regulatory T cells in diabetes and gastritis. Autoimmun. Rev. 8: 659-662 (2009).
Alperovich M, Neuman MI, Willett WC, Curhan GC. Fatty acid intake and the risk of community-acquired pneumonia in U.S. women. Nutrition 23: 196-202 (2007). *
Alpers DH. Enteral feeding and gut atrophy. Curr. Opin. Clin. Nutr. Metab. Care 5: 679-683 (2002).
Alpers DH. The role of nutritional deficiency in the osteopenia and osteoporosis of gastrointestinal diseases. Curr. Opin. Gastroenterol. 18: 203-208 (2002).
Alpers DH. Liver complications and failure in patients on home parenteral nutrition. Curr. Opin. Gastroenterol. 17: 147-149 (2001).
Alpers DH. Why, how, and to which part of the gastrointestinal tract should forced enteral feedings be delivered in patients?. Curr. Opin. Gastroenterol. 20: 104-109 (2004).
Alpini G, Ueno Y, Glaser SS, Marzioni M, Phinizy JL, Francis H, Lesage G. Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes. Hepatology 34: 868-876 (2001). *
Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm. Res. 24: 1803-1823 (2007). *
Alrefai WA, Saksena S, Tyagi S, Gill RK, Ramaswamy K, Dudeja PK. Taurodeoxycholate modulates apical Cl(-)/OH(-) exchange activity in Caco2 cells. Dig. Dis. Sci. 52: 1270-1278 (2007). *
Alrefai WA, Sarwar Z, Tyagi S, Saksena S, Dudeja PK, Gill RK. Cholesterol modulates human intestinal sodium-dependent bile acid transporter. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G978-G985 (2005). *
Alteheld B, Evans ME, Gu LH, Ganapathy V, Leibach FH, Jones DP, Ziegler TR. Alanylglutamine dipeptide and growth hormone maintain PepT1-mediated transport in oxidatively stressed Caco-2 cells. J. Nutr. 135: 19-26 (2005). *
Altobelli E, Petrocelli R, Maccarone M, Altomare G, Argenziano G, Giannetti A, Peserico A, Vena GA, Tiberti S, Chimenti S, Peris K. Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption. Eur. J. Dermatol. 19: 252-256 (2009).
Altuncu E, Akman I, Kiyan G, Ersu R, Yurdakul Z, Bilgen H, Ozdogan T, Ozek E. Report of three cases: congenital chylothorax and treatment modalities. Turk. J. Pediatr. 49: 418-421 (2007).
Altuntas B, Gul H, Yarali N, Ertan U. Etiology of chronic diarrhea. Indian J. Pediatr. 66: 657-661 (1999).
Altuntas B, Kansu A, Girgin N. Hepatic damage in gluten sensitive enteropathy. Acta Paediatr. Jpn. 40: 597-599 (1998).
Aluru M, Xu Y, Guo R, Wang Z, Li S, White W, Wang K, Rodermel S. Generation of transgenic maize with enhanced provitamin A content. J. Exp. Bot. 59: 3551-3562 (2008). *
Alvarez F. Treatments in chronic cholestasis in children. Ann. Nestle [Engl.] 66: 127-135 (2008).
Alvarez F. Round table: controversies in the treatment of autoimmune liver diseases in children. Cyclosporine indication in �autoimmune hepatitis (AIH)�. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 95-96 (2004). *
Alvarez F. Clinical and diagnostics aspects in children. Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 87-88 (2004). *
Alves Cde A, Aguiar RA, Alves AC, Santana MA. Diabetes mellitus in patients with cystic fibrosis. J. Bras. Pneumol. 33: 213-221 (2007). *
Alves Cde A, Lima DS. Cystic fibrosis-related dyslipidemia. J. Bras. Pneumol. 34: 829-837 (2008).
Alves M, Dias AC, Rocha EM. Dry eye in childhood: epidemiological and clinical aspects. Ocul. Surf. 6: 44-51 (2008).
Alwayn IP, Andersson C, Lee S, Arsenault DA, Bistrian B, Gura KM, Nose V, Zauscher B, Moses MA, Puder M. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G1011-G1019 (2006). *
Alwayn IP, Andersson C, Zauscher B, Gura K, Nose V, Puder M. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation 79: 606-608 (2005).
Alwayn IP, Gura K, Nose V, Zausche B, Javid P, Garza J, Verbesey J, Voss S, Ollero M, Andersson C, Bistrian B, Folkman J, Puder M. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr. Res. 57: 445-452 (2005). *
Alwitry A. Vitamin A deficiency in coeliac disease. Br. J. Ophthalmol. 84: 1079-1080 (2000). *
Alzahrani AS, Sheef MA. Severe primary hyperparathyroidism masked by asymptomatic celiac disease. Endocr. Pract. 14: 347-350 (2008).
Alzoghaibi MA, Walsh SW, Willey A, Fowler Iii AA, Graham MF. Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease. Clin. Nutr. 22: 529-535 (2003). *
Alzoghaibi MA, Walsh SW, Willey A, Yager DR, Fowler AA 3rd, Graham MF. Linoleic acid induces interleukin-8 production by Crohn's human intestinal smooth muscle cells via arachidonic acid metabolites. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G528-G537 (2004). *
Amadi B, Mwiya M, Chomba E, Thomson M, Chintu C, Kelly P, Walker-Smith J. Improved nutritional recovery on an elemental diet in Zambian children with persistent diarrhoea and malnutrition. J. Trop. Pediatr. 51: 5-10 (2005). *
Amar S, Zhou Q, Shaik-Dasthagirisaheb Y, Leeman S. Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc. Natl. Acad. Sci. U.S.A. 104: 20466-20471 (2007). *
Amaral JF, Gomes-Santos AC, Paula-Silva J, Nicoli JR, Vieira LQ, Faria AM, Menezes JS. Antigenic dietary protein guides maturation of the host immune system promoting resistance to Leishmania major infection in C57BL/6 mice. Immunology 129: 455-464 (2010). *
Amasheh M, Andres S, Amasheh S, Fromm M, Schulzke JD. Barrier effects of nutritional factors. Ann. N. Y. Acad. Sci. 1165: 267-273 (2009). *
Ambrosi P, Drici MD, Herpin D, Pathak A. The best of clinical pharmacology in 2006. Arch. Mal. Coeur. Vaiss. 100 Spec. No. 1: 99-102 (2007).
Amedee-Manesme O, Furr HC, Alvarez F, Hadchouel M, Alagille D, Olson JA. Biochemical indicators of vitamin A depletion in children with cholestasis. Hepatology 5: 1143-1148 (1985).
Amedee-Manesme O, Mourey MS, Therasse J, Couturier M, Alvarez F, Hanck A, Bernard O. Short- and long-term vitamin A treatment in children with cholestasis. Am. J. Clin. Nutr. 47: 690-693 (1988). *
Ameho CK, Adjei AA, Harrison EK, Takeshita K, Morioka T, Arakaki Y, Ito E, Suzuki I, Kulkarni AD, Kawajiri A, Yamamoto S. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 41: 487-493 (1997). *
Amemiya T. The eye and nutrition Jpn. J. Ophthalmol. 44: 320 (2000).
Amengual J, Ribot J, Bonet ML, Palou A. Retinoic acid treatment increases lipid oxidation capacity in skeletal muscle of mice. Obesity (Silver Spring) 16: 585-591 (2008). *
American Academy of Pediatrics Subcommittee on Chronic Abdominal Pain; North American Society for Pediatric Gastroenterology Hepatology, and Nutrition. Chronic abdominal pain in children. Pediatrics 115: e370-e381 (2005). *
Amerine E. Celiac disease goes against the grain. Nursing 36: 46-48 (2006).
Amesty-Valbuena A, Diez-Ewald M, de Villarroel M, Montiel N, Granados A, D�az S, Salas D, Rivero M. Immunologic characteristics of undernutrition. I. The undernourished patient in nutritional recovery. Invest. Clin. 37: 95-111 (1996).
Amigo L, Castro J, Miquel JF, Zanlungo S, Young SG, Nervi F. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones. Gastroenterology 131: 1870-1878 (2006). *
Amin AA, Menon RA, Reid KJ, Harris WS, Spertus JA. Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels. Psychosom. Med. 70: 856-862 (2008).
Amin MR, Malakooti J, Sandoval R, Dudeja PK, Ramaswamy K. IFN-gamma and TNF-alpha regulate the human NHE3 gene expression by modulating the Sp family transcription factors in human intestinal epithelial cell line, C2BBe1. Am. J. Physiol. Cell Physiol. 291: C887-C896 (2006). *
Amin R, Ratjen F. Cystic fibrosis: a review of pulmonary and nutritional therapies. Adv. Pediatr. 55: 99-121 (2008).
Amin RH, Mathews ST, Camp HS, Ding L, Leff T. Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance. Am. J. Physiol. Endocrinol. Metab. Oct 20 [Epub ahead of print] (2009). *
Amini R, Nosrati N, Yazdanparast R, Molaei M. Teucrium polium in prevention of steatohepatitis in rats. Liver Int. 29: 1216-1221 (2009). *
Amiot A, Joly F, Alves A, Panis Y, Bouhnik Y, Messing B. Long-term outcome of chronic intestinal pseudo-obstruction adult patients requiring home parenteral nutrition. Am. J. Gastroenterol. 104: 1262-1270 (2009). *
Amiot A, Tchikviladze M, Joly F, Slama A, Hatem DC, Jardel C, Messing B, Lombes A. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. Gastroenterology 137: 101-109 (2009). *
Amit-Romach E, Uni Z, Cheled S, Berkovich Z, Reifen R. Bacterial population and innate immunity-related genes in rat gastrointestinal tract are altered by vitamin A-deficient diet. J. Nutr. Biochem. 20: 70-77 (2009). *
Amit-Romach E, Uni Z, Reifen R. Multistep mechanism of probiotic bacterium, the effect on innate immune system. Mol. Nutr. Food Res. Dec 8 [Epub ahead of print] (2009). *
Amore A, Coppo R, Roccatello D, Piccoli G, Mazzucco G, Gomez-Chiarri M, Lamm ME, Emancipator SN. Experimental IgA nephropathy secondary to hepatocellular injury induced by dietary deficiencies and heavy alcohol intake. Lab. Invest. 70: 68-77 (1994).
Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, Israel D, Mack D, Ghadirian P, Deslandres C, Chotard V, Budai B, Law L, Levy E, Seidman EG. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am. J. Gastroenterol. 102: 2016-2025 (2007). *
Amre DK, Lu SE, Costea F, Seidman EG. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am. J. Gastroenterol. 101: 645-652 (2006). *
Amre DK, Mack DR, Morgan K, Israel D, Lambrette P, Costea I, Krupoves A, Fegury H, Dong J, Grimard G, Deslandres C, Levy E, Seidman EG. Interleukin 10 (IL-10) gene variants and susceptibility for pediatric onset Crohn's disease. Aliment. Pharmacol. Ther. 29: 1025-1031 (2009). *
Amre DK, Mack DR, Morgan K, Krupoves A, Costea I, Lambrette P, Grimard G, Dong J, Feguery H, Bucionis V, Deslandres C, Levy E, Seidman EG. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm. Bowel Dis. 15: 501-507 (2009). *
Amrouche Ch, Jamoussi Kamoun H, Trabelsi N, Blouza Chabchoub S. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers. Tunis. Med. 86: 316-318 (2008).
An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, Shulman GI, Koves TR, Stevens R, Millington D, Newgard CB. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 10: 268-274 (2004). *
An WS, Kim HJ, Cho KH, Vaziri ND. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation and tubulo-interstitial fibrosis in the remnant kidney. Am. J. Physiol. Renal Physiol. 297: F895-F903 (2009). *
An WS, Kim SE, Kim KH, Lee S, Park Y, Kim HJ, Vaziri ND. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients. J. Ren. Nutr. 19: 267-274 (2009). *
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol. Pharm. 4: 807-818 (2007). *
Anandan R, Mathew S, Sankar TV, Viswanathan Nair PG. Protective effect of n-3 polyunsaturated fatty acids concentrate on isoproterenol-induced myocardial infarction in rats. Prostaglandins Leukot. Essent. Fatty Acids 76: 153-158 (2007). *
Anandasabapathy S. Endoscopic imaging: emerging optical techniques for the detection of colorectal neoplasia. Curr. Opin. Gastroenterol. 24: 64-69 (2008). *
Anant S, Houchen CW. HuR and TTP: two RNA binding proteins that deliver message from the 3' end. Gastroenterology 136: 1495-1498 (2009). *
Ananthakrishnan AN, Issa M, Barboi A, Jaradeh S, Zadvornova Y, Skaros S, Johnson K, Otterson MF, Binion DG. Impact of autonomic dysfunction on inflammatory bowel disease. J. Clin. Gastroenterol. Sep 1 [Epub ahead of print] (2009).
Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Simple score to identify colectomy risk in ulcerative colitis hospitalizations. Inflamm. Bowel Dis. Jan 20 [Epub ahead of print] (2010). *
Anantharaju A, Baluch M, Van Thiel DH. Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren's syndrome. Dig. Dis. Sci. 48: 830-833 (2003). *
Anca I, Stanescu-Popp A, Arama V, Duta D, Alexe G, Colcer F. Celiac disease: diagnostic criteria and impact of gluten free diet - patients' perspective. Rev. Med. Chir. Soc. Med. Nat. Iasi. 113: 351-355 (2008).
Ander BP, Hurtado C, Raposo CS, Maddaford TG, Deniset JF, Hryshko LV, Pierce GN, Lukas A. Differential sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na(+)-Ca(2+) exchanger to alpha-linolenic acid. Cardiovasc. Res. 73: 395-403 (2007). *
Andersen G, Harnack K, Erbersdobler HF, Somoza V. Dietary eicosapentaenoic acid and docosahexaenoic acid are more effective than alpha-linolenic acid in improving insulin sensitivity in rats. Ann. Nutr. Metab. 52: 250-256 (2008).
Andersen J, Kehlet H. Fast track open ileo-colic resections for Crohn's disease. Colorectal Dis. 7: 394-397 (2005). *
Andersen KB, Nilsson A, Blomhoff HK, Oyen TB, Gabrielsen OS, Norum KR, Blomhoff R. Direct mobilization of retinol from hepatic perisinusoidal stellate cells to plasma. J. Biol. Chem. 267: 1340-1344 (1992). *
Andersen V, Agerstjerne L, Jensen D, Ostergaard M, Saebo M, Hamfjord J, Kure E, Vogel U. The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study. BMC Med. Genet. 10: 18 (2009). *
Andersen V, Ostergaard M, Christensen J, Overvad K, Tjonneland A, Vogel U. Polymorphisms in the xenobiotic transporter multidrug resistance 1 (MDR1) gene and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer 9: 407 (2009). *
Anderson AL, Harris TB, Houston DK, Tylavsky FA, Lee JS, Sellmeyer DE, Sahyoun NR. Relationships of dietary patterns with body composition in older adults differ by gender and PPAR-gamma Pro12Ala genotype. Eur. J. Nutr. Feb 21 [Epub ahead of print] (2010).
Anderson BM, Ma DW. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis. 8: 33 (2009). *
Anderson CM, Howard A, Walters JR, Ganapathy V, Thwaites DT. Taurine uptake across the human intestinal brush-border membrane is via two transporters: H+-coupled PAT1 (SLC36A1) and Na+ and Cl- dependent TauT (SLC6A6). J. Physiol. 587: 731-744 (2009). *
Anderson CM, Thwaites DT. Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3). Biochim. Biophys. Acta 1768: 1822-1829 (2007). *
Anderson JJ, Suchindran CM, Roggenkamp KJ. Micronutrient intakes in two US populations of older adults: lipid research clinics program prevalence study findings. J. Nutr. Health Aging 13: 595-600 (2009).
Anderson MJ, Fritsche KL. Dietary polyunsaturated fatty acids modulate in vivo, antigen-driven CD4+ T-cell proliferation in mice. J. Nutr. 134: 1978-1983 (2004). *
Anderson RP. Coeliac disease: current approach and future prospects. Intern. Med. J. 38: 790-799 (2008). *
Anderson RP. Coeliac disease. Aust. Fam. Physician 34: 239-242 (2005). *
Anderson RP, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat. Med. 6: 337-342 (2000). *
Anderson SG, Sanders TA, Cruickshank JK. Plasma fatty acid composition as a predictor of arterial stiffness and mortality. Hypertension 53: 839-845 (2009).
Anderson SW, Stapp JR, Burns JL, Qin X. Characterization of small colony variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis. J. Clin. Microbiol. 45: 529-535 (2007). *
Anderson VP, Jack S, Monchy D, Hem N, Hok P, Bailey KB, Gibson RS. Co-existing micronutrient deficiencies among stunted Cambodian infants and toddlers. Asia Pac. J. Clin. Nutr. 17: 72-79 (2008).
Andersson D, Kotarsky K, Wu J, Agace W, Duan RD. Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model. Dig. Dis. Sci. 54: 1440-1448 (2009). *
Andersson S, Gustafsson N, Warner M, Gustafsson JA. Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice. Proc. Natl. Acad. Sci. U.S.A. 102: 3857-3862 (2005). *
Andoh A, Bamba S, Brittan M, Fujiyama Y, Wright NA. Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol. Ther. 114: 94-106 (2007). *
Andoh A, Hirashima M, Maeda H, Hata K, Inatomi O, Tsujikawa T, Sasaki M, Takahashi K, Fujiyama Y. Serum selenoprotein-P levels in patients with inflammatory bowel disease. Nutrition 21: 574-579 (2005). *
Andoh A, Tsujikawa T, Fujiyama Y. Role of dietary fiber and short-chain fatty acids in the colon. Curr. Pharm. Des. 9: 347-358 (2003).
Andoh A, Tsujikawa T, Ishizuka I, Araki Y, Sasaki M, Koyama S, Fujiyama Y. n-3 Fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. Int. J. Mol. Med. 12: 721-725 (2003). *
Andoh A, Tsujikawa T, Sasaki M, Mitsuyama K, Suzuki Y, Matsui T, Matsumoto T, Benno Y, Fujiyama Y. Fecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis. Aliment. Pharmacol. Ther. 29: 75-82 (2009). *
Andoh A, Yagi Y, Shioya M, Nishida A, Tsujikawa T, Fujiyama Y. Mucosal cytokine network in inflammatory bowel disease. World J. Gastroenterol. 14: 5154-5161 (2008). *
Andou A, Hisamatsu T, Okamoto S, Chinen H, Kamada N, Kobayashi T, Hashimoto M, Okutsu T, Shimbo K, Takeda T, Matsumoto H, Sato A, Ohtsu H, Suzuki M, Hibi T. Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Gastroenterology 136: 564-574.e2 (2009). *
Andreasen CH, Andersen G. Gene-environment interactions and obesity - further aspects of genomewide association studies. Nutrition 25: 998-1003 (2009).
Andren-Sandberg A, Hardt PD. Second Second Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases. Castle of Rauischholzhausen of the Justus-Liebig-University, Giessen (Rauischholzhausen), Germany. March 7-8, 2008. JOP 9: 541-575 (2008). *
Andrews DB, Schwimmer JB, Lavine JE. Fast break on the fat brake: mechanism of peroxisome proliferator-activated receptor-delta regulation of lipid accumulation in hepatocytes. Hepatology 48: 355-357 (2008). *
Andus T, Gross V. Etiology and pathophysiology of inflammatory bowel disease - environmental factors. Hepatogastroenterology 47: 29-43 (2000).
Anes E, Jordao L. Trick-or-treat: dietary lipids and host resistance to infectious disease. Mini Rev. Med. Chem. 8: 1452-1458 (2008).
Ange-van Heugten KD, Burns R, Verstegen MW, Jansen WL, Ferket PR, van Heugten E. Evaluation of diabetes determinants in woolly monkeys (Lagothrix lagotricha). J. Anim. Physiol. Anim. Nutr. (Berl.) 91: 481-491 (2007). *
Angel B, Santos JL, Carrasco E, Albala C, Perez-Bravo F. Vitamin D receptor polymorphism and susceptibility to type 1 diabetes in Chilean subjects: a case-parent study. Eur. J. Epidemiol. 19: 1085-1087 (2004). *
Angela Liou Y, Innis SM. Dietary linoleic acid has no effect on arachidonic acid, but increases n-6 eicosadienoic acid, and lowers dihomo-gamma-linolenic and eicosapentaenoic acid in plasma of adult men. Prostaglandins Leukot. Essent. Fatty Acids 80: 201-206 (2009). *
Angele MK, Loehe F, Faist E. Immunomodulation during sepsis in organ transplanted children. Minerva Pediatr. 57: 259-268 (2005).
Angeli P, Albino G, Carraro P, Dalla Pria M, Merkel C, Caregaro L, De Bei E, Bortoluzzi A, Plebani M, Gatta A. Cirrhosis and muscle cramps: evidence of a causal relationship. Hepatology 23: 264-273 (1996). *
Angelo G, Lamon-Fava S, Sonna LA, Lindauer ML, Wood RJ. Heat shock protein 90beta: a novel mediator of vitamin D action. Biochem. Biophys. Res. Commun. 367: 578-583 (2008). *
Angulo P. Use of ursodeoxycholic acid in patients with liver disease. Curr. Gastroenterol. Rep. 4: 37-44 (2002).
Anheim M, Degos B, Echaniz-Laguna A, Fleury M, Grucker M, Tranchant C. Ataxia associated with gluten sensitivity, myth or reality? Rev. Neurol. (Paris) 162: 214-221 (2006).
Annaba F, Sarwar Z, Kumar P, Saksena S, Turner JR, Dudeja PK, Gill RK, Alrefai WA. Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G489-G497 (2008). *
Annahazi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztoczy A, Roka R, Molnar T, Theodorou V, Wittmann T, Bueno L, Eutamene H. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain 144: 209-217 (2009).
Anokhina SV. Effect of diet enriched with essential nutrients and S-adenosylmethionine on the structural and functional state of erythrocytes in patients with metabolic syndrome. Lik. Sprava. 2006: 16-23 (2006).
Ansaldo GL, Varaldo E, Assalino M, Borgonovo G. Artificial nutrition in inflammatory bowel disease. Ann. Ital. Chir. 75: 629-634 (2004).
Ansari A, Aslam Z, DE Sica A, Smith M, Gilshenan K, Fairbanks L, Marinaki A, Sanderson J, Duley J. The influence of xanthine oxidase on thiopurine metabolism in Crohn's disease. Aliment. Pharmacol. Ther. 28: 749-757 (2008). *
Ansenberger K, Richards C, Zhuge Y, Barua A, Bahr JM, Luborsky JL, Hales DB. Decreased severity of ovarian cancer and increased survival in hens fed a flaxseed-enriched diet for 1 year. Gynecol. Oncol. Feb 12 [Epub ahead of print] (2010).
Antebi H, Mansoor O, Ferrier C, Tetegan M, Morvan C, Rangaraj J, Alcindor LG. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. JPEN J. Parenter. Enteral Nutr. 28: 142-148 (2004). *
Anthoni H, Zucchelli M, Matsson H, Muller-Myhsok B, Fransson I, Schumacher J, Massinen S, Onkamo P, Warnke A, Griesemann H, Hoffmann P, Nopola-Hemmi J, Lyytinen H, Schulte-Korne G, Kere J, Nothen MM, Peyrard-Janvid M. A locus on 2p12 containing the co-regulated MRPL19 and C2ORF3 genes is associated to dyslexia. Hum. Mol. Genet. 16: 667-677 (2007). *
Anthonisen EH, Berven L, Holm S, Nygard M, Nebb HI, Gronning-Wang LM. The nuclear receptor LXR is O-GlcNAc modified in response to glucose. J. Biol. Chem. Nov 20 [Epub ahead of print] (2009). *
Anton AA, Artfield SD. Hydrocolloids in gluten-free breads: a review. Int. J. Food Sci. Nutr. 59: 11-23 (2008).
Anton DT, Moraru D, Cirdei E, Bozomitu L. Malnutrition and complex nutritional therapy in cystic fibrosis. Rev. Med. Chir. Soc. Med. Nat. Iasi. 110: 801-806 (2006).
Antonson P, Jakobsson T, Almlof T, Guldevall K, Steffensen KR, Gustafsson JA. RAP250 is a coactivator in the transforming growth factor beta signaling pathway that interacts with SMAD2 and SMAD3. J. Biol. Chem. 283: 8995-9001 (2008). *
Antoun S, Merad M, Raynard B, Ruffie P. Malnutrition in cancer patients. Rev. Prat. 56: 2025-2029 (2006).
Antunes DM, da Costa JP, Campos SM, Paschoal PO, Garrido V, Siqueira M, Teixeira GA, Cardoso GP. The serum D-xylose test as a useful tool to identify malabsorption in rats with antigen specific gut inflammatory reaction. Int. J. Exp. Pathol. 90: 141-147 (2009).
Antunes H, Abreu I, Nogueiras A, Sa C, Goncalves C, Cleto P, Garcia F, Alves A, Lemos D. First prevalence of celiac disease in a Portuguese population. Acta Med. Port. 19: 115-120 (2006).
Anzano MA, Lamb AJ, Olson JA. Impaired salivary gland secretory function following the induction of rapid, synchronous vitamin A deficiency in rats. J. Nutr. 111: 496-504 (1981). *
Aoun E, Muddana V, Papachristou GI, Whitcomb DC. SPINK1 N34S is strongly associated with recurrent acute pancreatitis but is not a risk factor for the first or sentinel acute pancreatitis event. Am. J. Gastroenterol. Nov 3 [Epub ahead of print] (2009). *
Aoun E, Slivka A, Papachristou DJ, Gleeson FC, Whitcomb DC, Papachristou GI. Rapid evolution from the first episode of acute pancreatitis to chronic pancreatitis in human subjects. JOP 8: 573-578 (2007). *
Aparicio Vizuete A, Robles F, Rodriguez-Rodriguez E, Lopez-Sobaler AM, Ortega RM. Association between food and nutrient intakes and cognitive capacity in a group of institutionalized elderly people. Eur. J. Nutr. Dec 14 [Epub ahead of print] (2009). *
Apel W, Bock R. Enhancement of carotenoid biosynthesis in transplastomic tomatoes by induced lycopene-to-provitamin A conversion. Plant Physiol. 151: 59-66 (2009). *
Apovian CM, Murphy MC, Cullum-Dugan D, Lin PH, Gilbert KM, Coffman G, Jenkins M, Bakun P, Tucker KL, Moore TJ. Validation of a web-based dietary questionnaire designed for the DASH (Dietary Approaches to Stop Hypertension) diet: the DASH Online Questionnaire. Public Health Nutr. Nov 16 [Epub ahead of print] (2009).
Appel LJ. Dietary approaches to reduce blood pressure. J. Anim. Physiol. Anim. Nutr. (Berl.) 89: 433 (2005). *
Aprahamian CJ, Chen M, Yang Y, Lorenz RG, Harmon CM. Two-hit rat model of short bowel syndrome and sepsis: independent of total parenteral nutrition, short bowel syndrome is proinflammatory and injurious to the liver. J. Pediatr. Surg. 42: 992-997 (2007).
Aprahamian T, Bonegio R, Rizzo J, Perlman H, Lefer DJ, Rifkin IR, Walsh K. Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. J. Immunol. 177: 3028-3034 (2006). *
Apte MV, Pirola RC, Wilson JS. Individual susceptibility to alcoholic pancreatitis. J. Gastroenterol. Hepatol. 23 Suppl. 1: S63-S68 (2008). *
Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK. Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol. Appl. Pharmacol. 207: 25-38 (2005). *
Arabi A, Mahfoud Z, Zahed L, El-Onsi L, El-Hajj Fuleihan G. Effect of age, gender and calciotropic hormones on the relationship between vitamin D receptor gene polymorphisms and bone mineral density. Eur. J. Clin. Nutr. Feb 10 [Epub ahead of print] (2010). *
Arachchige PG, Takahashi Y, Ide T. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats. Metabolism 55: 381-390 (2006). *
Arai T, Kim HJ, Chiba H, Matsumoto A. Interaction of fenofibrate and fish oil in relation to lipid metabolism in mice. J. Atheroscler. Thromb. 16: 283-291 (2009). *
Arai T, Kim HJ, Chiba H, Matsumoto A. Anti-obesity effect of fish oil and fish oil-fenofibrate combination in female KK mice. J. Atheroscler. Thromb. 16: 674-683 (2009).
Arai Y, Kitamura Y, Hayashi M, Oshida K, Shimizu T, Yamashiro Y. Effect of dietary Lorenzo's oil and docosahexaenoic acid treatment for Zellweger syndrome. Congenit. Anom. (Kyoto) 48: 180-182 (2008).
Arakawa Y, Moriyama M, Arakawa Y. Liver cirrhosis and metabolism (sugar, protein, fat and trace elements). Hepatol. Res. 30S: 46-58 (2004).
Araki Y, Andoh A, Takizawa J, Takizawa W, Fujiyama Y. Clostridium butyricum, a probiotic derivative, suppresses dextran sulfate sodium-induced experimental colitis in rats. Int. J. Mol. Med. 13: 577-580 (2004).
Araki Y, Fujiyama Y, Andoh A, Koyama S, Kanauchi O, Bamba T. The dietary combination of germinated barley foodstuff plus Clostridium butyricum suppresses the dextran sulfate sodium-induced experimental colitis in rats. Scand. J. Gastroenterol. 35: 1060-1067 (2000). *
Araki Y, Kanauchi O, Sugihara H, Fujiyama Y, Hattori T. Germinated barley foodstuff suppresses dextran sulfate experimental colitis in rats: the role of mast cells. Int. J. Mol. Med. 19: 257-262 (2007). *
Araki Y, Sugihara H, Hattori T. The free radical scavengers edaravone and tempol suppress experimental dextran sulfate sodium-induced colitis in mice. Int. J. Mol. Med. 17: 331-334 (2006). *
Araujo EP, De Souza CT, Ueno M, Cintra DE, Bertolo MB, Carvalheira JB, Saad MJ, Velloso LA. Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes. Endocrinology 148: 5991-5997 (2007). *
Araujo FG, Novaes FC, Santos NP, Martins VC, Souza SM, Santos SE, Ribeiro-Dos-Santos AK. Prevalence of deltaF508, G551D, G542X, and R553X mutations among cystic fibrosis patients in the North of Brazil. Braz. J. Med. Biol. Res. 38: 11-15 (2005). *
Araujo ML, Burgos MG, Moura IS. Nutritional influences in psoriasis. An. Bras. Dermatol. 84: 90-92 (2009).
Araujo SE, Nahas SC, Seid VE, Marchini GS, Torricelli FC. Laparoscopy-assisted ileal pouch-anal anastomosis: surgical outcomes after 10 cases. Surg. Laparosc. Endosc. Percutan. Tech. 15: 321-324 (2005).
Araya J, Rodrigo R, Pettinelli P, Araya AV, Poniachik J, Videla LA. Decreased liver fatty acid Delta-6 and Delta-5 desaturase activity in obese patients. Obesity (Silver Spring) Oct 29 [Epub ahead of print] (2009). *
Archer A, Lauter G, Hauptmann G, Mode A, Gustafsson JA. Transcriptional activity and developmental expression of liver X receptor (lxr) in zebrafish. Dev. Dyn. 237: 1090-1098 (2008). *
Arendash GW, Jensen MT, Salem Jr N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience 149: 286-302 (2007). *
Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G, van Bokhorst-de van der Schueren MA, von Meyenfeldt M. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin. Nutr. 25: 245-259 (2006).
Arendt BM, Mohammed SS, Aghdassi E, Prayitno NR, Ma DW, Nguyen A, Guindi M, Sherman M, Heathcote EJ, Allard JP. Hepatic fatty acid composition differs between chronic hepatitis C patients with and without steatosis. J. Nutr. 139: 691-695 (2009). *
Arentz-Hansen H, Fleckenstein B, Molberg O, Scott H, Koning F, Jung G, Roepstorff P, Lundin KE, Sollid LM. The molecular basis for oat intolerance in patients with celiac disease. Plos. Med. 1: e1 (2004). *
Argao EA, Heubi JE. Fat-soluble vitamin deficiency in infants and children. Curr. Opin. Pediatr. 5: 562-566 (1993).
Argyropoulos G, Harper ME. Uncoupling proteins and thermoregulation. J. Appl. Physiol. 92: 2187-2198 (2002). *
Arias Llorente RP, Bousono Garcia C, Diaz Martin JJ. Treatment compliance in children and adults with cystic fibrosis. J. Cyst. Fibros. 7: 359-367 (2008).
Arikan C, Berdeli A, Kilic M, Tumgor G, Yagci RV, Aydogdu S. Polymorphisms of the ICAM-1 gene are associated with biliary atresia. Dig. Dis. Sci. 53: 2000-2004 (2008). *
Arikan C, Berdeli A, Ozgenc F, Tumgor G, Yagci RV, Aydogdu S. Positive association of macrophage migration inhibitory factor gene-173G/C polymorphism with biliary atresia. J. Pediatr. Gastroenterol. Nutr. 42: 77-82 (2006). *
Arikan C, Zihni C, Cakir M, Alkanat M, Aydogdu S. Morphometric analysis of small-bowel mucosa in Turkish children with celiac disease and relationship with the clinical presentation and laboratory findings. Dig. Dis. Sci. 52: 2133-2139 (2007). *
Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11: 191-198 (2005). *
Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, Spur BW, Lee TH. Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 43: 84-92 (1988). *
Armstrong MJ, Robins GG, Howdle PD. Recent advances in coeliac disease. Curr. Opin. Gastroenterol. 25: 100-109 (2009).
Arnardottir HH, Petursdottir DH, Hardardottir I. The effects of dietary fish oil on chemokine secretion by murine peritoneal and spleen cells. Proc. Nutr. Soc. 67 (OCE): E7 (2008). *
Arndt S, Maegdefrau U, Dorn C, Schardt K, Hellerbrand C, Bosserhoff AK. Iron-induced expression of BMP6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo. Gastroenterology 138: 372-382 (2010). *
Arnlov J, Zethelius B, Riserus U, Basu S, Berne C, Vessby B, Alfthan G, Helmersson J. Serum and dietary beta-carotene and alpha-tocopherol and incidence of type 2 diabetes mellitus in a community-based study of Swedish men: report from the Uppsala Longitudinal Study of Adult Men (ULSAM) study. Diabetologia 52: 97-105 (2009). *
Arnon R, Yoshimura T, Reiss A, Budai K, Lefkowitch JH, Javitt NB. Cholesterol 7-hydroxylase knockout mouse: a model for monohydroxy bile acid-related neonatal cholestasis. Gastroenterology 115: 1223-1228 (1998). *
Aronis A, Aharoni-Simon M, Madar Z, Tirosh O. Triacylglycerol-induced impairment in mitochondrial biogenesis and function in J774.2 and mouse peritoneal macrophage foam cells. Arch. Biochem. Biophys. 492: 74-81 (2009). *
Arora M, Ettinger AS, Peterson KE, Schwartz J, Hu H, Hernandez-Avila M, Tellez-Rojo MM, Wright RO. Maternal dietary intake of polyunsaturated fatty acids modifies the relationship between lead levels in bone and breast milk. J. Nutr. 138: 73-79 (2008). *
Arpiainen S, Jarvenpaa SM, Manninen A, Viitala P, Lang MA, Pelkonen O, Hakkola J. Coactivator PGC-1alpha regulates the fasting inducible xenobiotic-metabolizing enzyme CYP2A5 in mouse primary hepatocytes. Toxicol. Appl. Pharmacol. 232: 135-141 (2008). *
Arraiz N, Bermudez V, Rondon N, Reyes F, Borjas L, Sol�s E, Mujica E, Prieto C, Reyna N, Velasco M. Novel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a Venezuelan population. Am. J. Ther. Dec 16 [Epub ahead of print] (2009).
Arrese M, Miquel JF, Ananthanarayanan M. BetaKlotho: a new kid on the bile acid biosynthesis block. Hepatology 43: 191-193 (2006). *
Arrington JL, Chapkin RS, Switzer KC, Morris JS, McMurray DN. Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation. Clin. Exp. Immunol. 125: 499-507 (2001). *
Arrington JL, McMurray DN, Switzer KC, Fan YY, Chapkin RS. Docosahexaenoic acid suppresses function of the CD28 costimulatory membrane receptor in primary murine and Jurkat T cells. J. Nutr. 131: 1147-1153 (2001). *
Arruda SF, Siqueira EM, de Valencia FF. Vitamin A deficiency increases hepcidin expression and oxidative stress in rat. Nutrition 25: 472-478 (2009). *
Arsenault LN, Matthan N, Scott TM, Dallal G, Lichtenstein AH, Folstein MF, Rosenberg I, Tucker KL. Validity of estimated dietary eicosapentaenoic acid and docosahexaenoic acid intakes determined by interviewer-administered food frequency questionnaire among older adults with mild-to-moderate cognitive impairment or dementia. Am. J. Epidemiol. 170: 95-103 (2009). *
Arsenescu R, Bruno ME, Rogier EW, Stefka AT, McMahan AE, Wright TB, Nasser MS, de Villiers WJ, Kaetzel CS. Signature biomarkers in Crohn's disease: toward a molecular classification. Mucosal Immunol. 1: 399-411 (2008).
Arslan N, Buyukgebiz B, Ozturk Y, Ozer E. The prevalence of liver function abnormalities in pediatric celiac disease patients and its relation with intestinal biopsy findings. Acta Gastroenterol. Belg. 68: 424-427 (2005).
Arslanoglu S, Moro GE, Tauschel HD, Boehm G. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition. J. Pediatr. Gastroenterol. Nutr. 46: 228-231 (2008). *
Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 83: 1467S-1476S (2006). *
Arterburn LM, Oken HA, Bailey Hall E, Hamersley J, Kuratko CN, Hoffman JP. Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid. J. Am. Diet. Assoc. 108: 1204-1209 (2008).
Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C, Nellemann C, Hansen SH, Hansen HS. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim. Biophys. Acta 1781: 200-212 (2008). *
Artz E, Warren-Ulanch J, Becker D, Greenspan S, Freemark M. Seropositivity to celiac antigens in asymptomatic children with type 1 diabetes mellitus: association with weight, height, and bone mineralization. Pediatr. Diabetes 9: 277-284 (2008).
Arundel C, Lewis JH. Drug-induced liver disease in 2006. Curr. Opin. Gastroenterol. 23: 244-254 (2007).
Arvay JL, Zemel BS, Gallagher PR, Rovner AJ, Mulberg AE, Stallings VA, Haber BA. Body composition of children aged 1 to 12 years with biliary atresia or Alagille syndrome. J. Pediatr. Gastroenterol. Nutr. 40: 146-150 (2005). *
Arzuaga X, Reiterer G, Majkova Z, Kilgore MW, Toborek M, Hennig B. PPARalpha ligands reduce PCB-induced endothelial activation: possible interactions in inflammation and atherosclerosis. Cardiovasc. Toxicol. 7: 264-272 (2007). *
Arzuaga X, Ren N, Stromberg A, Black EP, Arsenescu V, Cassis LA, Majkova Z, Toborek M, Hennig B. Induction of gene pattern changes associated with dysfunctional lipid metabolism induced by dietary fat and exposure to a persistent organic pollutant. Toxicol. Lett. 189: 96-101 (2009). *
Asakura H, Suzuki K, Kitahora T, Morizane T. Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis? J. Gastroenterol. Hepatol. 23: 1794-1801 (2008). *
Asanuma T, Ono M, Kubota K, Hirose A, Hayashi Y, Saibara T, Inanami O, Ogawa Y, Enzan H, Onishi S, Kuwabara M, Oben JA. Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease. Gut 59: 258-266 (2010).
Ascherio A, Munger K. Epidemiology of multiple sclerosis: from risk factors to prevention. Semin. Neurol. 28: 17-28 (2008).
Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann. Neurol. 61: 504-513 (2007).
Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 61: 288-299 (2007).
Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ, Hankinson SE, Hunter DJ. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286: 3083-3088 (2001). *
Ashar BH, Rice TN, Sisson SD. Medical residents' knowledge of dietary supplements. South. Med. J. 101: 996-1000 (2008).
Asheim P, Uggen PE, Aasarod K, Aadahl P. Intraperitoneal fluid therapy: an alternative to intravenous treatment in a patient with limited vascular access. Anaesthesia 61: 502-504 (2006). *
Ashida H, Nishiumi S, Fukuda I. An update on the dietary ligands of the AhR. Expert Opin. Drug Metab. Toxicol. 4: 1429-1447 (2008).
Ashorn S, Valineva T, Kaukinen K, Ashorn M, Braun J, Raukola H, Rantala I, Collin P, Maki M, Luukkaala T, Iltanen S. Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J. Clin. Immunol. 29: 190-195 (2009). *
Ashwood P, Anthony A, Pellicer AA, Torrente F, Walker-Smith JA, Wakefield AJ. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J. Clin. Immunol. 23: 504-517 (2003). *
Ashwood P, Anthony A, Torrente F, Wakefield AJ. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J. Clin. Immunol. 24: 664-673 (2004). *
Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am. J. Gastroenterol. 87: 432-437 (1992).
Aspirot A, Su W, Flageole H, Puligandla PS, Shaw K, Laberge JM. Cholestasis associated with small bowel atresia: do we always need to investigate? J. Pediatr. Surg. 42: 873-877 (2007).
Asserhoj M, Nehammer S, Matthiessen J, Michaelsen KF, Lauritzen L. Maternal fish oil supplementation during lactation may adversely affect long-term blood pressure, energy intake, and physical activity of 7-year-old boys. J. Nutr. 139: 298-304 (2009). *
Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol. Psychiatry 49: 510-522 (2001). *
Assiri AM, El Mouzan MI, Al Sanie A, Al Jurayyan N, Al Herbish AS, Bakr AA. Pattern of celiac disease in infants and children. Trop. Gastroenterol. 29: 217-220 (2008).
Assisi RF. Combined butyric acid/mesalazine treatment in ulcerative colitis with mild-moderate activity. Results of a multicentre pilot study. Minerva Gastroenterol. Dietol. 54: 231-238 (2008).
Asson-Batres MA, Smith WB, Clark G. Retinoic acid is present in the postnatal rat olfactory organ and persists in vitamin A-depleted neural tissue. J. Nutr. 139: 1067-1072 (2009). *
Astegiano M, Bresso F, Demarchi B, Sapone N, Pellicano R, Palmas F, Rizzetto M. Organisation of work teams at the gastroentero-hepatology outpatients clinic. The management of inflammatory bowel diseases. Minerva Gastroenterol. Dietol. 48: 1-5 (2002).
Astegiano M, Cammarota T, Bresso F, Sapone N, Demarchi B, Bertolusso L, Sarno A, Bruno M, Pellicano R, Rizzetto M. Abdominal pain and bowel dysfunction: diagnostic flow-chart could be semplified? Minerva Gastroenterol. Dietol. 47: 53-60 (2001).
Astorg P, Bertrais S, Alessandri JM, Guesnet P, Kesse-Guyot E, Linard A, Lallemand MS, Galan P, Hercberg S. Long-chain n-3 fatty acid levels in baseline serum phospholipids do not predict later occurrence of depressive episodes: a nested case-control study within a cohort of middle-aged French men and women. Prostaglandins Leukot. Essent. Fatty Acids 81: 265-271 (2009). *
Astorg P, Bertrais S, Laporte F, Arnault N, Estaquio C, Galan P, Favier A, Hercberg S. Plasma n-6 and n-3 polyunsaturated fatty acids as biomarkers of their dietary intakes: a cross-sectional study within a cohort of middle-aged French men and women. Eur. J. Clin. Nutr. 62: 1155-1161 (2008). *
Astorg P, Couthouis A, Bertrais S, Arnault N, Meneton P, Guesnet P, Alessandri JM, Galan P, Hercberg S. Association of fish and long-chain n-3 polyunsaturated fatty acid intakes with the occurrence of depressive episodes in middle-aged French men and women. Prostaglandins Leukot. Essent. Fatty Acids 78: 171-182 (2008). *
Astorg P, Gradelet S, Leclerc J, Siess MH. Effects of provitamin A or non-provitamin A carotenoids on liver xenobiotic-metabolizing enzymes in mice. Nutr. Cancer 27: 245-249 (1997).
Astorga G, Cubillos A, Masson L, Silva JJ. Active rheumatoid arthritis: effect of dietary supplementation with omega-3 oils. A controlled double-blind trial. Rev. Med. Chil. 119: 267-272 (1991).
Aszalos Z. Neurological and psychiatric aspects of some gastrointestinal diseases. Orv. Hetil. 149: 2079-2086 (2008).
Atay O, Radhakrishnan K, Arruda J, Wyllie R. Severe chest pain in a pediatric ulcerative colitis patient after 5-aminosalicylic acid therapy. World J. Gastroenterol. 14: 4400-4402 (2008). *
Ates Y, Degertekin B, Erdil A, Yaman H, Dagalp K. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status. Dig. Dis. Sci. 53: 2215-2221 (2008). *
Athanasiadou S, Kyriazakis I. Plant secondary metabolites: antiparasitic effects and their role in ruminant production systems. Proc. Nutr. Soc. 63: 631-639 (2004). *
Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Didangelos TP, Carina MV, Kranitsas DF, Kontopoulos AG. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia. Am. J. Cardiol. 80: 608-613 (1997). *
Atia AN, Buchman AL. Oral rehydration solutions in non-cholera diarrhea: a review. Am. J. Gastroenterol. 104: 2596-2604 (2009).
Atikou A, Rabhi M, Hidani H, El Alaoui Faris M, Toloune F. Coeliac crisis with quadriplegia due to potassium depletion as presenting feature of coeliac disease. Rev. Med. Interne. 30: 516-518 (2009).
Atkinson SH, Rockett KA, Morgan G, Bejon PA, Sirugo G, O'Connell MA, Hanchard N, Kwiatkowski D, Prentice AM. Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Blood 112: 4276-4283 (2008). *
Atkinson W, Elmslie J, Lever M, Chambers ST, George PM. Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects. Am. J. Clin. Nutr. 87: 577-585 (2008). *
Atkinson W, Slow S, Elmslie J, Lever M, Chambers ST, George PM. Dietary and supplementary betaine: effects on betaine and homocysteine concentrations in males. Nutr. Metab. Cardiovasc. Dis. 19: 767-773 (2009).
Attar-Bashi NM, Weisinger RS, Begg DP, Li D, Sinclair AJ. Failure of conjugated linoleic acid supplementation to enhance biosynthesis of docosahexaenoic acid from alpha-linolenic acid in healthy human volunteers. Prostaglandins Leukot. Essent. Fatty Acids 76: 121-130 (2007). *
Attard TM, Horton KM, DeVito K, Darbari A, Oliva-Hemker M, Thompson R, Cuffari C. Pediatric jejunoileitis: a severe Crohn's disease phenotype that requires intensive nutritional management. Inflamm. Bowel Dis. 10: 357-360 (2004). *
Attene-Ramos MS, Wagner ED, Gaskins HR, Plewa MJ. Hydrogen sulfide induces direct radical-associated DNA damage. Mol. Cancer Res. 5: 455-459 (2007). *
Attie AD, Flowers MT, Flowers JB, Groen AK, Kuipers F, Ntambi JM. Stearoyl-CoA desaturase deficiency, hypercholesterolaemia, cholestasis and diabetes. Novartis Found. Symp. 286: 47-53 (2007).
Attvall E, Frigyesi A, Sternby B. What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease? Int. J. Colorectal Dis. 21: 705-710 (2006). *
Auada MP, Taube MB, Collares EF, Tanaka AM, Cintra ML. Sjogren-Larsson syndrome: biochemical defects and follow up in three cases. Eur. J. Dermatol. 12: 263-266 (2002).
Aubourg P. X-linked adrenoleukodystrophy. Ann. Endocrinol. (Paris) 68: 403-411 (2007).
Augarten A, Kerem BS, Yahav Y, Noiman S, Rivlin Y, Tal A, Blau H, Ben-Tur L, Szeinberg A, Kerem E, et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation. Lancet 342: 25-26 (1993).
Augarten A, Paret G, Avneri I, Akons H, Aviram M, Bentur L, Blau H, Efrati O, Szeinberg A, Barak A, Kerem E, Yahav J. Systemic inflammatory mediators and cystic fibrosis genotype. Clin. Exp. Med. 4: 99-102 (2004). *
Augood C, Chakravarthy U, Young I, Vioque J, de Jong PT, Bentham G, Rahu M, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Vingerling JR, Fletcher AE. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am. J. Clin. Nutr. 88: 398-406 (2008). *
August A, Mueller C, Weaver V, Polanco TA, Walsh ER, Cantorna MT. Nutrients, nuclear receptors, inflammation, immunity lipids, PPAR, and allergic asthma. J. Nutr. 136: 695-699 (2006). *
Augustin MT, Kokkonen J, Karttunen R, Karttunen TJ. Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease. J. Allergy Clin. Immunol. 115: 157-162 (2005). *
Augusto JF, Sayegh J, Malinge MC, Illouz F, Subra JF, Ducluzeau PH. Severe episodes of extra cellular dehydration: an atypical adult presentation of cystic fibrosis. Clin. Nephrol. 69: 302-305 (2008).
Aupperle RL, Denney DR, Lynch SG, Carlson SE, Sullivan DK. Omega-3 fatty acids and multiple sclerosis: relationship to depression. J. Behav. Med. 31: 127-135 (2008). *
Aurangzeb B, Leach ST, Lemberg DA, Day AS. Nutritional status of children with coeliac disease. Acta Paediatr. Feb 19 [Epub ahead of print] (2010).
Auricchio R, Granata V, Borrelli M, Troncone R; on behalf of the Italian Society for Pediatric Gastroenterology Hepatology and Nutrition (SIGENP). Italian paediatricians' approach to coeliac disease diagnosis. J. Pediatr. Gastroenterol. Nutr. 49: 374-376 (2009).
Austen KF. The role of arachidonic acid metabolites in local and systemic inflammatory processes. Drugs 33 Suppl.1: 10-17 (1987).
Austenaa LM, Carlsen H, Ertesvag A, Alexander G, Blomhoff HK, Blomhoff R. Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. FASEB J. 18: 1255-1257 (2004). *
Austenaa LM, Carlsen H, Hollung K, Blomhoff HK, Blomhoff R. Retinoic acid dampens LPS-induced NF-kappaB activity: results from human monoblasts and in vivo imaging of NF-kappaB reporter mice. J. Nutr. Biochem. 20: 726-734 (2009). *
Austria JA, Richard MN, Chahine MN, Edel AL, Malcolmson LJ, Dupasquier CM, Pierce GN. Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J. Am. Coll. Nutr. 27: 214-221 (2008).
Auvin S, Molinie F, Gower-Rousseau C, Brazier F, Merle V, Grandbastien B, Marti R, Lerebours E, Dupas JL, Colombel JF, Salomez JL, Cortot A, Turck D. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in Northern France (1988-1999). J. Pediatr. Gastroenterol. Nutr. 41: 49-55 (2005). *
Avallone R, Demers A, Rodrigue-Way A, Bujold K, Harb D, Anghel S, Wahli W, Marleau S, Ong H, Tremblay A. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor upregulates ABC sterol transporters and cholesterol efflux in macrophages through a PPARgamma-dependent pathway. Mol. Endocrinol. 20: 3165-3178 (2006). *
Avinash B, Dutta AK, Chacko A. Pediatric inflammatory bowel disease in South India. Indian Pediatr. 46: 639-640 (2009). *
Avraham Y, Zolotarev O, Grigoriadis NC, Pautahidis T, Magen I, Vorobiav L, Zimmer A, Ilan Y, Mechoulam R, Berry EM. Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. Am. J. Gastroenterol. 103: 3047-3056 (2008). *
Awad J, Farah R, Reshef R, Cohen H, Horn I. Pyloric stenosis as a presenting symptom of Crohn's disease. J. Gastrointestin. Liver Dis. 15: 175-177 (2006). *
Awata T, Kawasaki E, Tanaka S, Ikegami H, Maruyama T, Shimada A, Nakanishi K, Kobayashi T, Iizuka H, Uga M, Kawabata Y, Kanazawa Y, Kurihara S, Osaki M, Katayama S; on behalf of the Japanese Study Group on Type 1 Diabetes Genetics. Association of type 1 diabetes with two loci on 12q13 and 16p13 and the influence coexisting thyroid autoimmunity in Japanese. J. Clin. Endocrinol. Metab. 94: 231-235 (2009).
Ayada K, Yokota K, Hirai K, Fujimoto K, Kobayashi K, Ogawa H, Hatanaka K, Hirohata S, Yoshino T, Shoenfeld Y, Matsuura E, Oguma K. Regulation of cellular immunity prevents Helicobacter pylori-induced atherosclerosis. Lupus 18: 1154-1168 (2009).
Ayala A, Chaudry IH. Dietary n-3 polyunsaturated fatty acid modulation of immune cell function before or after trauma. Nutrition 11: 1-11 (1995).
Ayalew-Pervanchon A, Rousseau D, Moreau D, Assayag P, Weill P, Grynberg A. Long-term effect of dietary alpha-linolenic acid or decosahexaenoic acid on incorporation of decosahexaenoic acid in membranes and its influence on rat heart in vivo. Am. J. Physiol. Heart Circ. Physiol. 293: H2296-H2304 (2007). *
Aydemir TB, Liuzzi JP, McClellan S, Cousins RJ. Zinc transporter ZIP8 (SLC39A8) and zinc influence IFN-gamma expression in activated human T cells. J. Leukoc. Biol. 86: 337-348 (2009). *
Aydog E, Yesilli O, Sever A, Usan H. Dermatitis herpetiformis and rheumatoid arthritis. Saudi Med. J. 27: 881-884 (2006).
Aydogan A, Kismet K, Kilicoglu B, Erel S, Ozcan AH, Gollu A, Yildiz E, Akkus MA. Effects of various enteral nutrition solutions on bacterial translocation and intestinal morphology during the postoperative period. Adv. Ther. 24: 41-49 (2007).
Aydogdu S, Arikan C, Kilic M, Ozgenc F, Akman S, Unal F, Yagci RV, Tokat Y. Outcome of pediatric liver transplant recipients in Turkey: single center experience. Pediatr. Transplant. 9: 723-728 (2005).
Aydogdu S, Cakir M, Ali Yuksekkaya H, Tumgor G, Baran M, Arikan C, Yagci RV. Helicobacter pylori infection in children with celiac disease. Scand. J. Gastroenterol. 43: 1088-1093 (2008). *
Aydogdu S, Cakir M, Arikan C, Tumgor G, Yuksekkaya HA, Yilmaz F, Kilic M. Liver transplantation for progressive familial intrahepatic cholestasis: clinical and histopathological findings, outcome and impact on growth. Pediatr. Transplant. 11: 634-640 (2007). *
Aydogdu S, Midyat L, Cakir M, Tumgor G, Yuksekkaya HA, Baran M, Arikan C, Ozgenc F, Yagci RV. Long-term effect of gluten-free diet on growth velocity in Turkish children with celiac disease. Dig. Dis. Sci. 54: 2183-2187 (2009). *
AydoGdu S, Ozgenc F, AtIk T, Unal F, Tokat Y, Yagci RV. Biliary atresia in Turkish children. Pediatr. Int. 46: 158-161 (2004). *
Aydogdu S, Ozgenc F, Yurtsever S, Akman SA, Tokat Y, Yagci RV. Our experience with fulminant hepatic failure in Turkish children: etiology and outcome. J. Trop. Pediatr. 49: 367-370 (2003). *
Ayse Selimoglu M, Ertekin V, Gursan N, Orbak Z, Esrefoglu M. Brunner's gland hyperplasia in a child with diabetes mellitus and coeliac disease. Acta Paediatr. 95: 508-510 (2006). *
Aziz A, Xiao CW, Cockell KA, Sarwar Gilani G, Cruz-Hernandez C, Nimal Ratnayake WM. Impact of dietary protein on lipid metabolism in hamsters is source-dependent and associated with changes in hepatic gene expression. Br. J. Nutr. 100: 503-511 (2008). *
Aziz S, Muzaffar R, Zafar MN, Mehnaz A, Mubarak M, Abbas Z, Naqvi SA, Rizvi AH. Celiac disease in children with persistent diarrhea and failure to thrive. J. Coll. Physicians Surg. Pak. 17: 554-557 (2007).
Babcock TA, Dekoj T, Espat NJ. Experimental studies defining omega-3 fatty acid antiinflammatory mechanisms and abrogation of tumor-related syndromes. Nutr. Clin. Pract. 20: 62-74 (2005).
Babio N, Bullo M, Salas-Salvado J. Mediterranean diet and metabolic syndrome: the evidence. Public Health Nutr. 12: 1607-1617 (2009).
Bacchetta J, Ranchin B, Brunet AS, Bouvier R, Duquesne A, Edery P, Fabien N, Peretti N. Autoimmune hypoparathyroidism in a 12-year-old girl with McKusick cartilage hair hypoplasia. Pediatr. Nephrol. 24: 2449-2453 (2009).
Baccini F, Aloe Spiriti MA, Vannella L, Monarca B, Delle Fave G, Annibale B. Unawareness of gastrointestinal symptomatology in adult coeliac patients with unexplained iron-deficiency anaemia presentation. Aliment. Pharmacol. Ther. 23: 915-921 (2006). *
Bachmann AS. The role of polyamines in human cancer: prospects for drug combination therapies. Hawaii Med. J. 63: 371-374 (2004).
Bachmann H, Desbarats A, Pattison P, Sedgewick M, Riss G, Wyss A, Cardinault N, Duszka C, Goralczyk R, Grolier P. Feedback regulation of beta,beta-carotene 15,15'-monooxygenase by retinoic acid in rats and chickens. J. Nutr. 132: 3616-3622 (2002). *
Badman MK, Flier JS. The gut and energy balance: visceral allies in the obesity wars. Science 307: 1909-1914 (2005). *
Badman MK, Koester A, Flier JS, Kharitonenkov A, Maratos-Flier E. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology 150: 4931-4940 (2009). *
Badou A, Saoudi A, Dietrich G, Druet E, Druet P, Pelletier L. Mercuric chloride-induced autoimmunity. Curr. Protoc. Immunol. Chapter 15: Unit 15.15 (2001).
Badr MZ, Shnyra A, Zoubine M, Norkin M, Herndon B, Quinn T, Miranda RN, Cunningham ML, Molteni A. Phthalate-induced liver protection against deleterious effects of the Th1 response: a potentially serious health hazard. PPAR Res. 2007: 49671 (2007). *
Bae SC, Jung WJ, Lee EJ, Yu R, Sung MK. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J. Am. Coll. Nutr. 28: 56-62 (2009). *
Baeuerlein A, Ackermann S, Parlesak A. Transepithelial activation of human leukocytes by probiotics and commensal bacteria: role of Enterobacteriaceae-type endotoxin. Microbiol. Immunol. 53: 241-250 (2009).
Bagdi E, Kiss J, Borbenyi Z, Piukovics K, Krenacs L. Refractory sprue - precursor lesion of enteropathy type T-cell lymphoma - a clinicopathological case report. Orv. Hetil. 149: 995-998 (2008).
Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc. Natl. Acad. Sci. U.S.A. 100: 1751-1756 (2003). *
Baggio B, Musacchio E, Priante G. Polyunsaturated fatty acids and renal fibrosis: pathophysiologic link and potential clinical implications. J. Nephrol. 18: 362-367 (2005).
Baggott JE, Tamura T. Iron-dependent formation of homocysteine from methionine and other thioethers. Eur. J. Clin. Nutr. 61: 1359-1363 (2007). *
Baghdasaryan A, Fickert P, Fuchsbichler A, Silbert D, Gumhold J, Horl G, Langner C, Moustafa T, Halilbasic E, Claudel T, Trauner M. Role of hepatic phospholipids in development of liver injury in Mdr2 (Abcb4) knockout mice. Liver Int. 28: 948-958 (2008). *
Bahn RS. Graves' ophthalmopathy. N. Engl. J. Med. 362: 726-738 (2010). *
Bai D, Brar P, Holleran S, Ramakrishnan R, Green P. Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men. Scand. J. Gastroenterol. 40: 183-187 (2005). *
Bai HW, Zhu BT. Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids. J. Lipid Res. 49: 2557-2570 (2008). *
Bai XP, Li HL, Yang WY, Xiao JZ, Wang B, Du RQ, Lou DJ. Effects of fenofibrate on gene expression of carnitine palmitoyltransferase 1 in liver and skeletal muscle and its influence on insulin sensitivity. Zhonghua Yi Xue Za Zhi 88: 268-270 (2008).
Baidoo L, Regueiro M. Radiologic testing in Crohn's disease. Inflamm. Bowel Dis. 14 Suppl. 2: S181-S182 (2008). *
Baijal PK, Fitzpatrick DW, Bird RP. Modulation of colonic xenobiotic metabolizing enzymes by feeding bile acids: comparative effects of cholic, deoxycholic, lithocholic and ursodeoxycholic acids. Food Chem. Toxicol. 36: 601-607 (1998). *
Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C-->T polymorphism affect cancer risk: intake recommendations. J. Nutr. 133: 3748S-3753S (2003). *
Bailey M, Haverson K, Inman C, Harris C, Jones P, Corfield G, Miller B, Stokes C. The development of the mucosal immune system pre- and post-weaning: balancing regulatory and effector function. Proc. Nutr. Soc. 64: 451-457 (2005). *
Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment. Pharmacol. Ther. 31: 537-547 (2010). *
Bajaj JS, Ananthakrishnan AN, Hafeezullah M, Zadvornova Y, Dye A, McGinley EL, Saeian K, Heuman D, Sanyal AJ, Hoffmann RG. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: a national and tertiary center perspective. Am. J. Gastroenterol. 105: 106-113 (2010). *
Bajaj JS, Hafeezullah M, Zadvornova Y, Martin E, Schubert CM, Gibson DP, Hoffmann RG, Sanyal AJ, Heuman DM, Hammeke TA, Saeian K. The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am. J. Gastroenterol. 104: 898-905 (2009). *
Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR, Gibson DP, Hoffmann RG, Stravitz RT, Heuman DM, Sterling RK, Shiffman M, Topaz A, Boyett S, Bell D, Sanyal AJ. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 50: 1175-1183 (2009). *
Bajaj JS, Sanyal AJ, Bell D, Gilles H, Heuman DM. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Aliment. Pharmacol. Ther. Feb 5 [Epub ahead of print] (2010). *
Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, Saeian K, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Luketic V, White MB, Sanyal AJ. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology Feb 20 [Epub ahead of print] (2010).
Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology 50: 2014-2021 (2009).
Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am. J. Gastroenterol. 104: 1130-1134 (2009). *
Baken KA, Ezendam J, Gremmer ER, de Klerk A, Pennings JL, Matthee B, Peijnenburg AA, van Loveren H. Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression. Int. J. Food Microbiol. 112: 8-18 (2006). *
Baker A, Alonso ME, Aw MM, Ciocca M, Porta G, Rosenthal P. Hepatic failure and liver transplant: working group report of the second world congress of pediatric gastroenterology, hepatology, and nutrition. J. Pediatr. Gastroenterol. Nutr. 39: S632-S639 (2004). *
Baker A, Stevenson R, Dhawan A, Goncalves I, Socha P, Sokal E. Guidelines for nutritional care for infants with cholestatic liver disease before liver transplantation. Pediatr. Transplant. 11: 825-834 (2007). *
Baker SS, Borowitz D, Baker RD. Pancreatic exocrine function in patients with cystic fibrosis. Curr. Gastroenterol. Rep. 7: 227-233 (2005).
Bakker EC, Hornstra G, Blanco CE, Vles JS. Relationship between long-chain polyunsaturated fatty acids at birth and motor function at 7 years of age. Eur. J. Clin. Nutr. 63: 499-504 (2009). *
Bakker GC, van Erk MJ, Pellis L, Wopereis S, Rubingh CM, Cnubben NH, Kooistra T, van Ommen B, Hendriks HF. An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach. Am. J. Clin. Nutr. Feb 24 [Epub ahead of print] (2010).
Bako W, Marek A, Sikorska-Wisniewska G, Liberek A, Raczkowska-Kozak J, Gora-Gebka M, Szlagatys-Sidorkiewicz A, Zagierski M, Jankowska A. Short bowel syndrome in children - own experience. Med. Wieku. Rozwoj. X: 563-572 (2006).
Bal D, Nath KG, Radhakrishna D, Indiramma AR, Vijayalakshmi NS. Storage behavior of immune-enhancing enteral formulation from natural sources. Int. J. Food Sci. Nutr. Mar 28 [Epub ahead of print] (2009).
Balaban DH, Chen J, Lin Z, Tribble CG, McCallum RW. Median arcuate ligament syndrome: a possible cause of idiopathic gastroparesis. Am. J. Gastroenterol. 92: 519-523 (1997).
Balani AR, Grendell JH. Drug-induced pancreatitis: incidence, management and prevention. Drug Saf. 31: 823-837 (2008).
Baldan A, Tarr P, Lee R, Edwards PA. ATP-binding cassette transporter G1 and lipid homeostasis. Curr. Opin. Lipidol. 17: 227-232 (2006).
Baldassano R, Braegger CP, Escher JC, DeWoody K, Hendricks DF, Keenan GF, Winter HS. Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease. Am. J. Gastroenterol. 98: 833-838 (2003). *
Baldassano RN, Bradfield JP, Monos DS, Kim CE, Glessner JT, Casalunovo T, Frackelton EC, Otieno FG, Kanterakis S, Shaner JL, Smith RM, Eckert AW, Robinson LJ, Onyiah CC, Abrams DJ, Chiavacci RM, Skraban R, Devoto M, Grant SF, Hakonarson H. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease. Clin. Gastroenterol. Hepatol. 5: 972-976 (2007).
Baldassarre M, Laneve AM, Grosso R, Laforgia N. Celiac disease: pathogenesis and novel therapeutic strategies. Endocr. Metab. Immune Disord. Drug Targets 8: 152-158 (2008).
Baldi F, Bianco MA, Nardone G, Pilotto A, Zamparo E. Focus on acute diarrhoeal disease. World J. Gastroenterol. 15: 3341-3348 (2009). *
Baldini V, Casella G, Perego D, Morcelli E, Fraterrigo RT. Hypocalcemic tetany due to coeliac disease. May this symptoms disappear? Minerva Gastroenterol. Dietol. 46: 99-104 (2000).
Balfour Sartor R. Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications. J. Clin. Gastroenterol. 41 Suppl. 1: S37-S43 (2007).
Balic I, Angel B, Codner E, Carrasco E, Perez-Bravo F. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children. Hum. Immunol. 70: 116-120 (2009).
Balistreri WF. Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J. Pediatr. Gastroenterol. Nutr. 24: 573-589 (1997). *
Balistreri WF. Genetic liver disease. 54th Annual Meeting of the American Association for the Study of Liver Diseases (2003).
Balistreri WF, Bezerra JA. Whatever happened to �neonatal hepatitis�? Clin. Liver Dis. 10: 27-53 (2006).
Balistreri WF, Bezerra JA, Jansen P, Karpen SJ, Shneider BL, Suchy FJ. Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference. Hepatology 42: 222-235 (2005). *
Balkova P, Jezkova J, Hlavackova M, Neckar J, Stankova B, Kolar F, Novak F, Novakova O. Dietary polyunsaturated fatty acids and adaptation to chronic hypoxia alter acyl composition of serum and heart lipids. Br. J. Nutr. 102: 1297-1307 (2009). *
Ballesteros Pomar MD, Vidal Casariego A. Short bowel syndrome: definition, causes, intestinal adaptation and bacterial overgrowth. Nutr. Hosp. 22 Suppl. 2: 74-85 (2007).
Ballinger A. Fundamental mechanisms of growth failure in inflammatory bowel disease. Horm. Res. 58 Suppl. 1: 7-10 (2002).
Ballinger AB, Azooz O, El-Haj T, Poole S, Farthing MJ. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 46: 694-700 (2000). *
Ballou MA, Gomes RC, Juchem SO, Depeters EJ. Effects of dietary supplemental fish oil during the peripartum period on blood metabolites and hepatic fatty acid compositions and total triacylglycerol concentrations of multiparous Holstein cows. J. Dairy Sci. 92: 657-669 (2009).
Balsara KP, Shah CR, Maru S, Sehgal R. Laparoscopic-assisted ileo-colectomy for tuberculosis. Surg. Endosc. 19: 986-989 (2005). *
Ban K, Kozar RA. Enteral glutamine: a novel mediator of PPARgamma in the postischemic gut. J. Leukoc. Biol. 84: 595-599 (2008). *
Ban Y, Tomer Y. Genetic susceptibility in thyroid autoimmunity. Pediatr. Endocrinol. Rev. 3: 20-32 (2005).
Ban Y, Tomer Y. Susceptibility genes in thyroid autoimmunity. Clin. Dev. Immunol. 12: 47-58 (2005). *
Ban Y, Tomer Y. The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 36: 367-379 (2003).
Banai J. Nutrition in inflammatory bowel disease. Orv. Hetil. 150: 839-845 (2009).
Banan A, Keshavarzian A, Zhang L, Shaikh M, Forsyth CB, Tang Y, Fields JZ. NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. Alcohol 41: 447-460 (2007).
Banaszkiewicz A, Wultanska D, Pituch H, Radzikowski A. Prevalence of Clostridium difficile infection in Polish pediatric patients with inflammatory bowel disease. Inflamm. Bowel Dis. Aug 24 [Epub ahead of print] (2009).
Bancroft LK, Lupton JR, Davidson LA, Taddeo SS, Murphy ME, Carroll RJ, Chapkin RS. Dietary fish oil reduces oxidative DNA damage in rat colonocytes. Free Radic. Biol. Med. 35: 149-159 (2003).
Bandaru SS, Lin K, Roming SL, Vellipuram R, Harney JP. Effects of PI3K inhibition and low docosahexaenoic acid on cognition and behavior. Physiol. Behav. Nov 12 [Epub ahead of print] (2009). *
Banka NH, Dhavan P, Chevale BP. Coeliac sprue - new frontiers in diagnosis and role of capsule endoscopy. J. Assoc. Physicians India 54: 959-961 (2006).
Bankar RN, Dafe CO, Kohnke A, Babu PS. Ulcerative colitis probably associated with isotretinoin. Indian J. Gastroenterol. 25: 171-172 (2006). *
Bannerjee K, Camacho-Hubner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, Sanderson IR, Croft NM. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J. Pediatr. Gastroenterol. Nutr. 38: 270-275 (2004). *
Banni S, Di Marzo V. Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. Mol. Nutr. Food Res. Dec 14 [Epub ahead of print] (2009). *
Banos G, Perez-Torres I, El Hafidi M. Medicinal agents in the metabolic syndrome. Cardiovasc. Hematol. Agents Med. Chem. 6: 237-252 (2008).
Banos Madrid R, Salama Benerroch H, Moran Sanchez S, Gallardo Sanchez F, Albadalejo Merono A, Mercader Martinez J. Lactose malabsorption in patients with inflammatory bowel disease without activity: it would be necessary to exclude the lactose products in their diet to all the patients? An. Med. Interna 21: 212-214 (2004).
Bansal V, Syres KM, Makarenkova V, Brannon R, Matta B, Harbrecht BG, Ochoa JB. Interactions between fatty acids and arginine metabolism: implications for the design of immune-enhancing diets. JPEN J. Parenter. Enteral Nutr. 29: S75-S80 (2005). *
Banus S, Bottema RW, Siezen CL, Vandebriel RJ, Reimerink J, Mommers M, Koppelman GH, Hoebee B, Thijs C, Postma DS, Kimman TG, Stelma FF. A Toll-like receptor 4 polymorphism is associated with the response to whole-cell pertussis vaccination in children from the KOALA study. Clin. Vaccine Immunol. 14: 1377-1380 (2007).
Banwell B, Bar-Or A, Cheung R, Kennedy J, Krupp LB, Becker DJ, Dosch HM; Wadsworth Pediatric Multiple Sclerosis Study Group. Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes. Ann. Neurol. 63: 98-111 (2008).
Barak AJ, Beckenhauer HC, Mailliard ME, Kharbanda KK, Tuma DJ. Betaine lowers elevated S-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats. J. Nutr. 133: 2845-2848 (2003). *
Baranowski M, Blachnio-Zabielska A, Gorski J. Peroxisome proliferator-activated receptor alpha activation induces unfavourable changes in fatty acid composition of myocardial phospholipids. J. Physiol. Pharmacol. 60: 13-20 (2009). *
Baranowski M, Blachnio-Zabielska A, Zabielski P, Gorski J. Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability. Arch. Biochem. Biophys. 477: 86-91 (2008). *
Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am. J. Gastroenterol. 100: 2560-2568 (2005). *
Barbato M, Viola F, Miglietta MR, Argo G, Iulianella VR, Di Giuseppe S, Pippa G, Gentiloni Silverj F, Lo Russo L, Frediani T, Lucarelli S, Multari G, Cardi E. Association between insulin dependent diabetes mellitus and coeliac disease. A study on 175 diabetes patients. Minerva Gastroenterol. Dietol. 44: 1-5 (1998).
Barbeau WE, Bassaganya-Riera J, Hontecillas R. Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetes. Med. Hypotheses 68: 607-619 (2007).
Barbeau WE, Novascone MA, Elgert KD. Is celiac disease due to molecular mimicry between gliadin peptide-HLA class II molecule-T cell interactions and those of some unidentified superantigen? Mol. Immunol. 34: 535-541 (1997).
Barber MD. The pathophysiology and treatment of cancer cachexia. Nutr. Clin. Pract. 17: 203-209 (2002).
Barber MD, Fearon KC, Ross JA. Eicosapentaenoic acid modulates the immune response but has no effect on a mimic of antigen-specific responses. Nutrition 21: 588-593 (2005). *
Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alperovitch A. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 69: 1921-1930 (2007).
Barbero Villares A, Moreno Monteagudo JA, Moreno Borque R, Moreno Otero R. Hepatic involvement in celiac disease. Gastroenterol. Hepatol. 31: 25-28 (2008).
Barbier O, Trottier J, Kaeding J, Caron P, Verreault M. Lipid-activated transcription factors control bile acid glucuronidation. Mol. Cell. Biochem. 326: 3-8 (2009). *
Barbosa DS, Cecchini R, El Kadri MZ, Rodriguez MA, Burini RC, Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 19: 837-842 (2003). *
Barbosa PR, Stabler SP, Trentin R, Carvalho FR, Luchessi AD, Hirata RD, Hirata MH, Allen RH, Guerra-Shinohara EM. Evaluation of nutritional and genetic determinants of total homocysteine, methylmalonic acid and S-adenosylmethionine/S-adenosylhomocysteine values in Brazilian childbearing-age women. Clin. Chim. Acta 388: 139-147 (2008). *
Barbosa VM, Miles EA, Calhau C, Lafuente E, Calder PC. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit. Care 14: R5 (2010). *
Barbot L, Topouchian A, Capet C, Magne D, Huneau JF, Kapel N, Gobert JG. Cryptosporidium parvum: functional study of the intestinal malabsorption syndrome. Ann. Pharm. Fr. 59: 305-311 (2001).
Barboza Tinoco SM, Sichieri R, Setta CL, Moura AS, Tavares do Carmo MG. n-3 Polyunsaturated fatty acids in milk is associate to weight gain and growth in premature infants. Lipids Health Dis. 8: 23 (2009). *
Barbuio R, Milanski M, Bertolo MB, Saad MJ, Velloso LA. Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J. Endocrinol. 194: 539-550 (2007). *
Barcelo-Coblijn G, Collison LW, Jolly CA, Murphy EJ. Dietary alpha-linolenic acid increases brain but not heart and liver docosahexaenoic acid levels. Lipids 40: 787-798 (2005).
Barcelo-Coblijn G, Kitajka K, Puskas LG, Hogyes E, Zvara A, Hackler L Jr, Farkas T. Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochim. Biophys. Acta 1632: 72-79 (2003). *
Barcelo-Coblijn G, Murphy EJ. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog. Lipid Res. 48: 355-374 (2009). *
Barcelo-Coblijn G, Murphy EJ, Othman R, Moghadasian MH, Kashour T, Friel JK. Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am. J. Clin. Nutr. 88: 801-809 (2008). *
Barceloux DG. Copper. J. Toxicol. Clin. Toxicol. 37: 217-230 (1999).
Barclay AR, Russell RK, Wilson ML, Gilmour WH, Satsangi J, Wilson DC. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J. Pediatr. 155: 421-426 (2009). *
Bardaoui M, Sakly R, Neffati F, Najjar MF, El Hani A. Effect of vitamin A supplemented diet on calcium oxalate renal stone formation in rats. Exp. Toxicol. Pathol. Sep 17 [Epub ahead of print] (2009). *
Bardella MT, Fredella C, Saladino V, Trovato C, Cesana BM, Quatrini M, Prampolini L. Gluten intolerance: gender- and age-related differences in symptoms. Scand. J. Gastroenterol. 40: 15-19 (2005).
Bardella MT, Valenti L, Pagliari C, Peracchi M, Fare M, Fracanzani AL, Fargion S. Searching for coeliac disease in patients with non-alcoholic fatty liver disease. Dig. Liver Dis. 36: 333-336 (2004).
Bardella MT, Velio P, Cesana BM, Prampolini L, Casella G, Di Bella C, Lanzini A, Gambarotti M, Bassotti G, Villanacci V. Coeliac disease: a histological follow-up study. Histopathology 50: 465-471 (2007). *
Bardin N, Reumaux D, Geboes K, Colombel JF, Blot-Chabaud M, Sampol J, Duthilleul P, Dignat-George F. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm. Bowel Dis. 12: 16-21 (2006). *
Bardin T. Current management of gout in patients unresponsive or allergic to allopurinol. Joint Bone Spine 71: 481-485 (2004).
Bardon S, Benelli C, Bernard-Gallon D, Blottiere H, Demarquoy J, Duee PH, Forest C. Dietary fatty acids and cancer: potential cellular and molecular mechanisms. Bull. Cancer 92: 697-707 (2005).
Bargon J, Stein J, Dietrich CF, Muller U, Caspary WF, Wagner TO. Gastrointestinal complications of adult patients with cystic fibrosis. Z. Gastroenterol. 37: 739-749 (1999).
Baric I. Inherited disorders in the conversion of methionine to homocysteine. J. Inherit. Metab. Dis. 32: 459-471 (2009). *
Barisani D, Ceroni S, Del Bianco S, Meneveri R, Bardella MT. Hemochromatosis gene mutations and iron metabolism in celiac disease. Haematologica 89: 1299-1305 (2004). *
Barish GD. Peroxisome proliferator-activated receptors and liver X receptors in atherosclerosis and immunity. J. Nutr. 136: 690-694 (2006). *
Barker JM, Liu E. Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv. Pediatr. 55: 349-365 (2008).
Barnard ND, Noble EP, Ritchie T, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Green AA, Ferdowsian H. D2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetes. Nutrition 25: 58-65 (2009). *
Barnes BH, Tucker RM, Wehrmann F, Mack DG, Ueno Y, Mack CL. Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia. Liver Int. 29: 1253-1261 (2009). *
Barnes DS. Intrahepatic cholestatic liver disease. http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm (2002). *
Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 31: 401-411 (2009). *
Barnes MS, Bonham MP, Robson PJ, Strain JJ, Lowe-Strong AS, Eaton-Evans J, Ginty F, Wallace JM. Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers. Mult. Scler. 13: 670-672 (2007). *
Barnholt KE, Kota RS, Aung HH, Rutledge JC. Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation. J. Immunol. 183: 6767-6777 (2009).
Barollo M, D'Inca R, Scarpa M, Medici V, Cardin R, Bortolami M, Ruffolo C, Angriman I, Sturniolo GC. Effects of iron manipulation on trace elements level in a model of colitis in rats. World J. Gastroenterol. 11: 4396-4399 (2005). *
Baron JA, Sandler RS, Bresalier RS, Quan H, Riddell R, Lanas A, Bolognese JA, Oxenius B, Horgan K, Loftus S, Morton DG. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 131: 1674-1682 (2006). *
Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A, Colombel JF. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 54: 357-363 (2005). *
Baroncelli GI, Bereket A, El Kholy M, Audi L, Cesur Y, Ozkan B, Rashad M, Fernandez-Cancio M, Weisman Y, Saggese G, Hochberg Z. Rickets in the Middle East: role of environment and genetic predisposition. J. Clin. Endocrinol. Metab. 93: 1743-1750 (2008). *
Barone M, Maiorano E, Ladisa R, Cuomo R, Pece A, Berloco P, Caruso ML, Valentini AM, Iolascon A, Francavilla A, Di Leo A, Ierardi E. Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice. Hepatology 37: 880-886 (2003). *
Baroni F, Ghisla MK, Leonardi R, Grassi V. Celiac disease in the elderly: a case report. Ann. Ital. Med. Int. 20: 253-257 (2005).
Barre DE. The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes - a mini-review. J. Oleo. Sci. 56: 319-325 (2007). *
Barrett JS, Gearry RB, Muir JG, Irving PM, Rose R, Rosella O, Haines ML, Shepherd SJ, Gibson PR. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment. Pharmacol. Ther. Jan 22 [Epub ahead of print] (2010). *
Barrie A, Plevy S. Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab. Gastroenterol. Clin. North Am. 35: 883-893 (2006).
Barrie A, Regueiro M. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease. Inflamm. Bowel Dis. 13: 1424-1429 (2007). *
Barrie III AM, Plevy SE. The interleukin-12 family of cytokines: therapeutic targets for inflammatory disease mediation. Clin. Appl. Immunol. Rev. 5: 225-240 (2005). *
Barroso E, Fernandez LP, Milne RL, Pita G, Sendagorta E, Floristan U, Feito M, Aviles JA, Martin-Gonzalez M, Arias JI, Zamora P, Blanco M, Lazaro P, Benitez J, Ribas G. Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies. BMC Cancer 8: 385 (2008). *
Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J. Clin. Endocrinol. Metab. 91: 1446-1452 (2006). *
Barry PJ, Waterhouse DF, Reilly CM, McKenna TJ, McKone EF, Gallagher CG. Androgens, exercise capacity and muscle function in cystic fibrosis. Chest 134: 1258-1264 (2008). *
Barta Z, Csipo I, Antal-Szalmas P, Sipka S, Szabo G, Szegedi G. Anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease. Orv. Hetil. 142: 2303-2307 (2001).
Bartel G, Weiss I, Turetschek K, Schima W, Puspok A, Waldhoer T, Gasche C. Ingested matter affects intestinal lesions in Crohn's disease. Inflamm. Bowel Dis. 14: 374-382 (2008). *
Bartelt S, Timm M, Damsgaard CT, Hansen EW, Hansen HS, Lauritzen L. The effect of dietary fish oil-supplementation to healthy young men on oxidative burst measured by whole blood chemiluminescence. Br. J. Nutr. 99: 1230-1238 (2008). *
Bartke A, Bonkowski M, Masternak M. THow diet interacts with longevity genes. Hormones (Athens) 7: 17-23 (2008).
Bartling B, Fuchs C, Somoza V, Niemann B, Silber RE, Simm A. Lung level of HMBG1 is elevated in response to advanced glycation end product-enriched food in vivo. Mol. Nutr. Food Res. 51: 479-487 (2007). *
Bartoli R, Fernandez-Banares F, Navarro E, Castella E, Mane J, Alvarez M, Pastor C, Cabre E, Gassull MA. Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut 46: 191-199 (2000). *
Barton SH, Kelly DG, Murray JA. Nutritional deficiencies in celiac disease. Gastroenterol. Clin. North Am. 36: 93-108 (2007).
Bartosik-Psujek H, Stelmasiak Z. Multiple sclerosis - difficult answers to easy questions. Neurol. Neurochir. Pol. 40: 441-445 (2006).
Barve A, Khan R, Marsano L, Ravindra KV, McClain C. Treatment of alcoholic liver disease. Ann. Hepatol. 7: 5-15 (2008). *
Bas A, Forsberg G, Sjoberg V, Hammarstrom S, Hernell O, Hammarstrom ML. Aberrant extrathymic T cell receptor gene rearrangement in the small intestinal mucosa: a risk factor for celiac disease? Gut 58: 189-195 (2009). *
Bas F, Kabatas-Eryilmaz S, Gunoz H, Darendeliler F, Kucukemre B, Bundak R, Saka N. Type 1 diabetes mellitus associated with autoimmune thyroid disease, celiac disease and familial Mediterranean fever: case report. Turk. J. Pediatr. 51: 183-186 (2009).
Basciano H, Miller AE, Naples M, Baker C, Kohen R, Xu E, Su Q, Allister E, Wheeler M, Adeli K. Metabolic effects of dietary cholesterol in an animal model of insulin resistance and hepatic steatosis. Am. J. Physiol. Endocrinol. Metab. 297: E462-E473 (2009). *
Baskin-Bey ES, Anan A, Isomoto H, Bronk SF, Gores GJ. Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse. World J. Gastroenterol. 13: 5635-5641 (2007). *
Bassaganya-Riera J, Guri AJ, Noble AM, Reynolds KA, King J, Wood CM, Ashby M, Rai D, Hontecillas R. Arachidonic acid-and docosahexaenoic acid-enriched formulas modulate antigen-specific T cell responses to influenza virus in neonatal piglets. Am. J. Clin. Nutr. 85: 824-836 (2007). *
Bassaganya-Riera J, Hontecillas R. CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD. Clin. Nutr. 25: 454-465 (2006).
Bassaganya-Riera J, Hontecillas R, Beitz DC. Colonic anti-inflammatory mechanisms of conjugated linoleic acid. Clin. Nutr. 21: 451-459 (2002).
Bassaganya-Riera J, Reynolds K, Martino-Catt S, Cui Y, Hennighausen L, Gonzalez F, Rohrer J, Benninghoff AU, Hontecillas R. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127: 777-791 (2004). *
Bassaganya-Riera J, Skoneczka J, Kingston DG, Krishnan A, Misyak SA, Guri AJ, Pereira A, Carter AB, Minorsky P, Tumarkin R, Hontecillas R. Mechanisms of action and medicinal applications of abscisic acid. Curr. Med. Chem. Dec 17 [Epub ahead of print] (2009).
Basselin M, Kim HW, Chen M, Ma K, Rapoport SI, Murphy RC, Farias SE. Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation. J. Lipid Res. Dec 29 [Epub ahead of print] (2009). *
Bassett CM, Rodriguez-Leyva D, Pierce GN. Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed. Appl. Physiol. Nutr. Metab. 34: 965-974 (2009). *
Basso D, Guariso G, Fasolo M, Pittoni M, Schiavon S, Fogar P, Greco E, Navaglia F, Zambon CF, Plebani M. A new indirect chemiluminescent immunoassay to measure anti-tissue transglutaminase antibodies. J. Pediatr. Gastroenterol. Nutr. 43: 613-618 (2006). *
Basso D, Guariso G, Fogar P, Meneghel A, Zambon CF, Navaglia F, Greco E, Schiavon S, Rugge M, Plebani M. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. Clin. Chem. 55: 150-157 (2009). *
Basso F, Freeman LA, Ko C, Joyce C, Amar MJ, Shamburek RD, Tansey T, Thomas F, Wu J, Paigen B, Remaley AT, Santamarina-Fojo S, Brewer HB Jr. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited. J. Lipid Res. 48: 114-126 (2007). *
Bassols J, Botas P, Moreno-Navarrete JM, Delgado E, Ortega F, Ricart W, Fernandez-Real JM. Environmental and genetic factors influence the relationship between circulating IL-10 and obesity phenotypes. Obesity (Silver Spring) Oct 1 [Epub ahead of print] (2009). *
Bassols J, Moreno JM, Ortega F, Ricart W, Fernandez-Real JM. Characterization of herpes virus entry mediator as a factor linked to obesity. Obesity (Silver Spring) Aug 13 [Epub ahead of print] (2009). *
Bassols J, Moreno-Navarrete JM, Ortega F, Ricart W, Fernandez-Real JM. LIGHT is associated with hypertriglyceridemia in obese subjects and increased cytokine secretion from cultured human adipocytes. Int. J. Obes. (Lond.) Sep 29 [Epub ahead of print] (2009).
Bassols J, Ortega FJ, Moreno-Navarrete JM, Peral B, Ricart W, Fernandez-Real JM. Study of the proinflammatory role of human differentiated omental adipocytes. J. Cell. Biochem. 107: 1107-1117 (2009). *
Bassotti G, Villanacci V, Mazzocchi A, Mariano M, Incardona P, Clerici C, Morelli A. Antroduodenojejunal motor activity in untreated and treated celiac disease patients. J. Gastroenterol. Hepatol. 23: e23-e28 (2008). *
Bastonero S, Gargouri M, Ortiou S, Gueant JL, Merten MD. Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene transfer in cystic fibrosis tracheal gland cells. J. Gene Med. 7: 1439-1449 (2005).
Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation. Arterioscler. Thromb. Vasc. Biol. 26: 995-1001 (2006). *
Basu A, Jensen MD, McCann F, Nandy D, Mukhopadhyay D, McConnell JP, Rizza RA. Lack of an effect of pioglitazone or glipizide on lipoprotein-associated phospholipase A2 in type 2 diabetes. Endocr. Pract. 13: 147-152 (2007).
Basude D, Dhawan A. Re: Minocycline-induced autoimmune hepatitis with subsequent cirrhosis. J. Pediatr. Gastroenterol. Nutr. 44: 389 (2007). *
Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 21: 437-451 (2001).
Batdelger D, Dandii D, Dahgwahdorj Y, Erdenetsogt E, Oyunbileg J, Tsend N, Bayarmagnai B, Jirathitikal V, Bourinbaiar AS. Clinical experience with therapeutic vaccines designed for patients with hepatitis. Curr. Pharm. Des. 15: 1159-1171 (2009).
Bateman EA, Ferry BL, Hall A, Misbah SA, Anderson R, Kelleher P. IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin. Gut 53: 1274-1278 (2004). *
Batetta B, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L, Giordano E, Sanna F, Bisogno T, Uda S, Collu M, Bruheim I, Di Marzo V, Banni S. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J. Nutr. 139: 1495-1501 (2009). *
Bathen TF, Holmgren K, Lundemo AG, Hjelstuen MH, Krokan HE, Gribbestad IS, Schonberg SA. Omega-3 fatty acids suppress growth of SW620 human colon cancer xenografts in nude mice. Anticancer Res. 28: 3717-3723 (2008).
Batra A, Zeitz M, Siegmund B. Adipokine signaling in inflammatory bowel disease. Inflamm. Bowel Dis. 15: 1897-1905 (2009).
Batres LA, Russo P, Mathews M, Piccoli DA, Chuang E, Ruchelli E. Primary sclerosing cholangitis in children: a histologic follow-up study. Pediatr. Dev. Pathol. 8: 568-576 (2005). *
Batta AK, Salen G, Holubec H, Brasitus TA, Alberts D, Earnest DL. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps. Cancer Res. 58: 1684-1687 (1998). *
Battezzati A, Battezzati PM, Costantini D, Seia M, Zazzeron L, Russo MC, Dacco V, Bertoli S, Crosignani A, Colombo C. Spontaneous hypoglycemia in patients with cystic fibrosis. Eur. J. Endocrinol. 156: 369-376 (2007). *
Bauchart-Thevret C, Stoll B, Burrin DG. Intestinal metabolism of sulfur amino acids. Nutr. Res. Rev. 22: 175-187 (2009).
Bauchart-Thevret C, Stoll B, Chacko SK, Burrin DG. Sulfur amino acid deficiency upregulates intestinal methionine cycle activity and suppresses epithelial growth in neonatal pigs. Am. J. Physiol. Endocrinol. Metab. 296: E1239-E1250 (2009). *
Baudet A, Rahmi G, Bretagne AL, Gloro R, Justum AM, Reimund JM. Severe ulcerative colitis: present medical treatment strategies. Expert Opin. Pharmacother. 9: 447-457 (2008).
Baudon JJ, Chevalier J, Boccon-Gibod L, Le Bars MA, Johanet C, Cosnes J. Outcome of infants with celiac disease. Gastroenterol. Clin. Biol. 29: 1097-1102 (2005). *
Bauer B, Hartz AM, Fricker G, Miller DS. Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol. Pharmacol. 66: 413-419 (2004). *
Bauer E, Williams BA, Smidt H, Verstegen MW, Mosenthin R. Influence of the gastrointestinal microbiota on development of the immune system in young animals. Curr. Issues Intest. Microbiol. 7: 35-51 (2006).
Bauer J, Liebisch G, Hofmann C, Huy C, Schmitz G, Obermeier F, Bock J. Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression. PLoS One 4: e7197 (2009). *
Baumgardner JN, Shankar K, Korourian S, Badger TM, Ronis MJ. Undernutrition enhances alcohol-induced hepatocyte proliferation in the liver of rats fed via total enteral nutrition. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G355-G364 (2007). *
Baumgart DC, McVay LD, Carding SR. Mechanisms of immune cell-mediated tissue injury in inflammatory bowel disease (review). Int. J. Mol. Med. 1: 315-332 (1998).
Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342 (2006). *
Baybutt RC, Rosales C, Brady H, Molteni A. Dietary fish oil protects against lung and liver inflammation and fibrosis in monocrotaline treated rats. Toxicology 175: 1-13 (2002). *
Bayes M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find. Exp. Clin. Pharmacol. 26: 587-612 (2004).
Bayraktar Y, Arslan S, Saglam F, Uzunalimoglu B, Kayhan B. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients? Hepatogastroenterology 45: 2064-2072 (1998).
Bayram I, Erbey F, Celik N, Nelson JL, Tanyeli A. The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in children. Pediatr. Blood Cancer 52: 571-574 (2009).
Baysoy G, Ertem D, Ademoglu E, Kotiloglu E, Keskin S, Pehlivanoglu E. Gastric histopathology, iron status and iron deficiency anemia in children with Helicobacter pylori infection. J. Pediatr. Gastroenterol. Nutr. 38: 146-151 (2004). *
Bazinet RP. Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder? Biochem. Soc. Trans. 37: 1104-1109 (2009). *
Bazzigaluppi E, Roggero P, Parma B, Brambillasca MF, Meroni F, Mora S, Bosi E, Barera G. Antibodies to recombinant human tissue-transglutaminase in coeliac disease: diagnostic effectiveness and decline pattern after gluten-free diet. Dig. Liver Dis. 38: 98-102 (2006).
Bazzone LE, Smith PM, Rutitzky LI, Shainheit MG, Urban JF, Setiawan T, Blum AM, Weinstock JV, Stadecker MJ. Coinfection with the intestinal nematode Heligmosomoides polygyrus markedly reduces hepatic egg-induced immunopathology and proinflammatory cytokines in mouse models of severe schistosomiasis. Infect. Immun. 76: 5164-5172 (2008). *
Beagle B, Yang TL, Hung J, Cogger EA, Moriarty DJ, Caudill MA. The glycine N-methyltransferase (GNMT) 1289 C->T variant influences plasma total homocysteine concentrations in young women after restricting folate intake. J. Nutr. 135: 2780-2785 (2005). *
Beattie RM. Symposium 6: Young people, artificial nutrition and transitional care. Nutrition, growth and puberty in children and adolescents with Crohn's disease. Proc. Nutr. Soc. Dec 8 [Epub ahead of print] (2009). *
Beattie RM. Enteral nutrition as primary therapy in childhood Crohn's disease: control of intestinal inflammation and anabolic response. JPEN J. Parenter. Enteral Nutr. 29: S151-S159 (2005). *
Beattie RM, Croft NM, Fell JM, Afzal NA, Heuschkel RB. Inflammatory bowel disease. Arch. Dis. Child. 91: 426-432 (2006). *
Beau P, Barrioz T, Ingrand P. Total parenteral nutrition-related cholestatic hepatopathy, is it an infectious disease? Gastroenterol. Clin. Biol. 18: 63-67 (1994).
Beau P, Labat-Labourdette J, Ingrand P, Beauchant M. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? J. Hepatol. 20: 240-244 (1994).
Beaugerie L. What is an inflammatory bowel disease? Rev. Prat. 55: 943-948 (2005).
Beaugerie L. Is the risk of lymphoma increased by immunosuppressive therapy in patients with inflammatory bowel disease? The missing link for considering early immunosuppressants. Gastroenterol. Clin. Biol. 28: 218-220 (2004).
Beaugerie L, Blain A, Brazier F, Gornet JM, Parc Y. Treatment of extended ulcerative colitis (severe colitis excluded). Gastroenterol. Clin. Biol. 28: 974-983 (2004).
Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients. Nephrology (Carlton) 13: 284-288 (2008). *
Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M. Effect of over-the-counter fish-oil administration on plasma Lp(a) levels in an end-stage renal disease population. J. Ren. Nutr. 19: 443-449 (2009).
Bebb JR, Lawson A, Knight T, Long RG. Long-term follow-up of coeliac disease - what do coeliac patients want? Aliment. Pharmacol. Ther. 23: 827-831 (2006). *
Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J. Pediatr. 150: 479-484 (2007). *
Bechade D, Desrame J, De Fuentes G, Camparo P, Raynaud JJ, Algayres JP. Common variable immunodeficiency and celiac disease. Gastroenterol. Clin. Biol. 28: 909-912 (2004).
Beckebaum S, Klein C, Varghese J, Sotiropoulos GC, Saner F, Schmitz K, Gerken G, Paul A, Cicinnati VR. Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients. Aliment. Pharmacol. Ther. 30: 834-842 (2009). *
Becker D, Enk A, Brauninger W, Knop J. Granuloma anulare disseminatum as a rare side effect of allopurinol. Hautarzt. 46: 343-345 (1995).
Becker KA, Riethmuller J, Luth A, Doring G, Kleuser B, Gulbins E. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am. J. Respir. Cell. Mol. Biol. Jul 27 [Epub ahead of print] (2009). *
Becker P, Maurer B, Schirmacher P, Waldherr R, Parlesak A, Bode C, Seitz HK. Vitamin A-induced cholestatic hepatitis: a case report. Z. Gastroenterol. 45: 1063-1066 (2007).
Beckles Willson N, Elliott TM, Everard ML. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst. Rev. 3: CD002201 (2002). *
Bedeir A, Jukic DM, Wang L, Mullady DK, Regueiro M, Krasinskas AM. Systemic mastocytosis mimicking inflammatory bowel disease: a case report and discussion of gastrointestinal pathology in systemic mastocytosis. Am. J. Surg. Pathol. 30: 1478-1482 (2006).
Bederman IR, Kasumov T, Reszko AE, David F, Brunengraber H, Kelleher JK. In vitro modeling of fatty acid synthesis under conditions simulating the zonation of lipogenic [13C]acetyl-CoA enrichment in the liver. J. Biol. Chem. 279: 43217-43226 (2004). *
Bederman IR, Reszko AE, Kasumov T, David F, Wasserman DH, Kelleher JK, Brunengraber H. Zonation of labeling of lipogenic acetyl-CoA across the liver: implications for studies of lipogenesis by mass isotopomer analysis. J. Biol. Chem. 279: 43207-43216 (2004). *
Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42: 44-52 (2005). *
Begg DP, Sinclair AJ, Stahl LA, Garg ML, Jois M, Weisinger RS. Dietary protein level interacts with omega-3 polyunsaturated fatty acid deficiency to induce hypertension. Am. J. Hypertens. Nov 5 [Epub ahead of print] (2009).
Beghin L, Michaud L, Loeuille GA, Wizla-Derambure N, Sayah H, Sardet A, Thumerelle C, Deschildre A, Turck D, Gottrand F. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa. Pediatr. Pulmonol. 44: 464-471 (2009).
Beharry SA, Ackerely C, Corey M, Kent G, Heng YM, Christensen H, Luk C, Yantiss RK, Nasser IA, Zaman M, Freedman SD, Durie PR. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G839-G848 (2007). *
Beigneux AP, Davies BS, Bensadoun A, Fong LG, Young SG. GPIHBP1 - a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins. J. Lipid Res. 50: S57-S62 (2009). *
Beland K, Lapierre P, Alvarez F. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J. Gastroenterol. 15: 1025-1034 (2009). *
Beland K, Lapierre P, Marceau G, Alvarez F. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection. J. Autoimmun. 22: 159-166 (2004).
Belanger J, Johns T. Biological diversity, dietary diversity, and eye health in developing country populations: establishing the evidence-base. Ecohealth 5: 244-256 (2008).
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355: 2297-2307 (2006). *
Beli E, Li M, Cuff C, Pestka JJ. Docosahexaenoic acid-enriched fish oil consumption modulates immunoglobulin responses to and clearance of enteric reovirus infection in mice. J. Nutr. 138: 813-819 (2008). *
Belisle SE, Leka LS, Delgado-Lista J, Jacques PF, Ordovas JM, Meydani SN. Polymorphisms at cytokine genes may determine the effect of vitamin E on cytokine production in the elderly. J. Nutr. 139: 1855-1860 (2009).
Belkind-Gerson J, Fernandez-Peters A, Furnes R, Oliver M, Perrault J, Robertson M, Witt H; Latin American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Pancreatic disorders and cystic fibrosis: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastroenterol. Nutr. 39 Suppl. 2: S688-S694 (2004). *
Bell Iii TA, Kelley K, Wilson MD, Sawyer JK, Rudel LL. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice. Arterioscler. Thromb. Vasc. Biol. 27: 1396-1402 (2007).
Bell JA, St Charles JL, Murphy AJ, Rathinam VA, Plovanich-Jones AE, Stanley EL, Wolf JE, Gettings JR, Whittam TS, Mansfield LS. Multiple factors interact to produce responses resembling spectrum of human disease in Campylobacter jejuni infected C57BL/6 IL-10-/- mice. BMC Microbiol. 9: 57 (2009). *
Bell SC, Robinson PJ. Exacerbations in cystic fibrosis. 2. Prevention. Thorax 62: 723-732 (2007). *
Bellentani S, Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann. Hepatol. 8 Suppl. 1: S4-S8 (2009). *
Belli DC, Fournier LA, Lepage G, Yousef I, Roy CC. S-Adenosylmethionine prevents total parenteral nutrition-induced cholestasis in the rat. J. Hepatol. 21: 18-23 (1994).
Bellisle F. Infrequently asked questions about the Mediterranean diet. Public Health Nutr. 12: 1644-1647 (2009).
Belluzzi A, Boschi S, Brignola C, Munarini A, Cariani G, Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am. J. Clin. Nutr. 71: 339S-342S (2000). *
Belo A, Marchbank T, Fitzgerald A, Ghosh S, Playford RJ. Gastroprotective effects of oral nucleotide administration. Gut 55: 165-171 (2006). *
Beltz BS, Tlusty MF, Benton JL, Sandeman DC. Omega-3 fatty acids upregulate adult neurogenesis. Neurosci. Lett. 415: 154-158 (2007). *
Belyaeva OV, Korkina OV, Stetsenko AV, Kedishvili NY. Human retinol dehydrogenase 13 (RDH13) is a mitochondrial short-chain dehydrogenase/reductase with a retinaldehyde reductase activity. FEBS J. 275: 138-147 (2008). *
Bemiss CJ, Mahon BD, Henry A, Weaver V, Cantorna MT. Interleukin-2 is one of the targets of 1,25-dihydroxyvitamin D3 in the immune system. Arch. Biochem. Biophys. 402: 249-254 (2002). *
Bemrah N, Sirot V, Leblanc JC, Volatier JL. Fish and seafood consumption and omega 3 intake in French coastal populations: CALIPSO survey. Public Health Nutr. 12: 599-608 (2009).
Ben Hamida KS, Serghini M, Ksontini I, Kedadi H, Ben Yaghlene L, Bougassas W, Dougui MH. Bone loss owing to inflammatory bowel disease: prospective study about 50 cases. Tunis. Med. 87: 144-148 (2009).
Ben Hriz F, Habbassi H, Maamouri N, Azaiez O, Chaabouni H, Chouaib S, Mnif E, Ben Mami N. Budd-Chiari syndrome associated with celiac disease. Rev. Med. Interne. Dec 30 [Epub ahead of print] (2009).
Ben-Ari Z, Dalal A, Morry A, Pitlik S, Zinger P, Cohen J, Fattal I, Galili-Mosberg R, Tessler D, Baruch RG, Nuoffer JM, Largiader CR, Mandel H. Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins' diet. J. Hepatol. 52: 292-295 (2010).
Ben-Horin S, Green PH, Bank I, Chess L, Goldstein I. Characterizing the circulating, gliadin-specific CD4+ memory T cells in patients with celiac disease: linkage among memory function, gut homing, and Th1 polarization. J. Leukoc. Biol. 79: 676-685 (2006). *
Benabdeslam H, Garcia I, Bellon G, Gilly R, Revol A. Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts. Am. J. Clin. Nutr. 67: 912-918 (1998). *
Benahmed M, Mention JJ, Matysiak-Budnik T, Cerf-Bensussan N. Celiac disease: a future without gluten-free diet?? Gastroenterology 125: 1264-1267 (2003). *
Benais-Pont G, Dupertuis YM, Kossovsky MP, Nouet P, Allal AS, Buchegger F, Pichard C. omega-3 Polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells. Nutrition 22: 931-939 (2006). *
Benatti P, Peluso G, Nicolai R, Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J. Am. Coll. Nutr. 23: 281-302 (2004). *
Benavente-Chenhalls L, Mathis KL, Dozois EJ, Cima RR, Pemberton JH, Larson DW. Laparoscopic ileal pouch-anal anastomosis in patients with chronic ulcerative colitis and primary sclerosing cholangitis: a case-matched study. Dis. Colon Rectum 51: 549-553 (2008). *
Benchimol EI, Turner D, Mann EH, Thomas KE, Gomes T, McLernon RA, Griffiths AM. Toxic megacolon in children with inflammatory bowel disease: clinical and radiographic characteristics. Am. J. Gastroenterol. 103: 1524-1531 (2008). *
Bendlova B, Vejralkova D, Vcelak J, Lukalova P, Burkonova D, Kunelova M, Vrbikova J, Dvorakova K, Vondra K, Vankova M. PPARgamma2 Pro12Ala polymorphism in relation to free fatty acids concentration and composition in lean healthy Czech individuals with and without family history of diabetes type 2. Physiol. Res. 57 Suppl. 1: S77-S90 (2008). *
Bendyk A, Marino V, Zilm PS, Howe P, Bartold PM. Effect of dietary omega-3 polyunsaturated fatty acids on experimental periodontitis in the mouse. J. Periodontal Res. 44: 211-216 (2009).
Bene J, Komlosi K, Gasztonyi B, Juhasz M, Tulassay Z, Melegh B. Plasma carnitine ester profile in adult celiac disease patients maintained on long-term gluten free diet. World J. Gastroenterol. 11: 6671-6675 (2005). *
Bengmark S, Gil A. Bioecological and nutritional control of disease: prebiotics, probiotics and synbiotics. Nutr. Hosp. 21 Suppl. 2: 72-84, 73-86 (2006).
Bengoa JM, Hanauer SB, Sitrin MD, Baker AL, Rosenberg IH. Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease. Hepatology 5: 79-84 (1985).
Bengtson MB, Ronning T, Vatn M, Harris J. Irritable bowel syndrome in twins: genes and environment. Gut 55: 1754-1759 (2006). *
Bengtsson A, Larsson Alminger M, Svanberg U. In vitro bioaccessibility of beta-carotene from heat-processed orange-fleshed sweet potato. J. Agric. Food Chem. Oct 6 [Epub ahead of print] (2009).
Benisek M, Blaha L, Hilscherova K. Interference of PAHs and their N-heterocyclic analogs with signaling of retinoids in vitro. Toxicol. In Vitro 22: 1909-1917 (2008).
Benito P, Caballero J, Moreno J, Gutierrez-Alcantara C, Munoz C, Rojo G, Garcia S, Soriguer FC. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin. Nutr. 25: 581-587 (2006).
Benito-Garcia E, Feskanich D, Hu FB, Mandl LA, Karlson EW. Protein, iron and meat consumption and risk of rheumatoid arthritis: a prospective cohort study. Arthritis Res. Ther. 9: R16 (2007). *
Beniwal RS, Arena VC, Thomas L, Narla S, Imperiale TF, Chaudhry RA, Ahmad UA. A randomized trial of yogurt for prevention of antibiotic-associated diarrhea. Dig. Dis. Sci. 48: 2077-2082 (2003). *
Benjamin J, Makharia GK, Ahuja V, Kalaivani M, Joshi YK. Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease. World J. Gastroenterol. 14: 1399-1405 (2008). *
Benjamin J, Makharia GK, Joshi YK. Association between intestinal permeability and anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease. Inflamm. Bowel Dis. 14: 1610-1611 (2008). *
Benjamin J, Makharia GK, Kalaivani M, Joshi YK. Nutritional status of patients with Crohn's disease. Indian J. Gastroenterol. 27: 195-200 (2008). *
Benkebil F, Nydegger A. Coeliac disease in children - an update. Rev. Med. Suisse. 3: 515-519 (2007).
Bennett WE Jr, Tarr PI. Enteric infections and diagnostic testing. Curr. Opin. Gastroenterol. 25: 1-7 (2009).
Beno I, Klvanova J, Magalova T, Brtkova A. Blood levels of natural antioxidants in gastric and colorectal precancerous lesions and cancers in Slovakia. Neoplasma 47: 37-40 (2000).
Bensaid M, Fruchon S, Mazeres C, Bahram S, Roth MP, Coppin H. Multigenic control of hepatic iron loading in a murine model of hemochromatosis. Gastroenterology 126: 1400-1408 (2004). *
Benson MK, Devi K. Influence of omega-6/omega-3 rich dietary oils on lipid profile and antioxidant enzymes in normal and stressed rats. Indian J. Exp. Biol. 47: 98-103 (2009).
Benson S, Janssen OE, Hahn S, Tan S, Dietz T, Mann K, Pleger K, Schedlowski M, Arck PC, Elsenbruch S. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav. Immun. 22: 177-184 (2008).
Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J. Gen. Intern. Med. 23: 854-859 (2008). *
Benton D. The influence of dietary status on the cognitive performance of children. Mol. Nutr. Food Res. Jan 13 [Epub ahead of print] (2010). *
Benton D; ILSI Europe a i.s.b.l. Micronutrient status, cognition and behavioral problems in childhood. Eur. J. Nutr. 47 Suppl. 3: 38-50 (2008). *
Beppu T, Seyama Y, Kasama T, Yamakawa T. Quantitative determination of individual non-sulfated bile acids and sulfated lithocholic acid in serum by mass fragmentography. J. Biochem. 89: 1963-1973 (1981).
Berard AM, Dumon MF, Darmon M. Dietary fish oil up-regulates cholesterol 7alpha-hydroxylase mRNA in mouse liver leading to an increase in bile acid and cholesterol excretion. FEBS Lett. 559: 125-128 (2004). *
Beraza N, Malato Y, Vander Borght S, Liedtke C, Wasmuth HE, Dreano M, de Vos R, Roskams T, Trautwein C. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut 57: 655-663 (2008).
Berbert AA, Kondo CR, Almendra CL, Matsuo T, Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition 21: 131-136 (2005). *
Berbis P, Hesse S, Privat Y. Essential fatty acids and the skin. Allerg. Immunol. (Paris) 22: 225-231 (1990).
Bere E. Wild berries: a good source of omega-3. Eur. J. Clin. Nutr. 61: 431-433 (2007). *
Berecki G, Den Ruijter HM, Verkerk AO, Schumacher CA, Baartscheer A, Bakker D, Boukens BJ, van Ginneken AC, Fiolet JW, Opthof T, Coronel R. Dietary fish oil reduces the incidence of triggered arrhythmias in pig ventricular myocytes. Heart Rhythm. 4: 1452-1460 (2007).
Bereket A. Vitamin D receptor polymorphism in nutritional rickets. Pediatr. Endocrinol. Rev. 3 Suppl. 3: 476-479 (2006).
Bergamaschi G, Markopoulos K, Albertini R, Di Sabatino A, Biagi F, Ciccocioppo R, Arbustini E, Corazza GR. Anemia of chronic disease and defective erythropoietin production in patients with celiac disease. Haematologica 93: 1785-1791 (2008). *
Berger A, Mutch DM, German JB, Roberts MA. Unraveling lipid metabolism with microarrays: effects of arachidonate and docosahexaenoate acid on murine hepatic and hippocampal gene expression. Genome Biol. 3: PREPRINT0004 (2002). *
Berger A, Mutch DM, German JB, Roberts MA. Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis. 1: 2 (2002). *
Berger A, Roberts MA, Hoff B. How dietary arachidonic- and docosahexaenoic- acid rich oils differentially affect the murine hepatic transcriptome. Lipids Health Dis. 5: 10 (2006). *
Berger MM. Vitamin C requirements in parenteral nutrition. Gastroenterology 137: S70-S78 (2009). *
Berger MM, Tappy L, Revelly JP, Koletzko BV, Gepert J, Corpataux JM, Cayeux MC, Chiolero RL. Fish oil after abdominal aorta aneurysm surgery. Eur. J. Clin. Nutr. 62: 1116-1122 (2008). *
Berger SG, de Pee S, Bloem MW, Halati S, Semba RD. Malnutrition and morbidity among children not reached by the national vitamin A capsule programme in urban slum areas of Indonesia. Public Health 122: 371-378 (2008).
Bergheim I, McClain CJ, Arteel GE. Treatment of alcoholic liver disease. Dig. Dis. 23: 275-284 (2005).
Bergheim I, Weber S, Vos M, Kramer S, Volynets V, Kaserouni S, McClain CJ, Bischoff SC. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 48: 983-992 (2008).
Bergman BC, Perreault L, Hunerdosse DM, Koehler MC, Samek AM, Eckel RH. Intramuscular lipid metabolism in the insulin resistance of smoking. Diabetes 58: 2220-2227 (2009). *
Bergseng E, Sidney J, Sette A, Sollid LM. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules. Hum. Immunol. 69: 94-100 (2008).
Berkenstam A, Farnegardh M, Gustafsson JA. Convergence of lipid homeostasis through liver X and thyroid hormone receptors. Mech. Ageing Dev. 125: 707-717 (2004).
Bermudez B, Lopez S, Pacheco YM, Villar J, Muriana FJ, Hoheisel JD, Bauer A, Abia R. The influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery. Cardiovasc. Res. 79: 294-303 (2008). *
Bermudez Menendez de la Granda M, Sinclair AJ. Fatty acids and obesity. Curr. Pharm. Des. 15: 4117-4125 (2009).
Bernal I, Manosa M, Domenech E, Garcia-Planella E, Navarro M, Lorenzo-Zuniga V, Cabre E, Gassull MA. Predictors of clinical response to systemic steroids in active ulcerative colitis. Dig. Dis. Sci. 51: 1434-1438 (2006). *
Bernard K, Wang W, Narlawar R, Schmidt B, Kirk KL. Curcumin cross-links cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides and potentiates CFTR channel activity by distinct mechanisms. J. Biol. Chem. 284: 30754-30765 (2009). *
Bernardo D, Garrote JA, Allegretti Y, Leon A, Gomez E, Bermejo-Martin JF, Calvo C, Riestra S, Fernandez-Salazar L, Blanco-Quiros A, Chirdo F, Arranz E. Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. Clin. Exp. Immunol. 154: 64-73 (2008). *
Bernardo D, van Hoogstraten IM, Verbeek WH, Pena AS, Mearin ML, Arranz E, Garrote JA, Scheper RJ, Schreurs MW, Bontkes HJ, Mulder CJ, von Blomberg BM. Decreased circulating iNKT cell numbers in refractory coeliac disease. Clin. Immunol. 126: 172-179 (2008). *
Bernhardt WM, Schefold JC, Weichert W, Rudolph B, Frei U, Groneberg DA, Schindler R. Amelioration of anemia after kidney transplantation in severe secondary oxalosis. Clin. Nephrol. 65: 216-221 (2006).
Berni Canani R, Terrin G, Borrelli O, Romano MT, Manguso F, Coruzzo A, D'Armiento F, Romeo EF, Cucchiara S. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig. Liver Dis. 38: 381-387 (2006).
Bernstein CN. Treatment of the extraintestinal manifestations of inflammatory bowel disease. Curr. Gastroenterol. Rep. 4: 513-516 (2002).
Bernstein CN, Bector S, Leslie WD. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease. Am. J. Gastroenterol. 98: 2468-2473 (2003). *
Bernstein CN, Leslie WD. The pathophysiology of bone disease in gastrointestinal disease. Eur. J. Gastroenterol. Hepatol. 15: 857-864 (2003).
Bernstein CN, Leslie WD. Osteoporosis and inflammatory bowel disease. Aliment. Pharmacol. Ther. 19: 941-952 (2004). *
Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am. J. Gastroenterol. 95: 677-683 (2000). *
Bernstein CN, Seeger LL, Anton PA, Artinian L, Geffrey S, Goodman W, Belin TR, Shanahan F. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment. Pharmacol. Ther. 10: 777-786 (1996).
Bernstein H, Holubec H, Bernstein C, Ignatenko N, Gerner E, Dvorak K, Besselsen D, Ramsey L, Dall'Agnol M, Blohm-Mangone KA, Padilla-Torres J, Cui H, Garewal H, Payne CM. Unique dietary-related mouse model of colitis. Inflamm. Bowel Dis. 12: 278-293 (2006). *
Bernstein H, Holubec H, Bernstein C, Ignatenko NA, Gerner E, Dvorak K, Besselsen D, Blohm-Mangone KA, Padilla-Torres J, Dvorakova B, Garewal H, Payne CM. Deoxycholate-induced colitis is markedly attenuated in Nos2 knockout mice in association with modulation of gene expression profiles. Dig. Dis. Sci. 52: 628-642 (2007). *
Bernstein-Hanley I, Balsara ZR, Ulmer W, Coers J, Starnbach MN, Dietrich WF. Genetic analysis of susceptibility to Chlamydia trachomatis in mouse. Genes Immun. 7: 122-129 (2006). *
Berntssen MH, Giskegjerde TA, Rosenlund G, Torstensen BE, Lundebye AK. Predicting World Health Organization toxic equivalency factor dioxin and dioxin-like polychlorinated biphenyl levels in farmed Atlantic salmon (Salmo salar) based on known levels in feed. Environ. Toxicol. Chem. 26: 13-23 (2007).
Berquin IM, Edwards IJ, Chen YQ. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett. 269: 363-377 (2008). *
Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ, D'Agostino R, Zhang H, Wu H, Kang JX, Chen YQ. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J. Clin. Invest. 117: 1866-1875 (2007). *
Berquist WE, Andrus JP. The value of the PRISM scores in comparing pediatric liver transplant outcomes. Pediatr. Transplant. 8: 208-209 (2004).
Berr F, Holl J, Jungst D, Fischer S, Richter WO, Seifferth B, Paumgartner G. Dietary n-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease. Hepatology 16: 960-967 (1992). *
Berrougui H, Khalil A. Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity. Rejuvenation Res. 12: 117-126 (2009).
Berry DC, Noy N. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor. Mol. Cell. Biol. 29: 3286-3296 (2009). *
Berry SD, Davis SR, Beattie EM, Thomas NL, Burrett AK, Ward HE, Stanfield AM, Biswas M, Ankersmit AE, Oxley PE, Barnett JL, Pearson JF, van der Does Y, Macgibbon AH, Spelman RJ, Lehnert K, Snell RG. Mutation in bovine beta-carotene oxygenase 2 affects milk color. Genetics 182: 923-926 (2009). *
Bersamin A, Luick BR, King IB, Stern JS, Zidenberg-Cherr S. Westernizing diets influence fat intake, red blood cell fatty acid composition, and health in remote Alaskan native communities in the Center for Alaska Native Health study. J. Am. Diet. Assoc. 108: 266-273 (2008).
Berstad P, Konstantinova SV, Refsum H, Nurk E, Vollset SE, Tell GS, Ueland PM, Drevon CA, Ursin G. Dietary fat and plasma total homocysteine concentrations in 2 adult age groups: the Hordaland Homocysteine Study. Am. J. Clin. Nutr. 85: 1598-1605 (2007). *
Berstad P, Seljeflot I, Veierod MB, Hjerkinn EM, Arnesen H, Pedersen JI. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1. Clin. Sci. (Lond.) 105: 13-20 (2003). *
Bertelsmann H, Behne D, Kyriakopoulos A. Studies with regard to the apoptosis of testicular germ cells in rats fed a diet enriched with polyunsaturated fatty acids. Ann. N. Y. Acad. Sci. 1171: 372-376 (2009). *
Berthiaume M, Laplante M, Festuccia WT, Berger JP, Thieringer R, Deshaies Y. Additive action of 11beta-HSD1 inhibition and PPAR-gamma agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats. Int. J. Obes. (Lond.) 33: 601-604 (2009). *
Berti PR, Soueida R, Kuhnlein HV. Dietary assessment of indigenous Canadian Arctic women with a focus on pregnancy and lactation. Int. J. Circumpolar Health 67: 349-362 (2008).
Bertini F, Costa NC, Brandao AA, Cavalcante AS, Almeida JD. Ulceration of the oral mucosa induced by antidepressant medication: a case report. J. Med. Case Reports 3: 98 (2009). *
Bertini I, Calabro A, De Carli V, Luchinat C, Nepi S, Porfirio B, Renzi D, Saccenti E, Tenori L. The metabonomic signature of celiac disease. J. Proteome Res. 8: 170-177 (2009). *
Bertrandt J, Klos A, Debski B. Polyunsaturated fatty acid (PUFA) changes in serum and liver of undernourished rats given dietary vitamin B6 supplementation. J. Nutr. Sci. Vitaminol. (Tokyo) 51: 129-134 (2005).
Besaratinia A, Kim SI, Hainaut P, Pfeifer GP. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure. Gastroenterology 137: 1127-1137.e5 (2009). *
Besnard P, Landrier JF, Grober J, Niot I. Is the ileal bile acid-binding protein (I-BABP) gene involved in cholesterol homeostasis? Med. Sci. (Paris) 20: 73-77 (2004).
Bethune MT, Borda JT, Ribka E, Liu MX, Phillippi-Falkenstein K, Jandacek RJ, Doxiadis GG, Gray GM, Khosla C, Sestak K. A non-human primate model for gluten sensitivity. PLoS ONE 3: e1614 (2008). *
Bethune MT, Ribka E, Khosla C, Sestak K. Transepithelial transport and enzymatic detoxification of gluten in gluten-sensitive rhesus macaques. PLoS ONE 3: e1857 (2008). *
Bethune MT, Siegel M, Howles-Banerji S, Khosla C. Interferon-gamma released by gluten-stimulated celiac disease-specific intestinal T cells enhances the transepithelial flux of gluten peptides. J. Pharmacol. Exp. Ther. 329: 657-668 (2009). *
Betterle C, Lazzarotto F, Spadaccino AC, Basso D, Plebani M, Pedini B, Chiarelli S, Albergoni M. Celiac disease in North Italian patients with autoimmune Addison's disease. Eur. J. Endocrinol. 154: 275-279 (2006). *
Betti M, Perez TI, Zuidhof MJ, Renema RA. Omega-3-enriched broiler meat: 3. Fatty acid distribution between triacylglycerol and phospholipid classes. Poult. Sci. 88: 1740-1754 (2009).
Betti M, Schneider BL, Wismer WV, Carney VL, Zuidhof MJ, Renema RA. Omega-3-enriched broiler meat: 2. Functional properties, oxidative stability, and consumer acceptance. Poult. Sci. 88: 1085-1095 (2009).
Beukeveld GJ, In 't Veld G, Havinga R, Groen AK, Wolthers BG, Kuipers F. Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport. J. Hepatol. 24: 343-352 (1996). *
Beulens JW, Rimm EB, Hendriks HF, Hu FB, Manson JE, Hunter DJ, Mukamal KJ. Alcohol consumption and type 2 diabetes: influence of genetic variation in alcohol dehydrogenase. Diabetes 56: 2388-2394 (2007). *
Beyan E, Pamukcuoglu M, Beyan C. Deep vein thrombosis associated with celiac disease. Bratisl. Lek. Listy. 110: 263-264 (2009).
Bezerra JA. The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia. J. Pediatr. Gastroenterol. Nutr. 43 Suppl. 1: S23-S29 (2006). *
Bezerra JA. Potential etiologies of biliary atresia. Pediatr. Transplant. 9: 646-651 (2005).
Bhagat G, Naiyer AJ, Shah JG, Harper J, Jabri B, Wang TC, Green PH, Manavalan JS. Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J. Clin. Invest. 118: 281-293 (2008). *
Bharadwaj AS, Hart SD, Brown BJ, Li Y, Watkins BA, Brown PB. Dietary source of stearidonic acid promotes higher muscle DHA concentrations than linolenic acid in hybrid striped bass. Lipids 45: 21-27 (2010).
Bhaskaram P. Micronutrient malnutrition, infection, and immunity: an overview. Nutr. Rev. 60: S40-S45 (2002).
Bhat PV, Manolescu DC. Role of vitamin A in determining nephron mass and possible relationship to hypertension. J. Nutr. 138: 1407-1410 (2008). *
Bhat YM, Papachristou GI, Park JS, Lamb J, Slivka A, Whitcomb DC. Gunctional polymorphisms of the GSTT-1 gene do not predict the severity of acute pancreatitis in the United States. Pancreatology 7: 180-186 (2007).
Bhathal PS, Gall JA. Deletion of hyperplastic biliary epithelial cells by apoptosis following removal of the proliferative stimulus. Liver 5: 311-325 (1985).
Bhatia E, Choudhuri G, Sikora SS, Landt O, Kage A, Becker M, Witt H. Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology 123: 1020-1025 (2002). *
Bhatia V, Tandon RK. Stress and the gastrointestinal tract. J. Gastroenterol. Hepatol. 20: 332-339 (2005). *
Bhatnagar S, Phillips AD, Bhan MK. Celiac disease in India. J. Pediatr. Gastroenterol. Nutr. 43: 263-264 (2006). *
Bhatnagar S, Tandon N. Diagnosis of celiac disease. Indian J. Pediatr. 73: 703-709 (2006). *
Bhattacharya A, Rahman M, Banu J, Lawrence RA, McGuff HS, Garrett IR, Fischbach M, Fernandes G. Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Faslpr mice by n-3 fatty acids. J. Am. Coll. Nutr. 24: 200-209 (2005). *
Bhattacharya A, Rahman M, Sun D, Fernandes G. Effect of fish oil on bone mineral density in aging C57BL/6 female mice. J. Nutr. Biochem. 18: 372-379 (2007). *
Bhattacharya A, Sun D, Rahman M, Fernandes G. Different ratios of eicosapentaenoic and docosahexaenoic omega-3 fatty acids in commercial fish oils differentially alter pro-inflammatory cytokines in peritoneal macrophages from C57BL/6 female mice. J. Nutr. Biochem. 18: 23-30 (2007). *
Bhattacharyya S, Gill R, Chen ML, Zhang F, Linhardt RJ, Dudeja PK, Tobacman JK. Toll-like receptor 4 mediates induction of Bcl10-NFkappa B-IL-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J. Biol. Chem. 283: 10550-10558 (2008). *
Bhura-Bandali FN, Suh M, Man SF, Clandinin MT. The deltaF508 mutation in the cystic fibrosis transmembrane conductance regulator alters control of essential fatty acid utilization in epithelial cells. J. Nutr. 130: 2870-2875 (2000). *
Bhutani M, Pathak AK, Nair AS, Kunnumakkara AB, Guha S, Sethi G, Aggarwal BB. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation. Clin. Cancer Res. 13: 3024-3032 (2007). *
Bhutta ZA. Micronutrient needs of malnourished children. Curr. Opin. Clin. Nutr. Metab. Care 11: 309-314 (2008).
Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, Haider BA, Kirkwood B, Morris SS, Sachdev H, Shekar M; for the Maternal and Child Undernutrition Study Group. What works? Interventions for maternal and child undernutrition and survival. Lancet 371: 417-440 (2008). *
Bhutta ZA, Rizvi A, Raza F, Hotwani S, Zaidi S, Moazzam Hossain S, Soofi S, Bhutta S. A comparative evaluation of multiple micronutrient and iron-folic acid supplementation during pregnancy in Pakistan: impact on pregnancy outcomes. Food Nutr. Bull. 30: S496-S505 (2009).
Bi Y, Sun WP, Chen X, Li M, Liang H, Cai MY, Zhu YH, He XY, Xu F, Weng JP. Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats. Acta Diabetol. 45: 167-178 (2008).
Biagi F, Andrealli A, Bianchi PI, Marchese A, Klersy C, Corazza GR. A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease. Br. J. Nutr. 102: 882-887 (2009). *
Biagi F, Bianchi PI, Campanella J Dr, Badulli C, Martinetti M, Klersy C, Alvisi C, Corazza GR Prof. The prevalence and the causes of minimal intestinal lesions in patients complaining of symptoms suggestive of enteropathy. A follow-up study. J. Clin. Pathol. 61: 1116-1168 (2008).
Biagi F, Campanella J, Bianchi PI, Corazza GR. Is a gluten-free diet necessary in patients with potential celiac disease? Minerva Gastroenterol. Dietol. 53: 387-389 (2007).
Biagi F, Campanella J, Martucci S, Pezzimenti D, Ciclitira PJ, Ellis HJ, Corazza GR. A milligram of gluten a day keeps the mucosal recovery away: a case report. Nutr. Rev. 62: 360-363 (2004).
Biagi F, Corazza GR. Mortality in celiac disease. Nat. Rev. Gastroenterol. Hepatol. Feb 2 [Epub ahead of print] (2010).
Bianchi A. From the cradle to enteral autonomy: the role of autologous gastrointestinal reconstruction. Gastroenterology 130: S138-S146 (2006). *
Bianchi G, Marzocchi R, Agostini F, Marchesini G. Update on branched-chain amino acid supplementation in liver diseases. Curr. Opin. Gastroenterol. 21: 197-200 (2005).
Bianchi G, Marzocchi R, Lorusso C, Ridolfi V, Marchesini G. Nutritional treatment of chronic liver failure. Hepatol. Res. 38 (s1: The 6 Japan Society of Hepatology Single Topic Conference: Liver Failure: Recent Progress and Pathogenesis to Management. 28-29 September 2007, Iwate, Japan): S93-S101 (2008). *
Bianchi ML, Bardella MT. Bone in celiac disease. Osteoporos. Int. 19: 1705-1716 (2008). *
Biasi F, Mascia C, Astegiano M, Chiarpotto E, Nano M, Vizio B, Leonarduzzi G, Poli G. Pro-oxidant and pro-apoptotic effects of cholesterol oxidation products on human colonic epithelial cells: a potential mechanism of inflammatory bowel disease progression. Free Radic. Biol. Med. 47: 1731-1741 (2009).
Biasi F, Mascia C, Poli G. TGFbeta1 expression in colonic mucosa: modulation by dietary lipids. Genes Nutr. 2: 233-243 (2007). *
Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100: 1539-1546 (2005). *
Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J. Med. Microbiol. 55: 1141-1149 (2006). *
Bibiloni R, Tandon P, Vargas-Voracka F, Barreto-Zuniga R, Lupian-Sanchez A, Rico-Hinojosa MA, Guban J, Fedorak R, Tannock GW. Differential clustering of bowel biopsy-associated bacterial profiles of specimens collected in Mexico and Canada: what do these profiles represent? J. Med. Microbiol. 57: 111-117 (2008). *
Bickler SW, Demaio A. Western diseases: current concepts and implications for pediatric surgery research and practice. Pediatr. Surg. Int. 24: 251-255 (2008). *
Bickston SJ, Comerford LW, Cominelli F. Future therapies for inflammatory bowel disease. Curr. Gastroenterol. Rep. 5: 518-523 (2003).
Bickston SJ, Foley E, Lawrence C, Rockoff T, Shaffer HA Jr, Yeaton P. Terminal ileal stricture in Crohn's disease: treatment using a metallic enteral endoprosthesis. Dis. Colon Rectum 48: 1081-1085 (2005). *
Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur. J. Clin. Nutr. 62: 178-185 (2008). *
Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflamm. Bowel Dis. 15: 778-788 (2009). *
Bierwirth J, Ulbricht KU, Schmidt RE, Witte T. Association of common variable immunodeficiency with vitamin B(6) deficiency. Eur. J. Clin. Nutr. 62: 332-335 (2008). *
Biesalski HK, Chichili GR, Frank J, von Lintig J, Nohr D. Conversion of beta-carotene to retinal pigment. Vitam. Horm. 75: 117-130 (2007).
Biesalski HK, Frank J, Beck SC, Heinrich F, Illek B, Reifen R, Gollnick H, Seeliger MW, Wissinger B, Zrenner E. Biochemical but not clinical vitamin A deficiency results from mutations in the gene for retinol binding protein. Am. J. Clin. Nutr. 69: 931-936 (1999). *
Biesalski HK, Tinz J. Nutritargeting. Adv. Food Nutr. Res. 54: 179-217 (2008).
Bijvelds MJ, Bronsveld I, Havinga R, Sinaasappel M, de Jonge HR, Verkade HJ. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G646-G653 (2005). *
Bilbao I, Armadans L, Lazaro JL, Hidalgo E, Castells L, Margarit C. Predictive factors for early mortality following liver transplantation. Clin. Transplant. 17: 401-411 (2003). *
Bilgic I, Oruc MT, Ozmen MM. Decreased bile acid synthesis with total parenteral nutrition. Am. J. Surg. 196: 461-462 (2008). *
Bilic-Curcic I, Milas-Ahic J, Smolic M, Smolic R, Mihaljevic I, Tucak-Zoric S. Urolithiasis and osteoporosis: clinical relevance and therapeutic implications. Coll. Antropol. 33 Suppl. 2: 189-192 (2009).
Bility MT, Zhu B, Kang BH, Gonzalez FJ, Peters JM. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) enhances inhibition of skin tumorigenesis. Toxicol. Sci. 113: 27-36 (2010). *
Billerey-Larmonier C, Uno JK, Larmonier N, Midura AJ, Timmermann B, Ghishan FK, Kiela PR. Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm. Bowel Dis. 14: 780-793 (2008). *
Billman GE, Nishijima Y, Belevych AE, Terentyev D, Xu Y, Haizlip KM, Monasky MM, Hiranandani N, Harris WS, Gyorke S, Carnes CA, Janssen PM. Effects of dietary omega-3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studies. Am. J. Physiol. Heart Circ. Physiol. Jan 22 [Epub ahead of print] (2010). *
Biltagi MA, Baset AA, Bassiouny M, Kasrawi MA, Attia M. Omega-3 fatty acids, vitamin C and Zn supplementation in asthmatic children: a randomized self-controlled study. Acta Paediatr. 98: 737-742 (2009).
Bilz S, Samuel V, Morino K, Savage D, Choi CS, Shulman GI. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters. Am. J. Physiol. Endocrinol. Metab. 290: E716-E722 (2006). *
Bingham S. The fibre-folate debate in colo-rectal cancer. Proc. Nutr. Soc. 65: 19-23 (2006). *
Binion DG, Rafiee P. Is inflammatory bowel disease a vascular disease? Targeting angiogenesis improves chronic inflammation in inflammatory bowel disease. Gastroenterology 136: 400-403 (2009). *
Biolato M, Gabrieli ML, Parente A, Racco S, Costantini M, Bonomo L, Rapaccini GL, Gasbarrini G, Grieco A. Abdominal angina due to recurrence of cancer of the papilla of Vater: a case report. J. Med. Case Reports 3: 9314 (2009). *
Biondo PD, Brindley DN, Sawyer MB, Field CJ. The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J. Nutr. Biochem. 19: 787-796 (2008). *
Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat. Rev. Immunol. 7: 93-104 (2007). *
Bischoff SC, Gebhardt T. Role of mast cells and eosinophils in neuroimmune interactions regulating mucosal inflammation in inflammatory bowel disease. Adv. Exp. Med. Biol. 579: 177-208 (2006).
Bischoff SC, Kramer S. Human mast cells, bacteria, and intestinal immunity. Immunol. Rev. 217: 329-337 (2007). *
Biselli PM, Guerzoni AR, de Godoy MF, Eberlin MN, Haddad R, Carvalho VM, Vannucchi H, Pavarino-Bertelli EC, Goloni-Bertollo EM. Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease. J. Thromb. Thrombolysis 29: 32-40 (2010).
Biselli PM, Sanches de Alvarenga MP, Abbud-Filho M, Ferreira-Baptista MA, Galbiatti AL, Goto MT, Cardoso MA, Eberlin MN, Haddad R, Goloni-Bertollo EM, Pavarino-Bertelli EC. Effect of folate, vitamin B(6), and vitamin B(12) intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients. Transplant. Proc. 39: 3163-3165 (2007). *
Bises G, Bajna E, Manhardt T, Gerdenitsch W, Kallay E, Cross HS. Gender-specific modulation of markers for premalignancy by nutritional soy and calcium in the mouse colon. J. Nutr. 137: 211S-215S (2007). *
Bishop NA, Guarente L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat. Rev. Genet. 8: 835-844 (2007). *
Bishop-Bailey D, Wray J. Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation. Prostaglandins Other Lipid Mediat. 71: 1-22 (2003).
Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, Jennane F, Grasset E, Sermet I, de Blic J, Lenoir G, Robert JJ. Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis. J. Pediatr. 152: 540-545.e1 (2008). *
Bismuth M, Aguilar-Martinez P, Michel H. Hereditary haemochromatosis. Presse. Med. 32: 1716-1723 (2003).
Bisschop PH, Bandsma RH, Stellaard F, Ter Harmsel A, Meijer AJ, Sauerwein HP, Kuipers F, Romijn JA. Low-fat, high-carbohydrate and high-fat, low-carbohydrate diets decrease primary bile acid synthesis in humans. Am. J. Clin. Nutr. 79: 570-576 (2004). *
Bistrian BR. Clinical aspects of essential fatty acid metabolism: Jonathan Rhoads Lecture. JPEN J. Parenter. Enteral Nutr. 27: 168-175 (2003). *
Bistrian BR. Role of the systemic inflammatory response in the development of protein-energy malnutrition in inflammatory bowel disease. Nestle Nutr. Workshop Ser. Clin. Perform. Programme 2: 1-6 (1999).
Biyikli NK, Gokce I, Cakalagoglu F, Arbak S, Alpay H. The co-existence of membranoproliferative glomerulonephritis type 1 and coeliac disease: a case report. Pediatr. Nephrol. 24: 1247-1250 (2009).
Bizzozero OA, Reyes S, Ziegler J, Smerjac S. Lipid peroxidation scavengers prevent the carbonylation of cytoskeletal brain proteins induced by glutathione depletion. Neurochem. Res. 32: 2114-2122 (2007). *
Bjarnason I. Intestinal permeability. Gut 35: S18-S22 (1994). *
Bjorkkjaer T, Araujo P, Madland TM, Berstad A, Froyland L. A randomized double blind comparison of short-term duodenally administrated whale and seal blubber oils in patients with inflammatory bowel disease and joint pain. Prostaglandins Leukot. Essent. Fatty Acids 81: 425-432 (2009). *
Bjorkkjaer T, Brun JG, Valen M, Arslan G, Lind R, Brunborg LA, Berstad A, Froyland L. Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease. Lipids Health Dis. 5: 6 (2006). *
Bjorkkjaer T, Brunborg LA, Arslan G, Lind RA, Brun JG, Valen M, Klementsen B, Berstad A, Froyland L. Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil. Scand. J. Gastroenterol. 39: 1088-1094 (2004). *
Bjorksten B. Environmental influences on the development of the immune system: consequences for disease outcome. Nestle Nutr. Workshop Ser. Pediatr. Program. 61: 243-254 (2008).
Bjornsson E. Management of primary sclerosing cholangitis. Minerva Gastroenterol. Dietol. 55: 163-172 (2009).
Bjornsson E, Chapman RW. Sclerosing cholangitis. Curr. Opin. Gastroenterol. 19: 270-275 (2003).
Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J. Immunol. 169: 5595-600 (2002). *
Black PN, Sharpe S. Dietary fat and asthma: is there a connection? Eur. Respir. J. 10: 6-12 (1997). *
Black RE, Allen LH, Bhutta ZA, Caulfield LE, de Onis M, Ezzati M, Mathers C, Rivera J; for the Maternal and Child Undernutrition Study Group. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 371: 243-260 (2008). *
Blackburn GL. Nutrition and inflammatory events: highly unsaturated fatty acids (omega-3 vs omega-6) in surgical injury. Proc. Soc. Exp. Biol. Med. 200: 183-188 (1992).
Blackburn GL, Mun EC. Effects of weight loss surgeries on liver disease. Semin. Liver Dis. 24: 371-379 (2004).
Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 116: 536-547 (2006). *
Blanchard DS. Omega-3 fatty acid supplementation in perinatal settings. MCN Am. J. Matern. Child. Nurs. 31: 250-256 (2006).
Blanchard RK, Cousins RJ. Regulation of intestinal gene expression by dietary zinc: induction of uroguanylin mRNA by zinc deficiency. J. Nutr. 130: 1393S-1398S (2000). *
Blanckaert V, Ulmann L, Mimouni V, Antol J, Brancquart L, Chenais B. Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. Int. J. Oncol. 36: 737-742 (2010).
Blanco Quiros A, Arranz Sanz E, Bernardo Ordiz D, Garrote Adrados JA. From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome. Allergol. Immunopathol. (Madr.) 37: 208-215 (2009). *
Blaner WS, O'Byrne SM, Wongsiriroj N, Kluwe J, D'Ambrosio D, Jiang H, Schwabe RF, Hillman EM, Piantedosi R, Libien J. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim. Biophys. Acta 1791: 467-473 (2009). *
Blaney S, Beaudry M, Latham M, Thibault M. Nutritional status and dietary adequacy in rural communities of a protected area in Gabon. Public Health Nutr. 12: 1946-1959 (2009).
Blaszyk H, Wild PJ, Oliveira A, Kelly DG, Burgart LJ. Hepatic copper in patients receiving long-term total parenteral nutrition. J. Clin. Gastroenterol. 39: 318-320 (2005).
Blau J, Sridhar S, Mathieson S, Chawla A. Effects of protein/nonprotein caloric intake on parenteral nutrition associated cholestasis in premature infants weighing 600-1000 grams. JPEN J. Parenter. Enteral Nutr. 31: 487-490 (2007). *
Blavy P, Gondret F, Guillou H, Lagarrigue S, Martin PG, van Milgen J, Radulescu O, Siegel A. A minimal model for hepatic fatty acid balance during fasting: application to PPAR alpha-deficient mice. J. Theor. Biol. 261: 266-278 (2009). *
Blazovics A. From free radicals to science of nutrition. Orv. Hetil. 150: 53-63 (2009).
Blazovics A, Hagymasi K, Pronai L. Cytokines, prostaglandins, nutritive and non-nuitritive factors in inflammatory bowel diseases. Orv. Hetil. 145: 2523-2529 (2004).
Blazovics A, Szentmihalyi K, Pronai L, Hagymasi K, Lugasi A, Kovacs A, Feher J. Redox homeostasis in inflammatory bowel diseases. Orv. Hetil. 145: 1459-1166 (2004).
Blei AT, Cordoba J; Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am. J. Gastroenterol. 96: 1968-1976 (2001). *
Bloch AS. Low carbohydrate diets, pro: time to rethink our current strategies. Nutr. Clin. Pract. 20: 3-12 (2005).
Block G, Jensen CD, Norkus EP, Dalvi TB, Wong LG, McManus JF, Hudes ML. Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study. Nutr. J. 6: 30 (2007). *
Block RC, Duff R, Lawrence P, Kakinami L, Brenna JT, Shearer GC, Meednu N, Mousa S, Friedman A, Harris WS, Larson M, Georas S. The effects of EPA, DHA, and aspirin ingestion on plasma lysophospholipids and autotaxin. Prostaglandins Leukot. Essent. Fatty Acids Jan 25 [Epub ahead of print] (2010). *
Blomhoff R, Berg T, Norum KR. Transfer of retinol from parenchymal to stellate cells in liver is mediated by retinol-binding protein. Proc. Natl. Acad. Sci. U.S.A. 85: 3455-3458 (1988). *
Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J. Neurobiol. 66: 606-630 (2006).
Blomhoff R, Green MH, Berg T, Norum KR. Transport and storage of vitamin A. Science 250: 399-404 (1990). *
Blomhoff R, Wake K. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J. 5: 271-277 (1991). *
Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H. Alteration of protein glycosylation in liver diseases. J. Hepatol. 50: 592-603 (2009). *
Bloomfeld RS, Graham BG, Schiffman SS, Killenberg PG. Alterations of chemosensory function in end-stage liver disease. Physiol. Behav. 66: 203-207 (1999).
Blum R, Kiy T, Tanaka S, Wong AW, Roberts A. Genotoxicity and subchronic toxicity studies of DHA-rich oil in rats. Regul. Toxicol. Pharmacol. 49: 271-284 (2007). *
Blum S, Schiffrin EJ. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria? Curr. Issues Intest. Microbiol. 4: 53-60 (2003).
Blumberg B, Sabbagh W Jr, Juguilon H, Bolado J Jr, van Meter CM, Ong ES, Evans RM. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 12: 3195-3205 (1998). *
Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, Pedrazzini T, Berger CT, Dirnhofer S, Matter CM, Penninger JM, Luscher TF, Eriksson U. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ. Res. 105: 912-920 (2009).
Bocca C, Bozzo F, Martinasso G, Canuto RA, Miglietta A. Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells. Br. J. Nutr. 100: 739-750 (2008). *
Bochkis IM, Rubins NE, White P, Furth EE, Friedman JR, Kaestner KH. Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress. Nat. Med. 14: 828-836 (2008). *
Bochkis IM, Schug J, Rubins NE, Chopra AR, O'Malley BW, Kaestner KH. Foxa2-dependent hepatic gene regulatory networks depend on physiological state. Physiol. Genomics 38: 186-195 (2009). *
Bode C, Bode JC. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol Clin. Exp. Res. 29: 166S-171S (2005).
Boden G. High or low carbohydrate diets: which is better for weight loss, insulin resistance and fatty livers? Gastroenterology 136: 1490-1492 (2009). *
Bodger K. Economic implications of biological therapies for Crohn's disease: review of infliximab. Pharmacoeconomics 23: 875-888 (2005).
Bodineau A, Folliguet M, Seguier S. Tissular senescence and modifications of oral ecosystem in the elderly: risk factors for mucosal pathologies. Curr. Aging Sci. 2: 109-120 (2009).
Body-Malapel M, Dharancy S, Berrebi D, Louvet A, Hugot JP, Philpott DJ, Giovannini M, Chareyre F, Pages G, Gantier E, Girardin SE, Garcia I, Hudault S, Conti F, Sansonetti PJ, Chamaillard M, Desreumaux P, Dubuquoy L, Mathurin P. NOD2: a potential target for regulating liver injury. Lab. Invest. 88: 318-327 (2008). *
Boeke CE, Mora-Plazas M, Forero Y, Villamor E. Intestinal protozoan infections in relation to nutritional status and gastrointestinal morbidity in Colombian school children. J. Trop. Pediatr. Jan 8 [Epub ahead of print] (2010).
Boelsma E, Hendriks HF, Roza L. Nutritional skin care: health effects of micronutrients and fatty acids. Am. J. Clin. Nutr. 73: 853-864 (2001). *
Bohme M, Nitz I, Doring F, Klapper M. Analysis of the transcriptional regulation of the FABP2 promoter haplotypes by PPARgamma/RXRalpha and Oct-1. Biochim. Biophys. Acta 1779: 616-621 (2008). *
Bokor S, Koletzko B, Decsi T. Systematic review of fatty acid composition of human milk from mothers of preterm compared to full-term infants. Ann. Nutr. Metab. 51: 550-556 (2008).
Boldt AB, Luty A, Grobusch MP, Dietz K, Dzeing A, Kombila M, Kremsner PG, Kun JF. Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun. 7: 393-400 (2006). *
Bolin T, Bare M, Caplan G, Daniells S, Holyday M. Malabsorption may contribute to malnutrition in the elderly. Nutrition Jan 22 [Epub ahead of print] (2010). *
Boll M, Foltz M, Rubio-Aliaga I, Kottra G, Daniel H. Functional characterization of two novel mammalian electrogenic proton-dependent amino acid cotransporters. J. Biol. Chem. 277: 22966-22973 (2002). *
Bollheimer LC, Buettner R, Kullmann A, Kullmann F. Folate and its preventive potential in colorectal carcinogenesis. How strong is the biological and epidemiological evidence? Crit. Rev. Oncol. Hematol. 55: 13-36 (2005).
Bolte G, Seilmeier W, Wieser H, Holm K, Beuermann K, Newport B, Stern M. Enhanced peptide-binding capacities of small intestinal brush border membranes in celiac disease. Pediatr. Res. 46: 666-670 (1999). *
Bommareddy A, Arasada BL, Mathees DP, Dwivedi C. Chemopreventive effects of dietary flaxseed on colon tumor development. Nutr. Cancer 54: 216-222 (2006). *
Bommareddy A, Zhang X, Schrader D, Kaushik RS, Zeman D, Matthees DP, Dwivedi C. Effects of dietary flaxseed on intestinal tumorigenesis in apc(min) mouse. Nutr. Cancer 61: 276-283 (2009).
Bonamico M, Mazzilli MC, Morellini M, Vania A, Carpino F, Nicotra MR, Natali PG. Expression of class II MHC antigens in the intestinal epithelium of pediatric celiac disease. J. Pediatr. Gastroenterol. Nutr. 9: 269-275 (1989).
Bonamico M, Nenna R, Luparia RP, Perricone C, Montuori M, Lucantoni F, Castronovo A, Mura S, Turchetti A, Strappini P, Tiberti C. Radioimmunological detection of anti-transglutaminase autoantibodies in human saliva: a useful test to monitor celiac disease follow-up. Aliment. Pharmacol. Ther. 28: 364-370 (2008). *
Bonamico M, Nenna R, Luparia RP, Perricone C, Montuori M, Lucantoni F, Castronovo A, Mura S, Turchetti A, Strappini P, Tiberti C. Radioimmunological detection of anti-transglutaminase autoantibodies in human saliva: a useful test to monitor coeliac disease follow-up. Aliment. Pharmacol. Ther. 28: 364-370 (2008). *
Bonamico M, Sabbatella L, Di Tola M, Vetrano S, Ferri M, Nenna R, Mariani P, Picarelli A. Antiendomysial antibody detection in biopsy culture allows avoidance of gluten challenge in celiac children. J. Pediatr. Gastroenterol. Nutr. 40: 165-169 (2005). *
Bonamico M, Thanasi E, Mariani P, Nenna R, Luparia RP, Barbera C, Morra I, Lerro P, Guariso G, De Giacomo C, Scotta S, Pontone S, Carpino F, Magliocca FM; Societa Italiana di Gastroenterologica, Epatologia, e Nutrizione Pediatrica. Duodenal bulb biopsies in celiac disease: a multicenter study. J. Pediatr. Gastroenterol. Nutr. 47: 618-622 (2008). *
Bonet ML, Oliver J, Pico C, Felipe F, Ribot J, Cinti S, Palou A. Opposite effects of feeding a vitamin A-deficient diet and retinoic acid treatment on brown adipose tissue uncoupling protein 1 (UCP1), UCP2 and leptin expression. J. Endocrinol. 166: 511-517 (2000). *
Bonet ML, Ribot J, Felipe F, Palou A. Vitamin A and the regulation of fat reserves. Cell. Mol. Life Sci. 60: 1311-1321 (2003).
Bongiovanni KD, Depeters EJ, VAN Eenennaam AL. Neonatal growth rate and development of mice raised on milk transgenically enriched with omega-3 fatty acids. Pediatr. Res. 62: 412-416 (2007). *
Bonilla DL, Fan YY, Chapkin RS, McMurray DN. Transgenic mice enriched in omega-3 fatty acids are more susceptible to pulmonary tuberculosis: impaired resistance to tuberculosis in fat-1 mice. J. Infect. Dis. Jan 6 [Epub ahead of print] (2010). *
Bonilla S, Redonnet A, Noel-Suberville C, Groubet R, Pallet V, Higueret P. Effect of a pharmacological activation of PPAR on the expression of RAR and TR in rat liver. J. Physiol. Biochem. 57: 1-8 (2001).
Bonilla S, Redonnet A, Noel-Suberville C, Pallet V, Garcin H, Higueret P. High-fat diets affect the expression of nuclear retinoic acid receptor in rat liver. Br. J. Nutr. 83: 665-671 (2000). *
Bonin A, Khan NA. Regulation of calcium signalling by docosahexaenoic acid in human T-cells. Implication of CRAC channels. J. Lipid Res. 41: 277-284 (2000). *
Boniotto M, Braida L, Baldas V, Not T, Ventura A, Vatta S, Radillo O, Tedesco F, Percopo S, Montico M, Amoroso A, Crovella S. Evidence of a correlation between mannose binding lectin and celiac disease: a model for other autoimmune diseases. J. Mol. Med. 83: 308-315 (2005). *
Bonkovsky HL. Hepatic manifestations of systemic disease. Clin. Liver Dis. 6: xiii-xiv (2002). *
Bonnet E, Touyarot K, Alfos S, Pallet V, Higueret P, Abrous DN. Retinoic acid restores adult hippocampal neurogenesis and reverses spatial memory deficit in vitamin A deprived rats. PLoS ONE 3: e3487 (2008). *
Bonofiglio D, Cione E, Qi H, Pingitore A, Perri M, Catalano S, Vizza D, Panno ML, Genchi G, Fuqua SA, Ando S. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells. Am. J. Pathol. 175: 1270-1280 (2009). *
Booth IW. The nutritional consequences of gastrointestinal disease in adolescence. Acta Paediatr. Scand. Suppl. 373: 91-102 (1991).
Booth SL. Roles for vitamin K beyond coagulation. Annu. Rev. Nutr. 29: 89-110 (2009). *
Borchers AT, Keen CL, Gershwin ME. Mushrooms, tumors, and immunity: an update. Exp. Biol. Med. (Maywood) 229: 393-406 (2004). *
Borchers AT, Selmi C, Cheema G, Keen CL, Shoenfeld Y, Gershwin ME. Juvenile idiopathic arthritis. Autoimmun. Rev. 5: 279-298 (2006).
Borchert DH. Cavoportal hemitransposition for the simultaneous thrombosis of the caval and portal systems - a review of the literature. Ann. Hepatol. 7: 200-211 (2008). *
Bordoni A, Di Nunzio M, Danesi F, Biagi PL. Polyunsaturated fatty acids: from diet to binding to PPARs and other nuclear receptors. Genes Nutr. 1: 95-106 (2006). *
Borel P, Drai J, Faure H, Fayol V, Galabert C, Laromiguiere M, Le Moel G. Recent knowledge about intestinal absorption and cleavage of carotenoids. Ann. Biol. Clin. (Paris) 63: 165-177 (2005).
Borges K. Mouse models: the ketogenic diet and polyunsaturated fatty acids. Epilepsia 49 Suppl. 8: 64-66 (2008).
Born P. Carbohydrate malabsorption in patients with non-specific abdominal complaints. World J. Gastroenterol. 13: 5687-5691 (2007). *
Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis. J. Pediatr. 155: S73-S93 (2009).
Borradale D, Kimlin M. Vitamin D in health and disease: an insight into traditional functions and new roles for the 'sunshine vitamin'. Nutr. Res. Rev. 22: 118-136 (2009).
Borrelli F, Izzo AA. Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Best Pract. Res. Clin. Endocrinol. Metab. 23: 33-49 (2009).
Borrelli O, Barbara G, Di Nardo G, Cremon C, Lucarelli S, Frediani T, Paganelli M, De Giorgio R, Stanghellini V, Cucchiara S. Neuroimmune interaction and anorectal motility in children with food allergy-related chronic constipation. Am. J. Gastroenterol. 104: 454-463 (2009).
Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig. Liver Dis. 36: 342-347 (2004).
Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, Russo PM, Cucchiara S. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin. Gastroenterol. Hepatol. 4: 744-753 (2006).
Borsonelo EC, Galduroz JC. The role of polyunsaturated fatty acids (PUFAs) in development, aging and substance abuse disorders: review and propositions. Prostaglandins Leukot. Essent. Fatty Acids 78: 237-245 (2008). *
Borszewska-Kornacka KM, Bober-Olesinska K. Nutrition in infants with BPD after hospital discharged. Przegl. Lek. 66: 61-64 (2009).
Borthakur A, Bhattacharyya S, Alrefai WA, Tobacman JK, Ramaswamy K, Dudeja PK. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. Inflamm. Bowel Dis. Aug 27 [Epub ahead of print] (2009).
Borthakur A, Bhattacharyya S, Dudeja PK, Tobacman JK. Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G829-G838 (2007). *
Borthwick L; on behalf of the UK Study Group. The effects of an omega-3 ethyl ester concentrate on blood lipid concentrations in patients with hyperlipidaemia. Clin. Drug Investig. 15: 397-404 (1998).
Borum M, Fromm H. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: first controlled data. Hepatology 12: 172-173 (1990).
Borum PR. Carnitine in parenteral nutrition. Gastroenterology 137: S129-S134 (2009). *
Bos AP, Tibboel D, Hazebroek FW, Bergmeijer JH, van Kalsbeek EJ, Molenaar JC. Total parenteral nutrition associated cholestasis: a predisposing factor for sepsis in surgical neonates? Eur. J. Pediatr. 149: 351-353 (1990).
Bosca MM, Anon R, Mayordomo E, Villagrasa R, Balza N, Amoros C, Corts JR, Benages A. Methotrexate induced sprue-like syndrome. World J. Gastroenterol. 14: 7009-7011 (2008). *
Bosco P, Gueant-Rodriguez RM, Anello G, Spada R, Romano A, Fajardo A, Caraci F, Ferri R, Gueant JL. Association of homocysteine (but not of MTHFR 677 C>T, MTR 2756 A>G, MTRR 66 A>G and TCN2 776 C>G) with ischaemic cerebrovascular disease in Sicily. Thromb. Haemost. 96: 154-159 (2006).
Bose M, Hao X, Ju J, Husain A, Park S, Lambert JD, Yang CS. Inhibition of tumorigenesis in Apc(Min/+) mice by a combination of (-)-epigallocatechin-3-gallate and fish oil. J. Agric. Food Chem. 55: 7695-7700 (2007). *
Bosetti C, Pelucchi C, La Vecchia C. Diet and cancer in Mediterranean countries: carbohydrates and fats. Public Health Nutr. 12: 1595-1600 (2009).
Bossa F, Caserta L, Selvaggi F, Riegler G. Infliximab in refractory, severe ulcerative colitis: a case report. Minerva Gastroenterol. Dietol. 51: 261-262 (2005).
Bosse T, Piaseckyj CM, Burghard E, Fialkovich JJ, Rajagopal S, Pu WT, Krasinski SD. Gata4 is essential for the maintenance of jejunal-ileal identities in the adult mouse small intestine. Mol. Cell. Biol. 26: 9060-9070 (2006). *
Bostick RM, Potter JD, Kushi LH, Sellers TA, Steinmetz KA, McKenzie DR, Gapstur SM, Folsom AR. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5: 38-52 (1994).
Botella Romero F, Alfaro Martinez JJ. Nutritional repercussions and management of chronic pancreatitis. Nutr. Hosp. 23 Suppl. 2: 59-63 (2008).
Botes L, van der Westhuizen FH, Loots du T. Phytochemical contents and antioxidant capacities of two Aloe greatheadii var. davyana extracts. Molecules 13: 2169-2180 (2008).
Botolin D, Wang Y, Christian B, Jump DB. Docosahexaneoic acid [22:6,n-3] regulates rat hepatocyte sterol regulatory element binding protein-1 (SREBP-1) nuclear abundance by Erk- and 26S proteasome-dependent pathways. J. Lipid Res. 47: 181-192 (2006). *
Botoman VA, Bonner GF, Botoman DA. Management of inflammatory bowel disease. Am. Fam. Physician 57: 57-68, 71-72 (1998).
Bott C, Lembcke B, Stein J. Colorectal cancer and folate. Z. Gastroenterol. 41: 263-270 (2003).
Boubaker J, Feki M, Hsairi M, Fekih M, Kaabachi N, Filali A, Mebazaa A. Osteoporosis and inflammatory bowel disease: prevalence and risk factors in Tunisian patients. Gastroenterol. Clin. Biol. 27: 901-907 (2003).
Boucher BJ. Comment on "Vitamin D discovery outpaces FDA decision making". Bioessays 30: 508-509 (2008). *
Boudrault C, Bazinet RP, Kang JX, Ma DW. Cyclooxygenase-2 and n-6 PUFA are lower and DHA is higher in the cortex of fat-1 mice. Neurochem. Int. Jan 8 [Epub ahead of print] (2010).
Boudrault C, Bazinet RP, Ma DW. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J. Nutr. Biochem. 20: 1-10 (2009). *
Bougarne N, Paumelle R, Caron S, Hennuyer N, Mansouri R, Gervois P, Staels B, Haegeman G, De Bosscher K. PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB. Proc. Natl. Acad. Sci. U.S.A. 106: 7397-7402 (2009). *
Bougnoux P, Giraudeau B, Couet C. Diet, cancer, and the lipidome. Cancer Epidemiol. Biomarkers Prev. 15: 416-421 (2006). *
Bougnoux P, Hajjaji N, Ferrasson MN, Giraudeau B, Couet C, Le Floch O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br. J. Cancer 101: 1978-1985 (2009). *
Bougnoux P, Hajjaji N, Maheo K, Couet C, Chevalier S. Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic regrowth. Prog. Lipid Res. Aug 25 [Epub ahead of print] (2009). *
Bougnoux P, Menanteau J. Dietary fatty acids and experimental carcinogenesis. Bull. Cancer 92: 685-696 (2005).
Bouhet S, Oswald IP. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet. Immunol. Immunopathol. 108: 199-209 (2005). *
Bouillon R, Verstuyf A, Mathieu C, Van Cromphaut S, Masuyama R, Dehaes P, Carmeliet G. Vitamin D resistance. Best Pract. Res. Clin. Endocrinol. Metab. 20: 627-645 (2006).
Boukhettala N, Leblond J, Claeyssens S, Faure M, Le Pessot F, Bole-Feysot C, Hassan A, Mettraux C, Vuichoud J, Lavoinne A, Breuille D, Dechelotte P, Coeffier M. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. Am. J. Physiol. Endocrinol. Metab. 296: E182-E190 (2009). *
Bouneva I, Kirby DF. Management of nonalcoholic fatty liver disease: weight control. Clin. Liver Dis. 8: 693-713, xii (2004).
Bourges O, Dorgeret S, Alberti C, Hugot JP, Sebag G, Cezard JP. Low bone mineral density in children with Crohn's disease. Arch. Pediatr. 11: 800-806 (2004).
Bourlioux P, Koletzko B, Guarner F, Braesco V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium "The Intelligent Intestine," held in Paris, June 14, 2002. Am. J. Clin. Nutr. 78: 675-683 (2003). *
Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J. Nutr. Health Aging 10: 377-385 (2006).
Bourre JM. Dietary omega-3 fatty acids and psychiatry: mood, behaviour, stress, depression, dementia and aging. J. Nutr. Health Aging 9: 31-38 (2005).
Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 8: 163-174 (2004).
Bourre JM. Omega-3 fatty acids in psychiatry. Med. Sci. (Paris) 21: 216-221 (2005).
Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J. Nutr. Health Aging 10: 386-399 (2006).
Bourre JM. Dietary omega-3 fatty acids for women. Biomed. Pharmacother. 61: 105-112 (2007).
Bourre JM, Galea F. An important source of omega-3 fatty acids, vitamins D and E, carotenoids, iodine and selenium: a new natural multi-enriched egg. J. Nutr. Health Aging 10: 371-376 (2006).
Bourre JM, Paquotte P. Seafood (wild and farmed) for the elderly: contribution to the dietary intakes of iodine, selenium, DHA and vitamins B12 and D. J. Nutr. Health Aging 12: 186-192 (2008).
Bourreille A, Humbert B, Maugere P, Galmiche JP, Darmaun D. Glutamine metabolism in Crohn's disease: a stable isotope study. Clin. Nutr. 23: 1167-1175 (2004).
Bourriaud C, Robins RJ, Martin L, Kozlowski F, Tenailleau E, Cherbut C, Michel C. Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident. J. Appl. Microbiol. 99: 201-212 (2005). *
Boursi B, Arber N. Small bowel malignancies: why are they so rare? Harefuah. 143: 727-732, 765 (2004).
Bouscarel B, Kroll SD, Fromm H. Signal transduction and hepatocellular bile acid transport: cross talk between bile acids and second messengers. Gastroenterology 117: 433-452 (1999). *
Bousquet M, Gibrat C, Saint-Pierre M, Julien C, Calon F, Cicchetti F. Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 in a parkinsonian animal model. Prog. Neuropsychopharmacol. Biol. Psychiatry 33: 1401-1408 (2009).
Boussetta T, Raad H, Letteron P, Gougerot-Pocidalo MA, Marie JC, Driss F, El-Benna J. Punicic acid a conjugated linolenic acid inhibits TNFalpha-induced neutrophil hyperactivation and protects from experimental colon inflammation in rats. PLoS One 4: e6458 (2009). *
Bousvaros A, Guandalini S, Baldassano RN, Botelho C, Evans J, Ferry GD, Goldin B, Hartigan L, Kugathasan S, Levy J, Murray KF, Oliva-Hemker M, Rosh JR, Tolia V, Zholudev A, Vanderhoof JA, Hibberd PL. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm. Bowel Dis. 11: 833-839 (2005). *
Bousvaros A, Sylvester F, Kugathasan S, Szigethy E, Fiocchi C, Colletti R, Otley A, Amre D, Ferry G, Czinn SJ, Splawski JB, Oliva-Hemker M, Hyams JS, Faubion WA, Kirschner BS, Dubinsky MC; and the Members of the Challenges in Pediatric IBD Study Groups. Challenges in pediatric inflammatory bowel disease. Inflamm. Bowel Dis. 12: 885-913 (2006). *
Bousvaros A, Zurakowski D, Duggan C, Law T, Rifai N, Goldberg NE, Leichtner AM. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J. Pediatr. Gastroenterol. Nutr. 26: 129-135 (1998). *
Bouter B, Geary N, Langhans W, Asarian L. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha. Metabolism Dec 30 [Epub ahead of print] (2009). *
Bouwens M, Afman LA, Muller M. Activation of peroxisome proliferator-activated receptor alpha in human peripheral blood mononuclear cells reveals an individual gene expression profile response. BMC Genomics 9: 262 (2008). *
Bouzaidi S, Ben Salem M, Mnif N, Ben Hammouda I, Ben Yedder J, Trabelsi S, Moussa A, Jemaa Y, Debbech R, Salem M, Najjar T, Hamza R. Bone mineral density in patients with Crohn's disease: about 53 cases. Tunis. Med. 82: 753-759 (2004).
Bowden RG, Wilson RL, Gentile M, Ounpraseuth S, Moore P, Leutholtz BC. Effects of omega-3 fatty acid supplementation on vascular access thrombosis in polytetrafluorethylene grafts. J. Ren. Nutr. 17: 126-131 (2007). *
Bower RH. Hepatic complications of parenteral nutrition. Semin. Liver Dis. 3: 216-224 (1983).
Bowling TE, Price AB, al-Adnani M, Fairclough PD, Menzies-Gow N, Silk DB. Interchange between collagenous and lymphocytic colitis in severe disease with autoimmune associations requiring colectomy: a case report. Gut 38: 788-791 (1996). *
Boyartchuk V, Dietrich W. Genetic dissection of host immune response. Genes Immun. 3: 119-122 (2002). *
Boyle E, Ridgway PF, Keane FB, Neary P. Laparoscopic colonic resection in inflammatory bowel disease: minimal surgery, minimal access and minimal hospital stay. Colorectal Dis. 10: 911-915 (2008). *
Boyle MP. Adult cystic fibrosis. JAMA 298: 1787-1793 (2007). *
Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, Bassuk AG, Kessler JA, Reed MC, Nijhout HF, George TM, Enterline DS, Gilbert JR, Speer MC. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ. Health Perspect. 114: 1547-1552 (2006). *
Bozzola M, Giovenale D, Bozzola E, Meazza C, Martinetti M, Tinelli C, Corazza GR. Growth hormone deficiency and coeliac disease: an unusual association? Clin. Endocrinol. (Oxf.) 62: 372-375 (2005). *
Bracken SC, Kilmartin C, Wieser H, Jackson J, Feighery C. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa. Aliment. Pharmacol. Ther. 23: 1307-1314 (2006). *
Brackenridge AL, Jackson N, Jefferson W, Stolinski M, Shojaee-Moradie F, Hovorka R, Umpleby AM, Russell-Jones D. Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with type 2 diabetes and normal lipids. Diabet. Med. 26: 532-539 (2009).
Braden B, Faust D, Ignee A, Schreiber D, Hirche T, Dietrich CF. Clinical relevance of perihepatic lymphadenopathy in acute and chronic liver disease. J. Clin. Gastroenterol. 42: 931-936 (2008).
Bradley R, Oberg EB, Calabrese C, Standish LJ. Algorithm for complementary and alternative medicine practice and research in type 2 diabetes. J. Altern. Complement. Med. 13: 159-176 (2007).
Bradley RL, Fisher FM, Maratos-Flier E. Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes. Obesity (Silver Spring) 16: 938-944 (2008). *
Bradna P. Gout and diabetes. Vnitr. Lek. 52: 488-492 (2006).
Braegger CP, MacDonald TT. Immune mechanisms in chronic inflammatory bowel disease. Ann. Allergy 72: 135-141 (1994).
Bragg LE, Thompson JS, Rikkers LF. Influence of nutrient delivery on gut structure and function. Nutrition 7: 237-243 (1991).
Bragin V, Chemodanova M, Dzhafarova N, Bragin I, Czerniawski JL, Aliev G. Integrated treatment approach improves cognitive function in demented and clinically depressed patients. Am. J. Alzheimers Dis. Other Demen. 20: 21-26 (2005).
Bragt MC, Popeijus HE. Peroxisome proliferator-activated receptors and the metabolic syndrome. Physiol. Behav. 94: 187-197 (2008). *
Braillon A. Nutrition and nonalcoholic fatty liver disease? Still in search of evidence! Am. J. Gastroenterol. 102: 1134 (2007). *
Branche J, Cortot A, Bourreille A, Coffin B, de Vos M, de Saussure P, Seksik P, Marteau P, Lemann M, Colombel JF. Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy. Inflamm. Bowel Dis. 15: 1044-1048 (2009). *
Brand A, Bauer NG, Hallott A, Goldbaum O, Ghebremeskel K, Reifen R, Richter-Landsberg C. Membrane lipid modification by polyunsaturated fatty acids sensitizes oligodendroglial OLN-93 cells against oxidative stress and promotes upregulation of heme oxygenase-1 (HSP32). J. Neurochem. Jan 22 [Epub ahead of print] (2010).
Brand A, Schonfeld E, Isharel I, Yavin E. Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage. J. Neurochem. 105: 1325-1335 (2008). *
Brand RE. Screening for familial pancreatic cancer: is doing something better than doing nothing? Gut 58: 1321-1322 (2009).
Brandacher G, Hoeller E, Fuchs D, Weiss HG. Chronic immune activation underlies morbid obesity: is IDO a key player? Curr. Drug Metab. 8: 289-295 (2007).
Brandimarte G, Tursi A, Giorgetti GM. Changing trends in clinical form of celiac disease. Which is now the main form of celiac disease in clinical practice? Minerva Gastroenterol. Dietol. 48: 121-130 (2002).
Brandtzaeg P. 'ABC' of mucosal immunology. Nestle Nutr. Workshop Ser. Pediatr. Program 64: 23-43 (2009).
Brandtzaeg P. Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses? Acta Odontol. Scand. 59: 235-243 (2001). *
Brandtzaeg P. Impact of immunodeficiency on immunological hoemostasis in the gut. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 61-62. September 12 - 13 (2003). *
Brandtzaeg P, Baekkevold ES, Farstad IN, Jahnsen FL, Johansen FE, Nilsen EM, Yamanaka T. Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol. Today 20: 141-151 (1999).
Brandtzaeg PE. Current understanding of gastrointestinal immunoregulation and its relation to food allergy. Ann. N. Y. Acad. Sci. 964: 13-45 (2002). *
Brannagan TH 3rd, Hays AP, Chin SS, Sander HW, Chin RL, Magda P, Green PH, Latov N. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch. Neurol. 62: 1574-1578 (2005). *
Brannon PM, Yetley EA, Bailey RL, Picciano MF. Summary of roundtable discussion on vitamin D research needs. Am. J. Clin. Nutr. 88: 587S-592S (2008). *
Branten AJ, Swinkels DW, Klasen IS, Wetzels JF. Serum ferritin levels are increased in patients with glomerular diseases and proteinuria. Nephrol. Dial. Transplant. 19: 2754-2760 (2004). *
Brantsaeter AL, Haugen M, Samuelsen SO, Torjusen H, Trogstad L, Alexander J, Magnus P, Meltzer HM. A dietary pattern characterized by high intake of vegetables, fruits, and vegetable oils is associated with reduced risk of preeclampsia in nulliparous pregnant Norwegian women. J. Nutr. 139: 1162-1168 (2009). *
Brantsaeter AL, Haugen M, Thomassen Y, Ellingsen DG, Ydersbond TA, Hagve TA, Alexander J, Meltzer HM. Exploration of biomarkers for total fish intake in pregnant Norwegian women. Public Health Nutr. 13: 54-62 (2010).
Brar P, Kwon GY, Holleran S, Bai D, Tall AR, Ramakrishnan R, Green PH. Change in lipid profile in celiac disease: beneficial effect of gluten-free diet. Am. J. Med. 119: 786-790 (2006). *
Brar P, Lee AR, Lewis SK, Bhagat G, Green PH. Celiac disease in African-Americans. Dig. Dis. Sci. 51: 1012-1015 (2006). *
Brar P, Lee S, Lewis S, Egbuna I, Bhagat G, Green PH. Budesonide in the treatment of refractory celiac disease. Am. J. Gastroenterol. 102: 2265-2269 (2007). *
Brasaemle DL. Cell biology. A metabolic push to proliferate. Science 313: 1581-1582 (2006). *
Braun A, Treede I, Gotthardt D, Tietje A, Zahn A, Ruhwald R, Schoenfeld U, Welsch T, Kienle P, Erben G, Lehmann WD, Fuellekrug J, Stremmel W, Ehehalt R. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis. Inflamm. Bowel Dis. 15: 1705-1720 (2009). *
Braun J, Arnemann J, Lohrey M, Donner H, Siegmund T, Usadel KH, Badenhoop K. No association between the deltaF508 cystic fibrosis mutation and type 2 diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 107: 568-569 (1999).
Braun N, Wade N, Wakeland E, Major A. Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr-/- mice. Lupus 17: 1070-1078 (2008). *
Brautbar N, Williams J 2nd. Industrial solvents and liver toxicity: risk assessment, risk factors and mechanisms. Int. J. Hyg. Environ. Health 205: 479-491 (2002).
Bravo E, Napolitano M, Lopez-Soldado I, Valeri M, Botham KM, Stefanutti C. Hypercholesterolaemia alters the responses of the plasma lipid profile and inflammatory markers to supplementation of the diet with n-3 polyunsaturated fatty acids from fish oil. Eur. J. Clin. Invest. 36: 788-795 (2006). *
Brazionis L, Rowley K, Itsiopoulos C, O'Dea K. Plasma carotenoids and diabetic retinopathy. Br. J. Nutr. 101: 270-277 (2009). *
Brazle AE, Johnson BJ, Webel SK, Rathbun TJ, Davis DL. Omega-3 fatty acids in the gravid pig uterus as affected by maternal supplementation with omega-3 fatty acids. J. Anim. Sci. 87: 994-1002 (2009). *
Breant B, Gesina E, Blondeau B. Nutrition, glucocorticoids and pancreas development. Horm. Res. 65 Suppl. 3: 98-104 (2006).
Breckwoldt MO, Chen JW, Stangenberg L, Aikawa E, Rodriguez E, Qiu S, Moskowitz MA, Weissleder R. Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc. Natl. Acad. Sci. U.S.A. 105: 18584-18589 (2008). *
Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, Walker-Smith JA, MacDonald TT. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106: 1455-1466 (1994).
Bregenzer N, Lange A, Furst A, Gross V, Scholmerich J, Andus T. Patient education in inflammatory bowel disease does not influence patients knowledge and long-term psychosocial well-being. Z. Gastroenterol. 43: 367-371 (2005).
Breinholt V, Lauridsen ST, Daneshvar B, Jakobsen J. Dose-response effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett. 154: 201-210 (2000). *
Breitling LP, Raum E, Muller H, Rothenbacher D, Brenner H. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 49: 802-808 (2009). *
Bremer LA, Blackman SM, Vanscoy LL, McDougal KE, Bowers A, Naughton KM, Cutler DJ, Cutting GR. Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis. Hum. Mol. Genet. 17: 2228-2237 (2008). *
Bremner AR, Beattie RM. Recent advances in the medical therapy of Crohn's disease in childhood. Expert Opin. Pharmacother. 8: 2553-2568 (2007).
Brenna JT, Salem N Jr, Sinclair AJ, Cunnane SC; for the International Society for the Study of Fatty Acids and Lipids, ISSFAL. alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fatty Acids 80: 85-91 (2009). *
Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am. J. Clin. Nutr. 85: 1457-1464 (2007). *
Bresalier RS. Chemoprevention of colorectal cancer: why all the confusion? Curr. Opin. Gastroenterol. 24: 48-50 (2008). *
Bresci G, Parisi G, Banti S. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment. Eur. J. Med. 2: 414-416 (1993).
Breslow JL. n-3 Fatty acids and cardiovascular disease. Am. J. Clin. Nutr. 83: 1477S-1482S (2006). *
Bresson JL, Schmitz J. Malnutrition in Crohn's disease: substrate deficiency or misuse? Horm. Res. 38 Suppl. 1: 76-78 (1992).
Brewer GJ. The risks of free copper in the body and the development of useful anticopper drugs. Curr. Opin. Clin. Nutr. Metab. Care 11: 727-732 (2008).
Brewer HB Jr, Santamarina-Fojo S. New insights into the role of the adenosine triphosphate-binding cassette transporters in high-density lipoprotein metabolism and reverse cholesterol transport. Am. J. Cardiol. 91: 3E-11E (2003). *
Briand F, Treguier M, Andre A, Grillot D, Issandou M, Ouguerram K, Sulpice T. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model. J. Lipid Res. Oct 27 [Epub ahead of print] (2009). *
Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun. Rev. 7: 644-650 (2008).
Briani C, Zara G, Alaedini A, Grassivaro F, Ruggero S, Toffanin E, Albergoni MP, Luca M, Giometto B, Ermani M, De Lazzari F, D'Odorico A, Battistin L. Neurological complications of celiac disease and autoimmune mechanisms: a prospective study. J. Neuroimmunol. 195: 171-175 (2008).
Briani C, Zara G, Toffanin E, Ruggero S, Ferrarini A, DE Lazzari F, Luca M, Faggian D, Grassivaro F, Ermani M, Pezzani R, Giometto B, D'Odorico A. Neurological complications of celiac disease and autoimmune mechanisms: preliminary data of a prospective study in adult patients. Ann. N. Y. Acad. Sci. 1051: 148-155 (2005). *
Briceno-Perez C, Briceno-Sanabria L, Vigil-De Gracia P. Prediction and prevention of preeclampsia. Hypertens. Pregnancy 28: 138-155 (2009).
Bridges KR. Iron overload and chelation therapy. ENCYCLOPEDIA OF LIFE SCIENCES Nature Publishing Group www.els.net (2001). *
Briede JJ, van Delft JM, de Kok TM, van Herwijnen MH, Maas LM, Gottschalk RW, Kleinjans JC. Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in Caco-2 cells. Toxicol. Sci. Dec 31 [Epub ahead of print] (2009). *
Brigelius-Flohe R. Induction of drug metabolizing enzymes by vitamin E. J. Plant Physiol. 162: 797-802 (2005).
Brigelius-Flohe R. Vitamin E and drug metabolism. Biochem. Biophys. Res. Commun. 305: 737-740 (2003). *
Bright JJ. Curcumin and autoimmune disease. Adv. Exp. Med. Biol. 595: 425-451 (2007).
Brigman C, Feranchak A. Liver involvement in cystic fibrosis. Curr. Treat. Options Gastroenterol. 9: 484-496 (2006).
Brihier H, Nion-Larmurier I, Afchain P, Tiret E, Beaugerie L, Gendre JP, Cosnes J. Intestinal perforation in Crohn's disease. Gastroenterol. Clin. Biol. 29: 1105-1111 (2005). *
Briskey EN, Pamies RJ. Colorectal cancer: update on recent advances and their impact on screening protocols. J. Natl. Med. Assoc. 92: 222-230 (2000).
Brix S, Lund P, Kjaer TM, Straarup EM, Hellgren LI, Frokiaer H. CD4+ T cell activation is differentially modulated by bacteria-primed dendritic cells, but generally downregulated by n-3 polyunsaturated fatty acids. Immunology 129: 338-350 (2010). *
Brochot A, Guinot M, Macaire JP, Weill P, Grynberg A, Rousseau-Ralliard D. Effects of alpha-linolenic acid vs. docosahexaenoic acid supply on the distribution of fatty acids among the rat cardiac subcellular membranes after a short- or long-term dietary exposure. Nutr. Metab. (Lond.) 6: 14 (2009). *
Brockmann JG, August C, Wolters HH, Homme R, Palmes D, Baba H, Spiegel HU, Dietl KH. Sequence of reperfusion influences ischemia/reperfusion injury and primary graft function following porcine liver transplantation. Liver Transpl. 11: 1214-1222 (2005). *
Brodanova M. Cholestasis. Vnitr. Lek. 49: 689-695 (2003).
Brodeur H, Parisotto M, Chagnon S, Mader S, Bhat PV. Isomer-specific retinoic acid biosynthesis in HeLa cells expressing recombinant class I aldehyde dehydrogenases. Biochim. Biophys. Acta 1770: 1548-1556 (2007). *
Broekaert IJ, Walker WA. Probiotics and chronic disease. J. Clin. Gastroenterol. 40: 270-274 (2006).
Broere F, du Pre MF, van Berkel LA, Garssen J, Schmidt-Weber CB, Lambrecht BN, Hendriks RW, Nieuwenhuis EE, Kraal G, Samsom JN. Cyclooxygenase-2 in mucosal DC mediates induction of regulatory T cells in the intestine through suppression of IL-4. Mucosal Immunol. 2: 254-264 (2009).
Broide E, Scapa E, Bloch O, Shapiro M, Kimchi NA, Ben-Yehudah G, Rapoport MJ. Evidence for aberrant regulation of MAP kinase signal transduction pathway in peripheral blood mononuclear cells in patients with active celiac disease. Dig. Dis. Sci. 54: 1270-1275 (2009). *
Bronner F. Calcium nutrition and metabolism. Dent. Clin. North Am. 47: 209-224 (2003).
Brookes KJ, Chen W, Xu X, Taylor E, Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol. Psychiatry 60: 1053-1061 (2006). *
Brookes MJ, Hughes S, Turner FE, Reynolds G, Sharma N, Ismail T, Berx G, McKie AT, Hotchin N, Anderson GJ, Iqbal T, Tselepis C. A modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55: 1449-1460 (2006). *
Brooks AD, Hochwald SN, Heslin MJ, Harrison LE, Burt M, Brennan MF. Intestinal permeability after early postoperative enteral nutrition in patients with upper gastrointestinal malignancy. JPEN J. Parenter. Enteral Nutr. 23: 75-79 (1999).
Brooks-Worrell B, Warsen A, Palmer JP. Improved T cell assay for identification of type 1 diabetes patients. J. Immunol. Methods 344: 79-83 (2009).
Brosnan JT, da Silva R, Brosnan ME. Amino acids and the regulation of methyl balance in humans. Curr. Opin. Clin. Nutr. Metab. Care 10: 52-57 (2006).
Bross DA, Leichtner AM, Zurakowski D, Law T, Bousvaros A. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. J. Pediatr. Gastroenterol. Nutr. 23: 164-171 (1996). *
Brottveit M, Lundin KE. Cancer risk in coeliac disease. Tidsskr. Nor. Laegeforen. 128: 2312-2315 (2008).
Broughton KS, Hahn B, Ross E. Docosahexaenoic acid and eicosapentaenoic acid affect ovarian prostaglandin levels differently in rats. Nutr. Res. 29: 510-518 (2009). *
Broughton KS, Wade JW. Total fat and (n-3):(n-6) fat ratios influence eicosanoid production in mice. J. Nutr. 132: 88-94 (2002). *
Brousse N, Meijer JW. Malignant complications of coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19: 401-412 (2005).
Brousseau ME. ATP-binding cassette transporter A1, fatty acids, and cholesterol absorption. Curr. Opin. Lipidol. 14: 35-40 (2003).
Brousseau ME, Schaefer EJ, Dupuis J, Eustace B, Van Eerdewegh P, Goldkamp AL, Thurston LM, FitzGerald MG, Yasek-McKenna D, O'Neill G, Eberhart GP, Weiffenbach B, Ordovas JM, Freeman MW, Brown RH Jr, Gu JZ. Novel mutations in the gene encoding ATP-binding cassette 1 in four tangier disease kindreds. J. Lipid Res. 41: 433-441 (2000). *
Brouwer IA. Omega-3 PUFA: good or bad for prostate cancer? Prostaglandins Leukot. Essent. Fatty Acids 79: 97-99 (2008). *
Brouwer IA, Geelen A, Katan MB. n-3 Fatty acids, cardiac arrhythmia and fatal coronary heart disease. Prog. Lipid Res. 45: 357-367 (2006). *
Brouwer IA, Heeringa J, Geleijnse JM, Zock PL, Witteman JC. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am. Heart J. 151: 857-862 (2006). *
Brouwer IA, Raitt MH, Dullemeijer C, Kraemer DF, Zock PL, Morris C, Katan MB, Connor WE, Camm JA, Schouten EG, McAnulty J. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur. Heart J. 30: 820-826 (2009).
Brouwer IA, Zock PL, Camm AJ, Bocker D, Hauer RN, Wever EF, Dullemeijer C, Ronden JE, Katan MB, Lubinski A, Buschler H, Schouten EG; SOFA Study Group. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 295: 2613-2619 (2006). *
Brown AC, Shovic A, Ibrahim SA, Holck P, Huang A. A non-dairy probiotic's (poi) influence on changing the gastrointestinal tract's microflora environment. Altern. Ther. Health Med. 11: 58-64 (2005). *
Brown AC, Valiere A. Probiotics and medical nutrition therapy. Nutr. Clin. Care 7: 56-68 (2004). *
Brown AJ, Slatopolsky E. Vitamin D analogs: therapeutic applications and mechanisms for selectivity. Mol. Aspects Med. 29: 433-452 (2008).
Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG. Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J. Am. Soc. Nephrol. 18: 1732-1739 (2007). *
Brown IL. Applications and uses of resistant starch. J. AOAC Int. 87: 727-732 (2004).
Brown JB, Lee G, Managlia E, Grimm GR, Dirisina R, Goretsky T, Cheresh P, Blatner NR, Khazaie K, Yang GY, Li L, Barrett TA. Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis. Gastroenterology 138: 595-605.e3 (2010). *
Brown JC, Jiang X. Prevalence of antibiotic-resistant bacteria in herbal products. J. Food Prot. 71: 1486-1490 (2008).
Brown JM, Chung S, Sawyer JK, Degirolamo C, Alger HM, Nguyen TM, Zhu X, Duong MN, Brown AL, Lord C, Shah R, Davis MA, Kelley K, Wilson MD, Madenspacher J, Fessler MB, Parks JS, Rudel LL. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30: 24-30 (2010).
Brown KJ, Jewells V, Herfarth H, Castillo M. White matter lesions suggestive of amyotrophic lateral sclerosis attributed to celiac disease. AJNR Am. J. Neuroradiol. Nov 12 [Epub ahead of print] (2009).
Brown KK, Blaikie FH, Smith RA, Tyndall JD, Lue H, Bernhagen J, Winterbourn CC, Hampton MB. Direct modification of the pro-inflammatory cytokine migration inhibitory factor by dietary isothiocyanates. J. Biol. Chem. 284: 32425-32433 (2009). *
Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol. Rev. 22: 283-297 (2000). *
Brown MD, Hart C, Gazi E, Gardner P, Lockyer N, Clarke N. Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer. Br. J. Cancer Dec 8 [Epub ahead of print] (2009). *
Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW. Promotion of prostatic metastatic migration towards human bone marrow stoma by omega 6 and its inhibition by omega 3 PUFAs. Br. J. Cancer 94: 842-853 (2006). *
Brown N, Nagarkatti M, Nagarkatti PS. Diethylstilbestrol alters positive and negative selection of T cells in the thymus and modulates T-cell repertoire in the periphery. Toxicol. Appl. Pharmacol. 212: 119-126 (2006). *
Brownawell AM, Harris WS, Hibbeln JR, Klurfeld DM, Newton I, Yates A. Assessing the environment for regulatory change for eicosapentaenoic acid and docosahexaenoic acid nutrition labeling. Nutr. Rev. 67: 391-397 (2009). *
Browne WJ, Wood CJ, Desai M, Weller PH. Urinary incontinence in 9-16 year olds with cystic fibrosis compared to other respiratory conditions and a normal group. J. Cyst. Fibros. 8: 50-57 (2009).
Browning BL, Huebner C, Petermann I, Demmers P, McCulloch A, Gearry RB, Barclay ML, Shelling AN, Ferguson LR. Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant. Inflamm. Bowel Dis. 13: 1069-1076 (2007). *
Browning BL, Huebner C, Petermann I, Gearry RB, Barclay ML, Shelling AN, Ferguson LR. Has Toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am. J. Gastroenterol. 102: 2504-2512 (2007). *
Browning JD, Davis J, Saboorian MH, Burgess SC. A low-carbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content. Hepatology 44: 487-488 (2006). *
Browning LM. n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. Proc. Nutr. Soc. 62: 447-453 (2003). *
Browning LM, Krebs JD, Moore CS, Mishra GD, O'Connell MA, Jebb SA. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes. Metab. 9: 70-80 (2007). *
Bruce KD, Cagampang FR, Argenton M, Zhang J, Ethirajan PL, Burdge GC, Bateman AC, Clough GF, Poston L, Hanson MA, McConnell JM, Byrne CD. Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology 50: 1796-1808 (2009).
Bruce WR, Cirocco M, Giacca A, Kim YI, Marcon N, Minkin S. A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation. Br. J. Cancer 93: 639-646 (2005).
Bruchfeld A, Qureshi AR, Lindholm B, Barany P, Yang L, Stenvinkel P, Tracey KJ. High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD). Mol. Med. 14: 109-115 (2008). *
Brugman S, Visser JT, Hillebrands JL, Bos NA, Rozing J. Prolonged exclusive breastfeeding reduces autoimmune diabetes incidence and increases regulatory T-cell frequency in bio-breeding diabetes-prone rats. Diabetes Metab. Res. Rev. 25: 380-387 (2009).
Brugnon F, Bilan F, Heraud MC, Grizard G, Janny L, Creveaux I. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance � Fertil. Steril. 90: 2004.e23-e26 (2008).
Bruinsma KA, Taren DL. Dieting, essential fatty acid intake, and depression. Nutr. Rev. 58: 98-108 (2000).
Brunborg LA, Madland TM, Lind RA, Arslan G, Berstad A, Froyland L. Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil. Clin. Nutr. 27: 614-622 (2008).
Brunelleschi S, Bardelli C, Amoruso A, Gunella G, Ieri F, Romani A, Malorni W, Franconi F. Minor polar compounds extra-virgin olive oil extract (MPC-OOE) inhibits NF-kappaB translocation in human monocyte/macrophages. Pharmacol. Res. 56: 542-549 (2007). *
Brunner J, Parhofer KG, Schwandt P, Bronisch T. Cholesterol, essential fatty acids, and suicide. Pharmacopsychiatry 35: 1-5 (2002).
Brunser O, Gotteland M, Cruchet S. Functional fermented milk products. Nestle Nutr. Workshop Ser. Pediatr. Program 60: 235-250 (2007).
Brunton S, Collins N. Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids. Curr. Med. Res. Opin. 23: 1139-1145 (2007).
Brusilow SW. Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion. Pediatr. Res. 29: 147-150 (1991).
Bryce J, Coitinho D, Darnton-Hill I, Pelletier D, Pinstrup-Andersen P; for the Maternal and Child Undernutrition Study Group. Maternal and child undernutrition: effective action at national level. Lancet 371: 510-526 (2008). *
Bryhn M, Hansteen H, Schanche T, Aakre SE. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters. Prostaglandins Leukot. Essent. Fatty Acids 75: 19-24 (2006). *
Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children. Pharmacotherapy 22: 188-211 (2002).
Bu SY, Mashek MT, Mashek DG. Suppression of long chain acyl-CoA synthetase 3 (ACSL3) decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J. Biol. Chem. 284: 30474-30483 (2009). *
Buaud B, Esterle L, Vaysse C, Alfos S, Combe N, Higueret P, Pallet V. A high-fat diet induces lower expression of retinoid receptors and their target genes GAP-43/neuromodulin and RC3/neurogranin in the rat brain. Br. J. Nutr. Jan 27 [Epub ahead of print] (2010). *
Bucci P, Carile F, Sangianantoni A, D'Angio F, Santarelli A, Lo Muzio L. Oral aphthous ulcers and dental enamel defects in children with coeliac disease. Acta Paediatr. 95: 203-207 (2006).
Buchanan E, Gaunt W, Cardigan T, Garrick V, McGrogan P, Russell R. The use of exclusive enteral nutrition (EEN) for induction of remission in children with Crohn's disease (CD) demonstrates that disease phenotype does not influence clinical remission. Aliment. Pharmacol. Ther. 30: 501-507 (2009). *
Buchman AL. Catheter-related complications of total parenteral nutrition. Am. J. Gastroenterol. 102 Suppl. 1: S97-S101 (2007). *
Buchman AL. Hepatobiliary complications of parenteral nutrition. Am. J. Gastroenterol. 102 Suppl. 1: S106-S111 (2007). *
Buchman AL. The addition of choline to parenteral nutrition. Gastroenterology 137: S119-S128 (2009). *
Buchman AL. Bones and Crohn's: problems and solutions. Inflamm. Bowel Dis. 5: 212-227 (1999).
Buchman AL, Howard LJ, Guenter P, Nishikawa RA, Compher CW, Tappenden KA. Micronutrients in parenteral nutrition: too little or too much? The past, present, and recommendations for the future. Gastroenterology 137: S1-S6 (2009). *
Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 43: 9-19 (2006). *
Buchman AL, Moukarzel AA, Bhuta S, Belle M, Ament ME, Eckhert CD, Hollander D, Gornbein J, Kopple JD, Vijayaroghavan SR. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J. Parenter. Enteral Nutr. 19: 453-460 (1995).
Buckley DB, Klaassen CD. Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of AhR, CAR, PXR, PPARalpha, and Nrf2. Drug Metab. Dispos. 37: 847-856 (2009). *
Buckley O, Brien JO, Ward E, Doody O, Govender P, Torreggiani WC. The imaging of coeliac disease and its complications. Eur. J. Radiol. 65: 483-490 (2008).
Bucuvalas J, Yazigi N, Squires Jr RH. Acute liver failure in children. Clin. Liver Dis. 10: 149-168 (2006).
Bucuvalas JC, Zeng L, Anand R, The Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Predictors of length of stay for pediatric liver transplant recipients. Liver Transpl. 10: 1011-1017 (2004). *
Budhu AS, Noy N. On the role of the carboxyl-terminal helix of RXR in the interactions of the receptor with ligand. Biochemistry 39: 4090-4095 (2000). *
Budick-Harmelin N, Dudas J, Demuth J, Madar Z, Ramadori G, Tirosh O. Triglycerides potentiate the inflammatory response in rat Kupffer cells. Antioxid. Redox Signal. 10: 2009-2022 (2008).
Budillon G. The epidemiology of cholestasis in hepatopathies. Ann. Ital. Med. Int. 8: 36S-40S (1993).
Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing "D"ecline? Mol. Aspects Med. 29: 415-422 (2008).
Bueno AA, Oyama LM, de Macedo Motoyama CS, da Silva Biz CR, Silveira VL, Ribeiro EB, Oller do Nascimento CM. Long chain saturated fatty acids increase haptoglobin gene expression in C57BL/6J mice adipose tissue and 3T3-L1 cells. Eur. J. Nutr. Oct 25 [Epub ahead of print] (2009). *
Bueno AA, Oyama LM, de Oliveira C, Pisani LP, Ribeiro EB, Silveira VL, Oller do Nascimento CM. Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue. Pflugers Arch. 455: 701-709 (2008). *
Bueno L, Fioramonti J. Protease-activated receptor 2 and gut permeability: a review. Neurogastroenterol. Motil. 20: 580-587 (2008).
Bueter M, Lowenstein C, Olbers T, Wang M, Cluny NL, Bloom SR, Sharkey KA, Lutz TA, Le Roux CW. Gastric bypass increases energy expenditure in rats. Gastroenterology Nov 17 [Epub ahead of print] (2009).
Buettner C, Phillips RS, Davis RB, Gardiner P, Mittleman MA. Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks. Am. J. Cardiol. 99: 661-666 (2007). *
Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Scholmerich J, Bollheimer LC. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J. Mol. Endocrinol. 36: 485-501 (2006). *
Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15: 798-808 (2007). *
Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, David E, Rizzetto M, Marchesini G. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am. J. Gastroenterol. 100: 1082-1090 (2005). *
Bugianesi E, Marzocchi R, Villanova N, Marchesini G. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Pract. Res. Clin. Gastroenterol. 18: 1105-1116 (2004).
Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, Garcia-Urkia N, Sarasqueta C, Cosme A, Irastorza B, Gonzalez A, Arenas J Jr. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol. 8: 40 (2008). *
Bujanover Y, Weiss B. Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases. Isr. Med. Assoc. J. 10: 634-639 (2008). *
Buller HA. Problems in diagnosis of IBD in children. Neth. J. Med. 50: S8-S11 (1997).
Bultron G, Latif U, Park A, Phatak U, Pashankar D, Husain SZ. Acute pancreatitis in a child with celiac disease. J. Pediatr. Gastroenterol. Nutr. 49: 137-138 (2009).
Bunger M, Hooiveld GJ, Kersten S, Muller M. Exploration of PPAR functions by microarray technology - a paradigm for nutrigenomics. Biochim. Biophys. Acta 1771: 1046-1064 (2007). *
Bunger M, van den Bosch HM, van der Meijde J, Kersten S, Hooiveld GJ, Muller M. Genome-wide analysis of PPARalpha activation in murine small intestine. Physiol. Genomics 30: 192-204 (2007). *
Buning J, Homann N, von Smolinski D, Borcherding F, Noack F, Stolte M, Kohl M, Lehnert H, Ludwig D. Helminths as governors of inflammatory bowel disease. Gut 57: 1182-1183 (2008).
Burakoff R. Inflammatory bowel disease workshop. Vail, Colorado, March 22 and 23, 1998. Less commonly used therapies for IBD or treatments on the fringe. Inflamm. Bowel Dis. 4: 308-313 (1998). *
Burch LR, Zhou K, Donnelly LA, Doney AS, Brady J, Goddard C, Morris AD, Hansen MK, Palmer CN. A single nucleotide polymorphism on exon-4 of the gene encoding PPARdelta is associated with reduced height in adults and children. J. Clin. Endocrinol. Metab. 94: 2587-2593 (2009). *
Burdelski M, Rogiers X. Liver transplantation in metabolic disorders. Acta Gastroenterol. Belg. 62: 300-305 (1999).
Burdge GC. Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot. Essent. Fatty Acids 75: 161-168 (2006). *
Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod. Nutr. Dev. 45: 581-597 (2005). *
Burdge GC, Powell J, Dadd T, Talbot D, Civil J, Calder PC. Acute consumption of fish oil improves postprandial VLDL profiles in healthy men aged 50-65 years. Br. J. Nutr. 102: 160-165 (2009). *
Burdge GC, Sala-Vila A, West AL, Robson HJ, Le Fevre LW, Powell J, Calder PC. The effect of altering the 20:5n-3 and 22:6n-3 content of a meal on the postprandial incorporation of n-3 polyunsaturated fatty acids into plasma triacylglycerol and non-esterified fatty acids in humans. Prostaglandins Leukot. Essent. Fatty Acids 77: 59-65 (2007). *
Burek CL, Rose NR. Autoimmune thyroiditis and ROS. Autoimmun. Rev. 7: 530-537 (2008).
Burek CL, Talor MV. Environmental triggers of autoimmune thyroiditis. J. Autoimmun. 33: 183-189 (2009).
Buretic-Tomljanovic A, Giacometti J, Nadalin S, Rubesa G, Vulin M, Tomljanovic D. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia. Psychiatr. Danub. 20: 372-383 (2008).
Burger J, Gochfeld M. Perceptions of the risks and benefits of fish consumption: individual choices to reduce risk and increase health benefits. Environ. Res. 109: 343-349 (2009). *
Burgmann T, Rawsthorne P, Bernstein CN. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use? Am. J. Gastroenterol. 99: 889-893 (2004). *
Buri C, Burri P, Bahler P, Straumann A, Muller-Schenker B, Birrer S, Mueller C. Cytotoxic T cells are preferentially activated in the duodenal epithelium from patients with florid coeliac disease. J. Pathol. 206: 178-185 (2005). *
Burja AM, Radianingtyas H, Windust A, Barrow CJ. Isolation and characterization of polyunsaturated fatty acid producing Thraustochytrium species: screening of strains and optimization of omega-3 production. Appl. Microbiol. Biotechnol. 72: 1161-1169 (2006). *
Burk K, Farecki ML, Lamprecht G, Roth G, Decker P, Weller M, Rammensee HG, Oertel W. Neurological symptoms in patients with biopsy proven celiac disease. Mov. Disord. 24: 2358-2362 (2009).
Burk RF. Selenium: recent clinical advances. Curr. Opin. Gastroenterol. 17: 162-166 (2001).
Burke A, Lichtenstein GR, Rombeau JL. Nutrition and ulcerative colitis. Baillieres Clin. Gastroenterol. 11: 153-174 (1997).
Burke KT, Horn PS, Tso P, Heubi JE, Woollett LA. Hepatic bile acid metabolism in the neonatal hamster: expansion of the bile acid pool parallels increased Cyp7a1 expression levels. Am. J. Physiol. Gastrointest. Liver Physiol. 297: G144-G151 (2009).
Burke PA, Ling PR, Forse RA, Lewis DW, Jenkins R, Bistrian BR. Sites of conditional essential fatty acid deficiency in end stage liver disease. JPEN J. Parenter. Enteral Nutr. 25: 188-193 (2001).
Burnham JM, Shults J, Semeao E, Foster BJ, Zemel BS, Stallings VA, Leonard MB. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am. J. Clin. Nutr. 82: 413-420 (2005). *
Burr ML, Dunstan FD, George CH. Is fish oil good or bad for heart disease? Two trials with apparently conflicting results. J. Membr. Biol. 206: 155-163 (2005). *
Burren KA, Savery D, Massa V, Kok RM, Scott JM, Blom HJ, Copp AJ, Greene ND. Gene-environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function. Hum. Mol. Genet. 17: 3675-3685 (2008).
Burrin DG, Stoll B. Emerging aspects of gut sulfur amino acid metabolism. Curr. Opin. Clin. Nutr. Metab. Care 10: 63-68 (2007).
Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA. Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes. Clin. Ther. 27: 1181-1195 (2005). *
Bushara KO. Neurologic presentation of celiac disease. Gastroenterology 128: S92-S97 (2005). *
Bushinsky DA, Laplante K, Asplin JR. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats. Kidney Int. 69: 1586-1592 (2006). *
Bustos D, Moret A, Tambutti M, Gogorza S, Testa R, Ascione A, Prigoshin N. Autoantibodies in Argentine women with recurrent pregnancy loss. Am. J. Reprod. Immunol. 55: 201-207 (2006). *
Butler JE, Sinkora M. The isolator piglet: a model for studying the development of adaptive immunity. Immunol. Res. 39: 33-51 (2007).
Butler LM, Wang R, Koh WP, Stern MC, Yuan JM, Yu MC. Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in Singapore Chinese: a prospective study. Int. J. Cancer 124: 678-686 (2008). *
Butler M, Boyle JJ, Powell JJ, Playford RJ, Ghosh S. Dietary microparticles implicated in Crohn's disease can impair macrophage phagocytic activity and act as adjuvants in the presence of bacterial stimuli. Inflamm. Res. 56: 353-361 (2007). *
Buts JP, Dekeyser N, Stilmant C, Delem E, Smets F, Sokal E. Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatr. Res. 60: 24-29 (2006). *
Butt MS, Sultan MT. Green tea: nature's defense against malignancies. Crit. Rev. Food Sci. Nutr. 49: 463-473 (2009).
Butt MS, Tahir-Nadeem M, Khan MK, Shabir R, Butt MS. Oat: unique among the cereals. Eur. J. Nutr. 47: 68-79 (2008). *
Butterly LF, Goodrich M, Onega T, Greene MA, Srivastava A, Burt R, Dietrich A. Improving the quality of colorectal cancer screening: assessment of familial risk. Dig. Dis. Sci. Jan 8 [Epub ahead of print] (2010). *
Butterworth RF. Complications of cirrhosis III. Hepatic encephalopathy. J. Hepatol. 32: S171-S180 (2000).
Butz DE, Li G, Huebner SM, Cook ME. A mechanistic approach to understanding conjugated linoleic acid's role in inflammation using murine models of rheumatoid arthritis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293: R669-R676 (2007). *
Buydens-Branchey L, Branchey M. n-3 Polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J. Clin. Psychopharmacol. 26: 661-665 (2006).
Buydens-Branchey L, Branchey M, Hibbeln JR. Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers. Prog. Neuropsychopharmacol. Biol. Psychiatry 32: 568-575 (2008).
Buydens-Branchey L, Branchey M, Hibbeln JR. Low plasma levels of docosahexaenoic acid are associated with an increased relapse vulnerability in substance abusers. Am. J. Addict. 18: 73-80 (2009).
Buysschaert M, Tomasi JP, Hermans MP. Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with type 1 diabetes. Diabet. Med. 22: 889-892 (2005). *
Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 23: 77-99 (2004). *
Byrd-Bredbenner C, Abbot JM. Differences in food supplies of U.S. households with and without overweight individuals. Appetite 52: 479-484 (2009).
Byrdwell WC, Devries J, Exler J, Harnly JM, Holden JM, Holick MF, Hollis BW, Horst RL, Lada M, Lemar LE, Patterson KY, Philips KM, Tarrago-Trani MT, Wolf WR. Analyzing vitamin D in foods and supplements: methodologic challenges. Am. J. Clin. Nutr. 88: 554S-557S (2008). *
Byres E, Paton AW, Paton JC, Lofling JC, Smith DF, Wilce MC, Talbot UM, Chong DC, Yu H, Huang S, Chen X, Varki NM, Varki A, Rossjohn J, Beddoe T. Incorporation of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature 456: 648-652 (2008). *
Caballeria J. Current concepts in alcohol metabolism. Ann. Hepatol. 2: 60-68 (2003). *
Caballeria L, Pares A, Rodes J. Treatment of primary biliary cirrhosis. Contributions to Science 1: 79-85 (1999). *
Cabre E, Gassull MA. Nutrition in inflammatory bowel disease: impact on disease and therapy. Curr. Opin. Gastroenterol. 17: 342-349 (2001).
Cabre E, Gassull MA. Nutrition in liver disease. Curr. Opin. Clin. Nutr. Metab. Care 8: 545-551 (2005).
Cabre E, Gassull MA. Nutritional and metabolic issues in inflammatory bowel disease. Curr. Opin. Clin. Nutr. Metab. Care 6: 569-576 (2003).
Cabre Gelada E. Nutrition and inflammatory bowel disease. Nutr. Hosp. 22 Suppl. 2: 65-73 (2007).
Cabrera R, Nelson DR. Review article: management of hepatocellular carcinoma. Aliment. Pharmacol. Ther. 31: 461-476 (2010). *
Cabrera-Abreu JC, Green A. Gamma-glutamyltransferase: value of its measurement in paediatrics. Ann. Clin. Biochem. 39: 22-25 (2002).
Cabrera-Chavez F, Barca AM. Bovine milk intolerance in celiac disease is related to IgA reactivity to alpha- and beta-caseins. Nutrition 25: 715-716 (2009). *
Cabrera-Chavez F, Rouzaud-Sandez O, Sotelo-Cruz N, Calderon de la Barca AM. Bovine milk caseins and transglutaminase-treated cereal prolamins are differentially recognized by IgA of celiac disease patients according to their age. J. Agric. Food Chem. 57: 3754-3759 (2009). *
Cacciapaglia F, Arcarese L, Rigon A, Vadacca M, Valorani MG, Pozzilli P, Afeltra A. Antinuclear antibodies prevalence in Filipinos migrated to Italy. Eur. Rev. Med. Pharmacol. Sci. 12: 267-270 (2008).
Cadahia V, Rodrigo L, Fuentes D, Riestra S, De Francisco R, Fernandez M. Celiac disease (CD), ulcerative colitis (UC), and primary sclerosing cholangitis (PSC) in one patient: a family study. Rev. Esp. Enferm. Dig. 97: 907-913 (2005). *
Caddy GR, Ardill JE, Fillmore D, Caldwell CM, McKibben BM, Gardiner KR, Watson PR. Plasma concentrations of glucagon-like peptide-2 in adult patients with treated and untreated coeliac disease. Eur. J. Gastroenterol. Hepatol. 18: 195-202 (2006).
Cadranel JF, Seddik M, Loric S, Jeanne S. Statins: hepatotoxicity and monitoring. Presse. Med. 38: 717-725 (2009).
Cadranel S, Gottrand F. Is upper gastro-intestinal endoscopy required for diagnosis and treatment of Helicobacter pylori infection in childhood? Pro and cons. Arch. Pediatr. 10: 256-259 (2003).
Caetano MC, Ortiz TT, Terreri MT, Sarni RO, Silva SG, Souza FI, Hilario MO. Inadequate dietary intake of children and adolescents with juvenile idiopathic arthritis and systemic lupus erythematosus. J. Pediatr. (Rio J.) 85: 509-515 (2009).
Cahoon EB, Shockey JM, Dietrich CR, Gidda SK, Mullen RT, Dyer JM. Engineering oilseeds for sustainable production of industrial and nutritional feedstocks: solving bottlenecks in fatty acid flux. Curr. Opin. Plant Biol. 10: 236-244 (2007). *
Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11: 183-190 (2005). *
Cai G, Cole SA, Butte NF, Smith CW, Mehta NR, Voruganti VS, Proffitt JM, Comuzzie AG. A genetic contribution to circulating cytokines and obesity in children. Cytokine 44: 242-247 (2008).
Cai W, Wu J, Hong L, Xu Y, Tang Q, Shi C. Oxidative injury and hepatocyte apoptosis in total parenteral nutrition-associated liver dysfunction. J. Pediatr. Surg. 41: 1663-1668 (2006).
Caicedo RA, Li N, DES Robert C, Scumpia PO, Hubsher CP, Wasserfall CH, Schatz DA, Atkinson MA, Neu J. Neonatal formula feeding leads to immunological alterations in an animal model of type 1 diabetes. Pediatr. Res. 63: 303-307 (2008). *
Caire-Juvera G, Ritenbaugh C, Wactawski-Wende J, Snetselaar LG, Chen Z. Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study. Am. J. Clin. Nutr. 89: 323-330 (2009). *
Cakir D, Tosun A, Polat M, Celebisoy N, Gokben S, Aydogdu S, Yagci RV, Tekgul H. Subclinical neurological abnormalities in children with celiac disease receiving a gluten-free diet. J. Pediatr. Gastroenterol. Nutr. 45: 366-369 (2007). *
Cakir M, Arikan C, Akman SA, Baran M, Saz UE, Yagci RV, Zeytunlu M, Kilic M, Aydogdu S. Infectious complications in pediatric liver transplantation candidates. Pediatr. Transplant. Mar 10 [Epub ahead of print] (2009).
Cakir M, Ozgenc F, Baran M, Arikan C, Sezak M, Tuncyurek M, Ergun O, Yagci RV. A rare cause of refractory ascites in a child: familial Mediterranean fever. Rheumatol. Int. May 23 [Epub ahead of print] (2009). *
Calabrese GC, Luczak EN, Estela Roux M. Importance of CCL25 in the attraction of T cells and the role of IL-7 on the signaling pathways in intestinal epithelial cells. Immunobiology Feb 25 [Epub ahead of print] (2009).
Calabrese V, Butterfield DA, Stella AM. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease. Ital. J. Biochem. 52: 177-181 (2003).
Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F, Bates TE, Giuffrida Stella AM, Schapira T, Dinkova Kostova AT, Rizzarelli E. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem. Res. 33: 2444-2471 (2008).
Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J. Neurol. Sci. 233: 145-162 (2005). *
Calabrese V, Scapagnini G, Colombrita C, Ravagna A, Pennisi G, Giuffrida Stella AM, Galli F, Butterfield DA. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach. Amino Acids 25: 437-444 (2003). *
Caldas CA, Lage LV, de Carvalho JF. Behcet's disease associated with celiac disease: a very rare association. Rheumatol. Int. May 15 [Epub ahead of print] (2009). *
Caldeira RJ, Fonseca VD, Gomes Junior SC, de Miranda Chaves CR. Prevalence of bone mineral disease among adolescents with cystic fibrosis. J. Pediatr. (Rio J.) 84: 18-25 (2008).
Calder PC. Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Braz. J. Med. Biol. Res. 31: 467-490 (1998). *
Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83: 1505S-1519S (2006). *
Calder PC. Use of fish oil in parenteral nutrition: rationale and reality. Proc. Nutr. Soc. 65: 264-277 (2006). *
Calder PC. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot. Essent. Fatty Acids 75: 197-202 (2006). *
Calder PC. n-3 Fatty acids, inflammation, and immunity - relevance to postsurgical and critically ill patients. Lipids 39: 1147-1161 (2004).
Calder PC. Immunological parameters: what do they mean? J. Nutr. 137: 773S-780S (2007). *
Calder PC. Fatty acids and gene expression related to inflammation. Nestle Nutr. Workshop Ser. Clin. Perform. Programme 7: 19-36 (2002).
Calder PC. Immunonutrition. BMJ 327: 117-118 (2003). *
Calder PC. n-3 Polyunsaturated fatty acids and cytokine production in health and disease. Ann. Nutr. Metab. 41: 203-234 (1997).
Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. (Lond.) 107: 1-11 (2004). *
Calder PC. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz. J. Med. Biol. Res. 36: 433-446 (2003). *
Calder PC. Branched-chain amino acids and immunity. J. Nutr. 136: 288S-293S (2006). *
Calder PC. The effects of fatty acids on lymphocyte functions. Braz. J. Med. Biol. Res. 26: 901-917 (1993).
Calder PC. Fat chance of immunomodulation. Immunol. Today 19: 244-247 (1998).
Calder PC. Dietary arachidonic acid: harmful, harmless or helpful? Br. J. Nutr. 98: 451-453 (2007). *
Calder PC. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease'. PUFA, inflammatory processes and rheumatoid arthritis. Proc. Nutr. Soc. 67: 409-418 (2008). *
Calder PC. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot. Essent. Fatty Acids 79: 101-108 (2008). *
Calder PC. Immunonutrition in surgical and critically ill patients. Br. J. Nutr. 98 Suppl. 1: S133-S139 (2007). *
Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 77: 327-335 (2007). *
Calder PC. Hot topics in parenteral nutrition. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults. Proc. Nutr. Soc. 68: 252-260 (2009). *
Calder PC. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie Feb 3 [Epub ahead of print] (2009).
Calder PC. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie. 91: 791-795 (2009).
Calder PC. Fatty acids and immune function: relevance to inflammatory bowel diseases. Int. Rev. Immunol. 28: 506-534 (2009).
Calder PC. The 2008 ESPEN Sir David Cuthbertson lecture: fatty acids and inflammation - from the membrane to the nucleus and from the laboratory bench to the clinic. Clin. Nutr. Nov 18 [Epub ahead of print] (2009).
Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36: 1007-1024 (2001).
Calder PC. n-3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38: 343-352 (2003).
Calder PC. Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 33: 423-427 (2005). *
Calder PC. Dietary modification of inflammation with lipids. Proc. Nutr. Soc. 61: 345-358 (2002). *
Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA, Folkerts G, Friedmann PS, Frost GS, Guarner F, L�vik M, Macfarlane S, Meyer PD, M'Rabet L, Serafini M, van Eden W, van Loo J, vas Dias W, Vidry S, Winklhofer-Roob BM, Zhao J. Nutrition and inflammatory processes. Proc. Nutr. Soc. 67(OCE): E9 (2008). *
Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA, Folkerts G, Friedmann PS, Frost GS, Guarner F, L�vik M, Macfarlane S, Meyer PD, M'Rabet L, Serafini M, van Eden W, van Loo J, Vas Dias W, Vidry S, Winklhofer-Roob BM, Zhao J. Inflammatory disease processes and interactions with nutrition. Br. J. Nutr. 101 Suppl. 1: S1-S45 (2009). *
Calder PC, Deckelbaum RJ. Omega-3 fatty acids: time to get the messages right! Curr. Opin. Clin. Nutr. Metab. Care 11: 91-93 (2008).
Calder PC, Dimitriadis G, Newsholme P. Glucose metabolism in lymphoid and inflammatory cells and tissues. Curr. Opin. Clin. Nutr. Metab. Care 10: 531-540 (2007).
Calder PC, Grimble RF. Polyunsaturated fatty acids, inflammation and immunity. Eur. J. Clin. Nutr. 56 Suppl. 3: S14-S19 (2002). *
Calder PC, Jensen GL, Koletzko BV, Singer P, Wanten GJ. Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med. Jan 14 [Epub ahead of print] (2010).
Calder PC, Kew S. The immune system: a target for functional foods? Br. J. Nutr. 88 Suppl. 2: S165-S177 (2002). *
Calder PC, Krauss-Etschmann S, de Jong EC, Dupont C, Frick JS, Frokiaer H, Heinrich J, Garn H, Koletzko S, Lack G, Mattelio G, Renz H, Sangild PT, Schrezenmeir J, Stulnig TM, Thymann T, Wold AE, Koletzko B. Early nutrition and immunity - progress and perspectives. Br. J. Nutr. 96: 774-790 (2006). *
Calder PC, Yaqoob P. Lipid rafts - composition, characterization, and controversies. J. Nutr. 137: 545-547 (2007). *
Calder PC, Yaqoob P. Omega-3 polyunsaturated fatty acids and human health outcomes. Biofactors 35: 266-272 (2009).
Calder PC, Yaqoob P. Understanding omega-3 polyunsaturated fatty acids. Postgrad. Med. 121: 148-157 (2009).
Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA. Fatty acids and lymphocyte functions. Br. J. Nutr. 87 Suppl. 1: S31-S48 (2002). *
Caldwell S, Lazo M. Is exercise an effective treatment for NASH? Knowns and unknowns. Ann. Hepatol. 8 Suppl. 1: S60-S66 (2009). *
Caldwell SH, de Freitas LA, Park SH, Moreno ML, Redick JA, Davis CA, Sisson BJ, Patrie JT, Cotrim H, Argo CK, Al-Osaimi A. Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 49: 1888-1895 (2009).
Calenda KA, Schornagel IL, Sadeghi-Nejad A, Grand RJ. Effect of recombinant growth hormone treatment on children with Crohn's disease and short stature: a pilot study. Inflamm. Bowel Dis. 11: 435-441 (2005). *
Calhoun AW, Sullivan JE. Omegaven for the treatment of parenteral nutrition associated liver disease: a case study. J. Ky. Med. Assoc. 107: 55-57 (2009).
Calis JC, Phiri KS, Faragher EB, Brabin BJ, Bates I, Cuevas LE, de Haan RJ, Phiri AI, Malange P, Khoka M, Hulshof PJ, van Lieshout L, Beld MG, Teo YY, Rockett KA, Richardson A, Kwiatkowski DP, Molyneux ME, van Hensbroek MB. Severe anemia in Malawian children. N. Engl. J. Med. 358: 888-899 (2008). *
Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N Jr, Frautschy SA, Cole GM. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur. J. Neurosci. 22: 617-626 (2005). *
Calpe-Berdiel L, Escola-Gil JC, Blanco-Vaca F. New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis 203: 18-31 (2009).
Calvisi DF, Ladu S, Hironaka K, Factor VM, Thorgeirsson SS. Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer. J. Hepatol. 41: 815-822 (2004). *
Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J. Nutr. 135: 310-316 (2005). *
Calzascia T, Loh JM, Di Berardino-Besson W, Masson F, Guillaume P, Burkhardt K, Herrera PL, Dietrich PY, Walker PR. Peripheral tolerance limits CNS accumulation of CD8 T cells specific for an antigen shared by tumor cells and normal astrocytes. Glia 56: 1625-1636 (2008).
Camargo R, Tomimori E, Neves S, Rubio I, Galrao A, Knobel M, Medeiros-Neto G. Thyroid and the environment: exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil. Eur. J. Endocrinol. 159: 293-299 (2008).
Cameron D. Fifty years of Australian pediatric gastroenterology. J. Gastroenterol. Hepatol. 24 Suppl. 3: S75-S80 (2009). *
Camilleri M. Gastroenterology and hepatology clinical research update: 2005-2006. Clin. Gastroenterol. Hepatol. 4: 1428-1433 (2006).
Camilleri M. GIH clinical research 2003-2004: the year in review. Clin. Gastroenterol. Hepatol. 2: 1043-1047 (2004). *
Caminha MD, Diniz AD, Falbo AR, Arruda IK, Serva VB, Albuquerque LL, Lola MM, Ebrahim GJ. Serum retinol concentrations in hospitalized severe protein-energy malnourished children. J. Trop. Pediatr. 54: 248-252 (2008).
Caminiti L, Passalacqua G, Magazzu G, Comisi F, Vita D, Barberio G, Sferlazzas C, Pajno GB. Chronic urticaria and associated coeliac disease in children: a case-control study. Pediatr. Allergy Immunol. 16: 428-432 (2005). *
Cammarota G, Cuoco L, Cesaro P, Santoro L, Cazzato A, Montalto M, La Mura R, Larocca LM, Vecchio FM, Gasbarrini A, Salvagnini M, Gasbarrini G. A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study. Endoscopy 39: 46-51 (2007).
Campanella J, Biagi F, Ilaria Bianchi P, Zanellati G, Marchese A, Roberto Corazza G. Clinical response to gluten withdrawal is not an indicator of coeliac disease. Scand. J. Gastroenterol. 43: 1311-1314 (2008). *
Campbell AA, Thorne-Lyman A, Sun K, de Pee S, Kraemer K, Moench-Pfanner R, Sari M, Akhter N, Bloem MW, Semba RD. Indonesian women of childbearing age are at greater risk of clinical vitamin A deficiency in families that spend more on rice and less on fruits/vegetables and animal-based foods. Nutr. Res. 29: 75-81 (2009). *
Campbell MJ, Abedin SA. Vitamin D and cancer. Expert Rev. Endocrinol. Metab. 1: 219-231 (2006). *
Campbell SE, Musich PR, Whaley SG, Stimmel JB, Leesnitzer LM, Dessus-Babus S, Duffourc M, Stone W, Newman RA, Yang P, Krishnan K. Gamma tocopherol upregulates the expression of 15-S-HETE and induces growth arrest through a PPAR gamma-dependent mechanism in PC-3 human prostate cancer cells. Nutr. Cancer 61: 649-662 (2009).
Campion J, Milagro FI, Goyenechea E, Martinez JA. TNF-alpha promoter methylation as a predictive biomarker for weight-loss response. Obesity (Silver Spring) 17: 1293-1297 (2009). *
Campisi G, Di Liberto C, Carroccio A, Compilato D, Iacono G, Procaccini M, Di Fede G, Lo Muzio L, Craxi A, Catassi C, Scully C. Coeliac disease: oral ulcer prevalence, assessment of risk and association with gluten-free diet in children. Dig. Liver Dis. 40: 104-107 (2008).
Campisi G, Di Liberto C, Iacono G, Compilato D, Di Prima L, Calvino F, Di Marco V, Lo Muzio L, Sferlazza C, Scalici C, Crax� A, Carroccio A. Oral pathology in untreated coeliac disease. Aliment. Pharmacol. Ther. 26: 1529-1536 (2007). *
Campo GM, Avenoso A, Campo S, D'Ascola A, Traina P, Sama D, Calatroni A. Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J. Cell. Biochem. 106: 83-92 (2009). *
Campolongo P, Roozendaal B, Trezza V, Cuomo V, Astarita G, Fu J, McGaugh JL, Piomelli D. Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. Proc. Natl. Acad. Sci. U.S.A. 106: 8027-8031 (2009). *
Campos FG, Logullo Waitzberg AG, Kiss DR, Waitzberg DL, Habr-Gama A, Gama-Rodrigues J. Diet and colorectal cancer: current evidence for etiology and prevention. Nutr. Hosp. 20: 18-25 (2005).
Campos FG, Waitzberg DL, Logulo AF, Torrinhas RS, Teixeira WG, Habr-Gama A. Immunonutrition in experimental colitis: beneficial effects of omega-3 fatty acids. Arq. Gastroenterol. 39: 48-54 (2002).
Campos FG, Waitzberg DL, Teixeira MG, Mucerino DR, Kiss DR, Habr-Gama A. Pharmacological nutrition in inflammatory bowel diseases. Nutr. Hosp. 18: 57-64 (2003).
Campos-Bowers MH, Wittenmyer BF. Biofortification in China: practice and policy. Health Res. Policy Syst. 5: 10 (2007).
Camuesco D, Comalada M, Concha A, Nieto A, Sierra S, Xaus J, Zarzuelo A, Galvez J. Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis. Clin. Nutr. 25: 466-476 (2006).
Camuesco D, Galvez J, Nieto A, Comalada M, Rodriguez-Cabezas ME, Concha A, Xaus J, Zarzuelo A. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J. Nutr. 135: 687-694 (2005). *
Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodr�guez M, Almaden Y. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate. Nephrol. Dial. Transplant. Nov 23 [Epub ahead of print] (2009).
Canales A, Bastida S, Librelottto J, Nus M, Sanchez-Muniz FJ, Benedi J. Platelet aggregation, eicosanoid production and thrombogenic ratio in individuals at high cardiovascular risk consuming meat enriched in walnut paste. A crossover, placebo-controlled study. Br. J. Nutr. 102: 134-141 (2009). *
Canales P, Mery VP, Larrondo FJ, Bravo FL, Godoy J. Epilepsy and celiac disease: favorable outcome with a gluten-free diet in a patient refractory to antiepileptic drugs. Neurologist 12: 318-321 (2006).
Canales RP, Araya QM, Alliende GF, Hunter MB, Alarcon OT, Chavez SE. Diagnosis and clinical presentations of celiac disease: a multicenter study. Rev. Med. Chil. 136: 296-303 (2008).
Candela G, Di Libero L, Varriale S, Manetta F, Giordano M, Lanza M, Argenziano G, Pizza A, Sciascia V, Napolitano S, Riccio M, Esposito D, Santini L. Diagnostic and therapeutic guidelines for entero-cutaneous fistulas. Personal experience and literature review. Minerva Chir. 62: 293-303 (2007).
Cangemi FE. TOZAL study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD. BMC Ophthalmol. 7: 3 (2007). *
Canhao H, Fonseca JE, Caetano-Lopes J, Saldanha C, Queiroz MV. Assessment of laboratory measurements and -308 TNFalpha gene promoter polymorphisms in normal bone mineral density. Clin. Rheumatol. 27: 301-307 (2008). *
Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck AM, Lambert DM, Muccioli GG, Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103 (2009). *
Cankurtaran M, Ulger Z, Dogan S, Balam Yavuz B, Halil M, Gullu I, Gedikoglu G, Aniogul S. Complications due to late diagnosis of celiac disease with co-existing plasma cell dyscrasia in an elderly patient. Aging Clin. Exp. Res. 18: 75-77 (2006).
Cannioto Z, Berti I, Martelossi S, Bruno I, Giurici N, Crovella S, Ventura A. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur. J. Pediatr. 168: 149-155 (2009). *
Cannistraci C, Lesnoni La Parola I, Cardinali G, Bolasco G, Aspite N, Stigliano V, Picardo M. Co-localization of IgA and TG3 on healthy skin of coeliac patients. J. Eur. Acad. Dermatol. Venereol. 21: 509-514 (2007). *
Cansell MS, Battin A, Degrace P, Gresti J, Clouet P, Combe N. Early dissimilar fates of liver eicosapentaenoic acid in rats fed liposomes or fish oil and gene expression related to lipid metabolism. Lipids 44: 237-247 (2009).
Cantarero Vallejo MD, Gomez Camarero J, Menchen L, Pajares Diaz JA, Lo Iacono O. Liver damage and celiac disease. Rev. Esp. Enferm. Dig. 99: 648-652 (2007). *
Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc. Soc. Exp. Biol. Med. 223: 230-233 (2000). *
Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol. 92: 60-64 (2006). *
Cantorna MT. Vitamin D and multiple sclerosis: an update. Nutr. Rev. 66: S135-S138 (2008). *
Cantorna MT, Mahon BD. D-hormone and the immune system. J. Rheumatol. Suppl. 76: 11-20 (2005). *
Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood) 229: 1136-1142 (2004). *
Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130: 2648-252 (2000). *
Cantorna MT, Nashold FE, Hayes CE. Vitamin A deficiency results in a priming environment conducive for Th1 cell development. Eur. J. Immunol. 25: 1673-1679 (1995).
Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr. 80: 1717S-1720S (2004). *
Canzian F, Kaaks R, Cox DG, Henderson KD, Henderson BE, Berg C, Bingham S, Boeing H, Buring J, Calle EE, Chanock SJ, Clavel-Chapelon F, Dossus L, Spencer Feigelson H, Haiman CA, Hankinson SE, Hoover R, Hunter DJ, Isaacs C, Lenner P, Lund E, et al. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). BMC Cancer 9: 257 (2009). *
Capell WH, Eckel RH. Severe hypertriglyceridemia with a history of treatment failure. Nat. Clin. Pract. Endocrinol. Metab. 1: 53-58 (2005). *
Capobianco E, Mart�nez N, Higa R, White V, Jawerbaum A. The effects of maternal dietary treatments with natural PPAR ligands on lipid metabolism in fetuses from control and diabetic rats. Prostaglandins Leukot. Essent. Fatty Acids 79: 191-199 (2008). *
Capobianco E, White V, Higa R, Mart�nez N, Jawerbaum A. Effects of natural ligands of PPARgamma on lipid metabolism in placental tissues from healthy and diabetic rats. Mol. Hum. Reprod. 14: 491-499 (2008). *
Caponi A, Lisotti A, Grenci C, Roda E. Are therapeutic doses of ursodeoxycholic acid in the cure of primary biliary cirrhosis inadequate? Some clinical considerations. Minerva Gastroenterol. Dietol. 54: 331-334 (2008).
Cappell MS. Hepatobiliary manifestations of the acquired immune deficiency syndrome. Am. J. Gastroenterol. 86: 1-15 (1991).
Cappell MS. Gastric and duodenal ulcers during pregnancy. Gastroenterol. Clin. North Am. 32: 263-308 (2003). *
Caprai S, Vajro P, Ventura A, Sciveres M, Maggiore G; SIGENP study group for autoimmune liver disorders in celiac disease. Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clin. Gastroenterol. Hepatol. 6: 803-806 (2008).
Capriles VD, Martini LA, Areas JA. Metabolic osteopathy in celiac disease: importance of a gluten-free diet. Nutr. Rev. 67: 599-606 (2009). *
Caprilli R, Frieri G. The dyspeptic macrophage 30 years later: and update in the pathogenesis of Crohn's disease. Dig. Liver Dis. 41: 166-168 (2009).
Capristo E, Valentini G, Scarfone A, Addolorato G, Giancaterini A, Ghittoni G, Mingrone G, Greco AV, Gasbarrini G. Alterations of nutrional status in the main gastro-intestinal pathologies. Minerva Gastroenterol. Dietol. 45: 137-151 (1999).
Capron JP, Sevenet F, Quenum C, Doutrellot C, Capron-Chivrac D, Delamarre J. Massive hepatic steatosis disclosing adult celiac disease. Study of a case and review of the literature. Gastroenterol. Clin. Biol. 7: 256-260 (1983).
Capuano P, Bacic D, Stange G, Hernando N, Kaissling B, Pal R, Kocher O, Biber J, Wagner CA, Murer H. Expression and regulation of the renal Na/phosphate cotransporter NaPi-IIa in a mouse model deficient for the PDZ protein PDZK1. Pflugers Arch. 449: 392-402 (2005). *
Capurso G, Marignani M, Piciucchi M, Merola E, Delle Fave G. Probiotics and severe acute pancreatitis. J. Clin. Gastroenterol. 42: S148-S151 (2008).
Caputo I, Barone MV, Martucciello S, Lepretti M, Esposito C. Tissue transglutaminase in celiac disease: role of autoantibodies. Amino Acids 36: 693-699 (2009). *
Caputo M, Brizzolara R, Schiavo M, Salmaso C, Pesce G, Bagnasco M. Occurrence of overt celiac disease in the elderly following total thyroidectomy. J. Endocrinol. Invest. 29: 831-833 (2006).
Caputo M, Eletto D, Torino G, Tecce MF. Cooperation of docosahexaenoic acid and vitamin E in the regulation of UDP-glucuronosyltransferase mRNA expression. J. Cell Physiol. 215: 765-770 (2008). *
Caramaschi P, Stanzial A, Volpe A, Pieropan S, Bambara LM, Carletto A, Biasi D. Celiac disease in a rheumatology unit: a case study. Rheumatol. Int. 28: 547-551 (2008). *
Caramia G. Omega-3: from cod-liver oil to nutrigenomics. Minerva Pediatr. 60: 443-455 (2008).
Caramia G. Gastroenteric pathology and probiotics: from myth to scientific evidence. Current aspects. Minerva Gastroenterol. Dietol. 55: 237-272 (2009).
Carbonnel F. Management of severe or corticosteroid resistant ulcerative colitis. Gastroenterol. Clin. Biol. 31: 398-403 (2007).
Carbonnel F. Why and how should we look for deep ulcerations in severe attacks of ulcerative colitis? Gastroenterol. Clin. Biol. 28: 215-217 (2004).
Carbonnel F, Boutron MC. Ulcerative colitis: is it in the diet? Gut 58: 1577-1579 (2009). *
Carbonnel F, Jantchou P, Monnet E, Cosnes J. Environmental risk factors in Crohn's disease and ulcerative colitis: an update. Gastroenterol. Clin. Biol. 33S3: S145-S157 (2009).
Carbonnel F, Macaigne G, Beaugerie L, Gendre JP, Cosnes J. Crohn's disease severity in familial and sporadic cases. Gut 44: 91-95 (1999). *
Cardenas A, Kelly CP. Celiac sprue. Semin. Gastrointest. Dis. 13: 232-244 (2002).
Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am. J. Epidemiol. 163: 127-134 (2006). *
Cardoso CR, Teixeira G, Provinciatto PR, Godoi DF, Ferreira BR, Milanezi CM, Ferraz DB, Rossi MA, Cunha FQ, Silva JS. Modulation of mucosal immunity in a murine model of food-induced intestinal inflammation. Clin. Exp. Allergy 38: 338-349 (2008). *
Carlsen H, Alexander G, Austenaa LM, Ebihara K, Blomhoff R. Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response. Mutat. Res. 551: 199-211 (2004).
Carlson BA, Kingston JD. Docosahexaenoic acid, the aquatic diet, and hominin encephalization: difficulties in establishing evolutionary links. Am. J. Hum. Biol. 19: 132-141 (2006). *
Carlson BA, Kingston JD. Docosahexaenoic acid biosynthesis and dietary contingency: encephalization without aquatic constraint. Am. J. Hum. Biol. 19: 585-588 (2007).
Carlson GL. Surgical management of intestinal failure. Proc. Nutr. Soc. 62: 711-718 (2003). *
Carlson SE. Docosahexaenoic acid supplementation in pregnancy and lactation. Am. J. Clin. Nutr. 89: 678S-684S (2009). *
Carlson SE. Early determinants of development: a lipid perspective. Am. J. Clin. Nutr. 89: 1523S-1529S (2009).
Carlsson A, Agardh D, Borulf S, Grodzinsky E, Axelsson I, Ivarsson SA. Prevalence of celiac disease: before and after a national change in feeding recommendations. Scand. J. Gastroenterol. 41: 553-558 (2006). *
Carlton VE, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum. Mol. Genet. 4: 1049-1053 (1995).
Carluccio MA, Ancora MA, Massaro M, Carluccio M, Scoditti E, Distante A, Storelli C, De Caterina R. Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation - protective role of Mediterranean diet polyphenolic antioxidants. Am. J. Physiol. Heart Circ. Physiol. 293: H2344-H2354 (2007). *
Carneiro F, Moutinho C, Pera G, Caldas C, Fenger C, Offerhaus J, Save V, Stenling R, Nesi G, Mahlke U, Blaker H, Torrado J, Roukos DH, Sabourin JC, Boeing H, Palli D, Bueno-de-Mesquita HB, Overvad K, Bingham S, Clavel-Chapelon F, Lund E, et al. Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scand. J. Gastroenterol. 42: 618-627 (2007). *
Caron P. Prevention of thyroid disorders in pregnant women. J. Gynecol. Obstet. Biol. Reprod. (Paris) 38: 574-579 (2009).
Caron-Dorval D, Paquet P, Paradis AM, Rudkowska I, Lemieux S, Couture P, Vohl MC. Effect of the PPAR-Alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids. J. Nutrigenet. Nutrigenomics 1: 205-212 (2008).
Caroprese M, Marzano A, Entrican G, Wattegedera S, Albenzio M, Sevi A. Immune response of cows fed polyunsaturated fatty acids under high ambient temperatures. J. Dairy Sci. 92: 2796-2803 (2009). *
Caroselli C, Bruno G, Manara F. A rare cutaneous case of carotenosis cutis: lycopenaemia. Ann. Nutr. Metab. 51: 571-573 (2008). *
Carpentier YA, Hacquebard M, Portois L, Dupont IE, Deckelbaum RJ, Malaisse WJ. Rapid cellular enrichment of eicosapentaenoate after a single intravenous injection of a novel medium-chain triacylglycerol:fish-oil emulsion in humans. Am. J. Clin. Nutr. Feb 10 [Epub ahead of print] (2010). *
Carpentier YA, Hacquebard M, Portois L, Malaisse WJ. The metabolic syndrome of omega3-depleted rats. VI. Intestinal phospholipid saturated and monodesaturated fatty acids. Int. J. Mol. Med. 25: 171-181 (2010).
Carpentier YA, Portois L, Malaisse WJ. n-3 Fatty acids and the metabolic syndrome. Am. J. Clin. Nutr. 83: 1499S-1504S (2006). *
Carrero JJ, Fonolla J, Marti JL, Jimenez J, Boza JJ, Lopez-Huertas E. Intake of fish oil, oleic acid, folic acid, and vitamins B-6 and E for 1 year decreases plasma C-reactive protein and reduces coronary heart disease risk factors in male patients in a cardiac rehabilitation program. J. Nutr. 137: 384-390 (2007). *
Carrero JJ, Grimble RF. Does nutrition have a role in peripheral vascular disease? Br. J. Nutr. 95: 217-229 (2006). *
Carrie I, Abellan Van Kan G, Rolland Y, Gillette-Guyonnet S, Vellas B. PUFA for prevention and treatment of dementia? Curr. Pharm. Des. 15: 4173-4185 (2009).
Carrier J, Medline A, Sohn KJ, Choi M, Martin R, Hwang SW, Kim YI. Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2- and beta(2)-microglobulin-deficient mice. Cancer Epidemiol. Biomarkers Prev. 12: 1262-1267 (2003). *
Carriere I, Delcourt C, Lacroux A, Gerber M; POLANUT Study Group. Nutrient intake in an elderly population in southern France (POLANUT): deficiency in some vitamins, minerals and omega-3 PUFA. Int. J. Vitam. Nutr. Res. 77: 57-65 (2007).
Carroccio A, Ambrosiano G, Di Prima L, Pirrone G, Iacono G, Florena AM, Porcasi R, Noto D, Fayer F, Soresi M, Geraci G, Sciume C, Di Fede G. Clinical symptoms in celiac patients on a gluten-free diet. Scand. J. Gastroenterol. 43: 1315-1321 (2008). *
Carroccio A, Brusca I, Iacono G, Alessio MG, Sonzogni A, Di Prima L, Barrale M, Ottomano C, Ambrosiano G, Teresi S, D'Angelo A, Pirrone G, Cefalu B, Scalici C, La Chiusa SM. IgA anti-actin antibodies ELISA in coeliac disease: a multicentre study. Dig. Liver Dis. 39: 818-823 (2007).
Carroccio A, Di Prima L, Scalici C, Soresi M, Cefalu AB, Noto D, Averna MR, Montalto G, Iacono G. Unexplained elevated serum pancreatic enzymes: a reason to suspect celiac disease. Clin. Gastroenterol. Hepatol. 4: 455-459 (2006).
Carroll KK. Neutral fats and cancer. Cancer Res. 41: 3695-3699 (1981). *
Carsia RV, Weber H, McIlroy PJ, Hock CE. Long-term dietary lipid regimen alters adrenocortical function at the cellular level. Horm. Metab. Res. 40: 848-853 (2008).
Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats. Neuroscience 139: 1163-1172 (2006). *
Carter AB, Misyak SA, Hontecillas R, Bassaganya-Riera J. Dietary modulation of inflammation-induced colorectal cancer through PPARgamma. PPAR Res. 2009: 498352 (2009). *
Carter BA, Karpen SJ. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future. Semin. Liver Dis. 27: 251-258 (2007).
Carter BA, Prendergast DR, Taylor OA, Zimmerman TL, Furstenberg RV, Moore DD, Karpen SJ. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr. Res. 62: 301-306 (2007). *
Carter BA, Shulman RJ. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis. Nat. Clin. Pract. Gastroenterol. Hepatol. 4: 277-287 (2007). *
Carter JC, Church FC. Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-gamma and plasminogen activator inhibitor-1. PPAR Res. 2009: 345320 (2009). *
Carter-Kent C, Yerian LM, Brunt EM, Angulo P, Kohli R, Ling SC, Xanthakos SA, Whitington PF, Charatcharoenwitthaya P, Yap J, Lopez R, McCullough AJ, Feldstein AE. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology 50: 1113-1120 (2009).
Carvalho R, Dilworth P, Docimo S, Cuffari C. Crohn disease of the neovagina and augmented bladder in a child born with cloacal exstrophy. J. Pediatr. Gastroenterol. Nutr. 48: 106-109 (2009). *
Casas M, Mora J, Fort E, Aracil C, Busquets D, Galter S, Jauregui CE, Ayala E, Cardona D, Gich I, Farre A. Total enteral nutrition vs. total parenteral nutrition in patients with severe acute pancreatitis. Rev. Esp. Enferm. Dig. 99: 264-269 (2007).
Case S. The gluten-free diet: how to provide effective education and resources. Gastroenterology 128: S128-S134 (2005). *
Casella G, De Marco E, Monti C, Baldini V. The therapeutic role of thalidomide in inflammatory bowel disease. Minerva Gastroenterol. Dietol. 52: 293-301 (2006).
Casellas F, Borruel N, Torrejon A, Varela E, Antolin M, Guarner F, Malagelada JR. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin. Aliment. Pharmacol. Ther. 25: 1061-1067 (2007). *
Casellas F, Lopez Vivancos J, Malagelada JR. Current epidemiology and accessibility to diet compliance in adult celiac disease. Rev. Esp. Enferm. Dig. 98: 408-419 (2006).
Casellas F, Lopez Vivancos J, Malagelada JR. Perceived health status in celiac disease. Rev. Esp. Enferm. Dig. 97: 794-804 (2005).
Casellas F, Rodrigo L, Vivancos JL, Riestra S, Pantiga C, Baudet JS, Junquera F, Divi VP, Abadia C, Papo M, Gelabert J, Malagelada JR. Factors that impact health-related quality of life in adults with celiac disease: a multicenter study. World J. Gastroenterol. 14: 46-52 (2008). *
Cases Amenos A, Goicoechea Diezhandino M, de Alvaro Moreno F. Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment. Nefrologia 28 Suppl. 3: 39-48 (2008).
Cashman KD. Vitamin D in childhood and adolescence. Postgrad. Med. J. 83: 230-235 (2007). *
Cashman KD. Altered bone metabolism in inflammatory disease: role for nutrition. Proc. Nutr. Soc. 67: 196-205 (2008). *
Cashman KD. Homocysteine and osteoporotic fracture risk: a potential role for B vitamins. Nutr. Rev. 63: 29-36 (2005).
Cashman KD. Calcium intake, calcium bioavailability and bone health. Br. J. Nutr. 87 Suppl. 2: S169-S177 (2002).
Cashman KD, Hill TR, Cotter AA, Boreham CA, Dubitzky W, Murray L, Strain J, Flynn A, Robson PJ, Wallace JM, Kiely M. Low vitamin D status adversely affects bone health parameters in adolescents. Am. J. Clin. Nutr. 87: 1039-1044 (2008). *
Casos K, Saiz MP, Ruiz-Sanz JI, Mitjavila MT. Atherosclerosis prevention by a fish oil-rich diet in apoE(-/-) mice is associated with a reduction of endothelial adhesion molecules. Atherosclerosis 201: 306-317 (2008).
Casper RC. Nutrients, neurodevelopment, and mood. Curr. Psychiatry Rep. 6: 425-429 (2004).
Cassio A, Ricci G, Baronio F, Miniaci A, Bal M, Bigucci B, Conti V, Cicognani A. Long-term clinical significance of thyroid autoimmunity in children with celiac disease. J. Pediatr. Oct 19 [Epub ahead of print] (2009).
Casswall TH, Nemeth A, Nilsson I, Wadstrom T, Nilsson HO. Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease. Scand. J. Gastroenterol. 45: 160-167 (2010). *
Casswall TH, Papadogiannakis N, Ghazi S, Nemeth A. Severe liver damage associated with celiac disease: findings in six toddler-aged girls. Eur. J. Gastroenterol. Hepatol. 21: 452-459 (2009).
Castagnini C, Luceri C, Toti S, Bigagli E, Caderni G, Femia AP, Giovannelli L, Lodovici M, Pitozzi V, Salvadori M, Messerini L, Martin R, Zoetendal EG, Gaj S, Eijssen L, Evelo CT, Renard CM, Baron A, Dolara P. Reduction of colonic inflammation in HLA-B27 transgenic rats by feeding Marie Menard apples, rich in polyphenols. Br. J. Nutr. 102: 1620-1628 (2009). *
Castaldo G, Fuccio A, Salvatore D, Raia V, Santostasi T, Leonardi S, Lizzi N, La Rosa M, Rigillo N, Salvatore F. Liver expression in cystic fibrosis could be modulated by genetic factors different from the cystic fibrosis transmembrane regulator genotype. Am. J. Med. Genet. 98: 294-297 (2001). *
Castano G, Fernandez L, Mas R, Illnait J, Mesa M, Fernandez JC. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus. Clin. Drug Investig. 23: 639-650 (2003).
Castellanos-Rubio A, Santin I, Irastorza I, Castano L, Carlos Vitoria J, Ramon Bilbao J. TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin. Autoimmunity 42: 69-73 (2009).
Castellanos-Rubio A, Santin I, Martin-Pagola A, Irastorza I, Castano L, Vitoria JC, Bilbao JR. Long-term and acute effects of gliadin on small intestine of patients on potentially pathogenic networks in celiac disease. Autoimmunity Oct 9 [Epub ahead of print] (2009).
Castellote J, Ariza J, Rota R, Girbau A, Xiol X. Serious drug-induced liver disease secondary to ezetimibe. World J. Gastroenterol. 14: 5098-5099 (2008). *
Castiglione F, Rispo A, Cozzolino A, Camera L, D'Argenio G, Tortora R, Grassia R, Bucci C, Ciacci C. Bowel sonography in adult celiac disease: diagnostic accuracy and ultrasonographic features. Abdom. Imaging 32: 73-77 (2007). *
Castillo LC, Rivas CC. Costs of a basic food basket for celiac patients in Chile. Rev. Med. Chil. 136: 613-619 (2008).
Castro IA, Monteiro VC, Barroso LP, Bertolami MC. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia. Nutrition 23: 127-137 (2007). *
Castro-Chavez F. Microarrays, antiobesity and the liver. Ann. Hepatol. 3: 137-145 (2004). *
Castro-Parodi M, Levi L, Dietrich V, Zotta E, Damiano AE. CFTR may modulate AQP9 functionality in preeclamptic placentas. Placenta 30: 642-648 (2009).
Castro-Silva C, Damasceno R, Neto O, Alves A, Bruin V. Clinical and laboratory features of 50 patients with cystic fibrosis from a reference center in Brazil. Rev. Port. Pneumol. 12: S18-S19 (2006).
Cataldo F, Accomando S, Fragapane ML, Montaperto D; SIGENP and GLNBI Working Groups on Food Intolerances*. Are food intolerances and allergies increasing in immigrant children coming from developing countries? Pediatr. Allergy Immunol. 17: 364-369 (2006).
Cataldo F, Lio D, Marino V, Picarelli A, Ventura A, Corazza GR. IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club del Tenue. Gut 47: 366-369 (2000). *
Cataldo F, Lio D, Marino V, Scola L, Crivello A, Corazza GR; Working Group of the SIGEP; Working Group of 'Club del Tenue'. Plasma cytokine profiles in patients with celiac disease and selective IgA deficiency. Pediatr. Allergy Immunol. 14: 320-324 (2003). *
Cataldo F, Montalto G. Celiac disease in the developing countries: a new and challenging public health problem. World J. Gastroenterol. 13: 2153-2159 (2007). *
Catassi C, Fabiani E, Iacono G, D'Agate C, Francavilla R, Biagi F, Volta U, Accomando S, Picarelli A, De Vitis I, Pianelli G, Gesuita R, Carle F, Mandolesi A, Bearzi I, Fasano A. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am. J. Clin. Nutr. 85: 160-166 (2007). *
Catassi C, Fasano A. Celiac disease. Curr. Opin. Gastroenterol. 24: 687-691 (2008). *
Catassi C, Kryszak D, Louis-Jacques O, Duerksen DR, Hill I, Crowe SE, Brown AR, Procaccini NJ, Wonderly BA, Hartley M D P, Moreci J, Bennett N, Horvath K, Burk M, Fasano A. Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am. J. Gastroenterol. 102: 1454-1460 (2007). *
Catassi C, Rossini M, Ratsch IM, Bearzi I, Santinelli A, Castagnani R, Pisani E, Coppa GV, Giorgi PL. Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 34: 1515-1519 (1993). *
Cather JC, Cohen PR. Ichthyosiform sarcoidosis. J. Am. Acad. Dermatol. 40: 862-865 (1999).
Catta-Preta M, Oliveira DA, Mandarim-de-Lacerda CA, Aguila MB. Adult cardiorenal benefits from postnatal fish oil supplement in rat offspring of low-protein pregnancies. Life Sci. 80: 219-229 (2006). *
Cattaneo A, Timmer A, Bomestar T, Bua J, Kumar S, Tamburlini G. Child nutrition in countries of the Commonwealth of Independent States: time to redirect strategies? Public Health Nutr. 11: 1209-1219 (2008). *
Caudill MA, Dellschaft N, Solis C, Hinkis S, Ivanov AA, Nash-Barboza S, Randall KE, Jackson B, Solomita GN, Vermeylen F. Choline intake, plasma riboflavin, and the phosphatidylethanolamine N-methyltransferase G5465A genoref-type predict plasma homocysteine in folate-deplete Mexican-American men with the methylenetetrahydrofolate reductase 677TT genoref-type. J. Nutr. 139: 727-733 (2009). *
Caulfield C, Kelly J, Jones B, Worrall S, Conlon L, Palmer T, Cassidy J. The experimental induction of leukoencephalomyelopathy in cats. Vet. Pathol. 46: 1258-1269 (2009).
Cavaglieri CR, Nishiyama A, Fernandes LC, Curi R, Miles EA, Calder PC. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci. 73: 1683-1690 (2003). *
Cavalieri D, Calura E, Romualdi C, Marchi E, Radonjic M, van Ommen B, Muller M. Filling gaps in PPAR-alpha signaling through comparative nutrigenomics analysis. BMC Genomics 10: 596 (2009). *
Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, McClain C. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J. Nutr. Biochem. 18: 184-195 (2007). *
Cave MC, Hurt RT, Frazier TH, Matheson PJ, Garrison RN, McClain CJ, McClave SA. Obesity, inflammation, and the potential application of pharmaconutrition. Nutr. Clin. Pract. 23: 16-34 (2008). *
Cave NJ. Chronic inflammatory disorders of the gastrointestinal tract of companion animals. N. Z. Vet. J. 51: 262-274 (2003).
Cave WT Jr. Dietary n-3 (omega-3) polyunsaturated fatty acid effects on animal tumorigenesis. FASEB J. 5: 2160-2166 (1991). *
Cawood AL, Carroll MP, Wootton SA, Calder PC. Is there a case for n-3 fatty acid supplementation in cystic fibrosis? Curr. Opin. Clin. Nutr. Metab. Care 8: 153-159 (2005).
Cawthorn WP, Sethi JK. TNF-alpha and adipocyte biology. FEBS Lett. 582: 117-131 (2008). *
Cayli S, Sati L, Seval-Celik Y, Tuncer MA, Yaymaci B, Berkman Z, Altug T, Demir R. The effects of eicosapentaenoic acid on the endothelium of the carotid artery of rabbits on a high-cholesterol diet. Histol. Histopathol. 25: 141-151 (2010).
Cazzola R, Rondanelli M, Russo Volpe S, Barzaghi E, Ferrari E, Cestaro B. The hypocaloric balanced diet therapy and the supplementation with antioxidant and omega-3. What are the effects on the oxidative balance and erythrocytes membrane fluidity status? Minerva Gastroenterol. Dietol. 47: 187-194 (2001).
Cazzola R, Russo-Volpe S, Miles EA, Rees D, Banerjee T, Roynette CE, Wells SJ, Goua M, Wahle KW, Calder PC, Cestaro B. Age- and dose-dependent effects of an eicosapentaenoic acid-rich oil on cardiovascular risk factors in healthy male subjects. Atherosclerosis 193: 159-167 (2007).
Cecil JE, Watt P, Palmer CN, Hetherington M. Energy balance and food intake: the role of PPARgamma gene polymorphisms. Physiol. Behav. 88: 227-233 (2006). *
Cederholm T, Palmblad J. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr. Opin. Clin. Nutr. Metab. Care Dec 16 [Epub ahead of print] (2009).
Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol. Aspects Med. 29: 407-414 (2008).
Cello JP, Day LW. Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology 136: 1952-1965 (2009). *
Cemlyn-Jones J, Gamboa F, Baganha M. Evaluation of bone mineral density in cystic fibrosis. Rev. Port. Pneumol. 13: S33 (2007).
Cemlyn-Jones J, Gamboa F, Loureiro M, Fontes Baganha M. Evaluation of bone mineral density in cystic fibrosis patients. Rev. Port. Pneumol. 14: 625-634 (2008).
Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, Wallace JL, Hollenberg MD, Bunnett NW, Garcia-Villar R, Bueno L, Vergnolle N. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am. J. Pathol. 161: 1903-1915 (2002). *
Centers for Disease Control and Prevention (CDC). Hepatic toxicity possibly associated with kava-containing products - United States, Germany, and Switzerland, 1999-2002. MMWR Morb. Mortal. Wkly. Rep. 51: 1065-1067 (2002).
Centritto F, Iacoviello L, di Giuseppe R, De Curtis A, Costanzo S, Zito F, Grioni S, Sieri S, Donati MB, de Gaetano G, Di Castelnuovo A; on behalf of Moli-sani Investigators. Dietary patterns, cardiovascular risk factors and C-reactive protein in a healthy Italian population. Nutr. Metab. Cardiovasc. Dis. 19: 697-706 (2009).
Ceperuelo-Mallafre V, Miranda M, Chacon MR, Vilarrasa N, Megia A, Gutierrez C, Fernandez-Real JM, Gomez JM, Caubet E, Fruhbeck G, Vendrell J. Adipose tissue expression of the glycerol channel aquaporin-7 gene is altered in severe obesity but not in type 2 diabetes. J. Clin. Endocrinol. Metab. 92: 3640-3645 (2007). *
Cereda S, Cefalo G, Spreafico F, Catania S, Meazza C, Podda M, Terenziani M. Celiac disease and childhood cancer. J. Pediatr. Hematol. Oncol. 28: 346-349 (2006).
Cerf-Bensussan N. Autoimmunity and diet. Nestle Nutr. Workshop Ser. Pediatr. Program 64: 91-104 (2009).
Cerf-Bensussan N, Matysiak-Budnik T, Cellier C, Heyman M. Oral proteases: a new approach to managing coeliac disease. Gut 56: 157-160 (2007). *
Ceryak S, Bouscarel B, Malavolti M, Robins SJ, Caslow KL, Fromm H. Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters. Atherosclerosis 153: 59-67 (2000).
Cetin I, Alvino G, Cardellicchio M. Long chain fatty acids and dietary fats in fetal nutrition. J. Physiol. 587: 3441-3451 (2009). *
Cetin I, Koletzko B. Long-chain omega-3 fatty acid supply in pregnancy and lactation. Curr. Opin. Clin. Nutr. Metab. Care 11: 297-302 (2008).
Cezard JP, Munck A, Mouterde O, Morali A, Lenaerts C, Lachaux A, Turck D, Schmitz J, Maurage C, Girardet JP, Belli D, Lamireau T, Sarles J, Chouraqui JP, Descos B, Dabadi A, Meyer M, Olives JP, Mary JY. Prevention of relapse by mesalazine (pentasa) in pediatric Crohn's disease: a multicenter, double-blind, randomized, placebo-controlled trial. Gastroenterol. Clin. Biol. 33: 31-40 (2009).
Cezard JP, Nouaili N, Talbotec C, Hugot JP, Gobert JG, Schmitz J, Mougenot JF, Alberti C, Goulet O. A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 36: 632-636 (2003). *
Cezard JP, Touati G, Alberti C, Hugot JP, Brinon C, Czernichow P. Growth in paediatric Crohn's disease. Horm. Res. 58 Suppl. 1: 11-15 (2002).
Ch'ng CL, Jones MK, Kingham JG. Celiac disease and autoimmune thyroid disease. Clin. Med. Res. 5: 184-192 (2007). *
Chahal P, Baron TH, Poterucha JJ, Rosen CB. Endoscopic retrograde cholangiography in post-orthotopic liver transplant population with Roux-en-Y biliary reconstruction. Liver Transpl. 13: 1168-1173 (2007). *
Chaillous L, Bouhanick B, Kerlan V, Mathieu E, Lecomte P, Ducluzeau PH, Delamaire M, Sonnet E, Maugendre D, Marechaud R, Rohmer V, Sai P, Charbonnel B. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control. Diabetes Metab. Jan 7 [Epub ahead of print] (2010).
Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, Thammavit W. Lack of association of VDR polymorphisms with Thai prostate cancer as compared with benign prostate hyperplasia and controls. Asian Pac. J. Cancer Prev. 7: 136-139 (2006).
Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J, Semenkovich CF. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell. Metab. 1: 309-322 (2005). *
Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 99: 1497-1502 (2004). *
Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; for the DILIN Study Group. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135: 1924-1934.e4 (2008). *
Challet E. Clock genes, circadian rhythms and food intake. Pathol. Biol. (Paris) 55: 176-177 (2007).
Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot. Essent. Fatty Acids 75: 259-269 (2006). *
Chalon S. The role of fatty acids in the treatment of ADHD. Neuropharmacology 57: 636-639 (2009).
Chamaillard M, Iacob R, Desreumaux P, Colombel JF. Advances and perspectives in the genetics of inflammatory bowel diseases. Clin. Gastroenterol. Hepatol. 4: 143-151 (2006).
Chamberlin W, Graham DY, Hulten K, El-Zimaity HM, Schwartz MR, Naser S, Shafran I, El-Zaatari FA. Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment. Pharmacol. Ther. 15: 337-346 (2001). *
Chambrier C, Bastard JP, Rieusset J, Chevillotte E, Bonnefont-Rousselot D, Therond P, Hainque B, Riou JP, Laville M, Vidal H. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes. Res. 10: 518-525 (2002). *
Champagne CM, Casey PH, Connell CL, Stuff JE, Gossett JM, Harsha DW, McCabe-Sellers B, Robbins JM, Simpson PM, Weber JL, Bogle ML; Lower Mississippi Delta Nutrition Intervention Research Initiative. Poverty and food intake in rural america: diet quality is lower in food insecure adults in the Mississippi delta. J. Am. Diet. Assoc. 107: 1886-1894 (2007). *
Champeil-Potokar G, Chaumontet C, Guesnet P, Lavialle M, Denis I. Docosahexaenoic acid (22:6n-3) enrichment of membrane phospholipids increases gap junction coupling capacity in cultured astrocytes. Eur. J. Neurosci. 24: 3084-3090 (2006). *
Chamulitrat W, Burhenne J, Rehlen T, Pathil A, Stremmel W. Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent. Hepatology 50: 143-154 (2009). *
Chan AT, Ma J, Tranah GJ, Giovannucci EL, Rifai N, Hunter DJ, Fuchs CS. Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women. J. Natl. Cancer Inst. 97: 917-926 (2005). *
Chan CC, Ross RJ, Shen D, Ding X, Majumdar Z, Bojanowski CM, Zhou M, Salem N Jr, Bonner R, Tuo J. Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res. 40: 124-128 (2008).
Chan DL. The role of nutrients in modulating disease. J. Small Anim. Pract. 49: 266-271 (2008). *
Chan E, Tan CS, Deurenberg-Yap M, Chia KS, Chew SK, Tai ES. The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women. Atherosclerosis 187: 309-315 (2006).
Chan EJ, Cho L. What can we expect from omega-3 fatty acids? Cleve. Clin. J. Med. 76: 245-251 (2009). *
Chan KH, Song Y, Hsu YH, You NC, F Tinker L, Liu S. Common genetic variants in fatty acid-binding protein-4 (FABP4) and clinical diabetes risk in the Women's Health Initiative Observational Study. Obesity (Silver Spring) Jan 28 [Epub ahead of print] (2010). *
Chance SA. Subtle changes in the ageing human brain. Nutr. Health 18: 217-224 (2006).
Chand N, Mihas AA. Celiac disease: current concepts in diagnosis and treatment. J. Clin. Gastroenterol. 40: 3-14 (2006).
Chand N, Sanyal AJ. Sepsis-induced cholestasis. Hepatology 45: 230-241 (2007). *
Chanda D, Lee CH, Kim YH, Noh JR, Kim DK, Park JH, Hwang JH, Lee MR, Jeong KH, Lee IK, Kweon GR, Shong M, Oh GT, Chiang JY, Choi HS. Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner. Hepatology 50: 880-892 (2009).
Chandra P, Wolfenden LL, Ziegler TR, Tian J, Luo M, Stecenko AA, Chen TC, Holick MF, Tangpricha V. Treatment of vitamin D deficiency with UV light in patients with malabsorption syndromes: a case series. Photodermatol. Photoimmunol. Photomed. 23: 179-185 (2007).
Chandra RK. Nutrition and the immune system: an introduction. Am. J. Clin. Nutr. 66: 460S-463S (1997). *
Chandra RK. Nutrition and immunology: from the clinic to cellular biology and back again. Proc. Nutr. Soc. 58: 681-683 (1999). *
Chandra RK. Nutrition and the immune system from birth to old age. Eur. J. Clin. Nutr. 56 Suppl. 3: S73-S76 (2002). *
Chandra RK, Kumari S. Nutrition and immunity: an overview. J. Nutr. 124: 1433S-1435S (1994). *
Chang CL, Seo T, Matsuzaki M, Worgall TS, Deckelbaum RJ. n-3 Fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution. Arterioscler. Thromb. Vasc. Biol. 29: 555-561 (2009).
Chang CY, Argo CK, Al-Osaimi AM, Caldwell SH. Therapy of NAFLD: antioxidants and cytoprotective agents. J. Clin. Gastroenterol. 40 Suppl. 1: S51-S60 (2006).
Chang HH, Chen CS, Lin JY. Dietary perilla oil lowers serum lipids and ovalbumin-specific IgG1, but increases total IgE levels in ovalbumin-challenged mice. Food Chem. Toxicol. Jan 15 [Epub ahead of print] (2009).
Chang HH, Chen CS, Lin JY. Dietary perilla oil lowers serum lipids and ovalbumin-specific IgG1, but increases total IgE levels in ovalbumin-challenged mice. Food Chem. Toxicol. 47: 848-854 (2009).
Chang JL, Bigler J, Schwarz Y, Li SS, Li L, King IB, Potter JD, Lampe JW. UGT1A1 polymorphism is associated with serum bilirubin concentrations in a randomized, controlled, fruit and vegetable feeding trial. J. Nutr. 137: 890-897 (2007). *
Chang ML, Yeh CT, Lin DY, Ho YP, Hsu CM, Bissell DM. Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation. BMC Med. Genomics 2: 51 (2009). *
Chang SY, Cha HR, Chang JH, Ko HJ, Yang H, Malissen B, Iwata M, Kweon MN. Lack of retinoic acid leads to increased langerin-expressing dendritic cells in gut-associated lymphoid tissues. Gastroenterology Nov 12 [Epub ahead of print] (2009). *
Chao CY, Mong MC, Chan KC, Yin MC. Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol. Nutr. Food Res. Nov 2 [Epub ahead of print] (2009). *
Chao PM, Yang MF, Tseng YN, Chang KM, Lu KS, Huang CJ. Peroxisome proliferation in liver of rats fed oxidized frying oil. J. Nutr. Sci. Vitaminol. (Tokyo) 51: 361-368 (2005).
Chapkin RS, Davidson LA, Ly L, Weeks BR, Lupton JR, McMurray DN. Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J. Nutr. 137: 200S-204S (2007). *
Chapkin RS, Kamen BA, Callaway ES, Davidson LA, George NI, Wang N, Lupton JR, Finnell RH. Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer. J. Nutr. Biochem. 20: 649-655 (2009). *
Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot. Essent. Fatty Acids 81: 187-191 (2009). *
Chapkin RS, McMurray DN, Davidson LA, Patil BS, Fan YY, Lupton JR. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br. J. Nutr. 100: 1152-1157 (2008). *
Chapkin RS, McMurray DN, Lupton JR. Colon cancer, fatty acids and anti-inflammatory compounds. Curr. Opin. Gastroenterol. 23: 48-54 (2007).
Chapkin RS, Seo J, McMurray DN, Lupton JR. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem. Phys. Lipids 153: 14-23 (2008). *
Chapkin RS, Wang N, Fan YY, Lupton JR, Prior IA. Docosahexaenoic acid alters the size and distribution of cell surface microdomains. Biochim. Biophys. Acta 1778: 466-471 (2008). *
Chapman C, Morgan LM, Murphy MC. Maternal and early dietary fatty acid intake: changes in lipid metabolism and liver enzymes in adult rats. J. Nutr. 130: 146-151 (2000). *
Chapman-Kiddell CA, Davies PS, Gillen L, Radford-Smith GL. Role of diet in the development of inflammatory bowel disease. Inflamm. Bowel Dis. 16: 137-151 (2010). *
Chapple IL. Potential mechanisms underpinning the nutritional modulation of periodontal inflammation. J. Am. Dent. Assoc. 140: 178-184 (2009).
Charbonnel B. What a psychiatrist needs to know about diabetes. Eur. Psychiatry 20 Suppl. 4: S330-S334 (2005).
Charlton M. Fetal obesity syndrome: maternal nutrition as a cause of nonalcoholic steatohepatitis. Hepatology 50: 1696-1698 (2009).
Charlton M. Obesity, hyperlipidemia, and metabolic syndrome. Liver Transpl. 15: S83-S89 (2009).
Charriere S, Bernard S, Aqallal M, Merlin M, Billon S, Perrot L, Le Coquil E, Sassolas A, Moulin P, Marcais C. Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clin. Chim. Acta 394: 99-103 (2008). *
Chase TH, Lyons BL, Bronson RT, Foreman O, Donahue LR, Burzenski LM, Gott B, Lane P, Harris B, Ceglarek U, Thiery J, Wittenburg H, Thon JN, Italiano JE Jr, Johnson KR, Shultz LD. The mouse mutation "thrombocytopenia and cardiomyopathy" (trac) disrupts Abcg5: a spontaneous single gene model for human hereditary phytosterolemia/sitosterolemia. Blood Oct 21 [Epub ahead of print] (2009). *
Chaudhary N, Pfluger PT. Metabolic benefits from Sirt1 and Sirt1 activators. Curr. Opin. Clin. Nutr. Metab. Care 12: 431-437 (2009).
Chaudhary R, Ghosh S. Infliximab in refractory coeliac disease. Eur. J. Gastroenterol. Hepatol. 17: 603-604 (2005).
Chaudhuri A. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med. Hypotheses 64: 608-618 (2005).
Chaudhury C, Kim J, Mehnaz S, Wani MA, Oberyszyn TM, Bronson CL, Mohanty S, Hayton WL, Robinson JM, Anderson CL. Accelerated transferrin degradation in HFE-deficient mice is associated with increased transferrin saturation. J. Nutr. 136: 2993-2998 (2006). *
Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Dietary fatty acid intakes and the risk of ovulatory infertility. Am. J. Clin. Nutr. 85: 231-237 (2007). *
Chaves CR, Britto JA, Oliveira CQ, Gomes MM, Cunha AL. Association between nutritional status measurements and pulmonary function in children and adolescents with cystic fibrosis. J. Bras. Pneumol. 35: 409-414 (2009).
Chavez ML. Herbal-drug interactions. InetCE 9: 2-30 (www.InetCE.com; 221-999-05-056-H01) (2005). *
Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 294: 1866-1870 (2001). *
Chawla RK, Bonkovsky HL, Galambos JT. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease. Drugs 40 Suppl. 3: 98-110 (1990).
Chazouilleres O. Chronic cholestatic disorders in the adult. Pathol. Biol. (Paris) 47: 974-982 (1999).
Cheatham CL, Colombo J, Carlson SE. n-3 Fatty acids and cognitive and visual acuity development: methodologic and conceptual considerations. Am. J. Clin. Nutr. 83: 1458S-1466S (2006). *
Chechi K, Cheema SK. Maternal diet rich in saturated fats has deleterious effects on plasma lipids of mice. Exp. Clin. Cardol. 11: 129-135 (2006). *
Cheema SK, Agarwal-Mawal A, Murray CM, Tucker S. Lack of stimulation of cholesterol ester transfer protein by cholesterol in the presence of a diet high in monounsaturated fatty acids. J. Lipid Res. 46: 2356-2366 (2005). *
Chemli J, Abid I, Yacoub M, Guedira I, Korbi S, Sahloul Essoussi A, Harbi A. Paediatric celiac disease in the region of Sousse: epidemiological and evolutive study of 80 cases. Tunis. Med. 86: 636-642 (2008).
Chen C, Cheng X, Dieter MZ, Tanaka Y, Klaassen CD. Activation of cyclic AMP (cAMP)-dependent signaling pathway induces mouse organic anion transporting polypeptide 2 (Oatp2) expression. Mol. Pharmacol. 71: 1159-1164 (2007). *
Chen C, Staudinger JL, Klaassen CD. Nuclear receptor, pregnane X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metab. Dispos. 31: 908-915 (2003). *
Chen CH, Wang PH, Liu BH, Hsu HH, Mersmann HJ, Ding ST. Serum amyloid A protein regulates the expression of porcine genes related to lipid metabolism. J. Nutr. 138: 674-679 (2008). *
Chen CT, Green JT, Orr SK, Bazinet RP. Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins Leukot. Essent. Fatty Acids 79: 85-91 (2008). *
Chen CT, Liu Z, Ouellet M, Calon F, Bazinet RP. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins Leukot. Essent. Fatty Acids 80: 157-163 (2009). *
Chen CY, Chen HL. The risk factors of parenteral nutrition-associated cholestasis in preterm infants. Pediatr. Neonatol. 50: 181-183 (2009).
Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS, Chang MH. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. J. Pediatr. 145: 317-321 (2004). *
Chen F, Ma L, Al-Ansari N, Shneider B. The role of AP-1 in the transcriptional regulation of the rat apical sodium-dependent bile acid transporter. J. Biol. Chem. 276: 38703-38714 (2001). *
Chen G, Zhang Y, Lu D, Li NQ, Ross AC. Retinoids synergize with insulin to induce hepatic Gck Expression. Biochem. J. 419: 645-653 (2009). *
Chen H, Xu H, Dong J, Li J, Ghishan FK. Tumor necrosis factor-alpha impairs intestinal phosphate absorption in colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G775-G781 (2009). *
Chen H, Zhuo Q, Yuan W, Wang J, Wu T. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database Syst. Rev. 1: CD006090 (2008). *
Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC, Hunter DJ. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56: 4862-4864 (1996). *
Chen J, Giovannucci EL, Hunter DJ. MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J. Nutr. 129: 560S-564S (1999). *
Chen J, Lee CS, Coleman RM, Yoon JY, Lohmann CH, Zustin J, Guldberg RE, Schwartz Z, Boyan BD. Formation of tethers linking the epiphysis and metaphysis is regulated by vitamin D receptor-mediated signaling. Calcif. Tissue Int. 85: 134-145 (2009). *
Chen J, Raymond K. Treatment effect of rifampicin on cholestasis. The Internet Journal of Pharmacology Vol. 4 (http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijpharm/vol4n2/colestasis.xml) (2006). *
Chen J, Zheng RD, Xu CR, Wu WP. Expression and significance of liver X receptor-alpha in nonalcoholic fatty liver disease in rats. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 23: 265-268 (2009).
Chen K, Li TY, Chen L, Qu P, Liu YX. Effects of vitamin A, vitamin A plus iron and multiple micronutrient-fortified seasoning powder on preschool children in a suburb of Chongqing, China. J. Nutr. Sci. Vitaminol. (Tokyo) 54: 440-447 (2008). *
Chen K, Nezu R, Inoue M, Wasa M, Iiboshi Y, Fukuzawa M, Kamata S, Takagi Y, Okada A. Beneficial effects of growth hormone combined with parenteral nutrition in the management of inflammatory bowel disease: an experimental study. Surgery 121: 212-218 (1997).
Chen MJ, Chu CH, Lin SC, Shih SC, Wang TE. Eosinophilic gastroenteritis: clinical experience with 15 patients. World J. Gastroenterol. 9: 2813-2816 (2003). *
Chen N, Bezzina R, Hinch E, Lewandowski PA, Cameron-Smith D, Mathai ML, Jois M, Sinclair AJ, Begg DP, Wark JD, Weisinger HS, Weisinger RS. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr. Res. 29: 784-793 (2009).
Chen N, Onisko B, Napoli JL. The nuclear transcription factor RARalpha associates with neuronal RNA granules and suppresses translation. J. Biol. Chem. 283: 20841-20847 (2008). *
Chen Q, Ross AC. Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4. Cell. Immunol. 249: 37-45 (2007). *
Chen Q, Ross AC. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells. Proc. Natl. Acad. Sci. U.S.A. 102: 14142-14149 (2005). *
Chen W, Chen G, Head DL, Mangelsdorf DJ, Russell DW. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell. Metab. 5: 73-79 (2007). *
Chen X, Matthews J, Zhou L, Pelton P, Liang Y, Xu J, Yang M, Cryan E, Rybczynski P, Demarest K. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist. Metabolism 57: 1516-1525 (2008). *
Chen X, Sebastian BM, Tang H, McMullen MM, Axhemi A, Jacobsen DW, Nagy LE. Taurine supplementation prevents ethanol-induced decrease in serum adiponectin and reduces hepatic steatosis in rats. Hepatology 49: 1554-1562 (2009).
Chen YH, Lin SJ, Chen YL, Liu PL, Chen JW. Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc. Hematol. Disord. Drug Targets 6: 279-304 (2006).
Chen ZC, Shin SJ, Kuo KK, Lin KD, Yu ML, Hsiao PJ. Significant association of ABCG8:D19H gene polymorphism with hypercholesterolemia and insulin resistance. J. Hum. Genet. 53: 757-763 (2008). *
Chen ZQ, Annilo T, Shulenin S, Dean M. Three ATP-binding cassette transporter genes, Abca14, Abca15, and Abca16, form a cluster on mouse chromosome 7F3. Mamm. Genome 15: 335-343 (2004). *
Chen ZY, Istfan NW. Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukot. Essent. Fatty Acids 63: 301-308 (2000). *
Chen ZY, Peng C, Jiao R, Wong YM, Yang N, Huang Y. Anti-hypertensive nutraceuticals and functional foods. J. Agric. Food Chem. 57: 4485-4499 (2009). *
Cheng AY, Leiter LA. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Curr. Opin. Cardiol. 21: 400-404 (2006).
Cheng CL, Fogel EL, Sherman S, McHenry L, Watkins JL, Croffie JM, Gupta SK, Fitzgerald JF, Lazzell-Pannell L, Schmidt S, Lehman GA. Diagnostic and therapeutic endoscopic retrograde cholangiopancreatography in children: a large series report. J. Pediatr. Gastroenterol. Nutr. 41: 445-453 (2005). *
Cheng HH, Hu XJ, Ruan QR. Dehydroepiandrosterone anti-atherogenesis effect is not via its conversion to estrogen. Acta Pharmacol. Sin. 30: 42-53 (2009).
Cheng J, Brar PS, Lee AR, Green PH. Body mass index in celiac disease: beneficial effect of a gluten-free diet. J. Clin. Gastroenterol. Sep 23 [Epub ahead of print] (2009).
Cheng JB, Motola DL, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Identification and characterization of CYP2R1, a microsomal vitamin D 25-hydroxylase. Falk Symposium 141. XVIII International Bile Acid Meeting: Bile Acid Biology and its Therapeutic Implications. Stockholm (Sweden). p. 21. June 18-19 (2004). *
Cheng X, Maher JM, Dieter MZ, Klaassen CD. Regulation of mouse organic anion transporting polypeptides (Oatps) in liver by prototypical microsome enzyme inducers that activate distinct transcription factor pathways. Drug Metab. Dispos. 33: 1276-1282 (2005). *
Cheng Y, Ohlsson L, Duan RD. Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice. Br. J. Nutr. 91: 715-723 (2004). *
Cheon HJ, Woo YS, Lee JY, Kim HS, Kim HJ, Cho S, Won NH, Sohn J. Signaling pathway for 2,3,7,8-tetrachlorodibenzo- p-dioxin-induced TNF-alpha production in differentiated THP-1 human macrophages. Exp. Mol. Med. 39: 524-534 (2007). *
Cheon Y, Nara TY, Band MR, Beever JE, Wallig MA, Nakamura MT. Induction of overlapping genes by fasting and a peroxisome proliferator in pigs: evidence of functional PPAR alpha in non-proliferating species. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288: R1525-R1535 (2005). *
Cherian G, Bautista-Ortega J, Goeger DE. Maternal dietary n-3 fatty acids alter cardiac ventricle fatty acid composition, prostaglandin and thromboxane production in growing chicks. Prostaglandins Leukot. Essent. Fatty Acids 80: 297-303 (2009). *
Cherian G, Hayat Z. Long-term effects of feeding flaxseeds on hepatic lipid characteristics and histopathology of laying hens. Poult. Sci. 88: 2555-2561 (2009).
Cherkaoui-Malki M, Meyer K, Cao WQ, Latruffe N, Yeldandi AV, Rao MS, Bradfield CA, Reddy JK. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. Gene Expr. 9: 291-304 (2001).
Cheroutre H. Starting at the beginning: new perspectives on the biology of mucosal T cells. Annu. Rev. Immunol. 22: 217-246 (2004). *
Chertok IR. The importance of exclusive breastfeeding in infants at risk for celiac disease. MCN Am. J. Matern. Child. Nurs. 32: 50-54 (2007).
Chess DJ, Khairallah RJ, O'Shea KM, Xu W, Stanley WC. A high fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload. Am. J. Physiol. Heart Circ. Physiol. 297: H1585-H1593 (2009). *
Chess DJ, Lei B, Hoit BD, Azimzadeh AM, Stanley WC. Effects of a high saturated fat diet on cardiac hypertrophy and dysfunction in response to pressure overload. J. Card. Fail. 14: 82-88 (2008).
Cheung HM, Lam HS, Tam YH, Lee KH, Ng PC. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin. Nutr. 28: 209-212 (2009).
Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, Kellum JM, Min H, Luketic VA, Sanyal AJ. Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression. Hepatology 48: 1810-1820 (2008). *
Cheung O, Regueiro MD. Inflammatory bowel disease emergencies. Gastroenterol. Clin. North Am. 32: 1269-1288 (2003).
Chhagan MK, Van den Broeck J, Luabeya KK, Mpontshane N, Tucker KL, Bennish ML. Effect of micronutrient supplementation on diarrhoeal disease among stunted children in rural South Africa. Eur. J. Clin. Nutr. 63: 850-857 (2009). *
Chiang JY, Kimmel R, Stroup D. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 262: 257-265 (2001). *
Chiang KC, Persons KS, Istfan NW, Holick MF, Chen TC. Fish oil enhances the antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 on liver cancer cells. Anticancer Res. 29: 3591-3596 (2009).
Chiappedi M, Bejor M. Herbals and natural dietary supplements in psychiatric practice. Recent Pat. CNS Drug Discov. Dec 23 [Epub ahead of print] (2009).
Chiarello PG, Penaforte FR, Japur CC, Souza CD, Vannucchi H, Troncon LE. Increased folate Intake with no changes in serum homocysteine and decreased levels of C-reactive protein in patients with inflammatory bowel diseases. Dig. Dis. Sci. 54: 627-633 (2009). *
Chiarenza L, Pignataro A, Lanza V. Refeeding syndrome in early pregnancy. Case report. Minerva Anestesiol. 71: 803-808 (2005).
Chiba M, Iizuka M, Horie Y, Igarashi K, Masamune O. HLA-DR antigen expression in macroscopically uninvolved areas of intestinal epithelia in Crohn's disease. Gastroenterol. Jpn. 24: 365-372 (1989).
Chicharro M, Guarner L, Vilaseca J, Planas M, Malagelada J. Does cyclosporin A worsen liver function in patients with inflammatory bowel disease and total parenteral nutrition? Rev. Esp. Enferm. Dig. 92: 68-77 (2000).
Chichili GR, Nohr D, Schaffer M, von Lintig J, Biesalski HK. beta-Carotene conversion into vitamin A in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 46: 3562-3569 (2005). *
Chikahisa S, Tominaga K, Kawai T, Kitaoka K, Oishi K, Ishida N, Rokutan K, Sei H. Bezafibrate, a PPARs agonist, decreases body temperature and enhances electroencephalogram delta-oscillation during sleep in mice. Endocrinology 149: 5262-5271 (2008). *
Childs CE, Romeu-Nadal M, Burdge GC, Calder PC. Gender differences in the n-3 fatty acid content of tissues. Proc. Nutr. Soc. 67: 19-27 (2008). *
Childs CE, Romeu-Nadal M, Burdge GC, Calder PC. The polyunsaturated fatty acid composition of hepatic and plasma lipids differ by both sex and dietary fat intake in rats. J. Nutr. Dec 14 [Epub ahead of print] (2009).
Childs S, Carter F, Lynch CO, Sreenan JM, Lonergan P, Hennessy AA, Kenny DA. Embryo yield and quality following dietary supplementation of beef heifers with n-3 polyunsaturated fatty acids (PUFA). Theriogenology 70: 992-1003 (2008).
Chilton FH. Regarding favorable and unfavorable PUFA in fish. J. Am. Diet. Assoc. 108: 1614-1616 (2008). *
Chilton FH, Patel M, Fonteh AN, Hubbard WC, Triggiani M. Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage. J. Clin. Invest. 91: 115-122 (1993). *
Chin J. Intestinal microflora: negotiating health outcomes with the warring community within us. Asia Pac. J. Clin. Nutr. 13: S24-S25 (2004).
Chin JJ. Revisiting the "hygiene hypothesis" in gastrointestinal allergy. Curr. Opin. Gastroenterol. 18: 705-710 (2002).
Chin RL, Latov N. Peripheral neuropathy and celiac disease. Curr. Treat. Options Neurol. 7: 43-48 (2005).
Chin RL, Tseng VG, Green PH, Sander HW, Brannagan TH 3rd, Latov N. Multifocal axonal polyneuropathy in celiac disease. Neurology 66: 1923-1925 (2006).
Chinuck RS, Fortnum H, Baldwin DR. Appetite stimulants in cystic fibrosis: a systematic review. J. Hum. Nutr. Diet. 20: 526-537 (2007). *
Chira EC, McMillen TS, Wang S, Haw A 3rd, O'Brien KD, Wight TN, Chait A. Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, reduces atherosclerosis in female low density lipoprotein receptor deficient mice. Atherosclerosis 195: 100-109 (2007).
Chirdo FG, Garrote JA, Arranz E. Celiac disease. New therapeutic alternatives based on a better knowledge of molecular pathogenesis. Acta Gastroenterol. Latinoam. 35: 183-189 (2005).
Chirdo FG, Rumbo M, Anon MC, Fossati CA. Presence of high levels of non-degraded gliadin in breast milk from healthy mothers. Scand. J. Gastroenterol. 33: 1186-1192 (1998). *
Chirico G, Barbieri F, Chirico C. Antibiotics for the newborn. J. Matern. Fetal Neonatal Med. 22 Suppl. 3: 46-49 (2009).
Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am. J. Gastroenterol. 100: 1868-1875 (2005). *
Chitturi S, Farrell GC. Hepatotoxic slimming aids and other herbal hepatotoxins. J. Gastroenterol. Hepatol. 23: 366-373 (2008). *
Chitturi S, Farrell GC. Drug-induced cholestasis. Semin. Gastrointest. Dis. 12: 113-124 (2001).
Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin. Liver Dis. 21: 27-41 (2001).
Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog. Neuropsychopharmacol. Biol. Psychiatry 32: 1538-1544 (2008).
Chiu CJ, Milton RC, Klein R, Gensler G, Taylor A. Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study. Ophthalmology 116: 939-946 (2009).
Chiu WC, Hou YC, Yeh CL, Hu YM, Yeh SL. Effect of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in diabetic mice with sepsis. Br. J. Nutr. 97: 685-691 (2007). *
Chiu WC, Tsou SS, Yeh CL, Hou YC, Yeh SL. Effects of omega-3 fatty acids on inflammatory mediators and splenocyte cytokine mRNA expressions in rats with polymicrobial sepsis. Nutrition 24: 484-491 (2008). *
Chiu WC, Wang YC, Chien YW, Hou YC, Hu YM, Yeh SL. Effects of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in hypercholesterolemic mice with sepsis. J. Nutr. Biochem. 20: 254-260 (2009). *
Chlon TM, Taffany DA, Welsh J, Rowling MJ. Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells. J. Nutr. 138: 1323-1328 (2008). *
Chmurova N, Parnicka Z, Svecova D, Manova A, Simaljakova M. Dermatitis herpetiformis in siblings. Bratisl. Lek. Listy. 108: 519-521 (2007).
Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS, Lee MK. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced obese mice. Food Chem. Toxicol. Jan 8 [Epub ahead of print] (2010). *
Cho E, Holmes MD, Hankinson SE, Willett WC. Choline and betaine intake and risk of breast cancer among post-menopausal women. Br. J. Cancer Jan 5 [Epub ahead of print] (2010). *
Cho JY, Matsubara T, Kang DW, Ahn SH, Krausz KW, Idle JR, Luecke H, Gonzalez FJ. Urinary metabolomics in Fxr-null mice reveals activated adaptive metabolic pathways upon bile acid challenge. J. Lipid Res. Nov 9 [Epub ahead of print] (2009). *
Cho SK, Sung YK, Park S, Bae SC. Etanercept treatment in rheumatoid arthritis patients with chronic kidney failure on predialysis. Rheumatol. Int. Aug 25 [Epub ahead of print] (2009). *
Cho SM, Cho SW, Regueiro M. Postoperative management of Crohn disease. Gastroenterol. Clin. North Am. 38: 753-762 (2009).
Cho SM, Cho SW, Regueiro M. Postoperative management of Crohn disease. Med. Clin. North Am. 94: 179-188 (2010).
Cho Y, Noshiro M, Choi M, Morita K, Kawamoto T, Fujimoto K, Kato Y, Makishima M. The basic helix-loop-helix proteins DEC1 and DEC2 function as corepressors of retinoid X receptors. Mol. Pharmacol. 76: 1360-1369 (2009).
Chocano-Bedoya P, Ronnenberg AG. Vitamin D and tuberculosis. Nutr. Rev. 67: 289-293 (2009). *
Choi EM. Ligularia fischeri leaf extract prevents the oxidative stress in DBA/1J mice with type II collagen-induced arthritis. J. Appl. Toxicol. 27: 176-182 (2007). *
Choi EM. Oxidative status of DBA/1J mice with type II collagen-induced arthritis. J. Appl. Toxicol. 27: 472-481 (2007). *
Choi HK. Dietary risk factors for rheumatic diseases. Curr. Opin. Rheumatol. 17: 141-146 (2005).
Choi JS, Bae JY, Kim DS, Li J, Kim JL, Lee YJ, Kang YH. Dietary compound quercitrin dampens VEGF induction and PPARgamma activation in oxidized LDL-exposed murine macrophages: association with scavenger receptor CD36. J. Agric. Food Chem. Nov 23 [Epub ahead of print] (2009). *
Chong AK, Chin BW, Meredith CG. Clinically significant small-bowel pathology identified by double-balloon enteroscopy but missed by capsule endoscopy. Gastrointest. Endosc. 64: 445-449 (2006).
Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch. Ophthalmol. 126: 826-833 (2008). *
Chong EW, Robman LD, Simpson JA, Hodge AM, Aung KZ, Dolphin TK, English DR, Giles GG, Guymer RH. Fat consumption and its association with age-related macular degeneration. Arch. Ophthalmol. 127: 674-680 (2009).
Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ 335: 755 (2007). *
Chopra AR, Louet JF, Saha P, An J, Demayo F, Xu J, York B, Karpen S, Finegold M, Moore D, Chan L, Newgard CB, O'Malley BW. Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science 322: 1395-1399 (2008). *
Chopra R, Sambaiah K. Effects of rice bran oil enriched with n-3 PUFA on liver and serum lipids in rats. Lipids 44: 37-46 (2009).
Chos D, Badel S, Golay A. Micronutrition: a global approach for obese patients. Rev. Med. Suisse. 3: 863-867 (2007).
Choudhuri S, Klaassen CD. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int. J. Toxicol. 25: 231-259 (2006). *
Choudhuri S, Valerio LG Jr. Usefulness of studies on the molecular mechanism of action of herbals/botanicals: the case of St. John's wort. J. Biochem. Mol. Toxicol. 19: 1-11 (2005). *
Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin. Liver Dis. 24: 349-362 (2004).
Choudhury J, Sanyal AJ. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin. Liver Dis. 8: 575-594, ix (2004).
Choudhury J, Sanyal AJ. Treatment of ascites. Curr. Treat. Options Gastroenterol. 6: 481-491 (2003).
Choudhury RP, Reddy AV, Garg AN. Availability of essential elements in nutrient supplements used as antidiabetic herbal formulations. Biol. Trace Elem. Res. 120: 148-162 (2007).
Chow DK, Sung JJ, Tsoi KK, Wong VW, Wu JC, Leong RW, L Chan FK. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study. Aliment. Pharmacol. Ther. 29: 843-854 (2009). *
Chowanadisai W, Bauerly KA, Tchaparian E, Wong A, Cortopassi GA, Rucker RB. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through CREB phosphorylation and increased PGC-1alpha expression. J. Biol. Chem. 285: 142-152 (2010). *
Christianson JL, Nicoloro S, Straubhaar J, Czech MP. Stearoyl CoA desaturase 2 is required for PPARgamma expression and adipogenesis in cultured 3T3-L1 cells. J. Biol. Chem. 283: 2906-2916 (2008). *
Christodoulides C, Dyson P, Sprecher D, Tsintzas K, Karpe F. Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man. J. Clin. Endocrinol. Metab. 94: 3594-3601 (2009).
Christoffolete M, Doleschall M, Egri P, Liposits Z, Zavacki AM, Bianco A, Gereben B. Regulation of thyroid hormone activation via the LXR/RXR pathway. J. Endocrinol. Feb 22 [Epub ahead of print] (2010). *
Christophe A, Robberecht E. Directed modification instead of normalization of fatty acid patterns in cystic fibrosis: an emerging concept. Curr. Opin. Clin. Nutr. Metab. Care 4: 111-113 (2001).
Chu AS, Friedman JR. A role for microRNA in cystic liver and kidney diseases. J. Clin. Invest. 118: 3585-3587 (2008). *
Chu NF. Plasma hyperhomocysteinemia, MTHFR polymorphism and thromboembolic disease: an example of gene-nutrition interactions in chronic disease. J. Chin. Med. Assoc. 68: 557-559 (2005).
Chuang E, Ruchelli E, Mulberg AE. Autoimmune liver disease and sickle cell anemia in children: a report of three cases. J. Pediatr. Hematol. Oncol. 19: 159-162 (1997).
Chuang JC, Cui H, Mason BL, Mahgoub M, Bookout AL, Yu HG, Perello M, Elmquist JK, Repa JJ, Zigman JM, Lutter M. Chronic social defeat stress disrupts regulation of lipid synthesis. J. Lipid Res. Feb 2 [Epub ahead of print] (2010). *
Chuang MH, Singh J, Ashouri N, Katz MH, Arrieta AC. Listeria meningitis after infliximab treatment of ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. Oct 13 [Epub ahead of print] (2009).
Chubinskaya S, Frank BS, Michalska M, Kumar B, Merrihew CA, Thonar EJ, Lenz ME, Otten L, Rueger DC, Block JA. Osteogenic protein 1 in synovial fluid from patients with rheumatoid arthritis or osteoarthritis: relationship with disease and levels of hyaluronan and antigenic keratan sulfate. Arthritis Res. Ther. 8: R73 (2006). *
Chuchalin A, Csiszer E, Gyurkovics K, Bartnicka MT, Sands D, Kapranov N, Varoli G, Monici Preti PA, Mazurek H. A formulation of aerosolized tobramycin (Bramitob((R))) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study. Paediatr. Drugs 9 Suppl. 1: 21-31 (2007).
Chung H, Nettleton JA, Lemaitre RN, Barr RG, Tsai MY, Tracy RP, Siscovick DS. Frequency and type of seafood consumed influence plasma (n-3) fatty acid concentrations. J. Nutr. 138: 2422-2427 (2008). *
Chung J, Veeramachaneni S, Liu C, Mernitz H, Russell RM, Wang XD. Vitamin E supplementation does not prevent ethanol-reduced hepatic retinoic acid levels in rats. Nutr. Res. 29: 664-670 (2009). *
Chung PH, Wong KK, Wong RM, Tsoi NS, Chan KL, Tam PK. Clinical experience in managing pediatric patients with ultra-short bowel syndrome using omega-3 fatty acid. Eur. J. Pediatr. Surg. Feb 22 [Epub ahead of print] (2010).
Chung S, Brown JM, Provo JN, Hopkins R, McIntosh MK. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J. Biol. Chem. 280: 38445-38456 (2005). *
Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, McIntosh MK. Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147: 5340-5351 (2006). *
Chung TP, Fleshman JW, Birnbaum EH, Hunt SR, Dietz DW, Read TE, Mutch MG. Laparoscopic vs. open total abdominal colectomy for severe colitis: impact on recovery and subsequent completion restorative proctectomy. Dis. Colon Rectum 52: 4-10 (2009).
Chung WL, Chen JJ, Su HM. Fish oil supplementation of control and (n-3) fatty acid-deficient male rats enhances reference and working memory performance and increases brain regional docosahexaenoic acid levels. J. Nutr. 138: 1165-1171 (2008). *
Church MW, Catherine Jen KL, Stafferton T, Hotra JW, Adams BR. Reduced auditory acuity in rat pups from excess and deficient omega-3 fatty acid consumption by the mother. Neurotoxicol. Teratol. 29: 203-210 (2007).
Church MW, Jen KL, Dowhan LM, Adams BR, Hotra JW. Excess and deficient omega-3 fatty acid during pregnancy and lactation cause impaired neural transmission in rat pups. Neurotoxicol. Teratol. 30: 107-117 (2008). *
Church MW, Jen KL, Jackson DA, Adams BR, Hotra JW. Abnormal neurological responses in young adult offspring caused by excess omega-3 fatty acid (fish oil) consumption by the mother during pregnancy and lactation. Neurotoxicol. Teratol. 31: 26-33 (2009).
Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ, McDonnell DP. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 103: 11707-11712 (2006). *
Chytrova G, Ying Z, Gomez-Pinilla F. Exercise contributes to the effects of DHA dietary supplementation by acting on membrane-related synaptic systems. Brain Res. May 13 [Epub ahead of print] (2009).
Ciacci C, Cirillo M, Cavallaro R, Mazzacca G. Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 66: 178-185 (2002).
Ciacci C, Gennarelli D, Esposito G, Tortora R, Salvatore F, Sacchetti L. Hereditary fructose intolerance and celiac disease: a novel genetic association. Clin. Gastroenterol. Hepatol. 4: 635-638 (2006).
Ciacci C, Iovino P, Amoruso D, Siniscalchi M, Tortora R, Di Gilio A, Fusco M, Mazzacca G. Grown-up coeliac children: the effects of only a few years on a gluten-free diet in childhood. Aliment. Pharmacol. Ther. 21: 421-429 (2005). *
Ciacci C, Maiuri L, Russo I, Tortora R, Bucci C, Cappello C, Santonicola A, Luciani A, Passananti V, Iovino P. Efficacy of budesonide therapy in the early phase of treatment of adult celiac disease patients with malabsorption: an in vivo/in vitro pilot study. Clin. Exp. Pharmacol. Physiol. 36: 1170-1176 (2009). *
Ciacci C, Peluso G, Iannoni E, Siniscalchi M, Iovino P, Rispo A, Tortora R, Bucci C, Zingone F, Margarucci S, Calvani M. L-Carnitine in the treatment of fatigue in adult celiac disease patients. A pilot study. Dig. Liver Dis. 39: 922-928 (2007).
Ciacci C, Spagnuolo G, Tortora R, Bucci C, Franzese D, Zingone F, Cirillo M. Urinary stone disease in adults with celiac disease: prevalence, incidence and urinary determinants. J. Urol. 180: 974-979 (2008).
Ciaccio M, Bivona G, Bellia C. Therapeutical approach to plasma homocysteine and cardiovascular risk reduction. Ther. Clin. Risk Manag. 4: 219-224 (2008). *
Ciana P, Biserni A, Tatangelo L, Tiveron C, Sciarroni AF, Ottobrini L, Maggi A. A novel PPRE-luciferase reporter mouse reveals gender specificity of peroxisome proliferators activated receptor activity in liver. Mol. Endocrinol. 21: 388-400 (2007). *
Ciccocioppo R, Corazza GR. Is a life-long gluten-free diet for patients with celiac disease successful? Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 290-291 (2005). *
Ciccocioppo R, Di Sabatino A, Corazza GR. The immune recognition of gluten in coeliac disease. Clin. Exp. Immunol. 140: 408-416 (2005). *
Ciccocioppo R, Ricci G, Rovati B, Pesce I, Mazzocchi S, Piancatelli D, Cagnoni A, Millimaggi D, Danova M, Corazza GR. Reduced number and function of peripheral dendritic cells in coeliac disease. Clin. Exp. Immunol. 140: 487-496 (2007). *
Cicero AF, Ertek S, Borghi C. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr. Vasc. Pharmacol. 7: 330-337 (2009).
Ciclitira PJ, Ellis HJ. In vivo gluten ingestion in coeliac disease. Dig. Dis. 16: 337-340 (1998).
Ciclitira PJ, Ellis HJ, Evans DJ. A solid-phase radioimmunoassay for measurement of circulating antibody titres to wheat gliadin and its subfractions in patients with adult coeliac disease. J. Immunol. Methods 62: 231-239 (1983).
Ciclitira PJ, Ellis HJ, Lundin KE. Gluten-free diet - what is toxic? Best Pract. Res. Clin. Gastroenterol. 19: 359-371 (2005).
Cifelli CJ, Green JB, Green MH. Use of model-based compartmental analysis to study vitamin A kinetics and metabolism. Vitam. Horm. 75: 161-195 (2007).
Cifelli CJ, Green JB, Wang Z, Yin S, Russell RM, Tang G, Green MH. Kinetic analysis shows that vitamin A disposal rate in humans is positively correlated with vitamin A stores. J. Nutr. 138: 971-977 (2008). *
Cifelli CJ, Ross AC. All-trans-retinoic acid distribution and metabolism in vitamin A-marginal rats. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G195-G202 (2006). *
Ciftcioglu N, Bjorklund M, Kuorikoski K, Bergstrom K, Kajander EO. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int. 56: 1893-1898 (1999). *
Cihakova D, Sharma RB, Fairweather D, Afanasyeva M, Rose NR. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol. Med. 102: 175-194 (2004).
Cijevschi C, Mihai C, Zbranca E, Gogalniceanu P. Osteoporosis in liver cirrhosis. Rom. J. Gastroenterol. 14: 337-341 (2005). *
Cil T, Altintas A, Isikdogan A, Pasa S, Bayan K, Batun S, Buyukbayram H. Screening for celiac disease in Hodgkin and non-Hodgkin lymphoma patients. Turk. J. Gastroenterol. 20: 87-92 (2009). *
Cinemre H, Bilir C, Gokosmanoglu F, Kadakal F. Anti-Saccharomyces cerevisiae antibodies in acute myocardial infarction. J. Investig. Med. 55: 444-449 (2007).
Cintra DE, Pauli JR, Araujo EP, Moraes JC, de Souza CT, Milanski M, Morari J, Gambero A, Saad MJ, Velloso LA. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J. Hepatol. 48: 628-637 (2008). *
Cione E, Senatore V, Tucci P, Giudetti AM, Genchi F, Gnoni GV, Genchi G. Dietary fatty acid composition differently influences retinoylation reaction in rat testes mitochondria. J. Bioenerg. Biomembr. 39: 203-209 (2007). *
Cipriani S, Mencarelli A, Palladino G, Fiorucci S. FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats. J. Lipid Res. Sep 25 [Epub ahead of print] (2009). *
Cipriano C, Caruso C, Lio D, Giacconi R, Malavolta M, Muti E, Gasparini N, Franceschi C, Mocchegiani E. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int. J. Immunogenet. 32: 13-18 (2005). *
Cirillo M, Iudici M, Marcarelli F, Laudato M, Zincone F. Nephrolithiasis in patients with intestinal diseases. G. Ital. Nefrol. 25: 42-48 (2008).
Clapham JC, Arch JR. Thermogenic and metabolic antiobesity drugs: rationale and opportunities. Diabetes Obes. Metab. 9: 259-275 (2007). *
Clapper ML, Chang WC, Meropol NJ. Chemoprevention of colorectal cancer. Curr. Opin. Oncol. 13: 307-313 (2001).
Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 98: 960-967 (2003). *
Clark KL. Nutritional considerations in joint health. Clin. Sports Med. 26: 101-118 (2007).
Clark V, Nelson DR. Novel interferons for treatment of hepatitis C virus. Clin. Liver Dis. 13: 351-363 (2009).
Clark WF, Parbtani A, Huff MW, Reid B, Holub BJ, Falardeau P. Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus. Kidney Int. 36: 653-660 (1989).
Clarke GA, Bouchard G, Paigen B, Carey MC. Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse. Gut 53: 136-142 (2004). *
Clarke JD, Thuluvath PJ. Endoscopic frontiers in the field of hepatology. Minerva Gastroenterol. Dietol. 53: 101-109 (2007).
Clarke R, Shipley M, Armitage J, Collins R, Harris W. Plasma phospholipid fatty acids and CHD in older men: Whitehall study of London civil servants. Br. J. Nutr. 102: 279-284 (2009). *
Clarke SD. Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G865-G869 (2001). *
Clarke SD. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr. Opin. Lipidol. 15: 13-18 (2004).
Clarke SD, Gasperikova D, Nelson C, Lapillonne A, Heird WC. Fatty acid regulation of gene expression: a genomic explanation for the benefits of the Mediterranean diet. Ann. N. Y. Acad. Sci. 967: 283-298 (2002). *
Clarke SD, Thuillier P, Baillie RA, Sha X. Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors. Am. J. Clin. Nutr. 70: 566-571 (1999). *
Claudel T, Staels B, Kuipers F. The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler. Thromb. Vasc. Biol. 25: 2020-2030 (2005). *
Claudel T, Sturm E, Kuipers F, Staels B. The farnesoid X receptor: a novel drug target? Expert Opin. Investig. Drugs 13: 1135-1148 (2004).
Claus SP, Tsang TM, Wang Y, Cloarec O, Skordi E, Martin FP, Rezzi S, Ross A, Kochhar S, Holmes E, Nicholson JK. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol. Syst. Biol. 4: 219 (2008). *
Clavel T, Haller D. Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation. Curr. Issues Intest. Microbiol. 8: 25-43 (2007).
Clavel T, Haller D. Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm. Bowel Dis. 13: 1153-1164 (2007). *
Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hazell PL. Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder. Lipids 43: 1031-1038 (2008).
Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hazell PL. Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. Eur. J. Clin. Nutr. 63: 1037-1040 (2009). *
Clayton EH, Hanstock TL, Watson JF. Estimated intakes of meat and fish by children and adolescents in Australia and comparison with recommendations. Br. J. Nutr. 101: 1731-1735 (2009). *
Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, Provost JP, Le Net JL, Baker D, Walley RJ, Everett JR, Nicholson JK. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440: 1073-1077 (2006). *
Cleary MA, Feillet F, White FJ, Vidailhet M, Macdonald A, Grimsley A, Maurin N, de Baulny HO, Rutherford PJ. Randomised controlled trial of essential fatty acid supplementation in phenylketonuria. Eur. J. Clin. Nutr. 60: 915-920 (2006). *
Cleland LG, James MJ, Keen H, Danda D, Caughey G, Proudman SM. Fish oil - an example of an anti-inflammatory food. Asia Pac. J. Clin. Nutr. 14: S66-S71 (2005).
Cleland LG, James MJ, Proudman SM. Food inflammation and the anti-inflammatory aspects of food. Asia Pac. J. Clin. Nutr. 13: S26 (2004).
Clemente MG, Musu MP, Frau F, Brusco G, Sole G, Corazza GR, De Virgiliis S. Immune reaction against the cytoskeleton in coeliac disease. Gut 47: 520-526 (2000). *
Clemenz M, Frost N, Schupp M, Caron S, Foryst-Ludwig A, Bohm C, Hartge M, Gust R, Staels B, Unger T, Kintscher U. Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan. Diabetes 57: 1405-1413 (2008). *
Click RE, Van Kampen CL. Short communication: progression of Johne's disease curtailed by a probiotic. J. Dairy Sci. 92: 4846-4851 (2009). *
Cobb CS, Ernst E. Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus. Clin. Rheumatol. 25: 275-284 (2006). *
Cock TA, Houten SM, Auwerx J. Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm. EMBO Rep. 5: 142-147 (2004). *
Coeffier M, Gloro R, Boukhettala N, Aziz M, Lecleire S, Vandaele N, Antonietti M, Savoye G, Bole-Feysot C, Dechelotte P, Reimund JM, Ducrotte P. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. Am. J. Gastroenterol. Dec 8 [Epub ahead of print] (2009). *
Coeffier M, Marion R, Ducrotte P, Dechelotte P. Modulating effect of glutamine on IL-1beta-induced cytokine production by human gut. Clin. Nutr. 22: 407-413 (2003).
Coeffier M, Marion-Letellier R, Dechelotte P. Potential for amino acids supplementation during inflammatory bowel diseases. Inflamm. Bowel Dis. 16: 518-524 (2010).
Coenen KR, Gruen ML, Lee-Young RS, Puglisi MJ, Wasserman DH, Hasty AH. Impact of macrophage Toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice. Diabetologia 52: 318-328 (2009). *
Coffey JC, Winter DC, Neary P, Murphy A, Redmond HP, Kirwan WO. Quality of life after ileal pouch-anal anastomosis: an evaluation of diet and other factors using the Cleveland Global Quality of Life instrument. Dis. Colon Rectum 45: 30-38 (2002).
Cohen BE, Garg SK, Ali S, Harris WS, Whooley MA. Red blood cell docosahexaenoic acid and eicosapentaenoic acid concentrations are positively associated with socioeconomic status in patients with established coronary artery disease: data from the heart and soul study. J. Nutr. 138: 1135-1140 (2008). *
Cohen BI, Hofmann AF, Mosbach EH, Stenger RJ, Rothschild MA, Hagey LR, Yoon YB. Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit. Gastroenterology 91: 189-197 (1986).
Cohen C, Olsen MM. Pediatric total parenteral nutrition. Liver histopathology. Arch. Pathol. Lab. Med. 105: 152-156 (1981).
Cohen JI, Roychowdhury S, Dibello PM, Jacobsen DW, Nagy LE. Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver. Hepatology 49: 1709-1717 (2009).
Cohen JT, Bellinger DC, Connor WE, Shaywitz BA. A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development. Am. J. Prev. Med. 29: 366-374 (2005). *
Cohen PA. American roulette - contaminated dietary supplements. N. Engl. J. Med. 361: 1523-1525 (2009). *
Cohen RD. Evolving medical therapies for ulcerative colitis. Curr. Gastroenterol. Rep. 4: 497-505 (2002).
Cohen RD, Larson LR, Roth JM, Becker RV, Mummert LL. The cost of hospitalization in Crohn's disease. Am. J. Gastroenterol. 95: 524-530 (2000). *
Cohen SA, Hatt H, Kubanek J, McCarty NA. Reconstitution of a chemical defense signaling pathway in a heterologous system. J. Exp. Biol. 211: 599-605 (2008). *
Cohen SL, Moore AM, Ward WE. Interleukin-10 knockout mouse: a model for studying bone metabolism during intestinal inflammation. Inflamm. Bowel Dis. 10: 557-563 (2004). *
Cohen SL, Moore AM, Ward WE. Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice. J. Nutr. Biochem. 16: 368-374 (2005). *
Cohen SM, Ahn J. Review article: the diagnosis and management of alcoholic hepatitis. Aliment. Pharmacol. Ther. 30: 3-13 (2009). *
Cohran VC, Heubi JE. Treatment of pediatric cholestatic liver disease. Curr. Treat. Options Gastroenterol. 6: 403-415 (2003).
Colangelo LA, He K, Whooley MA, Daviglus ML, Liu K. Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition 25: 1011-1019 (2009). *
Colas S, Maheo K, Denis F, Goupille C, Hoinard C, Champeroux P, Tranquart F, Bougnoux P. Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization. Clin. Cancer Res. 12: 5879-5886 (2006). *
Colburn JD, Skelo AS, Donahue SP. Corneal ulceration due to vitamin A deficiency in Zellweger syndrome. J. AAPOS 13: 289-291 (2009).
Cole GM, Frautschy SA. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's disease. Exp. Gerontol. 42: 10-21 (2007). *
Cole GM, Frautschy SA. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. Nutr. Health 18: 249-259 (2006).
Cole GM, Frautschy SA. DHA may prevent age-related dementia. J. Nutr. Feb 24 [Epub ahead of print] (2010).
Cole GM, Ma QL, Frautschy SA. Omega-3 fatty acids and dementia. Prostaglandins Leukot. Essent. Fatty Acids 81: 213-221 (2009). *
Colecchia A, Vestito A, Pasqui F, Mazzella G, Roda E, Pistoia F, Brandimarte G, Festi D. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J. Gastroenterol. 13: 264-269 (2007). *
Coleman H, Chew E. Nutritional supplementation in age-related macular degeneration. Curr. Opin. Ophthalmol. 18: 220-223 (2007).
Coleman LJ, Landstrom EK, Royle PJ, Bird AR, McIntosh GH. A diet containing alpha-cellulose and fish oil reduces aberrant crypt foci formation and modulates other possible markers for colon cancer risk in azoxymethane-treated rats. J. Nutr. 132: 2312-2318 (2002). *
Colin A, Reggers J, Castronovo V, Ansseau M. Lipids, depression and suicide. Encephale 29: 49-58 (2003).
Colin S, Bourguignon E, Boullay AB, Tousaint JJ, Huet S, Caira F, Staels B, Lestavel S, Lobaccaro JM, Delerive P. Intestine-specific regulation of PPARalpha gene transcription by liver X receptors. Endocrinology 149: 5128-5135 (2008). *
Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Specific duodenal and faecal bacterial groups are associated with paediatric celiac disease. J. Clin. Pathol. 62: 264-269 (2009).
Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiol. 8: 232 (2008). *
Collett ED, Davidson LA, Fan YY, Lupton JR, Chapkin RS. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am. J. Physiol. Cell. Physiol. 280: C1066-C1075 (2001). *
Colletti RB, Baldassano RN, Milov DE, Margolis PA, Bousvaros A, Crandall WV, Crissinger KD, D'Amico MA, Day AS, Denson LA, Dubinsky M, Ebach DR, Hoffenberg EJ, Kader HA, Keljo DJ, Leibowitz IH, Mamula P, Pfefferkorn MD, Qureshi MA. Variation in care in pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 49: 297-303 (2009).
Collin P. Should adults be screened for celiac disease? What are the benefits and harms of screening? Gastroenterology 128: S104-S108 (2005). *
Collin P, Huhtala H, Virta L, Kekkonen L, Reunala T. Diagnosis of celiac disease in clinical practice: physician's alertness to the condition essential. J. Clin. Gastroenterol. 41: 152-156 (2007).
Collin P, Kaukinen K, Mattila AK, Joukamaa M. Psychoneurotic symptoms and alexithymia in coeliac disease. Scand. J. Gastroenterol. 43: 1329-1333 (2008). *
Collin P, Reunala T. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. Am. J. Clin. Dermatol. 4: 13-20 (2003).
Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease - associated disorders and survival. Gut 35: 1215-1218 (1994). *
Collin P, Wahab PJ, Murray JA. Intraepithelial lymphocytes and coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19: 341-350 (2005).
Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69: 1052S-1057S (1999). *
Collins MD, Mao GE. Teratology of retinoids. Annu. Rev. Pharmacol. Toxicol. 39: 399-430 (1999). *
Collins N, Tighe AP, Brunton SA, Kris-Etherton PM. Differences between dietary supplement and prescription drug omega-3 fatty acid formulations: a legislative and regulatory perspective. J. Am. Coll. Nutr. 27: 659-666 (2008). *
Collins S, Denou E, Verdu E, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig. Liver Dis. 41: 850-853 (2009).
Collins S, Reynolds F. How do adults with cystic fibrosis cope following a diagnosis of diabetes? J. Adv. Nurs. 64: 478-487 (2008).
Collison LW, Collison RE, Murphy EJ, Jolly CA. Dietary n-3 polyunsaturated fatty acids increase T-lymphocyte phospholipid mass and acyl-CoA binding protein expression. Lipids 40: 81-87 (2005).
Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J. Parenter. Enteral Nutr. 24: 345-350 (2000).
Colombo C. Liver disease in cystic fibrosis. Falk Symposium 156. XIII Falk Liver Week (Part II). GENETICS IN LIVER DISEASES, Freiburg (Germany), October 8-9, 2006, p. 31-33 (2006). *
Colombo C, Apostolo MG, Assaisso M, Roman B, Bottani P. Liver disease in cystic fibrosis. Neth. J. Med. 41: 119-122 (1992).
Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 23: 1484-1490 (1996). *
Colombo C, Bennato V, Costantini D, Valmarana L, Dacco V, Zazzeron L, Ghisleni D, Bruzzese MG, Scaglioni S, Riva E, Agostoni C. Dietary and circulating polyunsaturated fatty acids in cystic fibrosis: are they related to clinical outcomes? J. Pediatr. Gastroenterol. Nutr. 43: 660-665 (2006). *
Colombo C, Costantini D, Rocchi A, Romano G, Rossi G, Bianchi ML, Bertoli S, Battezzati A. Effects of liver transplantation on the nutritional status of patients with cystic fibrosis. Transpl. Int. 18: 246-255 (2005).
Colombo C, Fredella C, Russo MC, Faelli N, Motta V, Valmarana L, Longo L, D'Orazio C. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study. Pancreas 38: 693-699 (2009).
Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 43 Suppl. 1: S49-S55 (2006). *
Colombo M, Donato MF. Prevention of hepatocellular carcinoma. Semin. Liver Dis. 25: 155-161 (2005).
Colombo M, Sangiovanni A. Etiology, natural history and treatment of hepatocellular carcinoma. Antiviral Res. 60: 145-150 (2003). *
Colossi FG, Casagrande DS, Chatkin R, Moretto M, Barhouch AS, Repetto G, Padoin AV, Mottin CC. Need for multivitamin use in the postoperative period of gastric bypass. Obes. Surg. 18: 187-191 (2008). *
Colquhoun A. Mechanisms of action of eicosapentaenoic acid in bladder cancer cells in vitro: alterations in mitochondrial metabolism, reactive oxygen species generation and apoptosis induction. J. Urol. 181: 1885-1893 (2009).
Colquhoun D, Ferreira-Jardim A, Eden B. Fish, fish oils and long chain omega 3 fatty acids - cardiac benefit and risk: review by the Nutrition and Metabolism Committee of the National Heart Foundation of Australia. Asia Pac. J. Clin. Nutr. 14: S83 (2005).
Colston K, Cleeve HJ. Effect of triiodothyronine on intestinal and kidney isoenzymes of alkaline phosphatase and on vitamin D metabolism in adult female rats. Comp. Biochem. Physiol. B. 83: 681-684 (1986).
Colter AL, Cutler C, Meckling KA. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr. J. 7: 8 (2008). *
Comar KM, Kirby DF. Herbal remedies in gastroenterology. J. Clin. Gastroenterol. 39: 457-468 (2005).
Combet E, Paterson S, Iijima K, Winter J, Mullen W, Crozier A, Preston T, McColl KE. Fat transforms ascorbic acid from inhibiting to promoting acid catalysed N-nitrosation. Gut 56: 1678-1684 (2007). *
Comelli EM, Lariani S, Zwahlen MC, Fotopoulos G, Holzwarth JA, Cherbut C, Dorta G, Corthesy-Theulaz I, Grigorov M. Biomarkers of human gastrointestinal tract regions. Mamm. Genome 20: 516-527 (2009). *
Comelli EM, Simmering R, Faure M, Donnicola D, Mansourian R, Rochat F, Corthesy-Theulaz I, Cherbut C. Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota. Genomics 91: 70-77 (2008). *
Comite de nutrition de la Societe francaise de pediatrie. Nutritional treatment in childhood Crohn's disease. Arch. Pediatr. 12: 1255-1266 (2005).
Commerford SR, Vargas L, Dorfman SE, Mitro N, Rocheford EC, Mak PA, Li X, Kennedy P, Mullarkey TL, Saez E. Dissection of the insulin-sensitizing effect of liver X receptor ligands. Mol. Endocrinol. 21: 3002-3112 (2007). *
Compher C, Pazianas M, Benedict S, Brown JC, Kinosian BP, Hise M. Systemic inflammatory mediators and bone homeostasis in intestinal failure. JPEN J. Parenter. Enteral Nutr. 31: 142-147 (2007). *
Compher CW, Kinosian BP, Evans-Stoner N, Huzinec J, Buzby GP. Hyperhomocysteinemia is associated with venous thrombosis in patients with short bowel syndrome. JPEN J. Parenter. Enteral Nutr. 25: 1-7 (2001).
Compher CW, Kinosian BP, Stoner NE, Lentine DC, Buzby GP. Choline and vitamin B12 deficiencies are interrelated in folate-replete long-term total parenteral nutrition patients. JPEN J. Parenter. Enteral Nutr. 26: 57-62 (2002). *
Compston JE. Detection of osteoporosis in patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 9: 931-933 (1997).
Compston JE, Thompson RP. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet 1: 721-724 (1977).
Conde CM, Cyrino FZ, Bottino DA, Gardette J, Bouskela E. Longchain n-3 polyunsaturated fatty acids and microvascular reactivity: observation in the hamster cheek pouch. Microvasc. Res. 73: 237-247 (2007).
Condello S, Caccamo D, Curro M, Ferlazzo N, Parisi G, Ientile R. Transglutaminase 2 and NF-kappaB interplay during NGF-induced differentiation of neuroblastoma cells. Brain Res. 1207: 1-8 (2008).
Condino AA, Fidanza S, Hoffenberg EJ. A home infliximab infusion program. J. Pediatr. Gastroenterol. Nutr. 40: 67-69 (2005). *
Condino AA, Hoffenberg EJ, Accurso F, Penvari C, Anthony M, Gralla J, O'Connor JA. Frequency of ASCA seropositivity in children with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 41: 23-26 (2005). *
Conklin SM, Harris JI, Manuck SB, Yao JK, Hibbeln JR, Muldoon MF. Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. Psychiatry Res. 152: 1-10 (2007).
Conlon MA, Bird AR. Interactive and individual effects of dietary non-digestible carbohydrates and oils on DNA damage, SCFA and bacteria in the large bowel of rats. Br. J. Nutr. 101: 1171-1177 (2009). *
Connor FL, Di Lorenzo C. Chronic intestinal pseudo-obstruction: assessment and management. Gastroenterology 130: S29-S36 (2006). *
Connor KM, Sangiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, Hong S, Pravda EA, Majchrzak S, Carper D, Hellstrom A, Kang JX, Chew EY, Salem N, Serhan CN, Smith LE. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 13: 868-873 (2007). *
Connor WE. Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 71: 171S-175S (2000). *
Connor WE, Connor SL. The importance of fish and docosahexaenoic acid in Alzheimer disease. Am. J. Clin. Nutr. 85: 929-930 (2007). *
Constantin C, Touraev A, Heberle-Bors E, Quirce S, Huber WD, Valenta R. Detection of antigens reactive to IgE and IgA during wheat seed maturation and in different wheat cultivars. Int. Arch. Allergy Immunol. 149: 181-187 (2009).
Contardo C DR. The role of Helicobacter pylori in gastroduodenal tumorous pathology. Rev. Gastroenterol. Peru. 17 Suppl. 1: 13-20 (1997).
Contessini Avesani E, Vicentini L, Carrara A, Botti F, Reduzzi R, Dallera P. Surgical treatment of Crohn's disease. Indication and management in 20 patients. Minerva Gastroenterol. Dietol. 44: 17-21 (1998).
Conti B, Sanchez-Alavez M, Winsky-Sommerer R, Morale MC, Lucero J, Brownell S, Fabre V, Huitron-Resendiz S, Henriksen S, Zorrilla EP, de Lecea L, Bartfai T. Transgenic mice with a reduced core body temperature have an increased life span. Science 314: 825-828 (2006). *
Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, Fisher RA, Ham J, Sanyal AJ. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl. 7: 363-373 (2001). *
Conway S, Morton A, Wolfe S. Enteral tube feeding for cystic fibrosis. Cochrane Database Syst. Rev. 2: CD001198 (2008). *
Coogan PF, Rosenberg L. The use of folic acid antagonists and the risk of colorectal cancer. Pharmacoepidemiol. Drug Saf. 16: 1111-1119 (2007).
Cook RJ, Horne DW, Wagner C. Effect of dietary methyl group deficiency on one-carbon metabolism in rats. J. Nutr. 119: 612-617 (1989). *
Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA. Oxidative stress, beta cell apoptosis and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145: 5305-5312 (2004). *
Coombes JL, Siddiqui KR, Arancibia-C�rcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta- and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764 (2007). *
Cooper A, Betts JM, Pereira GR, Ziegler MM. Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition. J. Pediatr. Surg. 19: 462-466 (1984).
Cooper JG, Purcell GP. Data mining for correlations between diet and Crohn's disease activity. AMIA Annu. Symp. Proc. 2006: 897 (2006). *
Cooray HC, Janvilisri T, van Veen HW, Hladky SB, Barrand MA. Interaction of the breast cancer resistance protein with plant polyphenols. Biochem. Biophys. Res. Commun. 317: 269-275 (2004). *
Copeland BH, Aramide O, Wehbe S, Fitzgerald SM, Krishnaswamy G. Eosinophilia in a patient with cyclical vomiting: a case report. Clin. Mol. Allergy 2: 7 (2004). *
Corazza GR, Stefano MD, Maurino E, Bai JC. Bones in coeliac disease: diagnosis and treatment. Best Pract. Res. Clin. Gastroenterol. 19: 453-465 (2005).
Corbett K, Kelleher S, Rowland M, Daly L, Drumm B, Canny G, Greally P, Hayes R, Bourke B. Cystic fibrosis-associated liver disease: a population-based study. J. Pediatr. 145: 327-332 (2004). *
Cordain L. Cereal grains: humanity's double-edged sword. World Rev. Nutr. Diet. 84: 19-73 (1999). *
Cordoba J, Lopez-Hellin J, Planas M, Sabin P, Sanpedro F, Castro F, Esteban R, Guardia J. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J. Hepatol. 41: 38-43 (2004). *
Cordova Guevara H, Guarner Aguilar L. Effective treatment of common variable immunodeficiency associated diarrhea. Rev. Esp. Enferm. Dig. 101: 215-219 (2009).
Corella D, Gonzalez JI, Bullo M, Carrasco P, Portoles O, Diez-Espino J, Covas MI, Ruiz-Gutierrez V, Gomez-Gracia E, Aros F, Fiol M, Herrera MC, Santos JM, Saez G, Lamuela R, Lahoz C, Vinyoles E, Ros E, Estruch R. Polymorphisms cyclooxygenase-2 -765G>C and interleukin-6 -174G>C are associated with serum inflammation markers in a high cardiovascular risk population and do not modify the response to a Mediterranean diet supplemented with virgin olive oil or nuts. J. Nutr. 139: 128-134 (2009). *
Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu. Rev. Nutr. 25: 341-390 (2005). *
Corella D, Qi L, Tai ES, Deurenberg-Yap M, Tan CE, Chew SK, Ordovas JM. Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high-saturated fat, low-carbohydrate diet. Diabetes Care 29: 1313-1319 (2006). *
Corfield AP, Carroll D, Myerscough N, Probert CS. Mucins in the gastrointestinal tract in health and disease. Front. Biosci. 6: D1321-D1357 (2001).
Cormier K, Mager D, Bannister L, Fortin M, Richards H, Jackson C, Pencharz P. Resting energy expenditure in the parenterally fed pediatric population with Crohn's disease. JPEN J. Parenter. Enteral Nutr. 29: 102-107 (2005). *
Cornelis MC, Bae SC, Kim I, El-Sohemy A. CYP1A2 genotype and rheumatoid arthritis in Koreans. Rheumatol. Int. Jul 5 [Epub ahead of print] (2009). *
Cornelis MC, El-Sohemy A, Campos H. GSTT1 genotype modifies the association between cruciferous vegetable intake and the risk of myocardial infarction. Am. J. Clin. Nutr. 86: 752-758 (2007). *
Cornelis MC, Qi L, Kraft P, Hu FB. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. Am. J. Clin. Nutr. 89: 1256-1262 (2009). *
Cornell HJ, Macrae FA, Melny J, Pizzey CJ, Cook F, Mason S, Bhathal PS, Stelmasiak T. Enzyme therapy for management of coeliac disease. Scand. J. Gastroenterol. 40: 1304-1312 (2005). *
Cornell HJ, Stelmasiak T. A unified hypothesis of coeliac disease with implications for management of patients. Amino Acids 33: 43-49 (2007). *
Cornick CL, Strongitharm BH, Sassano G, Rawlins C, Mayes AE, Joseph AN, O'Dowd J, Stocker C, Wargent E, Cawthorne MA, Brown AL, Arch JR. Identification of a novel agonist of peroxisome proliferator-activated receptors alpha and gamma that may contribute to the anti-diabetic activity of guggulipid in Lep(ob)/Lep(ob) mice. J. Nutr. Biochem. 20: 806-815 (2009). *
Coronel R, Wilms-Schopman FJ, Den Ruijter HM, Belterman CN, Schumacher CA, Opthof T, Hovenier R, Lemmens AG, Terpstra AH, Katan MB, Zock P. Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc. Res. 73: 386-394 (2007). *
Corporeau C, Foll CL, Taouis M, Gouygou JP, Berge JP, Delarue J. Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats. Am. J. Physiol. Endocrinol. Metab. 290: E78-E86 (2006). *
Corradini E, Garuti C, Montosi G, Ventura P, Andriopoulos B Jr, Lin HY, Pietrangelo A, Babitt JL. Bone morphogenetic protein signaling is impaired in an Hfe knockout mouse model of hemochromatosis. Gastroenterology 137: 1489-1497 (2009). *
Cortez AP, de Morais MB, Speridiao PD, da Motta Mattar RH, Calanca F, Neto UF. Food intake, growth and body composition of children and adolescents with autoimmune hepatitis. J. Clin. Gastroenterol. Oct 12 [Epub ahead of print] (2009).
Cortez-Pinto H, Ermelinda Camilo M. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. Best Pract. Res. Clin. Gastroenterol. 18: 1089-1104 (2004).
Corthesy-Theulaz I, den Dunnen JT, Ferre P, Geurts JM, Muller M, van Belzen N, van Ommen B. Nutrigenomics: the impact of biomics technology on nutrition research. Ann. Nutr. Metab. 49: 355-365 (2005).
Corton JC, Brown-Borg HM. Peroxisome proliferator-activated receptor gamma coactivator 1 in caloric restriction and other models of longevity. J. Gerontol. A. Biol. Sci. Med. Sci. 60: 1494-1509 (2005).
Corvo M, Ghiglioni D, Gemellaro L, Sarratud T, Fiocchi A. Gastrointestinal signs and symptoms of allergic diseases in children. Pediatr. Med. Chir. 31: 153-159 (2009).
Corvol H, Boelle PY, Brouard J, Knauer N, Chadelat K, Henrion-Caude A, Flamant C, Muselet-Charlier C, Boule M, Fauroux B, Vallet C, Feingold J, Ratjen F, Grasemann H, Clement A. Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis. Pediatr. Pulmonol. 43: 1224-1232 (2008).
Corvol H, Nathan N, Charlier C, Chadelat K, Le Rouzic P, Tabary O, Fauroux B, Henrion-Caude A, Feingold J, Boelle PY, Clement A. Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis. Respir. Res. 8: 88 (2007). *
Cosar M, Songur A, Sahin O, Uz E, Yilmaz R, Yagmurca M, Ozen OA. The neuroprotective effect of fish n-3 fatty acids in the hippocampus of diabetic rats. Nutr. Neurosci. 11: 161-166 (2008).
Cosmetic Ingredient Review Expert Panel. Final safety assessment of coal tar as used in cosmetics. Int. J. Toxicol. 27 Suppl. 2: 1-24 (2008).
Cosnes J. Diagnosis of celiac disease in a young woman. Gastroenterol. Clin. Biol. 33: 518-520 (2009).
Cosnes J. Can we modulate the clinical course of inflammatory bowel diseases by our current treatment strategies? Dig. Dis. 27: 516-521 (2009).
Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract. Res. Clin. Gastroenterol. 18: 481-496 (2004).
Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Gendre JP. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 45: 218-222 (1999). *
Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP. Long-term evolution of disease behavior of Crohn's disease. Inflamm. Bowel Dis. 8: 244-250 (2002). *
Cosnes J, Cellier C, Viola S, Colombel JF, Michaud L, Sarles J, Hugot JP, Ginies JL, Dabadie A, Mouterde O, Allez M, Nion-Larmurier I; Groupe D'Etude et de Recherche sur la Maladie Coeliaque. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin. Gastroenterol. Hepatol. 6: 753-758 (2008).
Cosnes J, Seksik P. Inflammatory bowel diseases: from sulfasalazine to biologics. Gastroenterol. Clin. Biol. 33: 692-701 (2009).
Cosnes J, Seksik P, Nion-Larmurier I, Beaugerie L, Gendre JP. Prior appendectomy and the phenotype and course of Crohn's disease. World J. Gastroenterol. 12: 1235-1242 (2006). *
Costa LG. Contaminants in fish: risk-benefit considerations. Arh. Hig. Rada. Toksikol. 58: 367-374 (2007).
Costa N, Paramanathan S, Donald DM, Wierzbicki AS, Hampson G. Factors regulating circulating vascular endothelial growth factor (VEGF): association with bone mineral density (BMD) in post-menopausal osteoporosis. Cytokine 46: 376-381 (2009).
Costa S, Maggio L, Sindico P, Cota F, De Carolis MP, Romagnoli C. Preterm small for gestational age infants are not at higher risk for parenteral nutrition-associated cholestasis. J. Pediatr. Dec 24 [Epub ahead of print] (2009). *
Costantino G, Della Torre A, Lo Presti MA, Caruso R, Mazzon E, Fries W. Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Dig. Liver Dis. 40: 74-77 (2008).
Costarelli V, Key TJ, Appleby PN, Allen DS, Fentiman IS, Sanders TA. A prospective study of serum bile acid concentrations and colorectal cancer risk in post-menopausal women on the island of Guernsey. Br. J. Cancer 86: 1741-1744 (2002). *
Costas Armada P, Garcia-Mayor RV, Larranaga A, Seguin P, Perez Mendez LF. Rate of undernutrition and response to specific nutritional therapy in Crohn's disease. Nutr. Hosp. 24: 161-166 (2009).
Coste A, Dubuquoy L, Barnouin R, Annicotte JS, Magnier B, Notti M, Corazza N, Antal MC, Metzger D, Desreumaux P, Brunner T, Auwerx J, Schoonjans K. LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease. Proc. Natl. Acad. Sci. U.S.A. 104: 13098-13103 (2007). *
Costenbader KH, Feskanich D, Benito-Garcia E, Holmes M, Karlson E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann. Rheum. Dis. 67: 530-535 (2008).
Costenbader KH, Karlson EW. Cigarette smoking and systemic lupus erythematosus: a smoking gun? Autoimmunity 38: 541-547 (2005).
Costet P, Cariou B, Lambert G, Lalanne F, Lardeux B, Jarnoux AL, Grefhorst A, Staels B, Krempf M. Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory-element binding protein 1c. J. Biol. Chem. 281: 6211-6218 (2006). *
Coti Bertrand P, O'kusky JR, Innis SM. Maternal dietary (n-3) fatty acid deficiency alters neurogenesis in the embryonic rat brain. J. Nutr. 136: 1570-1575 (2006). *
Coton T, Grassin F, Maslin J, Gidenne S, Sarret D, Petitjeans F, Benois A, Kraemer P, Cloatre G. Celiac disease: special features in Africa. Description of 8 cases in Djibouti (horn of Africa). Med. Trop. (Mars.) 68: 144-148 (2008).
Cottart CH, Bonvin E, Rey C, Wendum D, Bernaudin JF, Dumont S, Lasnier E, Debray D, Clement A, Housset C, Bonora M. Impact of nutrition on phenotype in CFTR-deficient mice. Pediatr. Res. 62: 528-532 (2007). *
Cottet V, Touvier M, Fournier A, Touillaud MS, Lafay L, Clavel-Chapelon F, Boutron-Ruault MC. Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC Prospective Cohort Study. Am. J. Epidemiol. 170: 1257-1267 (2009). *
Cottone M, Cipolla C, Rosselli M. Epidemiology and pathogenesis of Crohn's disease. Chir. Ital. 47: 1-7 (1995).
Cottone M, Mocciaro F, Orlando A. Infliximab prevents Crohn's disease recurrence after ileal resection. Expert Rev. Gastroenterol. Hepatol. 3: 231-234 (2009).
Cottone M, Orlando A, Modesto I. Postoperative maintenance therapy for inflammatory bowel disease. Curr. Opin. Gastroenterol. 22: 377-381 (2006).
Cottone M, Scimeca D, Mocciaro F, Civitavecchia G, Perricone G, Orlando A. Clinical course of ulcerative colitis. Dig. Liver Dis. 40 Suppl. 2: S247-S252 (2008).
Couderc AL, Costello R, Bagneres D, Rossi P, Vitton V, Demoux AL, Bonin-Guillaume S, Frances Y, Granel B. Is pure red cell aplasia a new extra digestive manifestation of celiac disease? Rev. Med. Interne. 27: 336-339 (2006).
Couplan E, Le Cann M, Le Foll C, Corporeau C, Blondel M, Delarue J. Polyunsaturated fatty acids inhibit PI3K activity in a yeast-based model system. Biotechnol. J. 4: 1190-1197 (2009).
Courtney ED, Matthews S, Finlayson C, Di Pierro D, Belluzzi A, Roda E, Kang JY, Leicester RJ. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int. J. Colorectal Dis. 22: 765-776 (2007). *
Courtney ED, Melville DM, Leicester RJ. Review article: chemoprevention of colorectal cancer. Aliment. Pharmacol. Ther. 19: 1-24 (2004). *
Courville AB, Keplinger MR, Judge MP, Lammi-Keefe CJ. Plasma or red blood cell phospholipids can be used to assess docosahexaenoic acid status in women during pregnancy. Nutr. Res. 29: 151-155 (2009). *
Coutinho BP, Oria RB, Vieira CM, Sevilleja JE, Warren CA, Maciel JG, Thompson MR, Pinkerton RC, Lima AA, Guerrant RL. Cryptosporidium infection causes under-nutrition, and conversely, weanling under-nutrition intensifies infection. J. Parasitol. 94: 1225-1232 (2008).
Covaci A, Voorspoels S, Vetter W, Gelbin A, Jorens PG, Blust R, Neels H. Anthropogenic and naturally occurring organobrominated compounds in fish oil dietary supplements. Environ. Sci. Technol. 41: 5237-5244 (2007).
Covington MB. Omega-3 fatty acids. Am. Fam. Physician 70: 133-140 (2004). *
Cowles RA, Ventura KA, Martinez M, Lobritto SJ, Harren PA, Brodlie S, Carroll J, Jan DM. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J. Pediatr. Surg. 45: 84-88 (2010).
Cox JT, Phelan ST. Prenatal nutrition: special considerations. Minerva Ginecol. 61: 373-400 (2009).
Cox KL, Cox KM. Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 27: 580-583 (1998). *
Cox MA, Lewis KO, Cooper BT. Measurement of small intestinal permeability markers, lactulose, and mannitol in serum: results in celiac disease. Dig. Dis. Sci. 44: 402-406 (1999). *
Cox SE, Doherty C, Atkinson SH, Nweneka CV, Fulford AJ, Ghattas H, Rockett KA, Kwiatkowski DP, Prentice AM. Haplotype association between haptoglobin (Hp2) and Hp promoter SNP (A-61C) may explain previous controversy of haptoglobin and malaria protection. PLoS ONE 2: e362 (2007). *
Coyne GS, Kenny DA, Childs S, Sreenan JM, Waters SM. Dietary n-3 polyunsaturated fatty acids alter the expression of genes involved in prostaglandin biosynthesis in the bovine uterus. Theriogenology 70: 772-782 (2008).
Crabb DW. Recent developments in alcoholism: the liver. Recent Dev. Alcohol. 11: 207-230 (1993).
Crabb DW, Galli A, Fischer M, You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol 34: 35-38 (2004). *
Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc. Nutr. Soc. 63: 49-63 (2004). *
Crabb DW, Pinaire J, Chou WY, Sissom S, Peters JM, Harris RA, Stewart M. Peroxisome proliferator-activated receptors (PPAR) and the mitochondrial aldehyde dehydrogenase (ALDH2) promoter in vitro and in vivo. Alcohol Clin. Exp. Res. 25: 945-952 (2001).
Cragg RA, Phillips SR, Piper JM, Varma JS, Campbell FC, Mathers JC, Ford D. Homeostatic regulation of zinc transporters in the human small intestine by dietary zinc supplementation. Gut 54: 469-478 (2005). *
Craig D, Robins G, Howdle PD. Advances in celiac disease. Curr. Opin. Gastroenterol. 23: 142-148 (2007).
Craig SA. Betaine in human nutrition. Am. J. Clin. Nutr. 80: 539-549 (2004). *
Craig WJ. Health effects of vegan diets. Am. J. Clin. Nutr. 89: 1627S-1633S (2009). *
Crandall WV, Halterman TE, Mackner LM. Anxiety and pain symptoms in children with inflammatory bowel disease and functional gastrointestinal disorders undergoing colonoscopy. J. Pediatr. Gastroenterol. Nutr. 44: 63-67 (2007). *
Cranney A, Zarkadas M, Graham ID, Butzner JD, Rashid M, Warren R, Molloy M, Case S, Burrows V, Switzer C. The Canadian celiac health survey. Dig. Dis. Sci. 52: 1087-1095 (2007). *
Craven M, Simpson JW, Ridyard AE, Chandler ML. Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). J. Small Anim. Pract. 45: 336-342 (2004).
Cravo ML, Mason JB, Dayal Y, Hutchinson M, Smith D, Selhub J, Rosenberg IH. Folate deficiency enhances the development of colonic neoplasia in dimethylhydrazine-treated rats. Cancer Res. 52: 5002-5006 (1992). *
Crawford C, Sepulveda MF, Elliott J, Harris PA, Bailey SR. Dietary fructan carbohydrate increases amine production in the equine large intestine: implications for pasture-associated laminitis. J. Anim. Sci. 85: 2949-2958 (2007). *
Crawford MA. Docosahexaenoic acid in neural signaling systems. Nutr. Health 18: 263-276 (2006).
Crawford MA, Golfetto I, Ghebremeskel K, Min Y, Moodley T, Poston L, Phylactos A, Cunnane S, Schmidt W. The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants. Lipids 38: 303-315 (2003).
Crawford RW, Rosales-Reyes R, Ramirez-Aguilar MD, Chapa-Azuela O, Alpuche-Aranda C, Gunn JS. Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage. Proc. Natl. Acad. Sci. U.S.A. Feb 22 [Epub ahead of print] (2010). *
Creel WB, Abell TL, Lobrano A, Deitcher SR, Dugdale M, Smalley D, Johnson WD. To clot or not to clot: are there predictors of clinically significant thrombus formation in patients with gastroparesis and prolonged IV access? Dig. Dis. Sci. 53: 1532-1536 (2008). *
Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin. Nutr. 27: 328-339 (2008).
Criscuoli V, Mocciaro F, Orlando A, Rizzuto MR, Renda MC, Cottone M. Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis. Inflamm. Bowel Dis. 15: 810-811 (2009). *
Criscuoli V, Plano S, Aragona E, Cottone M. Oral valganciclovir for colonic dilatation in ulcerative colitis associated with human cytomegalovirus infection. Inflamm. Bowel Dis. Aug 27 [Epub ahead of print] (2009).
Cristina M, Sara P, Kamilia L, Francesca C, Paola C, Agata B, Mauro B. Short stature in children with coeliac disease. Pediatr. Endocrinol. Rev. 6: 457-463 (2009).
Croce AC, De Simone U, Vairetti M, Ferrigno A, Boncompagni E, Freitas I, Bottiroli G. Liver autofluorescence properties in animal model under altered nutritional conditions. Photochem. Photobiol. Sci. 7: 1046-1053 (2008).
Crocenzi FA, Sanchez Pozzi EJ, Pellegrino JM, Rodriguez Garay EA, Mottino AD, Roma MG. Preventive effect of silymarin against taurolithocholate-induced cholestasis in the rat. Biochem. Pharmacol. 66: 355-364 (2003). *
Crochemore C, Virgili M, Bonamassa B, Canistro D, Pena-Altamira E, Paolini M, Contestabile A. Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model for amyotrophic lateral sclerosis. Muscle Nerve 39: 548-552 (2009).
Croft NM. Gluten-free diets in celiac disease: does life mean life? Gastroenterology 134: 883-885 (2008). *
Crowe FL, Allen NE, Appleby PN, Overvad K, Aardestrup IV, Johnsen NF, Tjonneland A, Linseisen J, Kaaks R, Boeing H, Kroger J, Trichopoulou A, Zavitsanou A, Trichopoulos D, Sacerdote C, Palli D, Tumino R, Agnoli C, Kiemeney LA, Bueno-de-Mesquita HB, et al. Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am. J. Clin. Nutr. 88: 1353-1363 (2008). *
Crowe FL, Skeaff CM, McMahon JA, Williams SM, Green TJ. Lowering plasma homocysteine concentrations of older men and women with folate, vitamin B-12, and vitamin B-6 does not affect the proportion of (n-3) long chain polyunsaturated fatty acids in plasma phosphatidylcholine. J. Nutr. 138: 551-555 (2008). *
Crowley-Weber CL, Dvorakova K, Crowley C, Bernstein H, Bernstein C, Garewal H, Payne CM. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem. Biol. Interact. 145: 53-66 (2003). *
Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, Waltmire CN, Crowley C, Dvorakova K, Bernstein C, Craven M, Garewal H, Bernstein H. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis 23: 2063-2080 (2002). *
Crozier SJ, D'Alecy LG, Ernst SA, Ginsburg LE, Williams JA. Molecular mechanisms of pancreatic dysfunction induced by protein malnutrition. Gastroenterology 137: 1093-1101.e3 (2009). *
Cruz-Garcia L, Minghetti M, Navarro I, Tocher DR. Molecular cloning, tissue expression and regulation of liver X receptor (LXR) transcription factors of Atlantic salmon (Salmo salar) and rainbow trout (Oncorhynchus mykiss). Comp. Biochem. Physiol. B. Biochem. Mol. Biol. Feb 4 [Epub ahead of print] (2009). *
Csak T, Folhoffer A, Horvath A, Halasz J, Diczhazi C, Schaff Z, Szalay F. Holmes-Adie syndrome, autoimmune hepatitis and celiac disease: a case report. World J. Gastroenterol. 12: 1485-1487 (2006). *
Csaplar M, Juhasz M, Muzes G, Jakab C, Aranyi Z, Rozsa C, Molnar B, Komoly S, Papay J, Zagoni T, Herszenyi L, Tulassay Z. Association of coeliac disease and myasthenia gravis. Orv. Hetil. 147: 841-844 (2006).
Cubelic S, Misak Z, Gasparov S, Kolacek S. Nonalcoholic steatohepatitis in children. Lijec. Vjesn. 126: 197-200 (2004).
Cucchiara S, Escher JC, Hildebrand H, Amil-Dias J, Stronati L, Ruemmele FM. Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies? J. Pediatr. Gastroenterol. Nutr. 48: 257-267 (2009).
Cucchiara S, Latiano A, Palmieri O, Canani RB, D'Inca R, Guariso G, Vieni G, De Venuto D, Riegler G, De'Angelis GL, Guagnozzi D, Bascietto C, Miele E, Valvano MR, Bossa F, Annese V; Italian Society of Pediatric Gastroenterology and Nutrition. Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 44: 171-179 (2007). *
Cucino C, Sonnenberg A. Cause of death in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 7: 250-255 (2001). *
Cueto Rua EA, Guzman L, Nanfito G, Barrera S, Drut R. Celiac disease, a paradigmatic disease. Arch. Argent. Pediatr. 106: 151-154 (2008).
Cuffari C. Anti-TNF therapy in Crohn's disease: a balance between a targeted therapeutic approach and drug-induced immunogenicity. Expert Rev. Gastroenterol. Hepatol. 1: 233-237 (2008).
Cuffari C, Dubinsky M, Darbari A, Sena L, Baldassano R. Crohn's jejunoileitis: the pediatrician's perspective on diagnosis and management. Inflamm. Bowel Dis. 11: 696-704 (2005). *
Cuffari C, Li DY, Mahoney J, Barnes Y, Bayless TM. Peripheral blood mononuclear cell DNA 6-thioguanine metabolite levels correlate with decreased interferon-gamma production in patients with Crohn's disease on AZA therapy. Dig. Dis. Sci. 49: 133-137 (2004). *
Cui G, Qin X, Zhang Y, Gong Z, Ge B, Zang YQ. Berberine differentially modulates the activities of Erk, p38 MAPK and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice. J. Biol. Chem. 284: 28420-28429 (2009). *
Cui G, Zhang Y, Gong Z, Zhang JZ, Zang YQ. Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes. Cell. Res. 19: 574-583 (2009).
Cui M, Klopot A, Jiang Y, Fleet JC. The effect of differentiation on 1,25 dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-2. J. Cell. Physiol. 218: 113-121 (2009). *
Cui M, Zhao Y, Hance KW, Shao A, Wood RJ, Fleet JC. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2. J. Cell. Physiol. 219: 132-142 (2009). *
Cui Y, Rohan TE. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol. Biomarkers Prev. 15: 1427-1437 (2006). *
Cukovic-Cavka S, Likic R, Francetic I, Rustemovic N, Opacic M, Vucelic B. Lactobacillus acidophilus as a cause of liver abscess in a NOD2/CARD15-positive patient with Crohn's disease. Digestion 73: 107-110 (2006). *
Culliford A, Markowitz D, Rotterdam H, Green PHR. Scalloping of duodenal mucosa in Crohn's disease. Inflamm. Bowel Dis. 10: 270-273 (2004). *
Culnan DM, Cooney RN, Stanley B, Lynch CJ. Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass. Obesity (Silver Spring) 17: 46-52 (2009). *
Culvenor CC, Clarke M, Edgar JA, Frahn JL, Jago MV, Peterson JE, Smith LW. Structure and toxicity of the alkaloids of Russian comfrey (Symphytum x uplandicum Nyman), a medicinal herb and item of human diet. Experientia 36: 377-379 (1980).
Cummins AG, Roberts-Thomson IC. Prevalence of celiac disease in the Asia-Pacific region. J. Gastroenterol. Hepatol. 24: 1347-1351 (2009). *
Cummins CL, Mangelsdorf DJ. Liver X receptors and cholesterol homoeostasis: spotlight on the adrenal gland. Biochem. Soc. Trans. 34: 1110-1113 (2006). *
Cummins CL, Volle DH, Zhang Y, McDonald JG, Sion B, Lefrancois-Martinez AM, Caira F, Veyssiere G, Mangelsdorf DJ, Lobaccaro JM. Liver X receptors regulate adrenal cholesterol balance. J. Clin. Invest. 116: 1902-1912 (2006). *
Cundiff DK, Lanou AJ, Nigg CR. Relation of omega-3 fatty acid intake to other dietary factors known to reduce coronary heart disease risk. Am. J. Cardiol. 99: 1230-1233 (2007). *
Cunnane SC. Survival of the fattest: the key to human brain evolution. Med. Sci. (Paris) 22: 659-663 (2006).
Cunnane SC, Plourde M, Pifferi F, Begin M, Feart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer's disease. Prog. Lipid Res. 48: 239-256 (2009). *
Cunnane SC, Plourde M, Stewart K, Crawford MA. Docosahexaenoic acid and shore-based diets in hominin encephalization: a rebuttal. Am. J. Hum. Biol. 19: 578-581 (2007).
Cunningham-Rundles S. Nutrition and the mucosal immune system. Curr. Opin. Gastroenterol. 17: 171-176 (2001).
Cuoco L, Cammarota G, Tursi A, Papa A, Certo M, Cianci R, Fedeli G, Gasbarrini G. Disappearance of gastric mucosa-associated lymphoid tissue in coeliac patients after gluten withdrawal. Scand. J. Gastroenterol. 33: 401-405 (1998). *
Cuoco L, Salvagnini M. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin. Minerva Gastroenterol. Dietol. 52: 89-95 (2006).
Cuoco L, Vescovo G, Castaman R, Ravara B, Cammarota G, Angelini A, Salvagnini M, Dalla Libera L. Skeletal muscle wastage in Crohn's disease: a pathway shared with heart failure? Int. J. Cardiol. 127: 219-227 (2008).
Cuperus FJ, Hafkamp AM, Havinga R, Vitek L, Zelenka J, Tiribelli C, Ostrow JD, Verkade HJ. Effective treatment of unconjugated hyperbilirubinemia with oral bile salts in Gunn rats. Gastroenterology 136: 673-682.e1 (2009). *
Curran DR, McArdle JR, Talwalkar JS. Diabetes mellitus and bone disease in cystic fibrosis. Semin. Respir. Crit. Care Med. 30: 514-530 (2009).
Curran-Celentano J, Erdman JW Jr, Nelson RA, Grater SJ. Alterations in vitamin A and thyroid hormone status in anorexia nervosa and associated disorders. Am. J. Clin. Nutr. 42: 1183-1191 (1985). *
Cursiefen C, Jacobi C, Dietrich T, Kruse FE. Current treatment for dry eye syndrome. Ophthalmologe 103: 18-24 (2006).
Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev. 13: 285-292 (2004). *
Curtis L. High-quality enteral nutrition essential for reducing morbidity and mortality in acute care patients. Crit. Care Med. 35: 988 (2007).
Curtis LT, Patel K. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. J. Altern. Complement. Med. 14: 79-85 (2008).
Cusack S, Molgaard C, Michaelsen KF, Jakobsen J, Lamberg-Allardt CJ, Cashman KD. Vitamin D and estrogen receptor-alpha genotype and indices of bone mass and bone turnover in Danish girls. J. Bone Miner. Metab. 24: 329-336 (2006). *
Cuskelly GJ, Stacpoole PW, Williamson J, Baumgartner TG, Gregory JF 3rd. Deficiencies of folate and vitamin B(6) exert distinct effects on homocysteine, serine, and methionine kinetics. Am. J. Physiol. Endocrinol. Metab. 281: E1182-E1190 (2001). *
Custer M, Spindler B, Verrey F, Murer H, Biber J. Identification of a new gene product (diphor-1) regulated by dietary phosphate. Am. J. Physiol. 273: F801-F806 (1997). *
Cutchins A, Roman MJ, Devereux RB, Ebbesson SO, Umans JG, Zhu J, Weissman NJ, Howard BV. Prevalence and correlates of subclinical atherosclerosis in Alaska Eskimos: the GOCADAN study. Stroke 39: 3079-3082 (2008).
Cuthbert JA. Wilson's disease: a new gene and an animal model for an old disease. J. Investig. Med. 43: 323-336 (1995).
Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun. Rev. 7: 59-64 (2007).
Cuvelier C, Mielants H, De Vos M, Quatacker J, Veys E. Idiopathic inflammatory bowel diseases: immunological hypothesis. Acta Gastroenterol. Belg. 57: 292-299 (1994).
Cuvelier C, Mielants H, De Vos M, Veys E, Roels H. Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy. Gut 31: 545-549 (1990). *
Cvjeticanin T, Miljkovic D, Stojanovic I, Dekanski D, Stosic-Grujicic S. Dried leaf extract of Olea europaea ameliorates islet-directed autoimmunity in mice. Br. J. Nutr. Dec 22 [Epub ahead of print] (2009). *
Cynober L. Can arginine and ornithine support gut functions? Gut 35: S42-S45 (1994). *
Cysneiros RM, Terra VC, Machado HR, Arida RM, Albuquerque M, Scorza CA, Cavalheiro EA, Scorza FA. Epilepsy and sudden unexpected death in epilepsy?: eat more fish! A group hypothesis. Arq. Neuropsiquiatr. 67: 927-929 (2009).
Czaja AJ. Autoimmune hepatitis - approach to diagnosis. MedGenMed. 8: 55 (2006). *
Czaja AJ. Diverse manifestations and evolving treatments of autoimmune hepatitis. Minerva Gastroenterol. Dietol. 51: 313-333 (2005).
Czaja AJ. Autoimmune liver disease and rheumatic manifestations. Curr. Opin. Rheumatol. 19: 74-80 (2007).
Czaja AJ. Evolving concepts in the diagnosis, pathogenesis and treatment of autoimmune hepatitis. Minerva Gastroenterol. Dietol. 53: 43-78 (2007).
Czako L, Hegyi P, Rakonczay Z Jr, Wittmann T, Otsuki M. Interactions between the endocrine and exocrine pancreas and their clinical relevance. Pancreatology 9: 351-359 (2009).
D'Amato M, Zucchelli M, Seddighzadeh M, Anedda F, Lindblad S, Kere J, Alfredsson L, Klareskog L, Padyukov L. Analysis of neuropeptide S receptor gene (NPSR1) polymorphism in rheumatoid arthritis. PLoS One 5: e9315 (2010). *
d'Annunzio G, Giannattasio A, Poggi E, Castellano E, Calvi A, Pistorio A, Barabino A, Lorini R. beta-Cell autoimmunity in pediatric celiac: the case for routine screening? Diabetes Care 32: 254-256 (2009).
D'Argenio G, Petrosino S, Gianfrani C, Valenti M, Scaglione G, Grandone I, Nigam S, Sorrentini I, Mazzarella G, Di Marzo V. Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. J. Mol. Med. 85: 523-530 (2007). *
D'Eredita G, Ferrarese F, Cecere V, Fabiano G. Factors affecting prognosis in patients with short bowel syndrome. G. Chir. 24: 302-304 (2003).
D'Inca R, Garribba AT, Vettorato MG, Martin A, Martines D, Di Leo V, Buda A, Sturniolo GC. Use of alternative and complementary therapies by inflammatory bowel disease patients in an Italian tertiary referral centre. Dig. Liver Dis. 39: 524-529 (2007).
D'Odorico A, Bortolan S, Cardin R, D'Inca' R, Martines D, Ferronato A, Sturniolo GC. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand. J. Gastroenterol. 36: 1289-1294 (2001).
D'Souza S, Levy E, Mack D, Israel D, Lambrette P, Ghadirian P, Deslandres C, Morgan K, Seidman EG, Amre DK. Dietary patterns and risk for Crohn's disease in children. Inflamm. Bowel Dis. 14: 367-373 (2008). *
da Silva EF, Barbaro G. New options in the treatment of lipid disorders in HIV-infected patients. Open AIDS J. 3: 31-37 (2009).
Da Silva Morais A, Abarca-Quinones J, Horsmans Y, Starkel P, Leclercq IA. Peroxisome proliferated-activated receptor gamma ligand, pioglitazone, does not prevent hepatic fibrosis in mice. Int. J. Mol. Med. 19: 105-112 (2007). *
Da Silva Morais A, Lebrun V, Abarca-Quinones J, Brichard S, Hue L, Guigas B, Viollet B, Leclercq IA. Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation. J. Hepatol. 50: 489-500 (2009).
da Silva PC, de Almeida PV, Machado MA, de Lima AA, Gregio AM, Trevilatto PC, Azevedo-Alanis LR. Oral manifestations of celiac disease. A case report and review of the literature. Med. Oral Patol. Oral Cir. Bucal. 13: E559-E562 (2008).
da Silva Ribeiro KD, de Araujo KF, de Souza HH, Soares FB, da Costa Pereira M, Dimenstein R. Nutritional vitamin A status in northeast Brazilian lactating mothers. J. Hum. Nutr. Diet. Jan 22 [Epub ahead of print] (2010).
Dabek M, Ferrier L, Roka R, Gecse K, Annahazi A, Moreau J, Escourrou J, Cartier C, Chaumaz G, Leveque M, Ait-Belgnaoui A, Wittmann T, Theodorou V, Bueno L. Luminal cathepsin G and protease-activated receptor 4. A duet involved in alterations of the colonic epithelial barrier in ulcerative colitis. Am. J. Pathol. 175: 207-214 (2009). *
Dabrowska E, Blahuszewska K, Minarowska A, Kaczmarski M, Niedzwiecka-Andrzejewicz I, Stokowska W. Assessment of dental status and oral hygiene in the study population of cystic fibrosis patients in the Podlasie province. Adv. Med. Sci. 51 Suppl. 1: 100-103 (2006).
Dady IM, Thomas AG, Miller V, Kelsey AJ. Inflammatory bowel disease in infancy: an increasing problem? J. Pediatr. Gastroenterol. Nutr. 23: 569-576 (1996). *
Dahl L, Bjorkkjaer T, Graff IE, Malde MK, Klementsen B. Fish provide more to the diet than just omega 3. Tidsskr. Nor. Laegeforen. 126: 309-311 (2006).
Dahlbom I, Korponay-Szabo IR, Kovacs JB, Szalai Z, Maki M, Hansson T. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J. Pediatr. Gastroenterol. Nutr. Oct 13 [Epub ahead of print] (2009).
Dahlin M, Hjelte L, Nilsson S, Amark P. Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. Epilepsy Res. 73: 199-207 (2007).
Dahlman I, Nilsson M, Jiao H, Hoffstedt J, Lindgren CM, Humphreys K, Kere J, Gustafsson JA, Arner P, Dahlman-Wright K. Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity. Pharmacogenet. Genomics 16: 881-889 (2006).
Dahlman-Wright K, Zhao C. LXR in cholesterol metabolism. J. Endocrinol. Oct 16 [Epub ahead of print] (2009). *
Dai D, Walker WA. Protective nutrients and bacterial colonization in the immature human gut. Adv. Pediatr. 46: 353-382 (1999).
Dai J, Su YX, Bartell S, Le NA, Ling WH, Liang YQ, Gao L, Wu HY, Veledar E, Vaccarino V. Beneficial effects of designed dietary fatty acid compositions on lipids in triacylglycerol-rich lipoproteins among Chinese patients with type 2 diabetes mellitus. Metabolism 58: 510-518 (2009). *
Dai Q, Shrubsole MJ, Ness RM, Schlundt D, Cai Q, Smalley WE, Li M, Shyr Y, Zheng W. The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am. J. Clin. Nutr. 86: 743-751 (2007). *
Dalcin Pde T, Abreu E Silva FA. Cystic fibrosis in adults: diagnostic and therapeutic aspects. J. Bras. Pneumol. 34: 107-117 (2008). *
Dalcin Pde T, Rampon G, Pasin LR, Ramon GM, Abrahao CL, Oliveira VZ. Adherence to treatment in patients with cystic fibrosis. J. Bras. Pneumol. 33: 663-670 (2007).
Dale OB, Torud B, Kvellestad A, Koppang HS, Koppang EO. From chronic feed-induced intestinal inflammation to adenocarcinoma with metastases in salmonid fish. Cancer Res. 69: 4355-4362 (2009). *
Dall'asta C, Galaverna G, Mangia M, Sforza S, Dossena A, Marchelli R. Free and bound fumonisins in gluten-free food products. Mol. Nutr. Food Res. 53: 492-499 (2009).
Dallaire P, Bellmann K, Laplante M, Gelinas S, Centeno-Baez C, Penfornis P, Peyot ML, Latour MG, Lamontagne J, Trujillo ME, Scherer PE, Prentki M, Deshaies Y, Marette A. Obese mice lacking iNOS are sensitized to the metabolic actions of PPARgamma agonism. Diabetes 57: 1999-2011 (2008). *
Dalmeijer GW, Olthof MR, Verhoef P, Bots ML, van der Schouw YT. Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. Eur. J. Clin. Nutr. 62: 386-394 (2008). *
Dalton A, Wolmarans P, Witthuhn RC, van Stuijvenberg ME, Swanevelder SA, Smuts CM. A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot. Essent. Fatty Acids 80: 143-149 (2009). *
Daly A, Walsh C, Feighery C, O'Shea U, Jackson J, Whelan A. Serum levels of soluble CD163 correlate with the inflammatory process in coeliac disease. Aliment. Pharmacol. Ther. 24: 553-559 (2006). *
Damasiewicz-Bodzek A, Wielkoszynski T. Serologic markers of celiac disease in psoriatic patients. J. Eur. Acad. Dermatol. Venereol. 22: 1055-1061 (2008). *
Damiano F, Gnoni GV, Siculella L. Functional analysis of rat liver citrate carrier promoter: differential responsiveness to polyunsaturated fatty acids. Biochem. J. 417: 561-571 (2009). *
Damink SW, Dejong CH, Jalan R. Review article: hyperammonaemic and catabolic consequences of upper gastrointestinal bleeding in cirrhosis. Aliment. Pharmacol. Ther. 29: 801-810 (2009). *
Damms A, Bischoff SC. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. Int. J. Colorectal Dis. 23: 985-992 (2008). *
Damsgaard CT, Frokiaer H, Andersen AD, Lauritzen L. Fish oil in combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J. Nutr. 138: 1061-1066 (2008). *
Damsgaard CT, Frokiaer H, Lauritzen L. The effects of fish oil and high or low linoleic acid intake on fatty acid composition of human peripheral blood mononuclear cells. Br. J. Nutr. 99: 147-154 (2008). *
Damsgaard CT, Lauritzen L, Calder PC, Kjaer TR, Frokiaer H. Reduced ex vivo interleukin-6 production by dietary fish oil is not modified by linoleic acid intake in healthy men. J. Nutr. 139: 1410-1414 (2009). *
Damsgaard CT, Lauritzen L, Kjaer TM, Holm PM, Fruekilde MB, Michaelsen KF, Frokiaer H. Fish oil supplementation modulates immune function in healthy infants. J. Nutr. 137: 1031-1036 (2007). *
Damsgaard CT, Schack-Nielsen L, Michaelsen KF, Fruekilde MB, Hels O, Lauritzen L. Fish oil affects blood pressure and the plasma lipid profile in healthy Danish infants. J. Nutr. 136: 94-99 (2006). *
Damude HG, Kinney AJ. Engineering oilseeds to produce nutritional fatty acids. Physiol. Plant. 132: 1-10 (2008). *
Damude HG, Kinney AJ. Engineering oilseed plants for a sustainable, land-based source of long chain polyunsaturated fatty acids. Lipids 42: 179-185 (2007).
Damude HG, Zhang H, Farrall L, Ripp KG, Tomb JF, Hollerbach D, Yadav NS. Identification of bifunctional Delta12/omega3 fatty acid desaturases for improving the ratio of omega-3 to omega-6 fatty acids in microbes and plants. Proc. Natl. Acad. Sci. U.S.A. 103: 9446-9451 (2006). *
Dan Z, Popov Y, Patsenker E, Preimel D, Liu C, Wang XD, Seitz HK, Schuppan D, Stickel F. Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential. FASEB J. 19: 845-847 (2005). *
Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 6: e1000058 (2009). *
Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int. 68: 2562-2571 (2005). *
Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 3: 394-400 (2004).
Daneshjoo R, J Talley N. Eosinophilic gastroenteritis. Curr. Gastroenterol. Rep. 4: 366-372 (2002).
Danesi F, Di Nunzio M, Boschetti E, Bordoni A. Green tea extract selectively activates peroxisome proliferator-activated receptor beta/delta in cultured cardiomyocytes. Br. J. Nutr. 101: 1736-1739 (2009). *
Danesi F, Philpott M, Huebner C, Bordoni A, Ferguson LR. Food-derived bioactives as potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases. Mutat. Res. Jan 9 [Epub ahead of print] (2010).
Danforth KN, Rodriguez C, Hayes RB, Sakoda LC, Huang WY, Yu K, Calle EE, Jacobs EJ, Chen BE, Andriole GL, Figueroa JD, Yeager M, Platz EA, Michaud DS, Chanock SJ, Thun MJ, Hsing AW. TNF polymorphisms and prostate cancer risk. Prostate 68: 400-407 (2008).
Dang H, Liu Y, Pang W, Wang N, Shyy JY, Zhu Y. Suppression of 2,3-oxidosqualene cyclase by high-fat diet contributes to liver X receptor-alpha-mediated improvement of hepatic lipid profile. J. Biol. Chem. 284: 6218-6226 (2009). *
Dangat KD, Mehendale SS, Yadav HR, Kilari AS, Kulkarni AV, Taralekar VS, Joshi SR. Long-chain polyunsaturated fatty acid composition of breast milk in pre-eclamptic mothers. Neonatology 97: 190-194 (2009).
Dangour AD, Allen E, Elbourne D, Fletcher A, Richards M, Uauy R. Fish consumption and cognitive function among older people in the UK: baseline data from the Opal study. J. Nutr. Health Aging 13: 198-202 (2009).
Dangour AD, Clemens F, Elbourne D, Fasey N, Fletcher AE, Hardy P, Holder GE, Huppert FA, Knight R, Letley L, Richards M, Truesdale A, Vickers M, Uauy R. A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people � Nutr. J. 5: 20 (2006). *
Daniel CR, McCullough ML, Patel RC, Jacobs EJ, Flanders WD, Thun MJ, Calle EE. Dietary intake of omega-6 and omega-3 fatty acids and risk of colorectal cancer in a prospective cohort of U.S. men and women. Cancer Epidemiol. Biomarkers Prev. 18: 516-525 (2009).
Darbari A, Kalloo AN, Cuffari C. Diagnostic yield, safety, and efficacy of push enteroscopy in pediatrics. Gastrointest. Endosc. 64: 224-228 (2006).
Darios F, Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 440: 813-817 (2006). *
Darlow B, Graham P. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst. Rev. 4: CD000501 (2007). *
Darshan D, Anderson GJ. Liver-gut axis in the regulation of iron homeostasis. World J. Gastroenterol. 13: 4737-4745 (2007). *
Dary O. Nutritional interpretation of folic acid interventions. Nutr. Rev. 67: 235-244 (2009). *
Das D, Arber N, Jankowski JA. Chemoprevention of colorectal cancer. Digestion 76: 51-67 (2007). *
Das JB, Poulos ND, Ansari GG. Biliary lipid composition and bile acid profiles during and after enteral fast of total parenteral nutrition in the rabbit. J. Pediatr. Gastroenterol. Nutr. 22: 85-91 (1996). *
Das KM, Bajpai M. Tropomyosins in human diseases: ulcerative colitis. Adv. Exp. Med. Biol. 644: 158-167 (2008).
Das SK, Chakrabarti R. Role of PPAR in cardiovascular diseases. Recent Patents Cardiovasc. Drug Discov. 1: 193-209 (2006).
Das UN. Essential fatty acids - a review. Curr. Pharm. Biotechnol. 7: 467-482 (2006).
Das UN. Biological significance of essential fatty acids. J. Assoc. Physicians India 54: 309-319 (2006).
Das UN. Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 21: 762-773 (2005). *
Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol. J. 1: 420-439 (2006). *
Das UN. Is metabolic syndrome X a disorder of the brain with the initiation of low-grade systemic inflammatory events during the perinatal period? J. Nutr. Biochem. 18: 701-713 (2007). *
Das UN. A defect in the activity of Delta(6) and Delta(5) desaturases may be a factor in the initiation and progression of atherosclerosis. Prostaglandins Leukot. Essent. Fatty Acids 76: 251-268 (2007). *
Das UN. A defect in the activity of Delta(6) and Delta(5) desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot. Essent. Fatty Acids 72: 343-350 (2005). *
Das UN. Essential fatty acids as possible enhancers of the beneficial actions of probiotics. Nutrition 18: 786 (2002). *
Das UN, Rao AA. Gene expression profile in obesity and type 2 diabetes mellitus. Lipids Health Dis. 6: 35 (2007). *
Datta V, Engledow A, Chan S, Forbes A, Cohen CR, Windsor A. The management of enterocutaneous fistula in a regional unit in the United kingdom: a prospective study. Dis. Colon Rectum 53: 192-199 (2010).
Daubioul CA, Horsmans Y, Lambert P, Danse E, Delzenne NM. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur. J. Clin. Nutr. 59: 723-726 (2005).
Daubresse JC, Sternon J. Omega-3 fatty acids and cardiovascular diseases. Rev. Med. Brux. 27: 43-48 (2006).
Daum S, Bauer U, Foss HD, Schuppan D, Stein H, Riecken EO, Ullrich R. Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease. Gut 44: 17-25 (1999). *
Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19: 413-424 (2005).
Daum S, Ipczynski R, Schumann M, Wahnschaffe U, Zeitz M, Ullrich R. High rates of complications and substantial mortality in both types of refractory sprue. Eur. J. Gastroenterol. Hepatol. 21: 66-70 (2009).
Dauncey MJ, White P, Burton KA, Katsumata M. Nutrition-hormone receptor-gene interactions: implications for development and disease. Proc. Nutr. Soc. 60: 63-72 (2001).
David K, Kowdley KV, Unalp A, Kanwal F, Brunt EM, Schwimmer JB; NASH CRN Research Group. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology 49: 1904-1912 (2009). *
Davidson G, Kritas S, Butler R. Stressed mucosa. Nestle Nutr. Workshop Ser. Pediatr. Program 59: 133-146 (2007).
Davidson LA, Nguyen DV, Hokanson RM, Callaway ES, Isett RB, Turner ND, Dougherty ER, Wang N, Lupton JR, Carroll RJ, Chapkin RS. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. Cancer Res. 64: 6797-6804 (2004). *
Davidson LA, Wang N, Shah MS, Lupton JR, Ivanov I, Chapkin RS. n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 30: 2077-2084 (2009).
Davidson MH, Yannicelli HD. New concepts in dyslipidemia in the metabolic syndrome and diabetes. Metab. Syndr. Relat. Disord. 4: 299-314 (2006).
Davies AR. Practicalities of nutrition support in the intensive care unit. Curr. Opin. Clin. Nutr. Metab. Care 10: 284-290 (2007).
Davies BS, Waki H, Beigneux AP, Farber E, Weinstein MM, Wilpitz DC, Tai LJ, Evans RM, Fong LG, Tontonoz P, Young SG. The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by PPARgamma. Mol. Endocrinol. 22: 2496-2504 (2008). *
Davies E, Tsang CW, Ghazali AR, Harris RM, Waring RH. Effects of culture with TNF-alpha, TGF-beta and insulin on sulphotransferase (SULT 1A1 and 1A3) activity in human colon and neuronal cell lines. Toxicol. In Vitro 18: 749-754 (2004).
Davies JS, Kotokorpi P, Eccles SR, Barnes SK, Tokarczuk PF, Allen SK, Whitworth HS, Guschina IA, Evans BA, Mode A, Zigman JM, Wells T. Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. Mol. Endocrinol. 23: 914-924 (2009). *
Davis AR, Rosenthal P, Newman TB. Nontransplant surgical interventions in progressive familial intrahepatic cholestasis. J. Pediatr. Surg. 44: 821-827 (2009).
Davis C, Jing H, Howe JA, Rocheford T, Tanumihardjo SA. beta-Cryptoxanthin from supplements or carotenoid-enhanced maize maintains liver vitamin A in Mongolian gerbils (Meriones unguiculatus) better than or equal to beta-carotene supplements. Br. J. Nutr. 100: 786-793 (2008). *
Davis CD. Vitamin D and cancer: current dilemmas and future research needs. Am. J. Clin. Nutr. 88: 565S-569S (2008). *
Davis GL. Thoughts on nutrition and liver disease. Nutr. Clin. Pract. 21: 243-244 (2006). *
Davis HR Jr, Basso F, Hoos LM, Tetzloff G, Lally SM, Altmann SW. Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 like 1 (NPC1L1). Atheroscler. Suppl. 9: 77-81 (2008).
Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME. TLR-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 16: 1248-1255 (2008). *
Davis JM, Alderson NL, Welsh RS. Serotonin and central nervous system fatigue: nutritional considerations. Am. J. Clin. Nutr. 72: 573S-578S (2000). *
Davis KG, Wertin TM, Schriver JP. The use of simvastatin for the prevention of gallstones in the lithogenic prairie dog model. Obes. Surg. 13: 865-868 (2003).
Davis LM, Pei Z, Trush MA, Cheskin LJ, Contoreggi C, McCullough K, Watkins PA, Moran TH. Bromocriptine reduces steatosis in obese rodent models. J. Hepatol. 45: 439-444 (2006). *
Davis LM, Rho JM, Sullivan PG. UCP-mediated free fatty acid uncoupling of isolated cortical mitochondria from fasted animals: correlations to dietary modulations. Epilepsia 49 Suppl. 8: 117-119 (2008).
Davis PA, Jenab M, Vanden Heuvel JP, Furlong T, Taylor S. Tree nut and peanut consumption in relation to chronic and metabolic diseases including allergy. J. Nutr. 138: 1757S-1762S (2008). *
Davis PB. Cystic fibrosis since 1938. Am. J. Respir. Crit. Care Med. 173: 475-482 (2006). *
Davis RA, Attie AD. Deletion of the ileal basolateral bile acid transporter identifies the cellular sentinels that regulate the bile acid pool. Proc. Natl. Acad. Sci. U.S.A. 105: 4965-4966 (2008). *
Davis SR, Quinlivan EP, Shelnutt KP, Ghandour H, Capdevila A, Coats BS, Wagner C, Shane B, Selhub J, Bailey LB, Shuster JJ, Stacpoole PW, Gregory JF 3rd. Homocysteine synthesis is elevated but total remethylation is unchanged by the methylenetetrahydrofolate reductase 677C->T polymorphism and by dietary folate restriction in young women. J. Nutr. 135: 1045-1050 (2005). *
Davis SR, Quinlivan EP, Shelnutt KP, Maneval DR, Ghandour H, Capdevila A, Coats BS, Wagner C, Selhub J, Bailey LB, Shuster JJ, Stacpoole PW, Gregory JF 3rd. The methylenetetrahydrofolate reductase 677C->T polymorphism and dietary folate restriction affect plasma one-carbon metabolites and red blood cell folate concentrations and distribution in women. J. Nutr. 135: 1040-1044 (2005). *
Davis SR, Stacpoole PW, Williamson J, Kick LS, Quinlivan EP, Coats BS, Shane B, Bailey LB, Gregory JF 3rd. Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor. Am. J. Physiol. Endocrinol. Metab. 286: E272-E279 (2004). *
Davis TA, Gao L, Yin H, Morrow JD, Porter NA. In vivo and in vitro lipid peroxidation of arachidonate esters: the effect of fish oil omega-3 lipids on product distribution. J. Am. Chem. Soc. 128: 14897-14904 (2006). *
Davis W, Rockway S, Kwasny M. Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in asymptomatic adults. Am. J. Ther. 16: 326-332 (2009).
Dawczynski C, Schubert R, Hein G, Muller A, Eidner T, Vogelsang H, Basu S, Jahreis G. Long-term moderate intervention with n-3 long-chain PUFA-supplemented dairy products: effects on pathophysiological biomarkers in patients with rheumatoid arthritis. Br. J. Nutr. 101: 1517-1526 (2009). *
Dawes LG, Laut HC, Woodruff M. Decreased bile acid synthesis with total parenteral nutrition. Am. J. Surg. 194: 623-627 (2007). *
Dawson H, Solano-Aguilar G, Beal M, Beshah E, Vangimalla V, Jones E, Botero S, Urban JF Jr. Localized Th1-, Th2-, Treg and inflammation-associated hepatic and pulmonary immune responses in Ascaris-infected swine are increased by retinoic acid. Infect. Immun. 77: 2576-2587 (2009). *
Dawson HD, Ross AC. Chronic marginal vitamin A status affects the distribution and function of T cells and natural T cells in aging Lewis rats. J. Nutr. 129: 1782-1790 (1999). *
Dawson PA, Haywood J, Craddock AL, Wilson M, Tietjen M, Kluckman K, Maeda N, Parks JS. Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J. Biol. Chem. 278: 33920-33927 (2003). *
Day AP, Feher MD, Chopra R, Mayne PD. The effect of bezafibrate treatment on serum alkaline phosphatase isoenzyme activities. Metabolism 42: 839-842 (1993).
Day AS, Stephenson T, Stewart M, Otley AR. Exclusive enteral nutrition for children with Crohn's disease: use in Australia and attitudes of Australian paediatric gastroenterologists. J. Paediatr. Child Health May 28 [Epub ahead of print] (2009).
Day AS, Whitten KE, Lemberg DA, Clarkson C, Vitug-Sales M, Jackson R, Bohane TD. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. J. Gastroenterol. Hepatol. 21: 1609-1614 (2006). *
Day AS, Whitten KE, Sidler M, Lemberg DA. Review article: nutritional therapy in paediatric Crohn's disease. Aliment. Pharmacol. Ther. 27: 293-307 (2008). *
Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 26: 1021-1028 (2006). *
Day CP. Alcoholic liver disease. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, p. 77 (2005). *
Dayal B, Ertel NH. Studies on N-nitroso bile acid amides in relation to their possible role in gastrointestinal cancer. Lipids 32: 1331-1340 (1997).
de Almeida Vasconcelos Fonseca EM, Chagas CE, Mazzantini RP, Heidor R, Ong TP, Moreno FS. All-trans and 9-cis retinoic acids, retinol and beta-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage. Carcinogenesis 26: 1940-1946 (2005). *
de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J. Hepatol. 48 Suppl. 1: S104-S112 (2008). *
De Angelis C, Mangone M, Bianchi M, Saracco G, Repici A, Rizzetto M, Pellicano R. An update on AIDS-related cholangiopathy. Minerva Gastroenterol. Dietol. 55: 79-82 (2009).
De Bandt JP, Lasnier E, Rey C, Coudray-Lucas C, Poupon R, Giboudeau J, Cynober LA. Effects of amino acids on bile acid-dependent and independent bile flow in the isolated perfused rat liver. J. Hepatol. 30: 843-849 (1999). *
de Carpi JM, Castejon E, Masiques L, Vilar P, Anton J, Varea V. Gastrointestinal involvement in pediatric polyarteritis nodosa. J. Pediatr. Gastroenterol. Nutr. 44: 274-278 (2007). *
de Carvalho EG, da Rosa Utiyama SR, da Silva Kotze LM, de Messias Reason IT. Serum mannan-binding lectin levels in patients with celiac disease: an analysis of clinical and autoimmune features. Dig. Dis. Sci. 52: 2145-2151 (2007). *
De Caterina R, Cybulsky MA, Clinton SK, Gimbrone MA Jr, Libby P. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot. Essent. Fatty Acids 52: 191-195 (1995).
De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MA Jr, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler. Thromb. 14: 1829-1836 (1994).
De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am. J. Clin. Nutr. 71: 213S-223S (2000). *
De Cavanagh EM, Piortkowski B, Fraga CG. The interaction between the renin-angiotensin system and peroxisome proliferator activated receptors: a hypothesis including the participation of mitochondria in aging. Front. Biosci. 12: 1049-1062 (2007).
de Deckere EA. Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer. Eur. J. Cancer Prev. 8: 213-221 (1999).
de Dombal FT. Epidemiology of Crohn's disease of the colon. Ann. Gastroenterol. Hepatol. (Paris) 21: 191-200 (1985).
de Fraia Pinto L, Compri CM, Fornari JV, Bartchewsky W, Cintra DE, Trevisan M, de Oliveira Carvalho P, Ribeiro ML, Velloso LA, Saad MJ, Pedrazzoli J Jr, Gambero A. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. Liver Int. 30: 603-610 (2010). *
de Gottardi A, de Saussure P. Celiac disease in disguise. Rev. Med. Suisse. 1: 2008-2011 (2005).
de Gracia J, Alvarez A, Mata F, Guarner L, Vendrell M, Gadtner S, Cobos N. Cystic fibrosis in adults: study of 111 patients. Med. Clin. (Barc.) 119: 605-609 (2002).
de Groot NL, Burgerhart JS, van de Meeberg PC, de Vries DR, Smout AJ, Siersema PD. Systematic review: effect of conservative and surgical treatment for obesity on gastroesophageal reflux disease. Aliment. Pharmacol. Ther. 30: 1091-1102 (2009). *
de Groot RH, Hornstra G, Jolles J. Exploratory study into the relation between plasma phospholipid fatty acid status and cognitive performance. Prostaglandins Leukot. Essent. Fatty Acids 76: 165-172 (2007). *
De Groote G, De Laporte A, Dhondt G, Christophe A. Improvement in the plasma omega-3 index by the use of a fish oil-enriched spread. Ann. Nutr. Metab. 53: 23-28 (2008).
de Haan W, de Vries-van der Weij J, Mol IM, Hoekstra M, A Romijn J, Jukema JW, Havekes LM, Princen HM, Rensen PC. PXR agonism decreases plasma HDL levels in apoE3-Leiden.CETP mice. Biochim. Biophys. Acta 1791: 191-197 (2009). *
De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors. HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 70: 1113-1118 (2008).
de Jong NS, Leach ST, Day AS. Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation. Dig. Dis. Sci. 52: 2029-2036 (2007). *
de Kauwe AL, Chen Z, Anderson RP, Keech CL, Price JD, Wijburg O, Jackson DC, Ladhams J, Allison J, McCluskey J. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells. J. Immunol. 182: 7440-7450 (2009).
de Korwin JD. Does Helicobacter pylori infection play a role in extragastric diseases? Presse. Med. 37: 525-534 (2008).
de la Fuente-Arrillaga C, Vazquez Ruiz Z, Bes-Rastrollo M, Sampson L, Martinez-Gonzalez MA. Reproducibility of an FFQ validated in Spain. Public Health Nutr. Jan 28 [Epub ahead of print] (2010).
de Leiris J, Lorgeril MD, Boucher F. Fish oil and heart health. J. Cardiovasc. Pharmacol. 54: 378-384 (2009).
De Lisle RC, Meldi L, Roach E, Flynn M, Sewell R. Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse. PLoS ONE 4: e4283 (2009). *
de Lorgeril M. Essential polyunsaturated fatty acids, inflammation, atherosclerosis and cardiovascular diseases. Subcell. Biochem. 42: 283-297 (2007).
de Lorgeril M, Salen P. The Mediterranean-style diet for the prevention of cardiovascular diseases. Public Health Nutr. 9: 118-123 (2006).
de Lorgeril M, Salen P. The Mediterranean diet in secondary prevention of coronary heart disease. Clin. Invest. Med. 29: 154-158 (2006).
de Lorgeril M, Salen P, Martin JL, Boucher F, de Leiris J. Interactions of wine drinking with omega-3 fatty acids in patients with coronary heart disease: a fish-like effect of moderate wine drinking. Am. Heart J. 155: 175-181 (2008). *
De Luis D, Aller R, Culebras J. Recommendations in artificial nutritional support in critically ill patients. Med. Clin. (Barc.) 127: 232-236 (2006).
De Luis D, Aller R, Zarzuelo S. Dietary salt in the era of anthypertensive drugs. Med. Clin. (Barc.) 127: 673-675 (2006).
de Luis D, Ballesteros M, Cano I, Fernandez M, Izaola O, de la Lama G, Lopez Guzman A, Maldonado A, Martin MA, Munoz C, Ruiz E. Current status of clinical nutrition at the network of public hospitals from Castilla y Leon. Nutr. Hosp. 21: 357-361 (2006).
de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R. Influence of G308A promoter variant of tumor necrosis factor-alpha gene on insulin resistance and weight loss secondary to two hypocaloric diets: a randomized clinical trial. Arch. Med. Res. 40: 36-41 (2009).
de Luis DA, Aller R, Izaola O, Terroba MC, Cabezas G, Cuellar LA. Experience of 6 years with home enteral nutrition in an area of Spain. Eur. J. Clin. Nutr. 60: 553-557 (2006). *
de Luis DA, Conde R, Aller R, Izaola O, Gonzalez Sagrado M, Perez Castrillon JL, Duenas A, Romero E. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study. Eur. Rev. Med. Pharmacol. Sci. 13: 51-55 (2009).
de Luis DA, Gonzalez Sagrado M, Aller R, Izaola O, Conde R. Influence of Lys656Asn polymorphism of leptin receptor gene on insulin resistance in patients with diabetes mellitus type 2. Diabetes Res. Clin. Pract. 81: e9-e11 (2008).
de Luis DA, Gonzalez Sagrado M, Vallejo LA, Gil Carcedo LM, Izaola O, Cuellar L, Terroba MC, Aller R. Influence of G308A polymorphism of tumor necrosis factor-alpha gene on inflammatory markers in postsurgical head and neck cancer patients with early enteral nutrition. Nutrition 23: 529-532 (2007). *
de Luis DA, Leon R, Izaola O. Influence of omega 3 fatty acid dietary intake on asthma. Rev. Clin. Esp. 207: 24-25 (2007).
de Luis DA, Pacheco D, Aller R, Gonzalez Sagrado M, Izaola O, Terroba MC, Cuellar L, Conde R, Martin T. Influence of G308A polymorphism of tumor necrosis factor alpha gene on surgical results of biliopancreatic diversion. Obes. Surg. Jun 20 [Epub ahead of print] (2008). *
de Luis DA, Pacheco D, Aller R, Gonzalez Sagrado M, Izaola O, Terroba MC, Cuellar L, Conde R, Martin T, Perez Castrillon JL. Influence of -55CT polymorphism of UCP3 gene on surgical results of biliopancreatic diversion. Obes. Surg. May 17 [Epub ahead of print] (2008).
de Luis DA, Pacheco D, Izaola O, Terroba MC, Cuellar L, Martin T. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up. Ann. Nutr. Metab. 53: 234-239 (2008).
de Luis DA, Perez Castrillon JL, Duenas A. Leptin and obesity. Minerva Med. 100: 229-236 (2009).
de Luis DA, Sagrado MG, Izaola O, Terroba MC, Cuellar L, Conde R, Martin T. Influence of Ala54Thr polymorphism of fatty acid-binding protein-2 on clinical results of biliopancreatic diversion. Nutrition 24: 300-304 (2008). *
de Lujan Alvarez M, Ronco MT, Ochoa JE, Monti JA, Carnovale CE, Pisani GB, Lugano MC, Carrillo MC. Interferon alpha-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor beta(1). Hepatology 40: 394-402 (2004). *
De Marco G, Barabino A, Gambarara M, Diamanti A, Martelossi S, Guarino A. Network approach to the child with primary intestinal failure. J. Pediatr. Gastroenterol. Nutr. 43 Suppl. 1: S61-S67 (2006). *
De Marco G, Sordino D, Bruzzese E, DI Caro S, Mambretti D, Tramontano A, Colombo C, Simoni P, Guarino A. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Aliment. Pharmacol. Ther. 24: 387-394 (2006). *
De Maria N, Colantoni A, Rosenbloom E, Van Thiel DH. Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period. Hepatogastroenterology 43: 1472-1479 (1996).
de Mascarel A, Belleannee G, Stanislas S, Merlio C, Parrens M, Laharie D, Dubus P, Merlio JP. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype. Am. J. Surg. Pathol. 32: 744-751 (2008).
De Matos V, Russo PA, Cohen AB, Mamula P, Baldassano RN, Piccoli DA. Frequency and clinical correlations of granulomas in children with Crohn disease. J. Pediatr. Gastroenterol. Nutr. 46: 392-398 (2008). *
de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J. Parenter. Enteral Nutr. 33: 541-547 (2009). *
de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M. Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease. Pediatr. Surg. Int. 25: 123-124 (2009).
de Meijer VE, Gura KM, Puder M. Parenteral nutrition in the critically ill patient. N. Engl. J. Med. 362: 81-82 (2010). *
de Meijer VE, Le HD, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J. Pediatr. Gastroenterol. Nutr. Dec 22 [Epub ahead of print] (2009).
de Moreno de Leblanc A, Perdigon G. Yogurt feeding inhibits promotion and progression of experimental colorectal cancer. Med. Sci. Monit. 10: BR96-BR104 (2004). *
De Nitto D, Monteleone I, Franze E, Pallone F, Monteleone G. Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease. World J. Gastroenterol. 15: 4609-4614 (2009). *
de Oliveira CP, Stefano JT, de Lima VM, de Sa SV, Simplicio FI, de Mello ES, Correa-Giannella ML, Alves VA, Laurindo FR, de Oliveira MG, Giannella-Neto D, Carrilho FJ. Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice. J. Hepatol. 45: 725-733 (2006). *
de Oliveira CP, Stefano JT, de Siqueira ER, Silva LS, de Campos Mazo DF, Lima VM, Furuya CK, Mello ES, Souza FG, Rabello F, Santos TE, Nogueira MA, Caldwell SH, Alves VA, Carrilho FJ. Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis. Hepatol. Res. 38: 159-165 (2008). *
de Oliveira GR, Sankarankutty AK, Castro E Silva O, Ferreira J, Kurachi C, Zucoloto S, Vannucchi H, Jordao AA Jr, Marchini JS, Bagnato VS. Fluorescence spectroscopy to diagnose hepatic steatosis in a rat model of fatty liver. Liver Int. 29: 331-336 (2009). *
de Pablo MA, Alvarez de Cienfuegos G. Modulatory effects of dietary lipids on immune system functions. Immunol. Cell Biol. 78: 31-39 (2000). *
de Pablo P, Chapple IL, Buckley CD, Dietrich T. Periodontitis in systemic rheumatic diseases. Nat. Rev. Rheumatol. 5: 218-224 (2009). *
De Palma G, Cinova J, Stepankova R, Tuckova L, Sanz Y. Pivotal advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease. J. Leukoc. Biol. Dec 14 [Epub ahead of print] (2009). *
De Palma G, Nadal I, Collado MC, Sanz Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br. J. Nutr. 102: 1154-1160 (2009). *
De Palma G, Nadal I, Medina M, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 10: 63 (2010).
De Paolis P, Marchigiano E, Carrera M, Leone N, Pellicano R, Fronda GR. Management of sepsis of the biliary tract. Indications to surgical treatment. Minerva Gastroenterol. Dietol. 48: 37-43 (2002).
De Pascalis B, Bianchi A, Satta MA, Lupascu A, Mentella MC, Leo D, Fiore F, Fedeli P, Pontecorvi A, Pola P, Melina D, Gasbarrini A, De Marinis L, Armuzzi A. Growth hormone in inflammatory bowel disease. Eur. Rev. Med. Pharmacol. Sci. 10: 13-16 (2006).
de Pee S, Bloem MW. The bioavailability of (pro) vitamin A carotenoids and maximizing the contribution of homestead food production to combating vitamin A deficiency. Int. J. Vitam. Nutr. Res. 77: 182-192 (2007).
De Preter V, Bulteel V, Suenaert P, Geboes KP, De Hertogh G, Luypaerts A, Geboes K, Verbeke K, Rutgeerts P. Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa. Inflamm. Bowel Dis. 15: 335-340 (2009).
De Re V, Simula MP, Cannizzaro R, Pavan A, De Zorzi MA, Toffoli G, Canzonieri V. Galectin-10, eosinophils, and celiac disease. Ann. N. Y. Acad. Sci. 1173: 357-364 (2009). *
de Roos B, Mavrommatis Y, Brouwer IA. Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br. J. Pharmacol. 158: 413-428 (2009).
de Rossi TM, Krauss N, Voll RE, Nagel A, Weidenhiller M, Konturek PC, Hahn EG, Raithel M. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease. Digestion 78: 195-200 (2008). *
De Simone C, Vesely R, Negri R, Bianchi Salvadori B, Zanzoglu S, Cilli A, Lucci L. Enhancement of immune response of murine Peyer's patches by a diet supplemented with yogurt. Immunopharmacol. Immunotoxicol. 9: 87-100 (1987).
De Simone M, Cioffi U, Quatrini M, Lemos A, Ciulla M, Botti F, Carrara A, Marconato R, Contessini Avesani E. Crohn's disease and Takayasu's arteritis: is this association difficult to find out? Minerva Gastroenterol. Dietol. 52: 441-443 (2006).
De Truchis P, Kirstetter M, Perier A, Meunier C, Zucman D, Force G, Doll J, Katlama C, Rozenbaum W, Masson H, Gardette J, Melchior JC; and the Maxepa-HIV Group. Reduction in triglyceride level with n-3 polyunsaturated fatty acids in HIV-infected patients taking potent antiretroviral therapy: a randomized prospective study. J. Acquir. Immune Defic. Syndr. 44: 278-285 (2007).
de Villiers WJ. Crohn's disease and IL-10 therapy: promise regained. Inflamm. Bowel Dis. 9: 210-211 (2003). *
De Vincenzi M, Vincentini O, Di Nardo G, Boirivant M, Gazza L, Pogna N. Two prolamin peptides from durum wheat preclude celiac disease-specific T cell activation by gluten proteins. Eur. J. Nutr. Nov 6 [Epub ahead of print] (2009). *
De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. JPEN J. Parenter. Enteral Nutr. 27: 52-57 (2003). *
de Vogel-van den Bosch HM, Bunger M, de Groot PJ, Bosch-Vermeulen H, Hooiveld GJ, Muller M. PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression. BMC Genomics 9: 231 (2008). *
De Vree JM, Ottenhoff R, Bosma PJ, Smith AJ, Aten J, Oude Elferink RP. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119: 1720-1730 (2000). *
de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 111: 1-66 (2008). *
de Vries A, Hazlewood L, Fitch PM, Seckl JR, Foster P, Howie SE. High-fat feeding redirects cytokine responses and decreases allergic airway eosinophilia. Clin. Exp. Allergy 39: 731-739 (2009).
de Vries B, Kohl J, Leclercq WK, Wolfs TG, van Bijnen AA, Heeringa P, Buurman WA. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J. Immunol. 170: 3883-3889 (2003). *
de Vries-van der Weij J, de Haan W, Hu L, Kuif M, Oei HL, van der Hoorn JW, Havekes LM, Princen HM, Romijn JA, Smit JW, Rensen PC. Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein. Endocrinology 150: 2368-2375 (2009). *
de Wilde J, Smit E, Snepvangers FJ, de Wit NW, Mohren R, Hulshof MF, Mariman EC. Adipophilin protein expression in muscle - a possible protective role against insulin resistance. FEBS J. Dec 22 [Epub ahead of print] (2009). *
de Wit NJ, Bosch-Vermeulen H, de Groot PJ, Hooiveld GJ, Grootte Bromhaar MM, Jansen J, Muller M, van der Meer R. The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice. BMC Med. Genomics 1: 14 (2008). *
de Zoeten E, Mamula P. What are the guidelines for using biologics in pediatric patients? Inflamm. Bowel Dis. 14 Suppl. 2: S259-S261 (2008). *
de Zoeten EF, Hancock WW. Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3(+) regulatory T cells. Gastroenterology 134: 2171-2174 (2008). *
de Zoeten EF, Wang L, Sai H, Dillmann WH, Hancock WW. Expression of HDAC9 by T regulatory cells prevents colitis in mice. Gastroenterology 138: 583-594 (2010). *
Deakin S, Guernier S, James RW. Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin. Pharmacogenet. Genomics 17: 451-457 (2007).
Dealberto MJ. Why are immigrants at increased risk for psychosis? Vitamin D insufficiency, epigenetic mechanisms, or both? Med. Hypotheses 68: 259-267 (2007).
Dean M. The genetics of ATP-binding cassette transporters. Methods Enzymol. 400: 409-429 (2005).
Deangelis RA, Markiewski MM, Taub R, Lambris JD. A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. Hepatology 42: 1148-1157 (2005). *
Deans DC, Tan BH, Ross JA, Rose-Zerilli M, Wigmore SJ, Howell WM, Grimble RF, Fearon KC. Cancer cachexia is associated with the IL10 -1082 gene promoter polymorphism in patients with gastroesophageal malignancy. Am. J. Clin. Nutr. 89: 1164-1172 (2009). *
Dear KL, Compston JE, Hunter JO. Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis. Clin. Nutr. 20: 541-546 (2001).
Debard C, Cozzone D, Ricard N, Vouillarmet J, Disse E, Husson B, Laville M, Vidal H. Short-term activation of peroxisome proliferator-activated receptor beta/delta increases fatty acid oxidation but does not restore insulin action in muscle cells from type 2 diabetic patients. J. Mol. Med. 84: 747-752 (2006). *
Debier C, Larondelle Y. Vitamins A and E: metabolism, roles and transfer to offspring. Br. J. Nutr. 93: 153-174 (2005). *
Decarlis S, Agostoni C, Ferrante F, Scarlino S, Riva E, Giovannini M. Combined hyperlipidaemia as a presenting sign of cholesteryl ester storage disease. J. Inherit. Metab. Dis. Feb 15 [Epub ahead of print]] (2009). *
DeCicco KL, Ross AC. All-trans-retinoic acid and polyriboinosinoic:polyribocytidylic acid cooperate to elevate anti-tetanus immunoglobulin G and immunoglobulin M responses in vitamin A-deficient lewis rats and Balb/c mice. Proc. Nutr. Soc. 59: 519-529 (2000). *
DeCicco KL, Youngdahl JD, Ross AC. All-trans-retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity. Immunology 104: 341-348 (2001). *
DeCicco KL, Zolfaghari R, Li N, Ross AC. Retinoic acid and polyriboinosinic acid act synergistically to enhance the antibody response to tetanus toxoid during vitamin A deficiency: possible involvement of interleukin-2 receptor-beta, signal transducer and activator of transcription-1 � J. Infect. Dis. 182 Suppl. 1: S29-S36 (2000). *
Deckelbaum RJ, Worgall TS, Seo T. n-3 Fatty acids and gene expression. Am. J. Clin. Nutr. 83: 1520S-1525S (2006). *
Decsi T, Campoy C, Koletzko B. Effect of n-3 polyunsaturated fatty acid supplementation in pregnancy: the Nuheal trial. Adv. Exp. Med. Biol. 569: 109-113 (2005).
Dedoussis GV, Kaliora AC, Panagiotakos DB. Genes, diet and type 2 diabetes mellitus: a review. Rev. Diabet. Stud. 4: 13-24 (2007). *
Dedoussis GV, Kapiri A, Kalogeropoulos N, Samara A, Dimitriadis D, Lambert D, Pfister M, Siest G, Visvikis-Siest S. Adipokine expression in adipose tissue and in peripheral blood mononuclear cells in children. Correlation with BMI and fatty acid content. Clin. Chim. Acta 410: 85-89 (2009). *
Dedoussis GV, Maumus S, Choumerianou DM, Skoumas J, Pitsavos C, Stefanadis C, Visvikis-Siest S. Different genes and polymorphisms affecting high-density lipoprotein cholesterol levels in Greek familial hypercholesterolemia patients. Genet. Test. 10: 192-199 (2006).
Dedoussis GV, Maumus S, Skoumas J, Choumerianou DM, Pitsavos C, Stefanadis C, Visvikis-Siest S. Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia. J. Clin. Lab. Anal. 20: 98-104 (2006).
Dedoussis GV, Panagiotakos DB, Vidra NV, Louizou E, Chrysohoou C, Germanos A, Mantas Y, Tokmakidis S, Pitsavos C, Stefanadis C; for the CARDIOGENE Study group. Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: the CARDIO2000-GENE study. Genet. Med. 7: 411-416 (2005).
Dedoussis GV, Vidra N, Butler J, Papoutsakis C, Yannakoulia M, Hirschhorn JN, Lyon HN. Peroxisome proliferator-activated receptor-gamma (PPARgamma) Pro12Ala polymorphism and risk for pediatric obesity. Clin. Chem. Lab. Med. 47: 1047-1050 (2009). *
Deedwania PC, Gupta R. Management issues in the metabolic syndrome. J. Assoc. Physicians India 54: 797-810 (2006).
Deems RO, Friedman LS, Friedman MI, Munoz SJ, Deems DA, Maddrey WC. Relationship between liver biochemical tests and dietary intake in patients with liver disease. J. Clin. Gastroenterol. 18: 304-308 (1994).
Deems RO, Friedman MI, Friedman LS, Munoz SJ, Maddrey WC. Chemosensory function, food preferences and appetite in human liver disease. Appetite 20: 209-216 (1993).
Deering TB, Dickson ER, Fleming CR, Geall MG, McCall JT, Baggenstoss AH. Effect of D-penicillamine on copper retention in patients with primary biliary cirrhosis. Gastroenterology 72: 1208-1212 (1977).
Degirolamo C, Kelley KL, Wilson MD, Rudel LL. Dietary n-3 LCPUFA from fish oil but not alpha-linolenic acid-derived LCPUFA confers atheroprotection in mice. J. Lipid Res. Feb 11 [Epub ahead of print] (2010). *
Deitch EA. Nutrition and the gut mucosal barrier. Curr. Opin. Gen. Surg. 1993: 85-91 (1993).
Deitch EA. Bacterial translocation: the influence of dietary variables. Gut 35: S23-S27 (1994). *
Dekking L, Koning F, Hosek D, Ondrak TD, Taylor SL, Schroeder JW, Bauer M. Intolerance of celiac disease patients to bovine milk is not due to the presence of T-cell stimulatory epitopes of gluten. Nutrition 25: 122-123 (2009). *
Del Bas JM, Ricketts ML, Vaque M, Sala E, Quesada H, Ardevol A, Salvado MJ, Blay M, Arola L, Moore DD, Pujadas G, Fernandez-Larrea J, Blade C. Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner. Mol. Nutr. Food Res. 53: 805-814 (2009).
del Real SI, Jaeger AS, Baron MA, Diaz N, Solano L, Velasquez E, Lopez J. Nutritional status in preschoolers attending a public day-care center in Valencia, Venezuela. Arch. Latinoam. Nutr. 57: 248-254 (2007).
Dela Pena A, Leclercq I, Field J, George J, Jones B, Farrell G. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129: 1663-1674 (2005). *
dela Pena A, Leclercq IA, Williams J, Farrell GC. NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis. J. Hepatol. 46: 304-313 (2007). *
Delage B, Rullier A, Capdepont M, Rullier E, Cassand P. The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers. Nutr. J. 6: 20 (2007). *
Delanghe JR, Langlois MR, De Buyzere ML, Torck MA. Vitamin C deficiency and scurvy are not only a dietary problem but are codetermined by the haptoglobin polymorphism. Clin. Chem. 53: 1397-1400 (2007). *
Delarue J, LeFoll C, Corporeau C, Lucas D. n-3 Long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod. Nutr. Dev. 44: 289-299 (2004).
Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 10: 142-148 (2007).
Delcourt C. Application of nutrigenomics in eye health. Forum Nutr. 60: 168-175 (2007).
DeLegge MH. Enteral feeding. Curr. Opin. Gastroenterol. 24: 184-189 (2008). *
Delgado Plasencia L, Arteaga Gonzalez I, Lopez-Tomassetti Fernandez EM, Martin Malagon A, Diaz Luis H, Carrillo Pallares A. Restorative proctocolectomy with an ileoanal pouch: the role of laparoscopy. Rev. Esp. Enferm. Dig. 98: 420-428 (2006).
Della Corte C, Falchetti D, Nebbia G, Calacoci M, Pastore M, Francavilla R, Marcellini M, Vajro P, Iorio R. Management of cholelithiasis in Italian children: a national multicenter study. World J. Gastroenterol. 14: 1383-1388 (2008). *
Della Manna T, Setian N, Rodrigues JC. Cystic fibrosis-related diabetes: a frequent co-morbidity. Arq. Bras. Endocrinol. Metabol. 52: 188-197 (2008).
Della Rocca G. Anaesthesia in patients with cystic fibrosis. Curr. Opin. Anaesthesiol. 15: 95-101 (2002).
Dellert SF, Nowicki MJ, Farrell MK, Delente J, Heubi JE. The 13C-xylose breath test for the diagnosis of small bowel bacterial overgrowth in children. J. Pediatr. Gastroenterol. Nutr. 25: 153-158 (1997). *
Delorme D, Miller SC. Dietary consumption of Echinacea by mice afflicted with autoimmune (type I) diabetes: effect of consuming the herb on hemopoietic and immune cell dynamics. Autoimmunity 38: 453-461 (2005).
DeLuca HF. Vitamin D and the parenteral nutrition patient. Gastroenterology 137: S79-S91 (2009). *
Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J. 15: 2579-2585 (2001). *
Delvecchio M, De Bellis A, Francavilla R, Rutigliano V, Predieri B, Indrio F, De Venuto D, Sinisi AA, Bizzarro A, Bellastella A, Iughetti L, Cavallo L. Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. Am. J. Gastroenterol. Nov 10 [Epub ahead of print] (2009). *
Delvecchio M, Zecchino C, Faienza MF, Acquafredda A, Barbetti F, Cavallo L. Sulfonylurea treatment in a girl with neonatal diabetes (KCNJ11 R201H) and celiac disease: impact of low compliance to the gluten free diet. Diabetes Res. Clin. Pract. 84: 332-334 (2009).
DeMar JC Jr, Dimartino C, Baca AW, Lefkowitz W, Salem N Jr. Effect of dietary docosaheaxenoic acid on the net accumulation of docosaheaxenoic acid biosynthesized from alpha-linolenic acid in organs of young rat. J. Lipid Res. 49: 1963-1980 (2008). *
Demar JC Jr, Ma K, Chang L, Bell JM, Rapoport SI. alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 94: 1063-1076 (2005). *
DeMar Jr JC, Ma K, Bell JM, Igarishi M, Greenstein D, Rapoport SI. Dietary n-3 polyunsaturated fatty acid deprivation in rats following weaning increases their behavioral depression and aggression test scores. J. Lipid Res. 47: 172-180 (2006). *
Demarchi B, Bresso F, Novero D, Palestro G, Sapone N, Pellicano R, Bonardi R, Smedile A, Rizzetto M, Astegiano M. Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report. Minerva Gastroenterol. Dietol. 53: 279-283 (2007).
Demaude J, Leveque M, Chaumaz G, Eutamene H, Fioramonti J, Bueno L, Ferrier L. Acute stress increases colonic paracellular permeability in mice through a mast cell-independent mechanism: Involvement of pancreatic trypsin. Life Sci. 84: 847-852 (2009). *
Demay MB. Mechanism of vitamin D receptor action. Ann. N. Y. Acad. Sci. 1068: 204-213 (2006). *
DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J. Clin. Gastroenterol. 34: 385-396 (2002). *
Demirag MD, Goker B, Haznedaroglu S, Ozturk MA, Karakan T, Kuruoglu R. Osteomalacic myopathy associated with coexisting coeliac disease and primary biliary cirrhosis. Med. Princ. Pract. 17: 425-428 (2008).
Demizieux L. Control and regulation of mitochondrial oxidation of long-chained fatty acids. J. Soc. Biol. 199: 143-155 (2005).
Demonty I, Chan YM, Pelled D, Jones PJ. Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am. J. Clin. Nutr. 84: 1534-1542 (2006). *
Demoor-Goldschmidt C, Raynard B. How can we integrate nutritional support in medical oncology? Bull. Cancer 96: 665-675 (2009).
Demoulins-Giacco N, Gagey V, Teillac-Hamel D, Fraitag S, Caillat-Zucman S, Schmitz J, de Prost Y. Dermatitis herpetiformis occuring in patients with celiac disease in childhood. Arch. Pediatr. 3: 541-548 (1996).
Den Ruijter HM, Berecki G, Opthof T, Verkerk AO, Zock PL, Coronel R. Pro- and antiarrhythmic properties of a diet rich in fish oil. Cardiovasc. Res. 73: 316-325 (2007). *
Den Ruijter HM, Berecki G, Verkerk AO, Bakker D, Baartscheer A, Schumacher CA, Belterman CN, de Jonge N, Fiolet JW, Brouwer IA, Coronel R. Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation 117: 536-544 (2008).
Denechaud PD, Bossard P, Lobaccaro JM, Millatt L, Staels B, Girard J, Postic C. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J. Clin. Invest. 118: 956-964 (2008). *
Deng QG, She H, Cheng JH, French SW, Koop DR, Xiong S, Tsukamoto H. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42: 905-914 (2005). *
Deng ZB, Liu Y, Liu C, Xiang X, Wang J, Cheng Z, Shah SV, Zhang S, Zhang L, Zhuang X, Michalek S, Grizzle WE, Zhang HG. Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 50: 1412-1420 (2009).
Denke MA. Dietary fats, fatty acids, and their effects on lipoproteins. Curr. Atheroscler. Rep. 8: 466-471 (2006).
Denke MA. Diet, lifestyle, and nonstatin trials: review of time to benefit. Am. J. Cardiol. 96: 3-10 (2005). *
Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 8: 1086-1094 (2007). *
Dennis T, Fanous M, Mousa S. Natural products for chemopreventive and adjunctive therapy in oncologic disease. Nutr. Cancer 61: 587-597 (2009).
Denson LA. Growth hormone therapy in children and adolescents: pharmacokinetic/pharmacodynamic considerations and emerging indications. Expert Opin. Drug Metab. Toxicol. 4: 1569-1580 (2008).
Dentener MA, Creutzberg EC, Pennings HJ, Rijkers GT, Mercken E, Wouters EF. Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study. Respiration 76: 275-282 (2008). *
Dentin R, Benhamed F, Pegorier JP, Foufelle F, Viollet B, Vaulont S, Girard J, Postic C. Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J. Clin. Invest. 115: 2843-2854 (2005). *
Denys A, Hichami A, Khan NA. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells. Mol. Cell. Biochem. 232: 143-148 (2002). *
Denys A, Hichami A, Khan NA. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells. J. Lipid Res. 42: 2015-2020 (2001). *
Deplancke B, Finster K, Graham WV, Collier CT, Thurmond JE, Gaskins HR. Gastrointestinal and microbial responses to sulfate-supplemented drinking water in mice. Exp. Biol. Med. (Maywood) 228: 424-433 (2003). *
Derijk RH, Wust S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer DH, Giacchetti G, Vreugdenhil E, Zitman FG, de Kloet ER. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J. Clin. Endocrinol. Metab. 91: 5083-5089 (2006). *
Derikx JP, van Waardenburg DA, Thuijls G, Willigers HM, Koenraads M, van Bijnen AA, Heineman E, Poeze M, Ambergen T, van Ooij A, van Rhijn LW, Buurman WA. New insight in loss of gut barrier during major non-abdominal surgery. PLoS ONE 3: e3954 (2008). *
Derikx JP, Vreugdenhil AC, Van den Neucker AM, Grootjans J, van Bijnen AA, Damoiseaux JG, van Heurn LW, Heineman E, Buurman WA. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J. Clin. Gastroenterol. 43: 727-733 (2009).
Desai F, Ramanathan M, Fink CS, Wilding GE, Weinstock-Guttman B, Awad AB. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients. Int. Immunopharmacol. 9: 153-157 (2009).
Desai HG, Gupte PA. Increasing incidence of Crohn's disease in India: is it related to improved sanitation? Indian J. Gastroenterol. 24: 23-24 (2005). *
Deschenes M, Villeneuve JP, Dagenais M, Fenyves D, Lapointe R, Pomier-Layrargues G, Roy A, Willems B, Marleau D. Lack of relationship between preoperative measures of the severity of cirrhosis and short-term survival after liver transplantation. Liver Transpl. Surg. 3: 532-537 (1997).
Descos L. Extra-intestinal manifestations. Rev. Prat. 41: 415-418 (1991).
Deshpande SS, Lalitha VS, Ingle AD, Raste AS, Gadre SG, Maru GB. Subchronic oral toxicity of turmeric and ethanolic turmeric extract in female mice and rats. Toxicol. Lett. 95: 183-193 (1998).
Despott EJ, Gupta A, Burling D, Tripoli E, Konieczko K, Hart A, Fraser C. Effective dilation of small-bowel strictures by double-balloon enteroscopy in patients with symptomatic Crohn's disease (with video). Gastrointest. Endosc. 70: 1030-1036 (2009).
Desreumaux P. New inflammatory bowel disease drugs targeting the inflammatory cascade. Gastroenterol. Clin. Biol. 25: B72-B78 (2001).
Desreumaux P, Dubuquoy L. PPARgamma agonists as a new class of effective treatment for ulcerative colitis. Inflamm. Bowel Dis. 15: 959-960 (2009). *
Desreumaux P, Ghosh S. Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence. Aliment. Pharmacol. Ther. 24 Suppl. 1: 2-9 (2006). *
Desreumaux P, Romano O. 5-Aminosalicylates and colorectal cancer: preventive role in chronic inflammatory bowel disease? Gastroenterol. Clin. Biol. 28: 509 (2004).
Destaillats F, Joffre C, Acar N, Joffre F, Bezelgues JB, Pasquis B, Cruz-Hernandez C, Rezzi S, Montoliu I, Dionisi F, Bretillon L. Differential effect of maternal diet supplementation with alpha-linolenic acid or n-3 long-chain polyunsaturated fatty acids on glial cell phosphatidylethanolamine and phosphatidylserine fatty acid profile in neonate rat brains. Nutr. Metab. (Lond.) 7: 2 (2010). *
Desvergne B, IJpenberg A, Devchand PR, Wahli W. The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling. J. Steroid Biochem. Mol. Biol. 65: 65-74 (1998).
Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449: 811-818 (2007). *
Detopoulou P, Panagiotakos DB, Antonopoulou S, Pitsavos C, Stefanadis C. Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: the ATTICA study. Am. J. Clin. Nutr. 87: 424-430 (2008). *
Devaraj S, Kasim-Karakas S, Jialal I. The effect of weight loss and dietary fatty acids on inflammation. Curr. Atheroscler. Rep. 8: 477-486 (2006).
Dever JT, Elfarra AA. L-Methionine toxicity in freshly-isolated mouse hepatocytes is gender-dependent and mediated in part by transamination. J. Pharmacol. Exp. Ther. 326: 809-817 (2008). *
Dever JT, Tanumihardjo SA. Hypervitaminosis A in experimental nonhuman primates: evidence, causes, and the road to recovery. Am. J. Primatol. 71: 813-816 (2009).
Devereux G. Early life events in asthma - diet. Pediatr. Pulmonol. 42: 663-673 (2007).
Devereux G. The increase in the prevalence of asthma and allergy: food for thought. Nat. Rev. Immunol. 6: 869-874 (2006). *
Devereux G. Session 1: allergic disease nutrition as a potential determinant of asthma. Proc. Nutr. Soc. Dec 8 [Epub ahead of print] (2009). *
Devore EE, Grodstein F, van Rooij FJ, Hofman A, Rosner B, Stampfer MJ, Witteman JC, Breteler MM. Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am. J. Clin. Nutr. 90: 170-176 (2009). *
Dew SE, Wardlaw SA, Ong DE. Effects of pharmacological retinoids on several vitamin A-metabolizing enzymes. Cancer Res. 53: 2965-299 (1993). *
Dewailly E, Ayotte P, Lucas M, Blanchet C. Risk and benefits from consuming salmon and trout: a Canadian perspective. Food Chem. Toxicol. 45: 1343-1348 (2007).
Dewailly E, Chateau-Degat L, Suhas E. Fish consumption and health in French Polynesia. Asia Pac. J. Clin. Nutr. 17: 86-93 (2008).
Dewar DH, Amato M, Ellis HJ, Pollock EL, Gonzalez-Cinca N, Wieser H, Ciclitira PJ. The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease. Eur. J. Gastroenterol. Hepatol. 18: 483-491 (2006).
Dewar DH, Ciclitira PJ. Clinical features and diagnosis of celiac disease. Gastroenterology 128: S19-S24 (2005). *
Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst. Rev. 1: CD004597 (2007). *
Dhamija R, Tan KM, Pittock SJ, Foxx-Orenstein A, Benarroch E, Lennon VA. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin. Gastroenterol. Hepatol. 6: 988-992 (2008).
Dharancy S, Body-Malapel M, Louvet A, Berrebi D, Gantier E, Gosset P, Viala J, Hollebecque A, Moreno C, Philpott DJ, Girardin SE, Sansonetti PJ, Desreumaux P, Mathurin P, Dubuquoy L. Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control. Gastroenterology Dec 17 [Epub ahead of print] (2009). *
Dharancy S, Lemoine M, Mathurin P, Serfaty L, Dubuquoy L. Peroxisome proliferator-activated receptors in HCV-related infection. PPAR Res. 2009: 357204 (2009). *
Dharancy S, Louvet A, Hollebecque A, Desreumaux P, Mathurin P, Dubuquoy L. Nuclear receptor PPAR and hepatology: pathophysiological and therapeutical aspects. Gastroenterol. Clin. Biol. 32: 339-350 (2008).
Dharancy S, Talbodec N, Asselah T, Hachulla E, Delaporte E, Cortot A, Colombel JF. The synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome, a rare extra-digestive manifestation of Crohn's disease. Presentation of 1 case and review of the literature. Gastroenterol. Clin. Biol. 22: 240-243 (1998).
Dhein S, Michaelis B, Mohr FW. Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids. Naunyn. Schmiedebergs Arch. Pharmacol. 371: 202-211 (2005). *
Dhonukshe-Rutten RA, de Vries JH, de Bree A, van der Put N, van Staveren WA, de Groot LC. Dietary intake and status of folate and vitamin B12 and their association with homocysteine and cardiovascular disease in European populations. Eur. J. Clin. Nutr. 63: 18-30 (2009). *
DI Biase AR, Colecchia A, Scaioli E, Berri R, Viola L, Vestito A, Balli F, Festi D. Systematic review: autoimmune liver diseases in a pediatric celiac population - a 10 year single-center experience. Aliment. Pharmacol. Ther. 31: 253-260 (2010). *
Di Cagno R, Rizzello CG, Gagliardi F, Ricciuti P, Ndagijimana M, Francavilla R, Guerzoni ME, Crecchio C, Gobbetti M, De Angelis M. Imbalance of the faecal microbiota and volatile organic compounds between treated and untreated coeliac children. Appl. Environ. Microbiol. 75: 3963-3971 (2009). *
di Giuseppe R, de Lorgeril M, Salen P, Laporte F, Di Castelnuovo A, Krogh V, Siani A, Arnout J, Cappuccio FP, van Dongen M, Donati MB, de Gaetano G, Iacoviello L; on behalf of the European Collaborative Group of the IMMIDIET Project. Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and women from 3 European populations. Am. J. Clin. Nutr. 89: 354-362 (2009). *
Di Lorenzo C, Colletti RB, Lehmann HP, Boyle JT, Gerson WT, Hyams JS, Squires RH Jr, Walker LS, Kanda PT; AAP Subcommittee and NASPGHAN Committee on Chronic Abdominal Pain. Chronic abdominal pain in children: a technical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 40: 249-261 (2005). *
Di Lorenzo C, Colletti RB, Lehmann HP, Boyle JT, Gerson WT, Hyams JS, Squires RH Jr, Walker LS, Kanda PT; American Academy of Pediatrics Subcommittee on Chronic Abdominal Pain and NASPGHAN Committee on Abdominal Pain. Chronic abdominal pain in children: a clinical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 40: 245-248 (2005). *
Di Niro R, Sblattero D, Florian F, Stebel M, Zentilin L, Giacca M, Villanacci V, Galletti A, Not T, Ventura A, Marzari R. Anti-idiotypic response in mice expressing human autoantibodies. Mol. Immunol. 45: 1782-1791 (2008). *
Di Pierro M, Lu R, Uzzau S, Wang W, Margaretten K, Pazzani C, Maimone F, Fasano A. Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J. Biol. Chem. 276: 19160-19165 (2001). *
Di Renzo L, Bertoli A, Bigioni M, Del Gobbo V, Premrov MG, Calabrese V, Di Daniele N, De Lorenzo A. Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Curr. Pharm. Des. 14: 2699-2706 (2008).
DI Renzo L, Saraceno R, Schipani C, Chimenti S, DE Lorenzo A. Why 3 mg/kg instead of 5 mg/kg of infliximab should work in psoriatic arthritis? J. Dermatol. 36: 666-668 (2009).
Di Sabatino A, Ciccocioppo R, D'Alo S, Parroni R, Millimaggi D, Cifone MG, Corazza GR. Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease. Gut 49: 380-386 (2001). *
Di Sabatino A, Corazza GR. Coeliac disease. Lancet 373: 1480-1493 (2009). *
Di Sabatino A, Rosado MM, Cazzola P, Riboni R, Biagi F, Carsetti R, Corazza GR. Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease. Clin. Gastroenterol. Hepatol. 4: 179-186 (2006).
Di Sabatino A, Rovedatti L, Rosado MM, Carsetti R, Corazza GR, Macdonald TT. Increased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrin alpha(4)beta(7)-positive T cells in blood. Hum. Pathol. 40: 699-704 (2009).
Di Sario A, Bendia E, Macarri G, Candelaresi C, Taffetani S, Marzioni M, Omenetti A, De Minicis S, Trozzi L, Benedetti A. The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen alpha1(I), TIMP-1 and MMP-2. Dig. Liver Dis. 36: 744-751 (2004).
Di Sario A, Bendia E, Taffetani S, Marzioni M, Candelaresi C, Pigini P, Schindler U, Kleemann HW, Trozzi L, Macarri G, Benedetti A. Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. Hepatology 37: 256-266 (2003). *
Diamanti A, Basso MS, Gambarara M, Papadatou B, Bracci F, Noto C, Castro M. Positive impact of blocking tumor necrosis factor alpha on the nutritional status in pediatric Crohn's disease patients. Int. J. Colorectal Dis. 24: 19-25 (2009). *
Diamanti A, Basso MS, Pietrobattista A, Nobili V. Prevalence of celiac disease in children with autoimmune hepatitis. Dig. Liver Dis. 40: 965 (2008).
Diamanti A, Colistro F, Calce A, Devito R, Ferretti F, Minozzi A, Santoni A, Castro M. Clinical value of immunoglobulin A antitransglutaminase assay in the diagnosis of celiac disease. Pediatrics 118: e1696-e1700 (2006). *
Diamanti A, Noto C, Basso MS, Papadatou B, Bracci F, Castro M. Efficacy and safety of intravenous neridronate in pediatric bone loss associated to Crohn's disease: a case report. Clin. Exp. Rheumatol. 27: 165 (2009).
Diamantis I, Boumpas DT. Autoimmune hepatitis: evolving concepts. Autoimmun. Rev. 3: 207-214 (2004).
Diamond IR, Pencharz PB, Wales PW. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome? Minerva Pediatr. 61: 263-272 (2009).
Diamond IR, Pencharz PB, Wales PW. Omega-3 lipids for intestinal failure associated liver disease. Semin. Pediatr. Surg. 18: 239-245 (2009).
Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 48: 209-215 (2009). *
Diamond IR, Sterescu A, Pencharz PB, Wales PW. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr. Surg. Int. 24: 773-778 (2008). *
Diamond IR, Wales PW, Grant DR, Fecteau A. Isolated liver transplantation in pediatric short bowel syndrome: is there a role? J. Pediatr. Surg. 41: 955-959 (2006).
Dias VC, Parsons HG. Modulation in delta 9, delta 6, and delta 5 fatty acid desaturase activity in the human intestinal CaCo-2 cell line. J. Lipid Res. 36: 552-563 (1995). *
Dias VC, Wallace JL, Parsons HG. Modulation of cellular phospholipid fatty acids and leukotriene B4 synthesis in the human intestinal cell (CaCo-2). Gut 33: 622-627 (1992). *
Diaz Encarnacion MM, Warner GM, Gray CE, Cheng J, Keryakos HK, Nath KA, Grande JP. Signaling pathways modulated by fish oil in salt-sensitive hypertension. Am. J. Physiol. Renal Physiol. 294: F1323-F1335 (2008). *
Diaz R, Kim JW, Hui JJ, Li Z, Swain GP, Fong KS, Csiszar K, Russo PA, Rand EB, Furth EE, Wells RG. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum. Pathol. 39: 102-115 (2007).
DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: part 2. Am. J. Gastroenterol. 99: 1823-1832 (2004). *
Dibble JB, Sheridan P, Losowsky MS. A survey of vitamin D deficiency in gastrointestinal and liver disorders. Q. J. Med. 53: 119-134 (1984).
DiCecco SR, Wieners EJ, Wiesner RH, Southorn PA, Plevak DJ, Krom RA. Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation. Mayo Clin. Proc. 64: 95-102 (1989).
Dichi I, Frenhane P, Dichi JB, Correa CR, Angeleli AY, Bicudo MH, Rodrigues MA, Victoria CR, Burini RC. Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis. Nutrition 16: 87-90 (2000).
Dickey W. A case of sequential development of celiac disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 4: 463-467 (2007). *
Dickey W. Making oats safer for patients with coeliac disease. Eur. J. Gastroenterol. Hepatol. 20: 494-495 (2008).
Dickey W, Hughes DF, McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand. J. Gastroenterol. 35: 181-183 (2000). *
Dickey W, Kearney N. Overweight in celiac disease: prevalence, clinical characteristics, and effect of a gluten-free diet. Am. J. Gastroenterol. 101: 2356-2359 (2006). *
Dickey W, Ward M, Whittle CR, Kelly MT, Pentieva K, Horigan G, Patton S, McNulty H. Homocysteine and related B-vitamin status in coeliac disease: effects of gluten exclusion and histological recovery. Scand. J. Gastroenterol. 43: 682-688 (2008). *
Dierich M, Fuehner T, Welte T, Simon A, Gottlieb J. Lung transplantation. Indications, long-term results and special impact of follow-up care. Internist (Berl.) 50: 561-571 (2009).
Dieter MZ, Maher JM, Cheng X, Klaassen CD. Expression and regulation of the sterol half-transporter genes ABCG5 and ABCG8 in rats. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 139: 209-218 (2004). *
Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 3: 797-801 (1997).
Dieterich W, Esslinger B, Schuppan D. Pathomechanisms in celiac disease. Int. Arch. Allergy Immunol. 132: 98-108 (2003).
Dieterich W, Esslinger B, Trapp D, Hahn E, Huff T, Seilmeier W, Wieser H, Schuppan D. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut 55: 478-484 (2006). *
Dieterich W, Laag E, Schopper H, Volta U, Ferguson A, Gillett H, Riecken EO, Schuppan D. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 115: 1317-1321 (1998). *
Dietert RR, Dietert JM, Gavalchin J. Risk of autoimmune disease: challenges for immunotoxicity testing. Methods Mol. Biol. 598: 39-51 (2010). *
Dietrich W, Erbguth F. Neurological complications of inflammatory intestinal diseases. Fortschr. Neurol. Psychiatr. 71: 406-414 (2003).
Dif F, Marty C, Baudoin C, De Vernejoul MC, Levi G. Severe osteopenia in CFTR-null mice. Bone 35: 595-603 (2004).
Dignass AU. Mechanisms and modulation of intestinal epithelial repair. Inflamm. Bowel Dis. 7: 68-77 (2001). *
Dignass AU, Bokemeyer B, Ad Amek H, Mross M, Vinter-Jensen L, Borner N, Silvennoinen J, Tan G, Pool MO, Stijnen T, Dietel P, Klugmann T, Vermeire S, Bhatt A, Veerman H. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis. Clin. Gastroenterol. Hepatol. 7: 762-769 (2009).
Dignass AU, Hartmann F, Sturm A, Stein J. Management of inflammatory bowel diseases during pregnancy. Dig. Dis. 27: 341-346 (2009).
Dijkstra G, Blokzijl H, Bok L, Homan M, van Goor H, Nico Faber K, Jansen PL, Moshage H. Opposite effect of oxidative stress on inducible nitric oxide synthase and haem oxygenase-1 expression in intestinal inflammation: anti-inflammatory effect of carbon monoxide. J. Pathol. 204: 296-303 (2004). *
Dijkstra G, Rings EH, van Dullemen HM, Bijleveld CM, Meessen NE, Karrenbeld A, Hofker HS, Porte RJ, Naber AH, Ploeg RJ. Small bowel transplantation as a treatment option for intestinal failure in children and adults. Ned. Tijdschr. Geneeskd. 149: 391-398 (2005).
Dijkstra SC, Brouwer IA, van Rooij FJ, Hofman A, Witteman JC, Geleijnse JM. Intake of very long chain n-3 fatty acids from fish and the incidence of heart failure: the Rotterdam Study. Eur. J. Heart Fail. 11: 922-928 (2009).
Dijkstra T, Dijkstra G, Bijleveld CM, Rings EH. Intestinal rehabilitation for children with short bowel syndrome. Ned. Tijdschr. Geneeskd. 149: 413-417 (2005).
Dillard AC, Lane MA. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines. Mol. Carcinog. 46: 315-329 (2007). *
Dillard AC, Lane MA. Retinol increases beta-catenin-RXRalpha binding leading to the increased proteasomal degradation of beta-catenin and RXRalpha. Nutr. Cancer 60: 97-108 (2008).
Dillard T, Yedinak CG, Alumkal J, Fleseriu M. Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes. Pituitary Jul 29 [Epub ahead of print] (2009).
Dillon CF, Rasch EK, Gu Q, Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J. Rheumatol. 33: 2271-2279 (2006).
DiMagno MJ, Lee SH, Hao Y, Zhou Sy, McKenna BJ, Owyang C. A proinflammatory, anti-apoptotic phenotype underlies the susceptibility to acute pancreatitis in UNC cftr (-/-) mice. Gastroenterology 129: 665-681 (2005). *
Dimitrova-Sumkovska J, Djosic-Markovska B, Zafirova-Roganovic D, Anastasovska V. Effects of different dietary fatty acid supplements uppon lipoprotein metabolism and lipid peroxides production in hyperlipidemic rats. Prilozi. 27: 67-86 (2006).
Dimmock D, Kobayashi K, Iijima M, Tabata A, Wong LJ, Saheki T, Lee B, Scaglia F. Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet. Pediatrics 119: e773-e777 (2007). *
Dimri M, Bommi P, Sahasrabuddhe AA, Khandekar JD, Dimri GP. Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis Dec 7 [Epub ahead of print] (2009). *
Din JN, Harding SA, Valerio CJ, Sarma J, Lyall K, Riemersma RA, Newby DE, Flapan AD. Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis 197: 290-296 (2008).
Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N. Engl. J. Med. 361: 1152-1163 (2009). *
Ding LA, Li JS, Li YS, Zhu NT, Liu FN, Tan L. Intestinal barrier damage caused by trauma and lipopolysaccharide. World J. Gastroenterol. 10: 2373-2378 (2004). *
Ding Q, Jin T, Wang Z, Chen Y. Catalase potentiates retinoic acid-induced THP-1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator-activated receptor gamma. J. Leukoc. Biol. 81: 1568-1576 (2007). *
Ding YC, Weizman Z, Yerushalmi B, Elbedour K, Garner CP, Neuhausen SL. An autosomal genome-wide screen for celiac disease in Bedouin families. Genes Immun. 9: 81-86 (2008). *
Dinler G, Atalay E, Kalayci AG. Celiac disease in 87 children with typical and atypical symptoms in Black Sea region of Turkey. World J. Pediatr. 5: 282-286 (2009). *
Dionne S, Laberge S, Deslandres C, Seidman EG. Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease. Clin. Exp. Immunol. 133: 108-114 (2003). *
Diosdado B, van Bakel H, Strengman E, Franke L, van Oort E, Mulder CJ, Wijmenga C, Wapenaar MC. Neutrophil recruitment and barrier impairment in celiac disease: a genomic study. Clin. Gastroenterol. Hepatol. 5: 574-581.e5 (2007).
Diosdado B, van Oort E, Wijmenga C. "Coelionomics": towards understanding the molecular pathology of coeliac disease. Clin. Chem. Lab. Med. 43: 685-695 (2005). *
Diosdado B, Wapenaar MC, Franke L, Duran KJ, Goerres MJ, Hadithi M, Crusius JB, Meijer JW, Duggan DJ, Mulder CJ, Holstege FC, Wijmenga C. A microarray screen for novel candidate genes in coeliac disease pathogenesis. Gut 53: 944-951 (2004). *
Diosdado B, Wijmenga C. Molecular mechanisms of the adaptive, innate and regulatory immune responses in the intestinal mucosa of celiac disease patients. Expert Rev. Mol. Diagn. 5: 681-700 (2005).
Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am. J. Clin. Nutr. 53: 189S-193S (1991).
Dipper C, Maitra S, Thomas R, Lamb C, McLean-Tooke A, Ward R, Smith D, Spickett G, Mansfield J. Anti-tissue transglutaminase antibodies in the follow-up of adult coeliac disease. Aliment. Pharmacol. Ther. 30: 236-244 (2009). *
Distrutti E, Mencarelli A, Santucci L, Renga B, Orlandi S, Donini A, Shah V, Fiorucci S. The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. Hepatology 47: 659-667 (2008). *
Dite P, Trna J, Novotny I. Autoimmune pancreatitis. Minerva Gastroenterol. Dietol. 54: 359-364 (2008).
Divisi D, Di Tommaso S, Salvemini S, Garramone M, Crisci R. Diet and cancer. Acta Biomed. Ateneo. Parmense. 77: 118-123 (2006).
Diwakar BT, Dutta PK, Lokesh BR, Naidu KA. Bio-availability and metabolism of n-3 fatty acid rich garden cress (Lepidium sativum) seed oil in albino rats. Prostaglandins Leukot. Essent. Fatty Acids 78: 123-130 (2008). *
Djeddi D, Kongolo G, Goissen C, Mounard J, Ribeiro L, Cevallos R, Gottrand F, Pautard JC. Pulmonary involvement with Crohn's disease in an adolescent. Arch. Pediatr. 13: 202-203 (2006).
Djuric Z, Kamenov B, Katic V. Celiac disease manifested by polyneuropathy and swollen ankles. World J. Gastroenterol. 13: 2636-2638 (2007). *
Djuric Z, Stamenkovic H, Stankovic T, Milicevic R, Brankovic L, Ciric V, Katic V. Celiac disease prevalence in children and adolescents with type 1 diabetes from Serbia. Pediatr Int. Jan 26 [Epub ahead of print] (2010).
Djuric Z, Zivic S, Katic V. Celiac disease with diffuse cutaneous vitamin K-deficiency bleeding. Adv. Ther. 24: 1286-1289 (2007).
Dobryniewski J, Szajda SD, Waszkiewicz N, Zwierz K. Biology of essential fatty acids (EFA). Przegl. Lek. 64: 91-99 (2007).
Dodds BF, Aguancha SI, Santamarina RM, Vega SJ. Celiac disease presenting as an intestinal intussusception. Report of one case. Rev. Med. Chil. 136: 1179-1182 (2008).
Dodge JA, Turck D. Cystic fibrosis: nutritional consequences and management. Best Pract. Res. Clin. Gastroenterol. 20: 531-546 (2006).
Dodig S, Cepelak I. The facts and controversies about selenium. Acta Pharm. 54: 261-276 (2004).
Dodig S, Richter D. Chronic autoimmune urticaria in children. Acta Dermatovenerol. Croat. 16: 65-71 (2008).
Doege H, Baillie RA, Ortegon AM, Tsang B, Wu Q, Punreddy S, Hirsch D, Watson N, Gimeno RE, Stahl A. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis. Gastroenterology 130: 1245-1258 (2006). *
Doggrell SA. New targets in and potential treatments for cholesterol gallstone disease. Curr. Opin. Investig. Drugs 7: 344-348 (2006).
Doggrell SA. Farnesoid X receptor agonism - a new approach to the treatment of cholesterol gallstone disease. Expert Opin. Investig. Drugs 14: 535-538 (2005).
Doherty M, Barry RE. Gluten-induced mucosal changes in subjects without overt small-bowel disease. Lancet 1: 517-520 (1981).
Domingo JL. Omega-3 fatty acids and the benefits of fish consumption: is all that glitters gold? Environ. Int. 33: 993-998 (2007).
Domingo JL, Bocio A, Falco G, Llobet JM. Benefits and risks of fish consumption Part I. A quantitative analysis of the intake of omega-3 fatty acids and chemical contaminants. Toxicology 230: 219-226 (2007). *
Domingo JL, Bocio A, Marti-Cid R, Llobet JM. Benefits and risks of fish consumption II. RIBEPEIX, a computer program to optimize the balance between the intake of omega-3 fatty acids and chemical contaminants. Toxicology 230: 227-233 (2007). *
Dominguez-Munoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr. Gastroenterol. Rep. 9: 116-122 (2007).
Donahue SM, Rifas-Shiman SL, Olsen SF, Gold DR, Gillman MW, Oken E. Associations of maternal prenatal dietary intake of n-3 and n-6 fatty acids with maternal and umbilical cord blood levels. Prostaglandins Leukot. Essent. Fatty Acids 80: 289-296 (2009). *
Donaldson MR, Book LS, Leiferman KM, Zone JJ, Neuhausen SL. Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J. Clin. Gastroenterol. 42: 256-260 (2008).
Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr. J. 3: 19 (2004). *
Donato LJ, Suh JH, Noy N. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Cancer Res. 67: 609-615 (2007). *
Dong D, Noy N. Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties. Biochemistry 37: 10691-10700 (1998). *
Dong J, Huang ZW, Piao JH, Gong J. Association of bone mineral density with gene polymorphisms and environmental factors in Chinese postmenopausal women. Wei Sheng Yan Jiu 35: 196-200 (2006).
Dong P, Tao Y, Yang Y, Wang W. Expression of retinoic acid receptors in intestinal mucosa and the effect of vitamin A on mucosal immunity. Nutrition Nov 19 [Epub ahead of print] (2009).
Dongowski G, Fritzsch B, Giessler J, Hartl A, Kuhlmann O, Neubert RH. The influence of bile salts and mixed micelles on the pharmacokinetics of quinine in rabbits. Eur. J. Pharm. Biopharm. 60: 147-151 (2005). *
Donohue TM, Curry-McCoy TV, Nanji AA, Kharbanda KK, Osna NA, Radio SJ, Todero SL, White RL, Casey CA. Lysosomal leakage and lack of adaptation of hepatoprotective enzyme contribute to enhanced susceptibility to ethanol-induced liver injury in female rats. Alcohol Clin. Exp. Res. 31: 1944-1952 (2007). *
Donthamsetty S, Bhave VS, Mitra MS, Latendresse JR, Mehendale HM. Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate. Toxicol. Appl. Pharmacol. 230: 327-337 (2008). *
Doo EC, Hoofnagle JH. The hepatitis B research network. Hepatology 49: S196-S197 (2009).
Doo EC, Hoofnagle JH, Rodgers GP. NIH consensus development conference: management of hepatitis B. Introduction. Hepatology 49: S1-S3 (2009).
Dore MP, Realdi G, Mura D, Graham DY, Sepulveda AR. Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig. Dis. Sci. 47: 1638-1643 (2002). *
Dorea JG. Studies of fish consumption as source of methylmercury should consider fish-meal-fed farmed fish and other animal foods. Environ. Res. 109: 131-132 (2009). *
Dorfmeister B, Brandlhofer S, Schaap FG, Hermann M, Furnsinn C, Hagerty BP, Stangl H, Patsch W, Strobl W. Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats. Diabetologia 49: 1324-1332 (2006). *
Doring F, Rimbach G, Lodge JK. In silico search for single nucleotide polymorphisms in genes important in vitamin E homeostasis. IUBMB Life. 56: 615-620 (2004). *
Dorn SD, Hernandez L, Minaya MT, Morris CB, Hu Y, Leserman J, Lewis S, Lee A, Bangdiwala SI, Green PH, Drossman DA. Development and validation of a new celiac disease quality of life survey (CD-QOL). Aliment. Pharmacol. Ther. 31: 666-675 (2010). *
Dorne JL. Metabolism, variability and risk assessment. Toxicology Nov 19 [Epub ahead of print] (2009). *
Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev. Anti Infect. Ther. 4: 261-275 (2006).
Dorsey J, Buckley D, Summer S, Jandacek RJ, Rider T, Tso P, Narkewicz MR, Heubi JE. Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid. J. Pediatr. Gastroenterol. Nutr. Feb 19 [Epub ahead of print] (2010).
Dorum S, Qiao SW, Sollid LM, Fleckenstein B. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease. J. Proteome Res. 8: 1748-1755 (2009). *
Dorvil NP, Yousef IM, Tuchweber B, Roy CC. Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs. Am. J. Clin. Nutr. 37: 221-232 (1983). *
Doshi M, Watanabe S, Niimoto T, Kawashima H, Ishikura Y, Kiso Y, Hamazaki T. Effect of dietary enrichment with n-3 polyunsaturated fatty acids (PUFA) or n-9 PUFA on arachidonate metabolism in vivo and experimentally induced inflammation in mice. Biol. Pharm. Bull. 27: 319-323 (2004). *
Dotan I, Rachmilewitz D. Probiotics in inflammatory bowel disease: possible mechanisms of action. Curr. Opin. Gastroenterol. 21: 426-430 (2005).
Dove-Edwin I, Thomas HJ. Review article: the prevention of colorectal cancer. Aliment. Pharmacol. Ther. 15: 323-336 (2001). *
Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast-Woelbern HR, Bowman ME, Ferrer JL, Anisfeld AM, Edwards PA, Rosenfeld JM, Alvarez JG, Noel JP, Nicolaou KC, Evans RM. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol. Cell 11: 1079-1092 (2003). *
Draganov K, Dimitrova V, Ionkov A, Rusenov D, Tosheva E, Dimitrov K, Tonev S. Acquired entero-cutaneous fistulas - diagnostic and terapeutic approach. Khirurgiia (Sofiia) 2: 42-46 (2005).
Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Sapone AT, Thakar M, Iacono G, Carroccio A, D'Agate C, Not T, Zampini L, Catassi C, Fasano A. Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand. J. Gastroenterol. 41: 408-419 (2006). *
Dragsted LO, Krath B, Ravn-Haren G, Vogel UB, Vinggaard AM, Bo Jensen P, Loft S, Rasmussen SE, Sandstrom TB, Pedersen A. Biological effects of fruit and vegetables. Proc. Nutr. Soc. 65: 61-67 (2006). *
Drai J, Borel P, Faure H, Galabert C, Le Moel G, Laromiguiere M, Fayol V. Fasting plasma carotenoids concentrations in Crohn's and pancreatic cancer patients compared to control subjects. Int. J. Vitam. Nutr. Res. 79: 87-94 (2009).
Dray X, Joly F, Lavergne-Slove A, Treton X, Bouhnik Y, Messing B. A severe but reversible refractory sprue. Gut 55: 1210-1211 (2006). *
Dray X, Kanaan R, Bienvenu T, Desmazes-Dufeu N, Dusser D, Marteau P, Hubert D. Malnutrition in adults with cystic fibrosis. Eur. J. Clin. Nutr. 59: 152-154 (2005). *
Dray X, Marteau P. Crohn's disease: nutrition should not be forgotten. Gastroenterol. Clin. Biol. 30: 215-216 (2006).
Dray X, Marteau P. The use of enteral nutrition in the management of Crohn's disease in adults. JPEN J. Parenter. Enteral Nutr. 29: S166-S172 (2005). *
Drew JE, Arthur JR, Farquharson AJ, Russell WR, Morrice PC, Duthie GG. Salicylic acid modulates oxidative stress and glutathione peroxidase activity in the rat colon. Biochem. Pharmacol. 70: 888-893 (2005). *
Drew JE, Padidar S, Horgan G, Duthie GG, Russell WR, Reid M, Duncan G, Rucklidge GJ. Salicylate modulates oxidative stress in the rat colon: a proteomic approach. Biochem. Pharmacol. 72: 204-216 (2006). *
Drewes AM, Krarup AL, Detlefsen S, Malmstrom ML, Dimcevski G, Funch-Jensen P. Pain in chronic pancreatitis: the role of neuropathic pain mechanisms. Gut 57: 1616-1627 (2008). *
Drewnowski A. The nutrient rich foods index helps to identify healthy, affordable foods. Am. J. Clin. Nutr. Feb 24 [Epub ahead of print] (2010).
Dring MM, Goulding CA, Trimble VI, Keegan D, Ryan AW, Brophy KM, Smyth CM, Keeling PWN, O�Donoghue D, O�Sullivan M, O�Morain C, Mahmud N, Wikstrom AC, Kelleher D, McManus R. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 130: 341-348 (2006). *
Driscoll DF. Lipid injectable emulsions: 2006. Nutr. Clin. Pract. 21: 381-386 (2006).
Driscoll DF, Ling PR, Bistrian BR. Pharmacopeial compliance of fish oil-containing parenteral lipid emulsion mixtures: globule size distribution (GSD) and fatty acid analyses. Int. J. Pharm. 379: 125-130 (2009). *
Drisko JA, Giles CK, Bischoff BJ. Probiotics in health maintenance and disease prevention. Altern. Med. Rev. 8: 143-155 (2003). *
Drivdal M, Loken EB, Hagve TA, Bergstad I, Aagenaes O. Do patients with lymphoedema cholestasis syndrome 1/Aagenaes syndrome need dietary counselling outside cholestatic episodes? Clin. Nutr. Feb 17 [Epub ahead of print] (2010).
Drivdal M, Trydal T, Hagve TA, Bergstad I, Aagenaes O. Prognosis, with evaluation of general biochemistry, of liver disease in lymphoedema cholestasis syndrome 1 (LCS1/Aagenaes syndrome). Scand. J. Gastroenterol. 41: 465-471 (2006). *
Driver JP, Foreman O, Mathieu C, van Etten E, Serreze DV. Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet. Clin. Exp. Immunol. 151: 76-85 (2008). *
Drochioiu G. Chronic metabolic acidosis may be the cause of cachexia: body fluid pH correction may be an effective therapy. Med. Hypotheses 70: 1167-1173 (2008).
Drouault-Holowacz S, Foligne B, Dennin V, Goudercourt D, Terpend K, Burckel A, Pot B. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolerance: in vitro and in vivo considerations. Clin. Nutr. 25: 994-1003 (2006).
Drouillet P, Forhan A, De Lauzon-Guillain B, Thiebaugeorges O, Goua V, Magnin G, Schweitzer M, Kaminski M, Ducimetiere P, Charles MA. Maternal fatty acid intake and fetal growth: evidence for an association in overweight women. The 'EDEN mother-child' cohort (study of pre- and early postnatal determinants of the child's development and health). Br. J. Nutr. 101: 575-583 (2009). *
Drover VA, Abumrad NA. CD36-dependent fatty acid uptake regulates expression of peroxisome proliferator activated receptors. Biochem. Soc. Trans. 33: 311-315 (2005). *
Dryden GW, Song M, McClain C. Polyphenols and gastrointestinal diseases. Curr. Opin. Gastroenterol. 22: 165-170 (2006).
du Bois TM, Deng C, Bell W, Huang XF. Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience 139: 1397-1403 (2006). *
Du C, Fujii Y, Ito M, Harada M, Moriyama E, Shimada R, Ikemoto A, Okuyama H. Dietary polyunsaturated fatty acids suppress acute hepatitis, alter gene expression and prolong survival of female Long-Evans Cinnamon rats, a model of Wilson disease. J. Nutr. Biochem. 15: 273-280 (2004). *
Du X, Tabeta K, Mann N, Crozat K, Mudd S, Beutler B. An essential role for Rxr alpha in the development of Th2 responses. Eur. J. Immunol. 35: 3414-3423 (2005). *
Du ZY, Demizieux L, Degrace P, Gresti J, Moindrot B, Liu YJ, Tian LX, Cao JM, Clouet P. Alteration of 20:5n-3 and 22:6n-3 fat contents and liver peroxisomal activities in fenofibrate-treated rainbow trout. Lipids 39: 849-855 (2004).
Du ZY, Ma T, Winterthun S, Kristiansen K, Froyland L, Madsen L. beta-Oxidation modulates metabolic competition between eicosapentaenoic acid and arachidonic acid regulating prostaglandin E(2) synthesis in rat hepatocytes-Kupffer cells. Biochim. Biophys. Acta Jan 14 [Epub ahead of print] (2010). *
Duan RD. Alkaline sphingomyelinase: an old enzyme with novel implications. Biochim. Biophys. Acta 1761: 281-291 (2006). *
Dubinsky MC. New patients: should children be treated differently? Colorectal Dis. 8 Suppl. 1: 15-19 (2006).
Dubinsky MC. Diffuse jejunoileitis in adolescence. Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 70. May 7-8 (2004). *
Dubinsky MC, Fleshner PP. Treatment of Crohn's disease of inflammatory, stenotic, and fistulizing phenotypes. Curr. Treat. Options Gastroenterol. 6: 183-200 (2003).
Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Theoret Y, Seidman EG. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 118: 705-713 (2000). *
Dubinsky MC, Seidman EG. Diagnostic markers of inflammatory bowel disease. Curr. Opin. Gastroenterol. 16: 337-342 (2000).
Dubuquoy L, Rousseaux C, Thuru X, Peyrin-Biroulet L, Romano O, Chavatte P, Chamaillard M, Desreumaux P. PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 55: 1341-1349 (2006). *
Ducluzeau R. Development, equilibrium and role of microbial flora in the newborn. Ann. Pediatr. (Paris) 40: 13-22 (1993).
Duda MK, O'Shea KM, Lei B, Barrows BR, Azimzadeh AM, McElfresh TE, Hoit BD, Kop WJ, Stanley WC. Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc. Res. 76: 303-310 (2007). *
Duda MK, O'Shea KM, Stanley WC. Omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential. Cardiovasc. Res. 84: 33-41 (2009).
Duda MK, O'Shea KM, Tintinu A, Xu W, Khairallah RJ, Barrows BR, Chess DJ, Azimzadeh AM, Harris WS, Sharov VG, Sabbah HN, Stanley WC. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc. Res. 81: 319-327 (2009). *
Duell EJ, Holly EA, Kelsey KT, Bracci PM. Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Int. J. Cancer 126: 790-795 (2009). *
Duerksen DR, Fallows G, Bernstein CN. Vitamin B12 malabsorption in patients with limited ileal resection. Nutrition 22: 1210-1213 (2006). *
Duerksen DR, Wilhelm-Boyles C, Parry DM. Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. Dig. Dis. Sci. 50: 785-790 (2005). *
Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM. A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig. Dis. Sci. Apr 28 [Epub ahead of print] (2009). *
Duerr RH. The genetics of inflammatory bowel disease. Gastroenterol. Clin. North Am. 31: 63-76 (2002).
Duerr RH, Barmada MM, Zhang L, Achkar JP, Cho JH, Hanauer SB, Brant SR, Bayless TM, Baldassano RN, Weeks DE. Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage. Hum. Mol. Genet. 11: 2599-2606 (2002). *
Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee A, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 315: 1461-1463 (2006). *
Duez H, Chao YS, Hernandez M, Torpier G, Poulain P, Mundt S, Mallat Z, Teissier E, Burton CA, Tedgui A, Fruchart JC, Fievet C, Wright SD, Staels B. Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice. J. Biol. Chem. 277: 48051-48057 (2002). *
Dufault R, Schnoll R, Lukiw WJ, Leblanc B, Cornett C, Patrick L, Wallinga D, Gilbert SG, Crider R. Mercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in children. Behav. Brain Funct. 5: 44 (2009).
Dufresne V, Knoop C, Van Muylem A, Malfroot A, Lamotte M, Opdekamp C, Deboeck G, Cassart M, Stallenberg B, Casimir G, Duchateau J, Estenne M. Effect of systemic inflammation on inspiratory and limb muscle strength and bulk in cystic fibrosis. Am. J. Respir. Crit. Care Med. 180: 153-158 (2009). *
Duggan JM, Duggan AE. Systematic review: the liver in coeliac disease. Aliment. Pharmacol. Ther. 21: 515-518 (2005). *
Duggan P, O'Brien M, Kiely M, McCarthy J, Shanahan F, Cashman KD. Vitamin K status in patients with Crohn's disease and relationship to bone turnover. Am. J. Gastroenterol. 99: 2178-2185 (2004). *
Dughera L, Elia C, Navino M, Cisaro F; ARMONIA Study Group. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms. Acta Biomed. 78: 111-116 (2007). *
Dugueperoux I, Tamalet A, Sermet-Gaudelus I, Le Bourgeois M, Gerardin M, Desmazes-Dufeu N, Hubert D. Clinical changes of patients with cystic fibrosis during transition from pediatric to adult care. J. Adolesc. Health 43: 459-465 (2008).
Dujardin KS, Dumotier B, David M, Guizy M, Valenzuela C, Hondeghem LM. Ultra fast sodium channel block by dietary fish oil prevents dofetilide-induced ventricular arrhythmias in rabbit hearts. Am. J. Physiol. Heart Circ. Physiol. 295: H1414-H1421 (2008). *
Dullens SP, Mensink RP, Mariman EC, Plat J. Differentiated CaCo-2 cells as an in-vitro model to evaluate de-novo apolipoprotein A-I production in the small intestine. Eur. J. Gastroenterol. Hepatol. 21: 642-649 (2009).
Dumas ME, Barton RH, Toye A, Cloarec O, Blancher C, Rothwell A, Fearnside J, Tatoud R, Blanc V, Lindon JC, Mitchell SC, Holmes E, McCarthy MI, Scott J, Gauguier D, Nicholson JK. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. U.S.A. 103: 12511-12516 (2006). *
Duncan JG, Fong JL, Medeiros DM, Finck BN, Kelly DP. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation 115: 909-917 (2007). *
Duncan RE, Archer MC. Farnesol induces thyroid hormone receptor (THR) beta1 but inhibits THR-mediated signaling in MCF-7 human breast cancer cells. Biochem. Biophys. Res. Commun. 343: 239-243 (2006). *
Duncan RE, Archer MC. Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARalpha and down-regulation of fatty acid synthase in hepatocytes. Lipids 43: 619-627 (2008).
Duncan RE, El-Sohemy A, Archer MC. Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin. Cancer Lett. 224: 221-228 (2005). *
Duncan SH, Louis P, Flint HJ. Cultivable bacterial diversity from the human colon. Lett. Appl. Microbiol. 44: 343-350 (2007). *
Dunlap S, Heinrichs SC. Neuronal depletion of omega-3 fatty acids induces flax seed dietary self-selection in the rat. Brain Res. 1250: 113-119 (2009).
Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 47: 1947-1954 (2008). *
Dunne C, Shanahan F. Role of probiotics in the treatment of intestinal infections and inflammation. Curr. Opin. Gastroenterol. 18: 40-45 (2002).
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin. Exp. Allergy 33: 442-448 (2003). *
Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, Prescott SL. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J. Allergy Clin. Immunol. 112: 1178-1184 (2003). *
Dunstan JA, Prescott SL. Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants? Curr. Opin. Allergy Clin. Immunol. 5: 215-221 (2005).
Dupasquier CM, Dibrov E, Kostenuk AL, Cheung PK, Lee KG, Alexander HK, Yeganeh BK, Moghadasian MH, Pierce GN. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am. J. Physiol. Heart Circ. Physiol. 293: H2394-H2402 (2007). *
Dupertuis YM, Meguid MM, Pichard C. Colon cancer therapy: new perspectives of nutritional manipulations using polyunsaturated fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 10: 427-432 (2007).
Dupont B, Dupont C, Justum AM, Piquet MA, Reimund JM. Enteral nutrition in adult Crohn's disease: present status and perspectives. Mol. Nutr. Food Res. 52: 875-884 (2008). *
Dupont C, Barau E, Dehennin L, Molkhou P. Measurement of intestinal permeability to sugars: application in the diagnosis of celiac disease and cow's milk protein enteropathy. Pathol. Biol. (Paris) 35: 1179-1182 (1987).
Dupont J, Froment P, Rame C, Pierre P, Coyral-Castel S, Chabrolle C. Role of the fatty acids in ovarian functions: involvement of peroxisome proliferator-activated receptors (PPAR) and adipokines. Gynecol. Obstet. Fertil. 36: 1230-1238 (2008).
Duque-Guimaraes DE, de Castro J, Martinez-Botas J, Sardinha FL, Ramos MP, Herrera E, do Carmo MD. Early and prolonged intake of partially hydrogenated fat alters the expression of genes in rat adipose tissue. Nutrition 25: 782-789 (2009). *
Durakovic C, Ray S, Holick MF. Topical paricalcitol (19-nor-1alpha,25-dihydroxyvitamin D) is a novel, safe and effective treatment for plaque psoriasis: a pilot study. Br. J. Dermatol. 151: 190-195 (2004).
Duran P, Mangialavori G, Biglieri A, Kogan L, Abeya Gilardon E. Nutrition status in Argentinean children 6 to 72 months old: results from the National Nutrition and Health Survey (ENNyS). Arch. Argent. Pediatr. 107: 397-404 (2009).
Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, Gonzalez FJ, Fruchart JC, Kuipers F, Staels B. The farnesoid X receptor modulates hepatic carbohydrate metabolism during fasting/refeeding transition. J. Biol. Chem. 280: 29971-29979 (2005). *
Durazo FA, Lassman C, Han SH, Saab S, Lee NP, Kawano M, Saggi B, Gordon S, Farmer DG, Yersiz H, Goldstein RL, Ghobrial M, Busuttil RW. Fulminant liver failure due to usnic acid for weight loss. Am. J. Gastroenterol. 99: 950-952 (2004). *
Durazzo M, Bresso F, Premoli A, Rabbione L. Variant syndromes in autoimmune hepatic diseases. Minerva Gastroenterol. Dietol. 47: 27-38 (2001).
Durga J, van Boxtel MP, Schouten EG, Bots ML, Kok FJ, Verhoef P. Folate and the methylenetetrahydrofolate reductase 677C-->T mutation correlate with cognitive performance. Neurobiol. Aging 27: 334-343 (2006).
Durham WJ, Dillon EL, Sheffield-Moore M. Inflammatory burden and amino acid metabolism in cancer cachexia. Curr. Opin. Clin. Nutr. Metab. Care 12: 72-77 (2009).
Durie PR, Bell L, Linton W, Corey ML, Forstner GG. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut 21: 778-786 (1980). *
Durie PR, Kent G, Phillips MJ, Ackerley CA. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am. J. Pathol. 164: 1481-1493 (2004). *
Durieu I, Abbas-Chorfa F, Drai J, Iwaz J, Steghens JP, Puget M, Ecochard R, Bellon G. Plasma fatty acids and lipid hydroperoxides increase after antibiotic treatment in cystic fibrosis. Eur. Respir. J. 29: 958-964 (2007).
Durieu I, Nove Josserand R. Cystic fibrosis in 2008. Rev. Med. Interne. 29: 901-907 (2008).
During A, Fields M, Lewis CG, Smith JC. Beta-carotene 15,15'-dioxygenase activity is responsive to copper and iron concentrations in rat small intestine. J. Am. Coll. Nutr. 18: 309-315 (1999). *
Durno C, Aronson M, Bapat B, Cohen Z, Gallinger S. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut 54: 1146-1150 (2005). *
Duro D, Duggan C, Valim C, Bechard L, Fitzgibbons S, Jaksic T, Yu YM. Novel intravenous (13)C-methionine breath test as a measure of liver function in children with short bowel syndrome. J. Pediatr. Surg. 44: 236-240 (2009).
Duseja A, Murlidharan R, Bhansali A, Sharma S, Das A, Das R, Chawla Y. Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis - a preliminary report. Indian J. Gastroenterol. 23: 12-15 (2004). *
Duthie SJ, Grant G, Pirie LP, Watson AJ, Margison GP. Folate deficiency alters hepatic and colon MGMT and OGG-1 DNA repair protein expression in rats but has no effect on genome-wide DNA methylation. Cancer Prev. Res. (Phila. Pa) 3: 92-100 (2010).
Duthie SJ, Narayanan S, Sharp L, Little J, Basten G, Powers H. Folate, DNA stability and colo-rectal neoplasia. Proc. Nutr. Soc. 63: 571-578 (2004). *
Duttaroy AK. Transport of fatty acids across the human placenta: a review. Prog. Lipid Res. 48: 52-61 (2009). *
Duty SM, Calafat AM, Silva MJ, Brock JW, Ryan L, Chen Z, Overstreet J, Hauser R. The relationship between environmental exposure to phthalates and computer-aided sperm analysis motion parameters. J. Androl. 25: 293-302 (2004).
Dvorak M. Gluten enteropathy - occurrence, diagnosis, therapy. Cas. Lek. Cesk. 144 Suppl. 1: 48-51 (2005).
Dwarakanathan A. Diabetes update. J. Insur. Med. 38: 20-30 (2006).
Dwarkanath P, Muthayya S, Thomas T, Vaz M, Parikh P, Mehra R, Kurpad AV. Polyunsaturated fatty acid consumption and concentration among South Indian women during pregnancy. Asia Pac. J. Clin. Nutr. 18: 389-394 (2009).
Dziechciarz P, Horvath A, Shamir R, Szajewska H. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment. Pharmacol. Ther. 26: 795-806 (2007). *
E X, Zhang L, Lu J, Tso P, Blaner WS, Levin MS, Li E. Increased neonatal mortality in mice lacking cellular retinol-binding protein II. J. Biol. Chem. 277: 36617-36623 (2002). *
Eadala P, Waud JP, Matthews SB, Green JT, Campbell AK. Quantifying the 'hidden' lactose in drugs used for the treatment of gastro-intestinal conditions. Aliment. Pharmacol. Ther. 29: 677-687 (2009). *
Earnest DL, Holubec H, Wali RK, Jolley CS, Bissonette M, Bhattacharyya AK, Roy H, Khare S, Brasitus TA. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res. 54: 5071-5074 (1994). *
Eastin CE, McClain CJ, Lee EY, Bagby GJ, Chawla RK. Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury. Alcohol Clin. Exp. Res. 21: 1037-1041 (1997). *
Eastwood GL. Pharmacologic prevention of colonic neoplasms. Effects of calcium, vitamins, omega fatty acids, and nonsteroidal anti-inflammatory drugs. Dig. Dis. 14: 119-128 (1996).
Ebach DR, Newberry R, Stenson WF. Differential role of tumor necrosis factor receptors in TNBS colitis. Inflamm. Bowel Dis. 11: 533-540 (2005). *
Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, Tejero ME. Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int. J. Circumpolar Health 64: 396-408 (2005).
Ebbesson SO, Roman MJ, Devereux RB, Kaufman D, Fabsitz RR, Maccluer JW, Dyke B, Laston S, Wenger CR, Comuzzie AG, Romenesko T, Ebbesson LO, Nobmann ED, Howard BV. Consumption of omega-3 fatty acids is not associated with a reduction in carotid atherosclerosis: the Genetics of Coronary Artery Disease in Alaska Natives study. Atherosclerosis 199: 346-353 (2008).
Eberhardie C. Nutritional supplements and the EU: is anyone happy? Proc. Nutr. Soc. 66: 508-511 (2007). *
Eberman LE, Cleary MA. Celiac disease in an elite female collegiate volleyball athlete: a case report. J. Athl. Train. 40: 360-364 (2005).
Ebert R, Schutze N, Adamski J, Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease. Mol. Cell. Endocrinol. 248: 149-159 (2006).
Ebert S, Weigelt K, Walczak Y, Drobnik W, Mauerer R, Hume DA, Weber BH, Langmann T. Docosahexaenoic acid attenuates microglial activation and delays early retinal degeneration. J. Neurochem. 110: 1863-1875 (2009).
Ebringer A, Ahmadi K, Fielder M, Rashid T, Tiwana H, Wilson C, Collado A, Tani Y. Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy. Clin. Rheumatol. 15 Suppl. 1: 57-61 (1996).
Ebringer A, Rashid T. Rheumatoid arthritis is an autoimmune disease triggered by Proteus urinary tract infection. Clin. Dev. Immunol. 13: 41-48 (2006). *
Ebringer A, Rashid T. "B27 disease" is a new autoimmune disease that affects millions of people. Ann. N. Y. Acad. Sci. 1110: 112-120 (2007). *
Ebringer A, Rashid T, Tiwana H, Wilson C. A possible link between Crohn's disease and ankylosing spondylitis via Klebsiella infections. Clin. Rheumatol. 26: 289-297 (2007). *
Ebringer A, Wilson C. The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis. Clin. Rheumatol. 15 Suppl. 1: 62-66 (1996).
Ecker J, Liebisch G, Patsch W, Schmitz G. The conjugated linoleic acid isomer trans-9, trans-11 is a dietary occurring agonist of liver X receptor alpha. Biochem. Biophys. Res. Commun. 388: 660-666 (2009). *
Edelblum KL, Yan F, Yamaoka T, Polk DB. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm. Bowel Dis. 12: 413-424 (2006). *
Edenborough FP, Borgo G, Knoop C, Lannefors L, Mackenzie WE, Madge S, Morton AM, Oxley HC, Touw DJ, Benham M, Johannesson M. Guidelines for the management of pregnancy in women with cystic fibrosis. J. Cyst. Fibros. 7 Suppl. 1: S2-S32 (2008).
Eder K, Gutgesell A, Ringseis R, Schmidt E, Brandsch C, Stangl G. Down-regulation of peroxisome proliferator-activated receptor alpha and its coactivators in liver and skeletal muscle mediates the metabolic adaptations during lactation in mice. J. Mol. Endocrinol. 43: 241-250 (2009). *
Eder P, Stawczyk-Eder K, Krela-Kazmierczak I, Linke K. Clinical utility of the assessment of fecal calprotectin in Lesniowski-Crohn's disease. Pol. Arch. Med. Wewn. 118: 622-626 (2008).
Edgar KS, Woodside JV, Skidmore P, Cardwell C, Farelll K, McKinley MC, Youngl IS, Whitehead AS, Gey F, Yarnell JW, Evans A. Thiol and cardiovascular risk factor status in a male northern Irish population. Int. J. Vitam. Nutr. Res. 78: 208-216 (2008).
Edgel KA, Leboeuf RC, Oram JF. Tumor necrosis factor-alpha and lymphotoxin-alpha increase macrophage ABCA1 by gene expression and protein stabilization via different receptors. Atherosclerosis Oct 22 [Epub ahead of print] (2009).
Edouard Bourre JM, Marc Paquotte P. Contributions (in 2005) of marine and fresh water products (finfish and shellfish, seafood, wild and farmed) to the French dietary intakes of vitamins D and B12, selenium, iodine and docosahexaenoic acid: impact on public health. Int. J. Food Sci. Nutr. 59: 491-501 (2008).
Edwards George JB, Leffler DA, Dennis MD, Franko DL, Blom-Hoffman J, Kelly CP. Psychological correlates of gluten-free diet adherence in adults with celiac disease. J. Clin. Gastroenterol. 43: 301-306 (2009).
Edwards IJ, O'Flaherty JT. Omega-3 fatty acids and PPARgamma in cancer. PPAR Res. 2008: 358052 (2008). *
Edwards IJ, Sun H, Hu Y, Berquin IM, O'Flaherty JT, Cline JM, Rudel LL, Chen YQ. In vivo and in vitro regulation of syndecan 1 in prostate cells by n-3 polyunsaturated fatty acids. J. Biol. Chem. 283: 18441-18449 (2008). *
Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J. Affect. Disord. 48: 149-155 (1998).
Efrati O, Kremer MR, Barak A, Augarten A, Reichart N, Vardi A, Modan-Moses D. Improved survival following lung transplantation with long-term use of bilevel positive pressure ventilation in cystic fibrosis. Lung 185: 73-79 (2007).
Efrati O, Nir J, Fraser D, Cohen-Cymberknoh M, Shoseyov D, Vilozni D, Modan-Moses D, Levy R, Szeinberg A, Kerem E, Rivlin J. Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli multicenter study. J. Pediatr. Gastroenterol. Nutr. Aug 4 [Epub ahead of print] (2009).
Efthimiou P, Kukar M. Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities. Rheumatol. Int. Oct 30 [Epub ahead of print] (2009). *
Egan KM, Signorello LB, Munro HM, Hargreaves MK, Hollis BW, Blot WJ. Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control 19: 527-535 (2008). *
Egana N, Paron L, Cuerda C, Breton I, Camblor M, Velasco C, Garcia-Peris P. Sea-blue histiocyte syndrome associated with home parenteral nutrition. Nutr. Hosp. 24: 361-363 (2009).
Egert S, Fobker M, Andersen G, Somoza V, Erbersdobler HF, Wahrburg U. Effects of dietary alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on parameters of glucose metabolism in healthy volunteers. Ann. Nutr. Metab. 53: 182-187 (2008).
Egert S, Kannenberg F, Somoza V, Erbersdobler HF, Wahrburg U. Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J. Nutr. 139: 861-868 (2009). *
Egert S, Somoza V, Kannenberg F, Fobker M, Krome K, Erbersdobler HF, Wahrburg U. Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers. Eur. J. Clin. Nutr. 61: 314-325 (2007). *
Ehren J, Moron B, Martin E, Bethune MT, Gray GM, Khosla C. A food-grade enzyme preparation with modest gluten detoxification properties. PLoS One 4: e6313 (2009). *
Ehses JA, Lacraz G, Giroix MH, Schmidlin F, Coulaud J, Kassis N, Irminger JC, Kergoat M, Portha B, Homo-Delarche F, Donath MY. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc. Natl. Acad. Sci. U.S.A. 106: 13998-14003 (2009). *
Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Ellingsen I, Seljeflot I. Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine. A randomized controlled trial. Nutr. Metab. (Lond.) 3: 4 (2006). *
Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M. Infliximab efficacy in pediatric ulcerative colitis. Inflamm. Bowel Dis. 11: 213-218 (2005). *
Eidelwein AP, Thompson R, Fiorino K, Abadom V, Oliva-Hemker M. Disease presentation and clinical course in black and white children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 44: 555-560 (2007). *
Eilat-Adar S, Mete M, Nobmann ED, Xu J, Fabsitz RR, Ebbesson SO, Howard BV. Dietary patterns are linked to cardiovascular risk factors but not to inflammatory markers in Alaska Eskimos. J. Nutr. 139: 2322-2328 (2009).
Eilat-Adar S, Xu J, Zephier E, O'Leary V, Howard BV, Resnick HE. Adherence to dietary recommendations for saturated fat, fiber, and sodium is low in American Indians and other U.S. adults with diabetes. J. Nutr. 138: 1699-1704 (2008). *
Eisenmann A, Murr C, Fuchs D, Ledochowski M. Gliadin IgG antibodies and circulating immune complexes. Scand. J. Gastroenterol. 44: 168-171 (2009). *
Eivindson M, Gronbaek H, Nielsen JN, Frystyk J, Flyvbjerg A, Jorgensen L, Vind I, Munkholm P, Jensen S, Brandslund I, Hey H. Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids. Scand. J. Gastroenterol. 40: 1214-1221 (2005). *
Ekaladze E, Akhmeteli K, Medoidze T, Melikishvili Z, Tushurashvili P. Study of distribution of the vitamin A after overdose feeding along the digestive tract of rats intestine by LIFS. Georgian Med. News 157: 76-80 (2008).
Ekbom A, Montgomery SM. Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses. Best Pract. Res. Clin. Gastroenterol. 18: 497-508 (2004).
Ekema G, Falchetti D, Boroni G, Tanca AR, Altana C, Righetti L, Ridella M, Gambarotti M, Berchich L. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (omega-3 fatty acids). J. Pediatr. Surg. 43: 1191-1195 (2008).
Ekema G, Milianti S, Boroni G. Total parenteral nutrition in patients with short bowel sindrome. Minerva Pediatr. 61: 283-291 (2009).
Eklund CM. Proinflammatory cytokines in CRP baseline regulation. Adv. Clin. Chem. 48: 111-136 (2009).
El Abed MM, Marzouk B, Medhioub MN, Helal AN, Medhioub A. Microalgae: a potential source of polyunsaturated fatty acids. Nutr. Health 19: 221-226 (2008).
El Ali Z, Fichna M, Piniewska J, Kosowicz J, Grzymislawski M. Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison's disease. J. Endocrinol. Invest. Sep 30 [Epub ahead of print] (2009).
El Kebbaj Z, Andreoletti P, Mountassif D, Kabine M, Schohn H, Dauca M, Latruffe N, El Kebbaj MS, Cherkaoui-Malki M. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal. Endocrinology 150: 1192-1201 (2009). *
El Moutawakil B, Chourkani N, Sibai M, Moutaouakil F, Rafai M, Bourezgui M, Slassi I. Celiac disease and ischemic stroke. Rev. Neurol. (Paris) 165: 962-966 (2009).
El Muhtaseb MS, Duncan A, Talwar DK, O'Reilly DS, McKee RF, Anderson JH, Finlay IG. Assessment of dietary intake and trace element status in patients with ileal pouch-anal anastomosis. Dis. Colon Rectum 50: 1553-1557 (2007). *
El Muhtaseb MS, Talwar D, Duncan A, O'Reilly DS, McKee RF, Anderson JH, Foulis A, Finlay IG. Free radical activity and lipid soluble anti-oxidant vitamin status in patients with long-term ileal pouch-anal anastomosis. Colorectal Dis. 11: 67-72 (2009). *
El-Abbadi MM, Pai AS, Leaf EM, Yang HY, Bartley BA, Quan KK, Ingalls CM, Liao HW, Giachelli CM. Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int. 75: 1297-1307 (2009). *
El-Badry AM, Graf R, Clavien PA. Omega 3 - omega 6: what is right for the liver? J. Hepatol. 47: 718-725 (2007). *
El-Badry AM, Moritz W, Contaldo C, Tian Y, Graf R, Clavien PA. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology 45: 855-863 (2007). *
El-Chennawi FA, Auf FA, Metwally SS, Mosaad YM, El-Wahab MA, Tawhid ZE. HLA-class II alleles in Egyptian patients with hepatocellular carcinoma. Immunol. Invest. 37: 661-674 (2008). *
El-Hachem S, Regueiro M. Postoperative Crohn's disease: prevention and treatment. Expert Rev. Gastroenterol. Hepatol. 3: 249-256 (2009).
El-Matary W. Enteral nutrition as a primary therapy of Crohn's disease: the pediatric perspective. Nutr. Clin. Pract. 24: 91-97 (2009). *
El-Matary W. Transition of children with inflammatory bowel disease: big task, little evidence. World J. Gastroenterol. 15: 3744-3747 (2009). *
El-Matary W, Girgis S, Huynh H, Turner J, Diederichs B. Microscopic colitis in children. Dig. Dis. Sci. Sep 3 [Epub ahead of print] (2009). *
El-Matary W, Huynh H, Vandermeer B. Diagnostic characteristics of given video capsule endoscopy in diagnosis of celiac disease: a meta-analysis. J. Laparoendosc. Adv. Surg. Tech. A. 19: 815-820 (2009).
El-Matary W, Roberts EA, Kim P, Temple M, Cutz E, Ling SC. Portal hypertensive biliopathy: a rare cause of childhood cholestasis. Eur. J. Pediatr. 167: 1339-1342 (2008).
El-Rifai N, Gottrand F. Role of ursodeoxycholic acid in pediatric cholestatic disease. Gastroenterol. Clin. Biol. 28: 852-859 (2004).
El-Sohemy A. Nutrigenetics. Forum Nutr. 60: 25-30 (2007).
Elefteriou F, Benson MD, Sowa H, Starbuck M, Liu X, Ron D, Parada LF, Karsenty G. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell. Metab. 4: 441-451 (2006). *
Elemraid MA, Mackenzie IJ, Fraser WD, Brabin BJ. Nutritional factors in the pathogenesis of ear disease in children: a systematic review. Ann. Trop. Paediatr. 29: 85-99 (2009).
Eletto D, Leone A, Bifulco M, Tecce MF. Effect of unsaturated fat intake from Mediterranean diet on rat liver mRNA expression profile: selective modulation of genes involved in lipid metabolism. Nutr. Metab. Cardiovasc. Dis. 15: 13-23 (2005).
Elia M, Engfer MB, Green CJ, Silk DB. Systematic review and meta-analysis: the clinical and physiological effects of fiber-containing enteral formulas. Aliment. Pharmacol. Ther. 27: 120-145 (2008). *
Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, Keinan-Boker L, Broide E, Ackerman Z, Kaluski DN, Lev B, Shouval D. Association between consumption of Herbalife((R)) nutritional supplements and acute hepatotoxicity. J. Hepatol. 47: 514-520 (2007). *
Eliseo T, Ragona L, Catalano M, Assfalg M, Paci M, Zetta L, Molinari H, Cicero DO. Structural and dynamic determinants of ligand binding in the ternary complex of chicken liver bile acid binding protein with two bile salts revealed by NMR. Biochemistry 46: 12557-12567 (2007). *
Elizondo A, Araya J, Rodrigo R, Signorini C, Sgherri C, Comporti M, Poniachik J, Videla LA. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease. Biol. Res. 41: 59-68 (2008). *
Ellingsgaard H, Ehses JA, Hammar EB, Van Lommel L, Quintens R, Martens G, Kerr-Conte J, Pattou F, Berney T, Pipeleers D, Halban PA, Schuit FC, Donath MY. Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc. Natl. Acad. Sci. U.S.A. 105: 13163-13168 (2008). *
Elliott R. Mechanisms of genomic and non-genomic actions of carotenoids. Biochim. Biophys. Acta 1740: 147-154 (2005). *
Ellis HJ, Ciclitira PJ. In vivo gluten challenge in celiac disease. Can. J. Gastroenterol. 15: 243-247 (2001). *
Ellis MK, Li Y, Hou X, Chen H, McManus DP. sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in Schistosomiasis japonica. Int. J. Parasitol. 38: 717-723 (2008). *
Ellis-Hutchings RG, Cherr GN, Hanna LA, Keen CL. The effects of marginal maternal vitamin A status on penta-brominated diphenyl ether mixture-induced alterations in maternal and conceptal vitamin A and fetal development in the Sprague Dawley rat. Birth Defects Res. B. Dev. Reprod. Toxicol. 86: 48-57 (2009).
Ells LJ, Hillier FC, Shucksmith J, Crawley H, Harbige L, Shield J, Wiggins A, Summerbell CD. A systematic review of the effect of dietary exposure that could be achieved through normal dietary intake on learning and performance of school-aged children of relevance to UK schools. Br. J. Nutr. 100: 927-936 (2008). *
Elmadfa I, Kornsteiner M. Dietary fat intake - a global perspective. Ann. Nutr. Metab. 54 Suppl. 1: 8-14 (2009).
Elmadfa I, Singer I. Vitamin B-12 and homocysteine status among vegetarians: a global perspective. Am. J. Clin. Nutr. 89: 1693S-1698S (2009). *
Elmarakby AA, Imig JD. Obesity is the major contributor to vascular dysfunction and inflammation in high fat diet hypertensive rats. Clin. Sci. (Lond.) Sep 3 [Epub ahead of print] (2009). *
Eloranta JJ, Hiller C, Hausler S, Stieger B, Kullak-Ublick GA. Vitamin D3 and its nuclear receptor increase the expression and activity of the human proton-coupled folate transporter. Mol. Pharmacol. 76: 1062-1071 (2009).
Elphick DA, Baker M, Baxter JP, Nightingale JM, Bowling T, Page KB, McAlindon ME. Muscle cramps are the commonest side effect of home parenteral nutrition. Clin. Nutr. 28: 351-354 (2009).
Elsborg L, Larsen L. Folate deficiency in chronic inflammatory bowel diseases. Scand. J. Gastroenterol. 14: 1019-1024 (1979).
Elsenbruch S, Langhorst J, Popkirowa K, Muller T, Luedtke R, Franken U, Paul A, Spahn G, Michalsen A, Janssen OE, Schedlowski M, Dobos G. Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother. Psychosom. 74: 277-287 (2005).
Elshorbagy AK, Nurk E, Gjesdal CG, Tell GS, Ueland PM, Nygard O, Tverdal A, Vollset SE, Refsum H. Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism? Am. J. Clin. Nutr. 88: 738-746 (2008). *
Elshorbagy AK, Valdivia-Garcia M, Refsum H, Smith AD, Mattocks DA, Perrone CE. Sulfur amino acids in methionine-restricted rats: hyperhomocysteinemia. Nutrition Jan 15 [Epub ahead of print] (2010). *
Elvang T, Christensen JP, Billeskov R, Thi Kim Thanh Hoang T, Holst P, Thomsen AR, Andersen P, Dietrich J. CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination. PLoS ONE 4: e5139 (2009). *
Elvevoll EO, Barstad H, Breimo ES, Brox J, Eilertsen KE, Lund T, Olsen JO, Osterud B. Enhanced incorporation of n-3 fatty acids from fish compared with fish oils. Lipids 41: 1109-1114 (2006).
Elvevoll EO, Eilertsen KE, Brox J, Dragnes BT, Falkenberg P, Olsen JO, Kirkhus B, Lamglait A, Osterud B. Seafood diets: hypolipidemic and antiatherogenic effects of taurine and n-3 fatty acids. Atherosclerosis 200: 396-402 (2008).
Enck P, Zimmermann K, Rusch K, Schwiertz A, Klosterhalfen S, Frick JS. The effects of ageing on the colonic bacterial microflora in adults. Z. Gastroenterol. 47: 653-658 (2009).
End C, Bikker F, Renner M, Bergmann G, Lyer S, Blaich S, Hudler M, Helmke B, Gassler N, Autschbach F, Ligtenberg AJ, Benner A, Holmskov U, Schirmacher P, Nieuw Amerongen AV, Rosenstiel P, Sina C, Franke A, Hafner M, Kioschis P, Schreiber S, et al. DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands. Eur. J. Immunol. 39: 833-842 (2009). *
Endo H, Hosono K, Fujisawa T, Takahashi H, Sugiyama M, Yoneda K, Nozaki Y, Fujita K, Yoneda M, Inamori M, Wada K, Nakagama H, Nakajima A. Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary condition. Gut 58: 1637-1643 (2009).
Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 320: 265-271 (1989).
Endresen MJ. The role of fatty acids in gene regulation. An example of an important nutritional factor which may influence our genes. Tidsskr. Nor. Laegeforen. 115: 2084-2086 (1995).
Engel JJ, Martin TL. Edwardsiella tarda as a cause of postdysenteric ulcerative colitis. Int. J. Colorectal Dis. 21: 184-185 (2006). *
Engeset D, Alsaker E, Lund E, Welch A, Khaw KT, Clavel-Chapelon F, Thiebaut A, Chajes V, Key TJ, Allen NE, Amiano P, Dorronsoro M, Tjonneland A, Stripp C, Peeters PH, van Gils CH, Chirlaque MD, Nagel G, Linseisen J, Ocke MC, Bueno-de-Mesquita HB, et al. Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer 119: 175-182 (2006). *
Engler MM, Engler MB. Omega-3 fatty acids: role in cardiovascular health and disease. J. Cardiovasc. Nurs. 21: 17-24 (2006).
Enke U, Seyfarth L, Schleussner E, Markert UR. Impact of PUFA on early immune and fetal development. Br. J. Nutr. 100: 1158-1168 (2008). *
Ensari A, Marsh MN, Loft DE, Morgan S, Moriarty K. Morphometric analysis of intestinal mucosa. V. Quantitative histological and immunocytochemical studies of rectal mucosae in gluten sensitivity. Gut 34: 1225-1229 (1993). *
Eny KM, El-Sohemy A, Cornelis MC, Sung YK, Bae SC. Catalase and PPARgamma2 genotype and risk of systemic lupus erythematosus in Koreans. Lupus 14: 351-355 (2005).
Epple HJ. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease. Dig. Dis. 27: 555-559 (2009).
Epplein M, Wilkens LR, Tiirikainen M, Dyba M, Chung FL, Goodman MT, Murphy SP, Henderson BE, Kolonel LN, Le Marchand L. Urinary isothiocyanates, glutathione S-transferase M1, T1, and P1 polymorphisms, and risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev. 18: 314-320 (2009).
Epstein J, Docena G, Macdonald TT, Sanderson IR. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease. Br. J. Nutr. Nov 2 [Epub ahead of print] (2009). *
Epstein O, Boss AM, Lyon TD, Sherlock S. Hair copper in primary biliary cirrhosis. Am. J. Clin. Nutr. 33: 965-967 (1980). *
Erbel C, Chen L, Bea F, Wangler S, Celik S, Lasitschka F, Wang Y, Bockler D, Katus HA, Dengler TJ. Inhibition of IL-17A attenuates atherosclerotic lesion development in ApoE-deficient mice. J. Immunol. 183: 8167-8175 (2009).
Ercan E, Tengiz I, Altuglu I, Sekuri C, Aliyev E, Ercan HE, Akin M. Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia. Kardiol. Pol. 60: 454-458 (2004).
Eren M, Saltik-Temizel IN, Demir H, Kocak N, Ozen H, Gurakan F, Yuce A. Thrombophilic factors in Turkish children with inflammatory bowel disease. Indian J. Gastroenterol. 25: 318-319 (2006). *
Ergas D, Eilat E, Mendlovic S, Sthoeger ZM. n-3 Fatty acids and the immune system in autoimmunity. Isr. Med. Assoc. J. 4: 34-38 (2002). *
Erichsen K, Milde AM, Arslan G, Helgeland L, Gudbrandsen OA, Ulvik RJ, Berge RK, Hausken T, Berstad A. Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflamm. Bowel Dis. 11: 744-748 (2005). *
Erickson RP, Bhattacharyya A, Hunter RJ, Heidenreich RA, Cherrington NJ. Liver disease with altered bile acid transport in Niemann-Pick C mice on a high fat, 1% cholesterol diet. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G300-G307 (2005). *
Erickson SK, Lear SR, Deane S, Dubrac S, Huling SL, Nguyen L, Bollineni JS, Shefer S, Hyogo H, Cohen DE, Shneider B, Sehayek E, Ananthanarayanan M, Balasubramaniyan N, Suchy FJ, Batta AK, Salen G. Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice. J. Lipid Res. 44: 1001-1009 (2003). *
Eriksen BB, Kare DL. Open trial of supplements of omega 3 and 6 fatty acids, vitamins and minerals in atopic dermatitis. J. Dermatolog. Treat. 17: 82-85 (2006).
Erion MD, Cable EE, Ito BR, Jiang H, Fujitaki JM, Finn PD, Zhang BH, Hou J, Boyer SH, van Poelje PD, Linemeyer DL. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index. Proc. Natl. Acad. Sci. U.S.A. 104: 15490-15495 (2007). *
Erkkila A, de Mello VD, Riserus U, Laaksonen DE. Dietary fatty acids and cardiovascular disease: an epidemiological approach. Prog. Lipid Res. 47: 172-187 (2008). *
Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippila C, Ahonen S, Nevalainen J, Veijola R, Pekkanen J, Ilonen J, Simell O, Knip M, Virtanen SM. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin. Exp. Allergy 39: 875-882 (2009). *
Errichiello S, Esposito O, Di Mase R, Camarca ME, Natale C, Limongelli MG, Marano C, Coruzzo A, Lombardo M, Strisciuglio P, Greco L. Celiac disease: predictors of compliance with a gluten-free diet in adolescents and young adults. J. Pediatr. Gastroenterol. Nutr. 50: 54-60 (2010).
Erridge C, Samani NJ. Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler. Thromb. Vasc. Biol. 29: 1944-1949 (2009).
Erskine JM, Lingard C, Sontag M. Update on enteral nutrition support for cystic fibrosis. Nutr. Clin. Pract. 22: 223-232 (2007).
Ersoz G, Gunsar F, Karasu Z, Akay S, Batur Y, Akarca US. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. Turk. J. Gastroenterol. 16: 124-128 (2005). *
Ertekin V, Ayse Selimoglu M, Doneray H, Orbak Z, Ozkan B. Prevalence of celiac disease in a sample of Turkish children and adolescents with type 1 diabetes mellitus. J. Clin. Gastroenterol. 40: 655-657 (2006).
Ertekin V, Orbak Z, Selimoglu MA, Yildiz L. Serum leptin levels in childhood celiac disease. J. Clin. Gastroenterol. 40: 906-909 (2006).
Ertekin V, Selimoglu MA. Prevalence of prolonged prothrombin time in children with coeliac disease. Eur. J. Gastroenterol. Hepatol. 18: 579-580 (2006).
Ertekin V, Selimoglu MA, Altnkaynak S. Prevalence of cyclic vomiting syndrome in a sample of Turkish school children in an urban area. J. Clin. Gastroenterol. 40: 896-898 (2006).
Ertekin V, Selimoglu MA, Okcu N, Orbak Z, Gundogdu C. Intestinal tuberculosis mimicking Crohn's disease. J. Emerg. Med. 33: 421-423 (2007).
Ertekin V, Selimoglu MA, Turgut A, Bakan N. Fecal calprotectin concentration in celiac disease. J. Clin. Gastroenterol. Jan 5 [Epub ahead of print] (2010).
Ertekin V, Selimoglu MA, Turkan Y, Akcay F. Serum nitric oxide levels in children with celiac disease. J. Clin. Gastroenterol. 39: 782-785 (2005).
Ertem D, Gonen I, Tanidir C, Ugras M, Yildiz A, Pehlivanoglu E, Eksioglu-Demiralp E. The response to hepatitis B vaccine: does it differ in celiac disease? Eur. J. Gastroenterol. Hepatol. Jul 4 [Epub ahead of print] (2009).
Ertesvag A, Austenaa LM, Carlsen H, Blomhoff R, Blomhoff HK. Retinoic acid inhibits in vivo interleukin-2 gene expression and T-cell activation in mice. Immunology 126: 514-522 (2009). *
Esaki M, Matsumoto T, Hizawa K, Nakamura S, Jo Y, Mibu R, Iida M. Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy. Scand. J. Gastroenterol. 40: 1431-1437 (2005). *
Esaki M, Matsumoto T, Nakamura S, Yada S, Fujisawa K, Jo Y, Iida M. Factors affecting recurrence in patients with Crohn's disease under nutritional therapy. Dis. Colon Rectum 49: S68-S74 (2006). *
Escaron AL, Green MH, Howe JA, Tanumihardjo SA. Mathematical modeling of serum 13C-retinol in captive Rhesus monkeys provides new insights on hypervitaminosis A. J. Nutr. 139: 2000-2006 (2009). *
Escaron AL, Green MH, Tanumihardjo SA. Plasma turnover of 3,4-didehydroretinol (vitamin A2) increases in vitamin A-deficient rats fed low versus high dietary fat. J. Lipid Res. 50: 694-703 (2009). *
Escher JC. Nutritional therapy in paediatric Crohn's disease: more food for thought? Dig. Liver Dis. 38: 387-388 (2006).
Escher JC, Taminiau JA, Nieuwenhuis EE, Buller HA, Grand RJ. Treatment of inflammatory bowel disease in childhood: best available evidence. Inflamm. Bowel Dis. 9: 34-58 (2003). *
Escher JC; European Collaborative Research Group on Budesonide in Paediatric IBD. Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial. Eur. J. Gastroenterol. Hepatol. 16: 47-54 (2004).
Esfandiari F, Medici V, Wong DH, Jose S, Dolatshahi M, Quinlivan E, Dayal S, Lentz SR, Tsukamoto H, Zhang YH, French SW, Halsted CH. Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse. Hepatology Oct 19 [Epub ahead of print] (2009).
Eskelinen MH, Ngandu T, Helkala EL, Tuomilehto J, Nissinen A, Soininen H, Kivipelto M. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int. J. Geriatr. Psychiatry 23: 741-747 (2008).
Esmaili A, Nazir SF, Borthakur A, Yu D, Turner JR, Saksena S, Singla A, Hecht GA, Alrefai WA, Gill RK. Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression. Gastroenterology 137: 2074-2083 (2009). *
Esmaillzadeh A, Azadbakht L. Home use of vegetable oils, markers of systemic inflammation, and endothelial dysfunction among women. Am. J. Clin. Nutr. 88: 913-921 (2008). *
Espe K, Galler A, Raila J, Kiess W, Schweigert FJ. High-normal C-reactive protein levels do not affect the vitamin A transport complex in serum of children and adolescents with type 1 diabetes. Pediatr. Res. 62: 741-745 (2007). *
Espe M, Rathore RM, Du ZY, Liaset B, El-Mowafi A. Methionine limitation results in increased hepatic FAS activity, higher liver 18:1 to 18:0 fatty acid ratio and hepatic TAG accumulation in Atlantic salmon, Salmo salar. Amino Acids Jan 30 [Epub ahead of print] (2010). *
Esposito C, Caputo I, Troncone R. New therapeutic strategies for coeliac disease: tissue transglutaminase as a target. Curr. Med. Chem. 14: 2572-2580 (2007).
Esposito G, Cirillo C, Sarnelli G, De Filippis D, D'armiento FP, Rocco A, Nardone G, Petruzzelli R, Grosso M, Izzo P, Iuvone T, Cuomo R. Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease. Gastroenterology 133: 918-925 (2007). *
Esteban-Pretel G, Mar�n MP, Cabezuelo F, Moreno V, Renau-Piqueras J, Timoneda J, Barber T. Vitamin A deficiency increases protein catabolism and induces urea cycle enzymes in rats. J. Nutr. Feb 24 [Epub ahead of print] (2010).
Esteban-Pretel G, Mar�n MP, Renau-Piqueras J, Barber T, Timoneda J. Vitamin A deficiency alters rat lung alveolar basement membrane: reversibility by retinoic acid. J. Nutr. Biochem. Mar 5 [Epub ahead of print] (2009). *
Estebe JP, Legay F, Gentili M, Wodey E, Leduc C, Ecoffey C, Moulinoux JP. An evaluation of a polyamine-deficient diet for the treatment of inflammatory pain. Anesth. Analg. 102: 1781-1788 (2006).
Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, Orloff SL. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch. Surg. 138: 852-858 (2003). *
Esteve M, Gisbert JP. Severe ulcerative colitis: at what point should we define resistance to steroids? World J. Gastroenterol. 14: 5504-5507 (2008). *
Esteve M, Rosinach M, Fernandez-Banares F, Farre C, Salas A, Alsina M, Vilar P, Abad-Lacruz A, Forne M, Marine M, Santaolalla R, Espinos JC, Viver JM. Spectrum of gluten sensitive enteropathy in first degree relatives of coeliac patients: clinical relevance of lymphocytic enteritis. Gut 55: 1739-1745 (2006). *
Esteve-Comas M, Nunez MC, Fernandez-Banares F, Abad-Lacruz A, Gil A, Cabre E, Gonzalez-Huix F, Bertran X, Gassull MA. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut 34: 1370-1373 (1993). *
Estivariz CF, Luo M, Umeakunne K, Bazargan N, Galloway JR, Leader LM, Ziegler TR. Nutrient intake from habitual oral diet in patients with severe short bowel syndrome living in the southeastern United States. Nutrition 24: 330-339 (2008). *
Eubank KV, Nash J, Duvic M. Sweet syndrome associated with celiac disease. Am. J. Clin. Dermatol. 10: 343-345 (2009).
Eussen SJ, Vollset SE, Hustad S, Midttun O, Meyer K, Fredriksen A, Ueland PM, Jenab M, Slimani N, Ferrari P, Agudo A, Sala N, Capella G, Del Giudice G, Palli D, Boeing H, Weikert C, Bueno-de-Mesquita HB, Buchner FL, Carneiro F, Berrino F, Vineis P, et al. Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol. Biomarkers Prev. 19: 28-38 (2010). *
Evans GW. Zinc and its deficiency diseases. Clin. Physiol. Biochem. 4: 94-98 (1986).
Evans KE, Leeds JS, Sanders DS. Be vigilant for patients with coeliac disease. Practitioner 253: 19-22, 2 (2009).
Evans KE, Sanders DS. Joint BAPEN and British Society of Gastroenterology Symposium on 'Coeliac disease: basics and controversies'. Coeliac disease: optimising the management of patients with persisting symptoms? Proc. Nutr. Soc. 68: 242-248 (2009). *
Evans MJ, Mahaney PE, Borges-Marcucci L, Lai K, Wang S, Krueger JA, Gardell SJ, Huard C, Martinez RV, Vlasuk GP, Harnish DC. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G543-G552 (2009). *
Evans NP, Misyak SA, Schmelz EM, Guri AJ, Hontecillas R, Bassaganya-Riera J. Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma. J. Nutr. Jan 20 [Epub ahead of print] (2010).
Evans S, Daly A, Davies P, Macdonald A. Fibre content of enteral feeds for the older child. J. Hum. Nutr. Diet. 22: 414-421 (2009). *
Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG; the HALT-C TrialGroup. Weight related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial. Gastroenterology 137: 549-557 (2009). *
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States. Part 1: overall and upper gastrointestinal diseases. Gastroenterology 136: 376-386 (2009). *
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States. Part 2: lower gastrointestinal diseases. Gastroenterology 136: 741-754 (2009). *
Everhart JE, Ruhl CE. Burden of digestive diseases in the United States. Part 3: liver, biliary tract, and pancreas. Gastroenterology 136: 1134-1144 (2009). *
Evers EA, Pfefferkorn MD, Steiner SJ. Factors predictive of Crohn disease following colectomy in medically refractory pediatric colitis. J. Pediatr. Gastroenterol. Nutr. 48: 283-286 (2009).
Everson GT, McKinley C, Kern F Jr. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J. Clin. Invest. 87: 237-246 (1991). *
Evert M, Seiler C, Dombrowski F. Aberrant acinar cell CA 19-9 expression and peri-insular acinar cell alterations in an adult human pancreas. Virchows Arch. 446: 68-72 (2005). *
Extier A, Langelier B, Perruchot MH, Guesnet P, Van Veldhoven PP, Lavialle M, Alessandri JM. Gender affects liver desaturase expression in a rat model of n-3 fatty acid repletion. J. Nutr. Biochem. Jan 19 [Epub ahead of print] (2009). *
Extier A, Perruchot MH, Baudry C, Guesnet P, Lavialle M, Alessandri JM. Differential effects of steroids on the synthesis of polyunsaturated fatty acids by human neuroblastoma cells. Neurochem. Int. 55: 295-301 (2009).
Eyles D, Almeras L, Benech P, Patatian A, Mackay-Sim A, McGrath J, Feron F. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J. Steroid Biochem. Mol. Biol. 103: 538-545 (2007).
Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51: 679-689 (2010).
Faber J, Vos P, Kegler D, van Norren K, Argiles JM, Laviano A, Garssen J, van Helvoort A. Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia. Br. J. Cancer 99: 2029-2036 (2008). *
Faber M, Laubscher R. Seasonal availability and dietary intake of beta-carotene-rich vegetables and fruit of 2-year-old to 5-year-old children in a rural South African setting growing these crops at household level. Int. J. Food Sci. Nutr. 59: 46-60 (2008).
Fabian E, Elmadfa I. Nutritional situation of the elderly in the European Union: data of the European Nutrition and Health Report (2004). Ann. Nutr. Metab. 52 Suppl. 1: 57-61 (2008).
Fabre EE, Raynaud-Simon A, Golmard JL, Hebert M, Dulcire X, Succari M, Myara J, Durand D, Nivet-Antoine V. Gene polymorphisms of oxidative stress enzymes: prediction of elderly renutrition. Am. J. Clin. Nutr. 87: 1504-1512 (2008). *
Fabris M, Visentini D, De Re V, Picierno A, Maieron R, Cannizzaro R, Villalta D, Curcio F, De Vita S, Tonutti E. Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease. Scand. J. Gastroenterol. 42: 1434-1439 (2007). *
Fagan EA. Intrahepatic cholestasis of pregnancy. Clin. Liver Dis. 3: 603-632 (1999).
Fagarasan S, Kinoshita K, Muramatsu M, Ikuta K, Honjo T. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413: 639-643 (2001). *
Fagoonee S, De Luca L, De Angelis C, Castelli A, Rizzetto M, Pellicano R. Anti-Saccharomyces cerevisiae as unusual antibodies in autoimmune hepatitis. Minerva Gastroenterol. Dietol. 55: 37-40 (2009).
Fagundes ED, Roquete ML, Penna FJ, Reis FJ, Goulart EM, Duque CG. Risk factors for cystic fibrosis related liver disease. J. Pediatr. (Rio J.) 81: 478-484 (2005). *
Fahey AJ, Adrian Robins R, Constantinescu CS. Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells. J. Cell. Mol. Med. 11: 1129-1137 (2007). *
Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, Talalay P, Lozniewski A. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl. Acad. Sci. U.S.A. 99: 7610-7615 (2002). *
Failla ML, Huo T, Thakkar SK. In vitro screening of relative bioaccessibility of carotenoids from foods. Asia Pac. J. Clin. Nutr. 17 Suppl. 1: 200-203 (2008).
Failla ML, Thakkar SK, Kim JY. In vitro bioaccessibility of beta-carotene in orange fleshed sweet potato (Ipomoea batatas, Lam.). J. Agric. Food Chem. 57: 10922-10927 (2009). *
Faintuch J. Nutritional abnormalities in inflammatory bowel disease. Rev. Hosp. Clin. Fac. Med. Sao Paulo 57: 129-130 (2002). *
Fakhrudin N, Ladurner A, Atanasov AG, Heiss EH, Baumgartner L, Markt P, Schuster D, Ellmerer EP, Wolber G, Rollinger JM, Stuppner H, Dirsch VM. Computer-aided discovery, validation and mechanistic characterisation of novel neolignan activators of PPARgamma. Mol. Pharmacol. Jan 11 [Epub ahead of print] (2010). *
Falcao HS, Mariath IR, Diniz MF, Batista LM, Barbosa-Filho JM. Plants of the American continent with antiulcer activity. Phytomedicine 15: 132-146 (2008). *
Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin. Liver Dis. 21: 17-26 (2001).
Famularo G, De Simone C, Pandey V, Sahu AR, Minisola G. Probiotic lactobacilli: an innovative tool to correct the malabsorption syndrome of vegetarians? Med. Hypotheses 65: 1132-1135 (2005).
Fan B, Ikuyama S, Gu JQ, Wei P, Oyama JI, Inoguchi T, Nishimura J. Oleic acid-induced ADRP expression requires both AP-1 and PPAR-response elements, and is reduced by pycnogenol through mRNA degradation in NMuLi liver cells. Am. J. Physiol. Endocrinol. Metab. 297: E112-E123 (2009). *
Fan J, Meng Q, Guo G, Xie Y, Li X, Xiu Y, Li T, Feng W, Ma L. Effects of glutamine added to enteral nutrition on Peyer's patch apoptosis in severely burned mice. Burns Sep 25 [Epub ahead of print] (2009).
Fan JG, Zhong L, Tia LY, Xu ZJ, Li MS, Wang GL. Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World J. Gastroenterol. 11: 2346-2350 (2005). *
Fan RX, Lu SW, DU YP, Hou MJ, Zhu HL. Anti-atherosclerotic effect of betaine in apolipoprotein E-deficient mice. Zhonghua Yu Fang Yi Xue Za Zhi 42: 742-747 (2008).
Fan X, Kim HJ, Bouton D, Warner M, Gustafsson JA. Expression of liver X receptor beta is essential for formation of superficial cortical layers and migration of later-born neurons. Proc. Natl. Acad. Sci. U.S.A. 105: 13445-13450 (2008). *
Fan Y, Wu SD, Sun L, Fu BB, Su Y. Possible relationship between intestinal barrier function and formation of pigment gallstones in hamsters. Hepatobiliary Pancreat. Dis. Int. 7: 529-532 (2008). *
Fan YY, Kim W, Callaway E, Smith R, Jia Q, Zhou L, McMurray DN, Chapkin RS. fat-1 transgene expression prevents cell culture-induced loss of membrane n-3 fatty acids in activated CD4(+) T-cells. Prostaglandins Leukot. Essent. Fatty Acids 79: 209-214 (2008). *
Fan YY, Ly LH, Barhoumi R, McMurray DN, Chapkin RS. Dietary docosahexaenoic acid suppresses T cell protein kinase C theta lipid raft recruitment and IL-2 production. J. Immunol. 173: 6151-6160 (2004). *
Fan YY, Spencer TE, Wang N, Moyer MP, Chapkin RS. Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis 24: 1541-1548 (2003). *
Fan YY, Zhan Y, Aukema HM, Davidson LA, Zhou L, Callaway E, Tian Y, Weeks BR, Lupton JR, Toyokuni S, Chapkin RS. Proapoptotic effects of dietary (n-3) fatty acids are enhanced in colonocytes of manganese-dependent superoxide dismutase knockout mice. J. Nutr. 139: 1328-1332 (2009). *
Fang Y, van Meurs JB, Arp P, van Leeuwen JP, Hofman A, Pols HA, Uitterlinden AG. Vitamin D binding protein genotype and osteoporosis. Calcif. Tissue Int. 85: 85-93 (2009). *
Fang YZ, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition 18: 872-879 (2002). *
Fang Z, Yao K, Zhang X, Zhao S, Sun Z, Tian G, Yu B, Lin Y, Zhu B, Jia G, Zhang K, Chen D, Wu D. Nutrition and health relevant regulation of intestinal sulfur amino acid metabolism. Amino Acids Feb 17 [Epub ahead of print] (2010). *
Fanjiang G, Russell GH, Katz AJ. Short- and long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 44: 312-317 (2007). *
Fanos JH. "We kept our promises": an oral history of Harry Shwachman, M.D. Am. J. Med. Genet. A. 146: 284-293 (2008).
Fantuzzi G. Adiponectin and inflammation: consensus and controversy. J. Allergy Clin. Immunol. 121: 326-330 (2008). *
Farage MA, Miller KW, Berardesca E, Maibach HI. Clinical implications of aging skin: cutaneous disorders in the elderly. Am. J. Clin. Dermatol. 10: 73-86 (2009).
Farah R, Glick Y, Farah R. Secrets of the Mediterranean diet. Harefuah. 147: 422-427, 477 (2008).
Farahani P, Chiu S, Bowlus CL, Boffelli D, Lee E, Fisler JS, Krauss RM, Warden CH. Obesity in BSB mice is correlated with expression of genes for iron homeostasis and leptin. Obes. Res. 12: 191-204 (2004). *
Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am. J. Gastroenterol. 96: 2448-2455 (2001). *
Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J. Gastroenterol. 13: 3027-3030 (2007). *
Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM, Keshavarzian A. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int. 28: 1026-1033 (2008). *
Farhadi A, Keshavarzian A, Fields JZ, Jakate S, Shaikh M, Banan A. Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease. J. Gastroenterol. Hepatol. 22: 2338-2343 (2007). *
Farhadi A, Keshavarzian A, Van de Kar LD, Jakate S, Domm A, Zhang L, Shaikh M, Banan A, Fields JZ. Heightened responses to stressors in patients with inflammatory bowel disease. Am. J. Gastroenterol. 100: 1796-1804 (2005). *
Farinotti M, Simi S, Di Pietrantonj C, McDowell N, Brait L, Lupo D, Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst. Rev. 1: CD004192 (2007). *
Farooqui AA, Horrocks LA, Farooqui T. Modulation of inflammation in brain: a matter of fat. J. Neurochem. 101: 577-599 (2007).
Farrell GC, Cooksley WG, Hart P, Powell LW. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. Gastroenterology 75: 580-688 (1978).
Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43: S99-S112 (2006). *
Farrell MK, Balistreri WF. Parenteral nutrition and hepatobiliary dysfunction. Clin. Perinatol. 13: 197-212 (1986).
Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 107: 1-13 (2001). *
Farzaneh-Far R, Harris WS, Garg S, Na B, Whooley MA. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 205: 538-543 (2009).
Fasano A. 50 years ago in The Journal of Pediatrics. Celiac disease: response to a gluten free diet. J. Pediatr. 153: 824 (2008).
Fasano A. Surprises from celiac disease. Sci. Am. 301: 54-61 (2009).
Fasano A. Intestinal zonulin: open sesame! Gut 49: 159-162 (2001). *
Fasano A, Araya M, Bhatnagar S, Cameron D, Catassi C, Dirks M, Mearin ML, Ortigosa L, Phillips A; Celiac Disease Working Group. Federation of International Societies of Pediatric Gastroenterology, Hepatology, and Nutrition Consensus report on celiac disease. J. Pediatr. Gastroenterol. Nutr. 47: 214-219 (2008). *
Fatehi-Hassanabad Z, Chan CB. Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell function. Nutr. Metab. (Lond.) 2: 1 (2005). *
Faucitano L, Chouinard PY, Fortin J, Mandell IB, Lafreniere C, Girard CL, Berthiaume R. Comparison of alternative beef production systems based on forage finishing or grain-forage diets with or without growth promotants: 2. Meat quality, fatty acid composition and overall palatability. J. Anim. Sci. 86: 1678-1689 (2008). *
Faulkner-Hogg K, Hodge L, Swain A. Coeliac disease. Aust. Fam. Physician 38: 785-786 (2009).
Faure M, Moennoz D, Mettraux C, Montigon F, Schiffrin EJ, Obled C, Breuille D, Boza J. The chronic colitis developed by HLA-B27 transgenic rats is associated with altered in vivo mucin synthesis. Dig. Dis. Sci. 49: 339-346 (2004). *
Faust TW. Budd-Chiari syndrome. Curr. Treat. Options Gastroenterol. 2: 491-504 (1999).
Faust TW, Reddy KR. Postoperative jaundice. Clin. Liver Dis. 8: 151-166 (2004).
Fava C, Montagnana M, Guerriero M, Almgren P, von Wowern F, Minuz P, Melander O. Chromosome 2q12, the ADRA2B I/D polymorphism and metabolic syndrome. J. Hypertens. 27: 1794-1803 (2009).
Favaloro EJ. Diagnostic issues in thrombophilia: a laboratory scientist's view. Semin. Thromb. Hemost. 31: 11-16 (2005).
Faxen Irving G, Freund-Levi Y, Eriksdotter-Jonhagen M, Basun H, Brismar K, Hjorth E, Palmblad J, Vessby B, Vedin I, Wahlund LO, Cederholm T. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the Omega-3 Alzheimer's Disease Study. J. Am. Geriatr. Soc. 57: 11-17 (2009). *
Fayad R, Pini M, Sennello JA, Cabay RJ, Chan L, Xu A, Fantuzzi G. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 132: 601-614 (2007). *
Fayard E, Schoonjans K, Auwerx J. Xol INXS: role of the liver X and the farnesol X receptors. Curr. Opin. Lipidol. 12: 113-120 (2001).
Faye A, Ramey G, Foretz M, Vaulont S. Haptoglobin is degraded by iron in C57BL/6 mice: a possible link with endoplasmic reticulum stress. Blood Cells Mol. Dis. 39: 229-237 (2007).
Feagan BG, Bala M, Yan S, Olson A, Hanauer S. Unemployment and disability in patients with moderately to severely active Crohn's disease. J. Clin. Gastroenterol. 39: 390-395 (2005).
Feagins LA, Kane SV. Sexual and reproductive issues for men with inflammatory bowel disease. Am. J. Gastroenterol. 104: 768-773 (2009). *
Fearnhead NS, Chowdhury R, Box B, George BD, Jewell DP, Mortensen NJ. Long-term follow-up of strictureplasty for Crohn's disease. Br. J. Surg. 93: 475-482 (2006). *
Feart C, Mingaud F, Enderlin V, Husson M, Alfos S, Higueret P, Pallet V. Differential effect of retinoic acid and triiodothyronine on the age-related hypo-expression of neurogranin in rat. Neurobiol. Aging 26: 729-738 (2005).
Feart C, Peuchant E, Letenneur L, Samieri C, Montagnier D, Fourrier-Reglat A, Barberger-Gateau P. Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. Am. J. Clin. Nutr. 87: 1156-1162 (2008). *
Fedacko J, Pella D, Mechirova V, Horvath P, Rybar R, Varjassyova P, Vargova V. n-3 PUFAs - from dietary supplements to medicines. Pathophysiology 14: 127-132 (2007).
Federico A, Filippelli A, Falciani M, Tuccillo C, Tiso A, Floreani A, Naccarato R, Rossi F, Del Vecchio Blanco C, Loguercio C. Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies. World J. Gastroenterol. 13: 3677-3683 (2007). *
Fedor D, Kelley DS. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Curr. Opin. Clin. Nutr. Metab. Care 12: 138-146 (2009).
Fedorak RN, Madsen KL. Probiotics and prebiotics in gastrointestinal disorders. Curr. Opin. Gastroenterol. 20: 146-155 (2004).
Fedorak RN, Penner R, Madsen KL. Probiotics in the treatment of gastrointestinal diseases. US Gastroenterology Review, p. 28-31 (2006). *
Fedorova I, Alvheim AR, Hussein N, Salem N Jr. Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency. Behav. Neurosci. 123: 1218-1225 (2009).
Fedorova I, Hussein N, Baumann MH, Di Martino C, Salem N. An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. Behav. Neurosci. 123: 196-205 (2009).
Feher J, Lengyel G. Nutrition and cardiovascular mortality. Orv. Hetil. 147: 1491-1496 (2006).
Feher J, Lengyel G. A new approach to drug therapy in non-alcoholic steatohepatitis (NASH). J. Int. Med. Res. 31: 537-551 (2003).
Feige JN, Gerber A, Casals-Casas C, Yang Q, Winkler C, Bedu E, Bueno M, Gelman L, Auwerx J, Gonzalez FJ, Desvergne B. The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanisms. Environ. Health Perspect. 118: 234-241 (2010).
Feighery CF, McManus R. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease' Proc. Nutr. Soc. 68: 122-126 (2009). *
Feillet F, Agostoni C. Nutritional issues in treating phenylketonuria. J. Inherit. Metab. Dis. Feb 12 [Epub ahead of print] (2010).
Feillet H, Bach JF. Increased incidence of inflammatory bowel disease: the price of the decline of infectious burden? Curr. Opin. Gastroenterol. 20: 560-564 (2004).
Fekete K, Marosvolgyi T, Jakobik V, Decsi T. Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am. J. Clin. Nutr. 89: 2070S-2084S (2009). *
Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, Gores GJ. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J. Hepatol. 39: 978-983 (2003). *
Feldstein RC, Sood S, Katz S. Small bowel adenocarcinoma in Crohn's disease. Inflamm. Bowel Dis. 14: 1154-1157 (2008). *
Felipe F, Bonet ML, Ribot J, Palou A. Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes 53: 882-889 (2004). *
Fell JM. Control of systemic and local inflammation with transforming growth factor beta containing formulas. JPEN J. Parenter. Enteral Nutr. 29: S126-S133 (2005). *
Fellah H, Omar S, Feki M, Abderrahim E, Abdallah TB, Massy ZA, Lacour B, Maiz HB, Kaabachi N, Mebazaa A. Is serum transthyretin a reliable marker of nutritional status in patients with end-stage renal disease? Clin. Biochem. 41: 493-497 (2008). *
Feng R, Li Y, Zhao D, Wang C, Niu Y, Sun C. Lack of association between TNF 238 G/A polymorphism and type 2 diabetes: a meta-analysis. Acta Diabetol. 46: 339-343 (2009).
Feng RN, Li Y, Sun CH. TNF 308 G/A polymorphism and type 1 diabetes: a meta-analysis. Diabetes Res. Clin. Pract. 85: e4-e7 (2009).
Feng X, Li H, Rumbin AA, Wang X, La Cava A, Brechtelsbauer K, Castellani LW, Witztum JL, Lusis AJ, Tsao BP. ApoE-/-Fas-/-C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis and osteopenia. J. Lipid Res. 48: 794-805 (2007). *
Feng YX, Zhao JS, Li JJ, Wang T, Cheng SQ, Yuan Y, Wang F, Wang XF, Xie D. Liver cancer: EphrinA2 promotes tumorigenicity through Rac1/Ak/NF-kB signaling pathway. Hepatology 51: 535-544 (2010).
Feranchak AP. Hepatobiliary complications of cystic fibrosis. Curr. Gastroenterol. Rep. 6: 231-239 (2004).
Feranchak AP, Gralla J, King R, Ramirez RO, Corkill M, Narkewicz MR, Sokol RJ. Comparison of indices of vitamin A status in children with chronic liver disease. Hepatology 42: 782-792 (2005). *
Feranchak AP, Sokol RJ. Cholangiocyte biology and cystic fibrosis liver disease. Semin. Liver Dis. 21: 471-488 (2001).
Ferguson A. Mechanisms in adverse reactions to food. The gastrointestinal tract. Allergy 50: S32-S38 (1995).
Ferguson A. Immunological functions of the gut in relation to nutritional state and mode of delivery of nutrients. Gut 35: S10-S12 (1994). *
Ferguson JH, Chang AB. Vitamin D supplementation for cystic fibrosis. Cochrane Database Syst. Rev. 4: CD007298 (2009).
Ferguson LR. Dissecting the nutrigenomics, diabetes, and gastrointestinal disease interface: from risk assessment to health intervention. OMICS 12: 237-244 (2008).
Ferguson LR, Browning BL, Huebner C, Petermann I, Shelling AN, Demmers P, McCulloch A, Gearry RB, Barclay ML, Philpott M. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population. Dig. Liver Dis. 40: 723-730 (2008).
Ferguson LR, Han DY, Fraser AG, Huebner C, Lam WJ, Morgan AR, Duan H, Karunasinghe N. Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population. Mutat. Res. Jan 25 [Epub ahead of print] (2010).
Ferguson LR, Han DY, Huebner C, Petermann I, Barclay ML, Gearry RB, McCulloch A, Demmers PS. Tumor necrosis factor receptor superfamily, member 1B haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand Caucasian population. Gastroenterol. Res. Pract. 2009:591704 (2009).
Ferguson LR, Huebner C, Petermann I, Gearry RB, Barclay ML, Demmers P, McCulloch A, Han DY. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J. Gastroenterol. 14: 4652-4661 (2008). *
Ferguson LR, Peterman I, Hubner C, Philpott M, Shellin AN. Uncoupling gene-diet interactions in inflammatory bowel disease (IBD). Genes Nutr. 2: 71-73 (2007). *
Ferguson LR, Philpott M. Cancer prevention by dietary bioactive components that target the immune response. Curr. Cancer Drug Targets 7: 459-464 (2007).
Ferguson LR, Philpott M, Dryland P. Nutrigenomics in the whole-genome scanning era: Crohn's disease as example. Cell. Mol. Life Sci. 64: 3105-3118 (2007). *
Ferguson LR, Shelling AN, Browning BL, Huebner C, Petermann I. Genes, diet and inflammatory bowel disease. Mutat. Res. 622: 70-83 (2007).
Ferguson LR, Shelling AN, Lauren D, Heyes JA, McNabb WC; Nutrigenomics New Zealand. Nutrigenomics and gut health. Mutat. Res. 622: 1-6 (2007).
Ferguson MM, MacFadyen EE. Orofacial granulomatosis - a 10 year review. Ann. Acad. Med. Singapore 15: 370-377 (1986).
Fernandes AR, Rose M, White S, Mortimer DN, Gem M. Dioxins and polychlorinated biphenyls (PCBs) in fish oil dietary supplements: occurrence and human exposure in the UK. Food Addit. Contam. 23: 939-947 (2006).
Fernandes G. Progress in nutritional immunology. Immunol. Res. 40: 244-261 (2008). *
Fernandes G, Bhattacharya A, Rahman M, Zaman K, Banu J. Effects of n-3 fatty acids on autoimmunity and osteoporosis. Front. Biosci. 13: 4015-4020 (2008).
Fernandes J, Reshef A, Patton L, Ayuso R, Reese G, Lehrer SB. Immunoglobulin E antibody reactivity to the major shrimp allergen, tropomyosin, in unexposed Orthodox Jews. Clin. Exp. Allergy 33: 956-961 (2003). *
Fernandes JS, Mori MA, Ekuni R, Oliveira RM, Milani H. Long-term treatment with fish oil prevents memory impairments but not hippocampal damage in rats subjected to transient, global cerebral ischemia. Nutr. Res. 28: 798-808 (2008). *
Fernandes-Santos C, Carneiro RE, Mendonca LD, Aguila MB, Mandarim-de-Lacerda CA. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet. Nutrition 25: 818-827 (2009). *
Fernandes-Santos C, Evangelista Carneiro R, de Souza Mendonca L, Barbosa Aguila M, Alberto Mandarim-de-Lacerda C. Rosiglitazone aggravates nonalcoholic fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas 38: e80-e86 (2009).
Fernandez A, Colell A, Caballero F, Matias N, Garcia-Ruiz C, Fernandez-Checa JC. Mitochondrial S-adenosyl-L-methionine transport is insensitive to alcohol-mediated changes in membrane dynamics. Alcohol Clin. Exp. Res. 33: 1169-1180 (2009).
Fernandez E, Gallus S, La Vecchia C. Nutrition and cancer risk: an overview. J. Br. Menopause Soc. 12: 139-142 (2006).
Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, Esteve M, Gonzalez-Huix F, Gassull MA. Vitamin status in patients with inflammatory bowel disease. Am. J. Gastroenterol. 84: 744-748 (1989).
Fernandez-Banares F, Cabre E, Gonzalez-Huix F, Gassull MA. Enteral nutrition as primary therapy in Crohn's disease. Gut 35: S55-S59 (1994). *
Fernandez-Banares F, Esteve M, Farre C, Salas A, Alsina M, Casalots J, Espinos J, Forne M, Viver JM. Predisposing HLA-DQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis. Eur. J. Gastroenterol. Hepatol. 17: 1333-1338 (2005).
Fernandez-Banares F, Esteve M, Salas A, Alsina M, Farre C, Gonzalez C, Buxeda M, Forne M, Rosinach M, Espinos JC, Maria Viver J. Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am. J. Gastroenterol. 102: 2520-2528 (2007). *
Fernandez-Banares F, Mingorance MD, Esteve M, Cabre E, Lachica M, Abad-Lacruz A, Gil A, Humbert P, Boix J, Gassull MA. Serum zinc, copper, and selenium levels in inflammatory bowel disease: effect of total enteral nutrition on trace element status. Am. J. Gastroenterol. 85: 1584-1589 (1990).
Fernandez-Calle P, Codoceo R, Polanco I, Gomez-Cerezo J, Orsi M, Tenias JM. Is an intestinal permeability test a valid marker for slight dietary transgressions in adolescents with coeliac disease? Gut 34: 774-777 (1993). *
Fernandez-Real JM, Broch M, Vendrell J, Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 26: 1362-1368 (2003). *
Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clin. Chem. 51: 1201-1205 (2005). *
Fernandez-Real JM, Moreno JM, Ricart W. Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload. Diabetes 57: 1918-1925 (2008). *
Fernandez-Rodriguez E, Camarero-Gonzalez E. Patient with Crohn's disease and seizures due to hypomagnesemia. Nutr. Hosp. 22: 720-722 (2007).
Ferrante E, Giavoli C, Elli L, Redaelli A, Novati E, De Bellis A, Ronchi CL, Bergamaschi S, Lania A, Bardella MT, Bellastella G, Beck-Peccoz P. Evaluation of GH-IGF-I axis in adult patients with coeliac disease. Horm. Metab. Res. 42: 45-49 (2010).
Ferrante M, Penninckx F, De Hertogh G, Geboes K, D'Hoore A, Noman M, Vermeire S, Rutgeerts P, Van Assche G. Protein-losing enteropathy in Crohn's disease. Acta Gastroenterol. Belg. 69: 384-389 (2006).
Ferrante P, Masci S, D'Ovidio R, Lafiandra D, Volpi C, Mattei B. A proteomic approach to verify in vivo expression of a novel gamma-gliadin containing an extra cysteine residue. Proteomics 6: 1908-1914 (2006). *
Ferrara CT, Wang P, Neto EC, Stevens RD, Bain JR, Wenner BR, Ilkayeva OR, Keller MP, Blasiole DA, Kendziorski C, Yandell BS, Newgard CB, Attie AD. Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet. 4: e1000034 (2008). *
Ferrara F, Quaglia S, Caputo I, Esposito C, Lepretti M, Pastore S, Giorgi R, Martelossi S, Dal Molin G, Di Toro N, Ventura A, Not T. Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. Clin. Exp. Immunol. 159: 217-223 (2010). *
Ferrara P, Cicala M, Tiberi E, Spadaccio C, Marcella L, Gatto A, Calzolari P, Castellucci G. High fat consumption in children with celiac disease. Acta Gastroenterol. Belg. 72: 296-300 (2009).
Ferrarese F, Cecere V, Fabiano G. Extensive small bowel resections. Chir. Ital. 57: 631-634 (2005).
Ferrari S, Bonjour JP, Rizzoli R. The vitamin D receptor gene and calcium metabolism. Trends Endocrinol. Metab. 9: 259-265 (1998). *
Ferraz AC, Kiss A, Araujo RL, Salles HM, Naliwaiko K, Pamplona J, Matheussi F. The antidepressant role of dietary long-chain polyunsaturated n-3 fatty acids in two phases in the developing brain. Prostaglandins Leukot. Essent. Fatty Acids 78: 183-188 (2008). *
Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 53 Suppl. 1: S43-S50 (2004). *
Ferreira AC, Almeida S, Tavares M, Canedo P, Pereira F, Regalo G, Figueiredo C, Trindade E, Seruca R, Carneiro F, Amil J, Machado JC, Tavarela-Veloso F. NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease. Inflamm. Bowel Dis. 11: 331-339 (2005). *
Ferrier L, Mazelin L, Cenac N, Desreumaux P, Janin A, Emilie D, Colombel JF, Garcia-Villar R, Fioramonti J, Bueno L. Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology 125: 795-804 (2003). *
Ferroni P, Palmirotta R, Martini F, Riondino S, Savonarola A, Spila A, Ciatti F, Sini V, Mariotti S, Del Monte G, Roselli M, Guadagni F. Determinants of homocysteine levels in colorectal and breast cancer patients. Anticancer Res. 29: 4131-4138 (2009).
Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab. 91: 439-446 (2006). *
Ferrucci L, Perry JR, Matteini A, Perola M, Tanaka T, Silander K, Rice N, Melzer D, Murray A, Cluett C, Fried LP, Albanes D, Corsi AM, Cherubini A, Guralnik J, Bandinelli S, Singleton A, Virtamo J, Walston J, Semba RD, Frayling TM. Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am. J. Hum. Genet. 84: 123-133 (2009). *
Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol. Biomarkers Prev. 13: 1502-1508 (2004). *
Festen EA, Szperl AM, Weersma RK, Wijmenga C, Wapenaar MC. Inflammatory bowel disease and celiac disease: overlaps in the pathology and genetics, and their potential drug targets. Endocr. Metab. Immune Disord. Drug Targets 9: 199-218 (2009).
Fetissov SO, Hamze Sinno M, Coeffier M, Bole-Feysot C, Ducrotte P, Hokfelt T, Dechelotte P. Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 24: 348-359 (2008). *
Feuer G, Di Fonzo CJ. Intrahepatic cholestasis: a review of biochemical-pathological mechanisms. Drug Metabol. Drug Interact. 10: 1-161 (1992).
Fewtrell MS, Benden C, Williams JE, Chomtho S, Ginty F, Nigdikar SV, Jaffe A. Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis. J. Cyst. Fibros. 7: 307-312 (2008).
Fiaccadori E, Cremaschi E. Nutritional assessment and support in acute kidney injury. Curr. Opin. Crit. Care 15: 474-480 (2009).
Fiaccavento R, Carotenuto F, Minieri M, Masuelli L, Vecchini A, Bei R, Modesti A, Binaglia L, Fusco A, Bertoli A, Forte G, Carosella L, Di Nardo P. alpha-Linolenic acid-enriched diet prevents myocardial damage and expands longevity in cardiomyopathic hamsters. Am. J. Pathol. 169: 1913-1924 (2006). *
Fiala M. Re-balancing of inflammation and immunity as a therapeutic for Alzheimer's disease - view from the bedside. CNS Neurol. Disord. Drug Targets Oct 7 [Epub ahead of print] (2009).
Fickert P, Fuchsbichler A, Marschall HU, Wagner M, Zollner G, Krause R, Zatloukal K, Jaeschke H, Denk H, Trauner M. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. Am. J. Pathol. 168: 410-422 (2006). *
Fickert P, Fuchsbichler A, Wagner M, Silbert D, Zatloukal K, Denk H, Trauner M. The role of the hepatocyte cytokeratin network in bile formation and resistance to bile acid challenge and cholestasis in mice. Hepatology 50: 893-899 (2009).
Fickert P, Moustafa T, Fuchsbichler A, Claudel T, Halilbasic E, Kratky D, Zatloukal K, Denk H, Trauner M. Differential effects of ursodeoxycholic acid (UDCA) and sidechain-shortened norUDCA in the treatment of fatty liver and atherosclerosis. Falk Symposium 165: XX International Bile Acid Meeting. Bile Acid Biology and Therapeutic Actions. June 13-14, 2008, Amsterdam, Netherlands, p. 54 (2008). *
Fickert P, Stoger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, Tsybrovskyy O, Jaeschke H, Zatloukal K, Denk H, Trauner M. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am. J. Pathol. 171: 525-536 (2007). *
Fickert P, Trauner M, Fuchsbichler A, Stumptner C, Zatloukal K, Denk H. Bile acid-induced Mallory body formation in drug-primed mouse liver. Am. J. Pathol. 161: 2019-2026 (2002). *
Fickert P, Trauner M, Fuchsbichler A, Stumptner C, Zatloukal K, Denk H. Cytokeratins as targets for bile acid-induced toxicity. Am. J. Pathol. 160: 491-499 (2002). *
Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovskyy O, Zatloukal K, Liu J, Waalkes MP, Cover C, Denk H, Hofmann AF, Jaeschke H, Trauner M. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 130: 465-481 (2006). *
Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, Tsybrovskyy O, Zatloukal K, Denk H, Trauner M. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 123: 1238-1251 (2002). *
Field CJ, Clandinin MT, Van Aerde JE. Polyunsaturated fatty acids and T-cell function: implications for the neonate. Lipids 36: 1025-1032 (2001).
Field CJ, Johnson IR, Schley PD. Nutrients and their role in host resistance to infection. J. Leukoc. Biol. 71: 16-32 (2002). *
Field CJ, Schley PD. Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids. Am. J. Clin. Nutr. 79: 1190S-1198S (2004). *
Field CJ, Van Aerde JE, Robinson LE, Thomas Clandinin M. Effect of providing a formula supplemented with long-chain polyunsaturated fatty acids on immunity in full-term neonates. Br. J. Nutr. 99: 91-99 (2008). *
Fierce Y, de Morais Vieira M, Piantedosi R, Wyss A, Blaner WS, Paik J. In vitro and in vivo characterization of retinoid synthesis from beta-carotene. Arch. Biochem. Biophys. 472: 126-138 (2008). *
Fievet C, Fruchart JC, Staels B. Genetically-engineered animals as research models for atherosclerosis : their use for the characterization of PPAR agonists in the treatment of cardiometabolic disorders. Front. Biosci. 12: 4132-4156 (2007).
Figge A, Lammert F, Paigen B, Henkel A, Matern S, Korstanje R, Shneider BL, Chen F, Stoltenberg E, Spatz K, Hoda F, Cohen DE, Green RM. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis. J. Biol. Chem. 279: 2790-2799 (2004). *
Figler M, Gasztonyi B, Cseh J, Horvath G, Kisbenedek AG, Bokor S, Decsi T. Association of n-3 and n-6 long-chain polyunsaturated fatty acids in plasma lipid classes with inflammatory bowel diseases. Br. J. Nutr. 97: 1154-1161 (2007). *
Figueiredo JC, Levine AJ, Lee WH, Conti DV, Poynter JN, Campbell PT, Duggan D, Lewinger JP, Martinez ME, Ulrich CM, Newcomb P, Potter J, Limburg PJ, Hopper J, Jenkins MA, Le Marchand L, Baron JA, Haile RW. Genes involved with folate uptake and distribution and their association with colorectal cancer risk. Cancer Causes Control Dec 27 [Epub ahead of print] (2009). *
Fila L, Sedlak V, Binkova I, Jakubec P, Bittenglova R, Musil J. Twenty years of care for cystic fibrosis adults in Czech Republic. Vnitr. Lek. 55: 542-548 (2009).
Filippi J, Al-Jaouni R, Wiroth JB, Hebuterne X, Schneider SM. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm. Bowel Dis. 12: 185-191 (2006). *
Fimmel CJ, Wright L. Golgi protein 73 as a biomarker of hepatocellular cancer: development of a quantitative serum assay and expression studies in hepatic and extrahepatic malignancies. Hepatology 49: 1421-1423 (2009).
Finamore A, Massimi M, Conti Devirgiliis L, Mengheri E. Zinc deficiency induces membrane barrier damage and increases neutrophil transmigration in Caco-2 cells. J. Nutr. 138: 1664-1670 (2008). *
Finck BN. The PPAR regulatory system in cardiac physiology and disease. Cardiovasc. Res. 73: 269-277 (2007). *
Finck BN. Effects of PPARalpha on cardiac glucose metabolism: a transcriptional equivalent of the glucose-fatty acid cycle? Expert Rev. Cardiovasc. Ther. 4: 161-171 (2006).
Finck BN, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation 115: 2540-2548 (2007). *
Finco C, Magnanini P, Sarzo G, Vecchiato M, Luongo B, Savastano S, Bortoliero M, Barison P, Merigliano S. Prospective randomized study on perioperative enteral immunonutrition in laparoscopic colorectal surgery. Surg. Endosc. 21: 1175-1179 (2007). *
Fine KD, Do K, Schulte K, Ogunji F, Guerra R, Osowski L, McCormack J. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am. J. Gastroenterol. 95: 1974-1982 (2000). *
Fink LN, Frikiaer H. Dendritic cells from Peyer's patches and mesenteric lymph nodes differ from spleen dendritic cells in their response to commensal gut bacteria. Scand. J. Immunol. 68: 270-279 (2008). *
Finkel Y, Bjarnason I, Lindblad A, Lange S. Specially processed cereals: a clinical innovation for children suffering from inflammatory bowel disease? Scand. J. Gastroenterol. 39: 87-88 (2004). *
Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J. Biol. Chem. 259: 9508-9513 (1984). *
Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Adaptation to methionine excess. J. Biol. Chem. 261: 1582-1587 (1986). *
Finn RD, Henderson CJ, Scott CL, Wolf CR. Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway. Biochem. J. 417: 43-54 (2009). *
Fiocchi C. The multifactorial pathogenesis of IBD. Falk Symposium 154: INFLAMMATORY BOWEL DISEASE - DIAGNOSTIC AND THERAPEUTIC STRATEGIES, Moscow (Russia), June 9 - 10, 2006, pp. 21-22 (2006). *
Fiocchi C. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy. Minerva Gastroenterol. Dietol. 48: 215-226 (2002).
Fiocchi C. Inflammatory bowel disease pathogenesis: therapeutic implications. Chin. J. Dig. Dis. 6: 6-9 (2005).
Fioramonti J, Theodorou V, Bueno L. Probiotics: what are they? What are their effects on gut physiology? Best Pract. Res. Clin. Gastroenterol. 17: 711-724 (2003).
Fiore CE, Pennisi P, Ferro G, Ximenes B, Privitelli L, Mangiafico RA, Santoro F, Parisi N, Lombardo T. Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet. Horm. Metab. Res. 38: 417-422 (2006).
Fiorentino L, Vivanti A, Cavalera M, Marzano V, Ronci M, Fabrizi M, Menini S, Pugliese G, Menghini R, Khokha R, Lauro R, Urbani A, Federici M. Increased tumor necrosis factor alpha-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatology 51: 103-110 (2010).
Fireman Z, Zachlka R, Abu Mouch S, Kopelman Y. The role of endoscopy in the evaluation of iron deficiency anemia in premenopausal women. Isr. Med. Assoc. J. 8: 88-90 (2006). *
Fischer Aggarwal BA, Liao M, Mosca L. Physical activity as a potential mechanism through which social support may reduce cardiovascular disease risk. J. Cardiovasc. Nurs. 23: 90-96 (2008).
Fischer F, Bruch HP, Roblick U, Schwandner O, Schiedeck T. Early results of laparoscopic surgical procedures in Crohn's disease. Zentralbl. Chir. 129: 200-204 (2004).
Fischer HB, Illek B, Finkbeiner WE, Widdicombe JH. Basolateral Cl channels in primary airway epithelial cultures. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1432-L1443 (2007). *
Fischer MA, Black HS. Modification of membrane composition, eicosanoid metabolism, and immunoresponsiveness by dietary omega-3 and omega-6 fatty acid sources, modulators of ultraviolet-carcinogenesis. Photochem. Photobiol. 54: 381-387 (1991). *
Fischer R, Debbabi H, Dubarry M, Boyaka P, Tome D. Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochem. Cell. Biol. 84: 303-311 (2006). *
Fischer R, Dechend R, Qadri F, Markovic M, Feldt S, Herse F, Park JK, Gapelyuk A, Schwarz I, Zacharzowsky UB, Plehm R, Safak E, Heuser A, Schirdewan A, Luft FC, Schunck WH, Muller DN. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension. Hypertension 51: 540-546 (2008).
Fischer-Rosinsky A, Fisher E, Kovacs P, Bluher M, Mohlig M, Pfeiffer AF, Boeing H, Spranger J. Lack of association between the tagging SNP A+930-->G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations. PLoS ONE 3: e3852 (2008). *
Fischman D, Nookala VK. Cystic fibrosis-related diabetes mellitus: etiology, evaluation, and management. Endocr. Pract. 14: 1169-1179 (2008).
Fish D, Kugathasan S. Inflammatory bowel disease. Adolesc. Med. Clin. 15: 67-90 (2004).
Fishbein TM, Matsumoto CS. Intestinal replacement therapy: timing and indications for referral of patients to an intestinal rehabilitation and transplant program. Gastroenterology 130: S147-S151 (2006). *
Fisher CD, Jackson JP, Lickteig AJ, Augustine LM, Cherrington NJ. Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis. Arch. Toxicol. 82: 959-964 (2008). *
Fisher E, Li Y, Burwinkel B, Kuhr V, Hoffmann K, Mohlig M, Spranger J, Pfeiffer A, Boeing H, Schrezenmeir J, Doring F. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Horm. Metab. Res. 38: 341-345 (2006).
Fisher E, Schulze MB, Stefan N, Haring HU, Doring F, Joost HG, Al-Hasani H, Boeing H, Pischon T. Association of the FTO rs9939609 single nucleotide polymorphism with C-reactive protein levels. Obesity (Silver Spring) 17: 330-334 (2009). *
Fishman DS, Sailhamer EA, Cohen DT, Mino-Kenudson M, Doody DP, Winter HS. Intussusception of the appendix causing small bowel obstruction in a patient with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 50: 1 (2010).
Fitten LJ, Ortiz F, Fairbanks L, Rosenthal M, Cole GN, Nourhashemi F, Sanchez MA. Depression, diabetes and metabolic-nutritional factors in elderly hispanics. J. Nutr. Health Aging 12: 634-640 (2008).
Fitzgerald ML, Moore KJ, Freeman MW. Nuclear hormone receptors and cholesterol trafficking: the orphans find a new home. J. Mol. Med. 80: 271-281 (2002). *
Fitzgibbons SC, Jones BA, Hull MA, Zurakowski D, Duro D, Duggan C, Boctor D, Sigalet DL, Jaksic T. Relationship between biopsy-proven parenteral nutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndrome. J. Pediatr. Surg. 45: 95-99 (2010).
Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin. Proc. 77: 453-468 (2002). *
Fiume L, Bolondi L, Busi C, Chieco P, Kratz F, Lanza M, Mattioli A, Di Stefano G. Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. J. Hepatol. 43: 645-652 (2005). *
Fjerbaek A, Knudsen UB. Endometriosis, dysmenorrhea and diet - what is the evidence? Eur. J. Obstet. Gynecol. Reprod. Biol. 132: 140-147 (2007).
Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, Franssen-van Hal N, Ruzickova J, Sponarova J, Drahota Z, Vlcek C, Keijer J, Houstek J, Kopecky J. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 48: 2365-2375 (2005). *
Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, Ruzickova J, Kopecky J. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 49: 394-397 (2006). *
Fleet JC. Molecular regulation of calcium and bone metabolism through the vitamin D receptor. J. Musculoskelet. Neuronal Interact. 6: 336-337 (2006).
Fleet JC. Molecular actions of vitamin D contributing to cancer prevention. Mol. Aspects Med. 29: 388-396 (2008).
Fleith M, Clandinin MT. Dietary PUFA for preterm and term infants: review of clinical studies. Crit. Rev. Food Sci. Nutr. 45: 205-229 (2005). *
Fleming RE. Advances in understanding the molecular basis for the regulation of dietary iron absorption. Curr. Opin. Gastroenterol. 21: 201-206 (2005).
Fleming RE, Sly WS. Mechanisms of iron accumulation in hereditary hemochromatosis. Annu. Rev. Physiol. 64: 663-680 (2002). *
Fleshman JW. Pyogenic complications of Crohn's disease, evaluation, and management. J. Gastrointest. Surg. 12: 2160-2163 (2008). *
Fletcher PC, Jamieson AE, Schneider MA, Harry RJ. "I know this is bad for me, but...": a qualitative investigation of women with irritable bowel syndrome and inflammatory bowel disease: part II. Clin. Nurse Spec. 22: 184-191 (2008).
Floch MH. A hypothesis: is diverticulitis a type of inflammatory bowel disease? J. Clin. Gastroenterol. 40 Suppl. 3: S121-S125 (2006).
Flohe S, Flohe SB, Schade FU, Waydhas C. Immune response of severely injured patients - influence of surgical intervention and therapeutic impact. Langenbecks Arch. Surg. 392: 639-648 (2007). *
Flood KL, Carr DB. Nutrition in the elderly. Curr. Opin. Gastroenterol. 20: 125-129 (2004).
Flood VM, Webb KL, Rochtchina E, Kelly B, Mitchell P. Fatty acid intakes and food sources in a population of older Australians. Asia Pac. J. Clin. Nutr. 16: 322-330 (2007).
Floreani A, Baragiotta A, Martines D, Naccarato R, D'odorico A. Plasma antioxidant levels in chronic cholestatic liver diseases. Aliment. Pharmacol. Ther. 14: 353-358 (2000). *
Flores YN, Yee HF Jr, Leng M, Escarce JJ, Bastani R, Salmeron J, Morales LS. Risk factors for chronic liver disease in blacks, Mexican Americans, and whites in the United States: results from NHANES IV, 1999-2004. Am. J. Gastroenterol. 103: 2231-2238 (2008). *
Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, Hamman RF, Knowler WC, Nathan DM, Altshuler D. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J. Clin. Endocrinol. Metab. 92: 1502-1509 (2007). *
Flower RJ, Perretti M. Controlling inflammation: a fat chance? J. Exp. Med. 201: 671-674 (2005). *
Flowers MT, Groen AK, Oler AT, Keller MP, Choi Y, Schueler KL, Richhards OC, Lan H, Miyazaki M, Kuipers F, Kendziorski CM, Ntambi JM, Attie AD. Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet. J. Lipid Res. 47: 2668-2680 (2006). *
Flowers MT, Keller MP, Choi Y, Lan H, Kendziorski CM, Ntambi JM, Attie AD. Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet. Physiol. Genomics 33: 361-372 (2008). *
Fluge G, Olesen HV, Gilljam M, Meyer P, Pressler T, Storrosten OT, Karpati F, Hjelte L. Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients. J. Cyst. Fibros. 8: 198-202 (2009).
Flume PA, Ciolino J, Gray S, Lester MK. Patient-reported pain and impaired sleep quality in adult patients with cystic fibrosis. J. Cyst. Fibros. 8: 321-325 (2009).
Flynn A, Hirvonen T, Mensink GB, Ocke MC, Serra-Majem L, Stos K, Szponar L, Tetens I, Turrini A, Fletcher R, Wildemann T. Intake of selected nutrients from foods, from fortification and from supplements in various European countries. Food Nutr. Res.Dec 14 [Epub ahead of print] (2009). *
Foitzik T, Eibl G, Schneider P, Wenger FA, Jacobi CA, Buhr HJ. Omega-3 fatty acid supplementation increases anti-inflammatory cytokines and attenuates systemic disease sequelae in experimental pancreatitis. JPEN J. Parenter. Enteral Nutr. 26: 351-356 (2002). *
Foltz M, Mertl M, Dietz V, Boll M, Kottra G, Daniel H. Kinetics of bidirectional H+ and substrate transport by the proton-dependent amino acid symporter PAT1. Biochem. J. 386: 607-616 (2005). *
Fondacaro JD, Heubi JE, Kellogg FW. Intestinal bile acid malabsorption in cystic fibrosis: a primary mucosal cell defect. Pediatr. Res. 16: 494-498 (1982).
Fong DG, Nehra V, Lindor KD, Buchman AL. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 32: 3-10 (2000). *
Fong TL, Klontz KC, Canas-Coto A, Casper SJ, Durazo FA, Davern TJ 2nd, Hayashi P, Lee WM, Seeff LB. Hepatotoxicity due to hydroxycut: a case series. Am. J. Gastroenterol. Jan 26 [Epub ahead of print] (2010). *
Fonolla J, Lopez-Huertas E, Machado FJ, Molina D, Alvarez I, Marmol E, Navas M, Palac�n E, Garcia-Valls MJ, Remon B, Boza JJ, Marti JL. Milk enriched with "healthy fatty acids" improves cardiovascular risk markers and nutritional status in human volunteers. Nutrition 25: 408-414 (2009). *
Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. Adipose tissue as an endocrine organ: from theory to practice. J. Pediatr. (Rio J.) 83: S192-S203 (2007).
Fontaine-Bisson B, El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and plasma high-density lipoprotein-cholesterol concentrations in a population of young adults. J. Nutrigenet. Nutrigenomics 1: 215-223 (2008).
Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, Connelly PW, Corey PN, El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am. J. Clin. Nutr. 86: 768-774 (2007). *
Fontaine-Bisson B, Wolever TM, Connelly PW, Corey PN, El-Sohemy A. NF-kappaB -49Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations. Atherosclerosis 204: 465-470 (2009).
Fontana L. The scientific basis of caloric restriction leading to longer life. Curr. Opin. Gastroenterol. 25: 144-150 (2009).
Fontana L. Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction. Exp. Gerontol. 44: 41-45 (2009).
Fonzo LS, Golini RS, Delgado SM, Ponce IT, Bonomi MR, Rezza IG, Gimenez MS, Anzulovich AC. Temporal patterns of lipoperoxidation and antioxidant enzymes are modified in the hippocampus of vitamin A-deficient rats. Hippocampus 19: 869-880 (2009).
Fooks LJ, Gibson GR. Probiotics as modulators of the gut flora. Br. J. Nutr. 88 Suppl. 1: S39-S49 (2002). *
Forbes A. Parenteral nutrition. Curr. Opin. Gastroenterol. 22: 160-164 (2006).
Forbes A. Review article: Crohn's disease - the role of nutritional therapy. Aliment. Pharmacol. Ther. 16 Suppl. 4: 48-52 (2002). *
Forbes A. Is there a role for multidrug therapy in active Crohn's disease? Inflamm. Bowel Dis. 14 Suppl. 2: S257-S258 (2008). *
Forbes A. Iron and parenteral nutrition. Gastroenterology 137: S47-S54 (2009). *
Forbes A. Parenteral nutrition: new advances and observations. Curr. Opin. Gastroenterol. 20: 114-118 (2004).
Forbes A. Parenteral nutrition. Curr. Opin. Gastroenterol. 21: 192-196 (2005).
Forchielli ML, Bersani G, Tala S, Grossi G, Puggioli C, Masi M. The spectrum of plant and animal sterols in different oil-derived intravenous emulsions. Lipids 45: 63-71 (2010).
Forchielli ML, Richardson D, Folkman J, Gura K, Lo CW. Better living through chemistry, constant monitoring, and prompt interventions: 26 years on home parenteral nutrition without major complications. Nutrition 24: 103-107 (2008). *
Forchielli ML, Walker WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Adv. Pediatr. 50: 245-267 (2003).
Forchielli ML, Walker WA. The role of gut-associated lymphoid tissues and mucosal defence. Br. J. Nutr. 93 Suppl. 1: S41-S48 (2005). *
Ford AC. Management of irritable bowel sindrome. Minerva Gastroenterol. Dietol. 55: 273-287 (2009).
Ford RP. The gluten syndrome: a neurological disease. Med. Hypotheses 73: 438-440 (2009).
Ford TJ, Dillon JF. Minocycline hepatitis. Eur. J. Gastroenterol. Hepatol. 20: 796-799 (2008).
Forges T, Pellanda H, Diligent C, Monnier P, Gueant JL. Do folates have an impact on fertility? Gynecol. Obstet. Fertil. 36: 930-939 (2008).
Forget S, Senesse P, Burlet G, Lacroix N, Boulot P. Total parenteral nutrition for recurrent episodes of acute pancreatitis during pregnancy. A case report and literature review. J. Gynecol. Obstet. Biol. Reprod. (Paris) 36: 817-820 (2007).
Forlani G, Di Bonito P, Mannucci E, Capaldo B, Genovese S, Orrasch M, Scaldaferri L, Di Bartolo P, Melandri P, Dei Cas A, Zavaroni I, Marchesini G. Prevalence of elevated liver enzymes in type 2 diabetes mellitus and its association with the metabolic syndrome. J. Endocrinol. Invest. 31: 146-152 (2008).
Forman D, Bulwer BE. Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle. Curr. Treat. Options Cardiovasc. Med. 8: 47-57 (2006).
Forman JP, Fisher ND, Pollak MR, Cox DG, Tonna S, Curhan GC. Renin-angiotensin system polymorphisms and risk of hypertension: influence of environmental factors. J. Clin. Hypertens. (Greenwich) 10: 459-466 (2008).
Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49: 1063-1069 (2007).
Forman MR, Hursting SD, Umar A, Barrett JC. Nutrition and cancer prevention: a multidisciplinary perspective on human trials. Annu. Rev. Nutr. 24: 223-254 (2004). *
Forones NM, de Lima JM, de Souza LG, da Silva ID. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients. J. Gastrointest. Cancer 39: 118-123 (2008).
Forrest EH, Oien KA, Dickson S, Galloway D, Mills PR. Improvement in cholestasis associated with total parenteral nutrition after treatment with an antibody against tumour necrosis factor alpha. Liver 22: 317-320 (2002).
Forsberg G, Hernell O, Hammarstrom S, Hammarstrom ML. Concomitant increase of IL-10 and pro-inflammatory cytokines in intraepithelial lymphocyte subsets in celiac disease. Int. Immunol. 19: 993-1001 (2007). *
Forsmark CE, Baillie J; AGA Institute Clinical Practice and Economics Committee; AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology 132: 2022-2044 (2007). *
Forstner JF. Intestinal mucins in health and disease. Digestion 17: 234-263 (1978).
Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43: 163-172 (2009).
Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, Kraemer WJ, Feinman RD, Volek JS. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 43: 65-77 (2008).
Forsythe LK, Wallace JM, Livingstone MB. Obesity and inflammation: the effects of weight loss. Nutr. Res. Rev. 21: 117-133 (2008).
Forte A, De Sanctis R, Leonetti G, Manfredelli S, Urbano V, Bezzi M. Dietary chemoprevention of colorectal cancer. Ann. Ital. Chir. 79: 261-267 (2008).
Fortes C, Forastiere F, Agabiti N, Fano V, Pacifici R, Virgili F, Piras G, Guidi L, Bartoloni C, Tricerri A, Zuccaro P, Ebrahim S, Perucci CA. The effect of zinc and vitamin A supplementation on immune response in an older population. J. Am. Geriatr. Soc. 46: 19-26 (1998).
Fortin G, Yurchenko K, Collette C, Rubio M, Villani AC, Bitton A, Sarfati M, Franchimont D. L-Carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation. Clin. Exp. Immunol. 156: 161-171 (2009). *
Fortunato F, Burgers H, Bergmann F, Rieger P, Buchler MW, Kroemer G, Werner J. Impaired autolysosome formation correlates with Lamp-2 depletion: role of apoptosis, autophagy and necrosis in pancreatitis. Gastroenterology 137: 350-360.e1-e5 (2009). *
Fortunato JE, Darbari A, Mitchell SE, Thompson RE, Cuffari C. The limitations of gastro-jejunal (G-J) feeding tubes in children: a 9-year pediatric hospital database analysis. Am. J. Gastroenterol. 100: 186-189 (2005). *
Fosgerau K, Hansen T, Galle P, Albrechtsen A, Rieper C, Pedersen B, Larsen L, Thomsen A, Pedersen O, Hansen M, Steensberg A. Interleukin-6 autoantibodies are involved in the pathogenesis of a subset of type 2 diabetes. J. Endocrinol. Dec 16 [Epub ahead of print] (2009). *
Foucaud P, de Truchis A, Tassin E, Allouch P, Pangon B. Pseudomonas aeruginosa and cystic fibrosis: non-antibiotic strategy. Arch. Pediatr. 13 Suppl. 1: S44-S47 (2006).
Fourcade S, Ruiz M, Camps C, Schluter A, Houten S, Mooyer P, Pampols T, Dacremont G, Wanders R, Giros M, Pujol A. A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am. J. Physiol. Endocrinol. Metab. 296: E211-E221 (2009). *
Fourgeux C, Martine L, Bjorkhem I, Diczfalusy U, Joffre C, Acar N, Creuzot-Garcher C, Bron A, Bretillon L. Primary open angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. Invest. Ophthalmol. Vis. Sci. 50: 5712-5717 (2009). *
Fowell AJ, Thomas PW, Surgenor SL, Snook JA. The epidemiology of coeliac disease in East Dorset 1993-2002: an assessment of the 'coeliac iceberg', and preliminary evidence of case clustering. QJM 99: 453-460 (2006). *
Fowkes L, Krishna K, Menon A, Greenslade GL, Dixon AR. Laparoscopic emergency and elective surgery for ulcerative colitis. Colorectal Dis. 10: 373-378 (2008). *
Fowler KH, Chapkin RS, McMurray DN. Effects of purified dietary n-3 ethyl esters on murine T lymphocyte function. J. Immunol. 151: 5186-5197 (1993).
Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, Ericson RL, Lau CN, Correa P, Araya JC, Roa I. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114: 755-763 (1998). *
Fox VL, Cohen MB, Whitington PF, Colletti RB. Outpatient liver biopsy in children: a medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 23: 213-216 (1996). *
Fradet V, Cheng I, Casey G, Witte JS. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin. Cancer Res. 15: 2559-2566 (2009). *
Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu. Rev. Nutr. 24: 277-298 (2004). *
France MW, Tai S, Masel PJ, Moore VL, McMahon TL, Ritchie AJ, Bell SC. The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis. BMC Pulm. Med. 10: 8 (2010).
Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 65: 261-311 (2003). *
Franco J, Saeian K. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Curr. Gastroenterol. Rep. 1: 95-101 (1999).
Franke C, Verwied-Jorky S, Campoy C, Trak-Fellermeier M, Decsi T, Dolz V, Koletzko B. Dietary intake of natural sources of docosahexaenoic acid and folate in pregnant women of three European cohorts. Ann. Nutr. Metab. 53: 167-174 (2008).
Frankenberg T, Miloh T, Chen FY, Ananthanarayanan M, Sun AQ, Balasubramaniyan N, Arias I, Setchell KD, Suchy FJ, Shneider BL. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor. Hepatology 48: 1896-1905 (2008). *
Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D, Knowler WC, Florez JC; Diabetes Prevention Program Research Group. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 50: 2451-2460 (2007). *
Franze A, Galeazzi R, Marcucci F, Biraghi M. Topical treatment of ulcerative colitis. Double-bling study between beclomethasone dipropionate and mesalazine. Minerva Gastroenterol. Dietol. 45: 287-296 (1999).
Franzese A, Valerio G, Buono P, Spagnuolo MI, Sepe A, Mozzillo E, De Simone I, Raia V. Continuous glucose monitoring system in the screening of early glucose derangements in children and adolescents with cystic fibrosis. J. Pediatr. Endocrinol. Metab. 21: 109-116 (2008).
Franzini L, Ardigo D, Zavaroni I. Dietary antioxidants and glucose metabolism. Curr. Opin. Clin. Nutr. Metab. Care 11: 471-476 (2008).
Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology 133: 1814-1820 (2007). *
Fraser JS, Engel W, Ellis HJ, Moodie SJ, Pollock EL, Wieser H, Ciclitira PJ. Coeliac disease: in vivo toxicity of the putative immunodominant epitope. Gut 52: 1698-1702 (2003). *
Frasure-Smith N, Lesperance F, Julien P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol. Psychiatry 55: 891-896 (2004). *
Fratesi JA, Hogg RC, Young-Newton GS, Patterson AC, Charkhzarin P, Block Thomas K, Sharratt MT, Stark KD. Direct quantitation of omega-3 fatty acid intake of Canadian residents of a long-term care facility. Appl. Physiol. Nutr. Metab. 34: 1-9 (2009). *
Frazer DM, Wilkins SJ, Becker EM, Vulpe CD, McKie AT, Trinder D, Anderson GJ. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 123: 835-844 (2002). *
Fredenrich A, Grimaldi P. PPAR delta: an uncompletely known nuclear receptor. Diabetes Metab. 31: 23-27 (2005). *
Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R; HALT-C Trial Group. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 50: 1360-1369 (2009).
Freedman SD, Shea JC, Blanco PG, Alvarez JG. Fatty acids in cystic fibrosis. Curr. Opin. Pulm. Med. 6: 530-532 (2000).
Freeman C, Delegge MH. Small bowel endoscopic enteral access. Curr. Opin. Gastroenterol. 25: 155-159 (2009).
Freeman C, Ricevuto A, Delegge MH. Enteral nutrition in patients with dementia and stroke. Curr. Opin. Gastroenterol. Nov 10 [Epub ahead of print] (2009).
Freeman HJ. Hepatobiliary and pancreatic disorders in celiac disease. World J. Gastroenterol. 12: 1503-1508 (2006). *
Freeman HJ. Adult celiac disease followed by onset of systemic lupus erythematosus. J. Clin. Gastroenterol. 42: 252-255 (2008).
Freeman HJ. Pancreatic endocrine and exocrine changes in celiac disease. World J. Gastroenterol. 13: 6344-6346 (2007). *
Freeman HJ. Refractory celiac disease and sprue-like intestinal disease. World J. Gastroenterol. 14: 828-830 (2008). *
Freeman HJ. Pearls and pitfalls in the diagnosis of adult celiac disease. Can. J. Gastroenterol. 22: 273-280 (2008). *
Freeman HJ. Adult autoimmune enteropathy. World J. Gastroenterol. 14: 1156-1158 (2008). *
Freeman HJ. Neurological disorders in adult celiac disease. Can. J. Gastroenterol. 22: 909-911 (2008). *
Freeman HJ. Update on collagenous sprue. World J. Gastroenterol. 16: 296-298 (2010). *
Freeman HJ. Long-term clinical behavior of jejunoileal involvement in Crohn's disease. Can. J. Gastroenterol. 19: 575-578 (2005). *
Freeman HJ. Hepatobiliary tract and pancreatic disorders in celiac disease. Can. J. Gastroenterol. 11: 77-81 (1997). *
Freeman HJ, Freeman KJ. Prevalence rates and an evaluation of reported risk factors for osteonecrosis (avascular necrosis) in Crohn's disease. Can. J. Gastroenterol. 14: 138-143 (2000). *
Freeman HJ, Gillett HR, Gillett PM, Oger J. Adult celiac disease with acetylcholine receptor antibody positive myasthenia gravis. World J. Gastroenterol. 15: 4741-4744 (2009). *
Freeman HJ, Webber DL. Free perforation of the small intestine in collagenous sprue. World J. Gastroenterol. 15: 4446-4448 (2009). *
Freeman MP. Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research. Prostaglandins Leukot. Essent. Fatty Acids 75: 291-297 (2006). *
Freeman MP, Davis M, Sinha P, Wisner KL, Hibbeln JR, Gelenberg AJ. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J. Affect. Disord. 110: 142-148 (2008).
Freeman MP, Hibbeln JR, Wisner KL, Brumbach BH, Watchman M, Gelenberg AJ. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr. Scand. 113: 31-35 (2006). *
Freije A. Fatty acid profile of the erythrocyte membranes of healthy Bahraini citizens in comparison with coronary heart disease patients. J. Oleo. Sci. 58: 379-388 (2009).
Freitag T, Rietdijk S, Junker Y, Popov Y, Bhan AK, Kelly CP, Terhorst C, Schuppan D. Gliadin-primed CD4+CD45RBlowCD25- effector/memory T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice. Gut 58: 1597-1605 (2009).
Freitas AI, Mendonca I, Guerra G, Brion M, Reis RP, Carracedo A, Brehm A. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal). Thromb. Res. 122: 648-656 (2008). *
Freudenberg F, Carey MC. Hepatobiliary manifestations in inflammatory bowel disease. Falk Symposium 146: GUT-LIVER INTERACTIONS: BASIC AND CLINICAL CONCEPTS, Innsbruck (Austria), March 11-12, 2005, pp. 56-57 (2005). *
Freund-Levi Y, Basun H, Cederholm T, Faxen-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jonhagen M. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int. J. Geriatr. Psychiatry 23: 161-169 (2008).
Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. omega-3 Fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch. Neurol. 63: 1402-1408 (2006). *
Freund-Levi Y, Hjorth E, Lindberg C, Cederholm T, Faxen-Irving G, Vedin I, Palmblad J, Wahlund LO, Schultzberg M, Basun H, Eriksdotter Jonhagen M. Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: The OmegAD Study. Dement. Geriatr. Cogn. Disord. 27: 481-490 (2009).
Frey MR, Edelblum KL, Mullane MT, Liang D, Polk DB. The ErbB4 growth factor receptor is required for colon epithelial cell survival in the presence of TNF. Gastroenterology 136: 217-226 (2009). *
Frezza M, Terpin MM, Peri A. S-Adenosyl-L-methionine (SAMe) and its use in hepatology. Minerva Gastroenterol. Dietol. 38: 145-151 (1992).
Frias Perez MA, Ibarra de la Rosa I, Garcia Menor E, Santos Luna F, Ulloa Santamaria E, Velasco Jabalquinto MJ, Jaraba Caballero S. Invasive mechanical ventilation in cystic fibrosis: influence in lung transplant. An. Pediatr. (Barc.) 71: 128-134 (2009).
Friberg P, Johansson M. Effects of an omega-3-enriched Mediterranean diet (modified diet of Crete) versus a Swedish diet. World Rev. Nutr. Diet. 97: 52-66 (2007).
Fridell JA, Vianna R, Kwo PY, Howenstine M, Sannuti A, Molleston JP, Pescovitz MD, Tector AJ. Simultaneous liver and pancreas transplantation in patients with cystic fibrosis. Transplant. Proc. 37: 3567-3569 (2005). *
Fridell JA, Wozniak TC, Powelson JA, Reynolds JM. Simultaneous bilateral lung and pancreas transplantation in recipient with cystic fibrosis. Transplant. Proc. 40: 494-497 (2008). *
Friedland RP, Tedesco JM, Wilson AC, Atwood CS, Smith MA, Perry G, Zagorski MG. Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies. J. Biol. Chem. 283: 22550-22556 (2008). *
Friedman A, Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin. J. Am. Soc. Nephrol. 1: 182-192 (2006). *
Friedman AN, Moe SM, Perkins SM, Li Y, Watkins BA. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am. J. Kidney Dis. 47: 1064-1071 (2006).
Friedman JR, Kaestner KH. The Foxa family of transcription factors in development and metabolism. Cell. Mol. Life Sci. 63: 2317-2328 (2006). *
Friesecke S, Lotze C, Kohler J, Heinrich A, Felix SB, Abel P. Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med. 34: 1411-1420 (2008). *
Friesen RW, Innis SM. Dietary arachidonic acid to EPA and DHA balance is increased among Canadian pregnant women with low fish intake. J. Nutr. 139: 2344-2350 (2009).
Frijters CM, Ottenhoff R, Van Wijland MJ, Van Nieuwkerk C, Groen AK, Oude Elferink RP. Influence of bile salts on hepatic mdr2 P-glycoprotein expression. Adv. Enzyme Regul. 36: 351-363 (1996). *
Frisk G, Hansson T, Dahlbom I, Tuvemo T. A unifying hypothesis on the development of type 1 diabetes and celiac disease: gluten consumption may be a shared causative factor. Med. Hypotheses 70: 1207-1209 (2008).
Friso S, Choi SW. Gene-nutrient interactions in one-carbon metabolism. Curr. Drug Metab. 6: 37-46 (2005). *
Frisullo G, Nociti V, Iorio R, Patanella AK, Marti A, Bianco A, Plantone D, Cammarota G, Tonali PA, Batocchi AP. Increased CD4(+)CD25(+)Foxp3(+) T cells in peripheral blood of celiac disease patients: correlation with dietary treatment. Hum. Immunol. 70: 430-435 (2009).
Frisullo G, Nociti V, Iorio R, Patanella AK, Plantone D, Bianco A, Marti A, Cammarota G, Tonali PA, Batocchi AP. T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity. Clin. Exp. Immunol. 158: 106-114 (2009). *
Fritsche K. Fatty acids as modulators of the immune response. Annu. Rev. Nutr. 26: 45-73 (2006). *
Fritsche K. Important differences exist in the dose-response relationship between diet and immune cell fatty acids in humans and rodents. Lipids 42: 961-979 (2007).
Fritsche KL, Byrge M, Feng C. Dietary omega-3 polyunsaturated fatty acids from fish oil reduce interleukin-12 and interferon-gamma production in mice. Immunol. Lett. 65: 167-173 (1999).
Froh M, Zhong Z, Walbrun P, Lehnert M, Netter S, Wiest R, Conzelmann L, Gabele E, Hellerbrand C, Scholmerich J, Thurman RG. Dietary glycine blunts liver injury after bile duct ligation in rats. World J. Gastroenterol. 14: 5996-6003 (2008). *
Frohlich T, Richter M, Carbon R, Barth B, Kohler H. Review article: percutanous endoscopic gastrostomy in infants and children. Aliment. Pharmacol. Ther. Jan 22 [Epub ahead of print] (2010).
Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 8: 5 (2007). *
Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol. 17: 2386-2392 (2003). *
Frolich J, Dopfner M. The treatment of attention-deficit/hyperactivity disorders with polyunsaturated fatty acids - an effective treatment alternative? Z. Kinder. Jugendpsychiatr. Psychother. 36: 109-116 (2008).
Frontela C, Canali R, Virgili F. Use of dietary phenols to modulate inflammatory bowel response. Gastroenterol. Hepatol. Nov 17 [Epub ahead of print] (2009).
Froy O. The relationship between nutrition and circadian rhythms in mammals. Front. Neuroendocrinol. 28: 61-71 (2007).
Froy O, Chapnik N. Circadian oscillation of innate immunity components in mouse small intestine. Mol. Immunol. 44: 1964-1970 (2007). *
Froy O, Chapnik N, Miskin R. Long-lived alphaMUPA transgenic mice exhibit pronounced circadian rhythms. Am. J. Physiol. Endocrinol. Metab. 291: E1017-E1024 (2006). *
Froy O, Chapnik N, Miskin R. Relationship between calorie restriction and the biological clock: lessons from long-lived transgenic mice. Rejuvenation Res. 11: 467-471 (2008).
Froy O, Miskin R. The interrelations among feeding, circadian rhythms and ageing. Prog. Neurobiol. 82: 142-150 (2007).
Froy O, Sthoeger ZM. Defensins in systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 1173: 365-369 (2009). *
Fry L. Dermatitis herpetiformis. Baillieres Clin. Gastroenterol. 9: 371-393 (1995).
Fryer J, Pellar S, Ormond D, Koffron A, Abecassis M. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants. Liver Transpl. 9: 748-753 (2003). *
Fryer JP. Intestinal transplantation: an update. Curr. Opin. Gastroenterol. 21: 162-168 (2005).
Fu J, Oveisi F, Gaetani S, Lin E, Piomelli D. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 48: 1147-1153 (2005). *
Fu JF, Fang YL, Liang L, Wang CL, Hong F, Dong GP. A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin. World J. Gastroenterol. 15: 912-918 (2009). *
Fu JH, Xie SR, Kong SJ, Wang Y, Wei W, Shan Y, Luo YM. The combination of a high-fat diet and chronic stress aggravates insulin resistance in Wistar male rats. Exp. Clin. Endocrinol. Diabetes 117: 354-360 (2009).
Fu T, Kashireddy P, Borensztajn J. The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E. Biochem. J. 373: 941-947 (2003). *
Fu X, Wang XD, Mernitz H, Wallin R, Shea MK, Booth SL. 9-cis Retinoic acid reduces 1alpha,25-dihydroxycholecalciferol-induced renal calcification by altering vitamin K-dependent gamma-carboxylation of matrix gamma-carboxyglutamic acid protein in A/J male mice. J. Nutr. 138: 2337-2341 (2008). *
Fuchtenbusch M, Ziegler AG, Hummel M. Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev. Diabet. Stud. 1: 39-41 (2004). *
Fudge NJ, Kovacs CS. Pregnancy up-regulates intestinal calcium absorption and skeletal mineralization independently of the vitamin D receptor. Endocrinology Jan 5 [Epub ahead of print] (2010). *
Fueger PT, Schisler JS, Lu D, Babu DA, Mirmira RG, Newgard CB, Hohmeier HE. Trefoil factor 3 stimulates human and rodent pancreatic islet beta-cell replication with retention of function. Mol. Endocrinol. 22: 1251-1259 (2008). *
Fuentebella J, Bass D, Longacre T, Ro K. Abdominal pain, gastrointestinal bleeding, and weight loss in a 17-year-old male. Dig. Dis. Sci. 54: 722-724 (2009). *
Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosom. Med. 61: 712-728 (1999). *
Fuhr U, Jetter A, Kirchheiner J. Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach. Clin. Pharmacol. Ther. 81: 270-283 (2007). *
Fuhrman B, Volkova N, Aviram M. Postprandial serum triacylglycerols and oxidative stress in mice after consumption of fish oil, soy oil or olive oil: possible role for paraoxonase-1 (PON1) triacylglycerol lipase-like activity. Nutrition 22: 922-930 (2006). *
Fujii H. Anti-inflammatory action of PPARs. Nippon Rinsho 63: 609-615 (2005).
Fujii T, Shiba M, Takatera H. A case of ammonium urate urolithiasis with Crohn's disease. Hinyokika. Kiyo. 49: 615-617 (2003).
Fujiki K, Ishiguro H, Ko SB, Mizuno N, Suzuki Y, Takemura T, Yamamoto A, Yoshikawa T, Kitagawa M, Hayakawa T, Sakai Y, Takayama T, Saito M, Kondo T, Naruse S. Genetic evidence for CFTR dysfunction in Japanese: background for chronic pancreatitis. J. Med. Genet. 41: e55 (2004). *
Fujimori S, Gudis K, Mitsui K, Seo T, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 25: 520-525 (2009). *
Fujimoto S, Mochizuki K, Shimada M, Murayama Y, Goda T. Variation in gene expression of inflammatory cytokines in leukocyte-derived cells of high-fat-diet-induced insulin-resistant rats. Biosci. Biotechnol. Biochem. 72: 2572-2579 (2008). *
Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, Saito S, Inamori M, Nakajima N, Watanabe M, Kubota N, Yamauchi T, Kadowaki T, Wada K, Nakagama H, Nakajima A. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 57: 1531-1538 (2008). *
Fujise T, Iwakiri R, Kakimoto T, Shiraishi R, Sakata Y, Wu B, Tsunada S, Ootani A, Fujimoto K. Long term feeding of various fat diets modulates azoxymethane-induced colon carcinogenesis through Wnt/beta-catenin signaling in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1150-G1156 (2007). *
Fujiwara K, Davaadash B, Yatabe M, Kikuchi M, Horiguchi K, Kusumoto K, Kouki T, Yashiro T. Reduction of retinaldehyde dehydrogenase 1 expression and production in estrogen-induced prolactinoma of rat. Med. Mol. Morphol. 41: 126-131 (2008). *
Fujiwara Y, Yokoyama M, Sawada R, Seyama Y, Ishii M, Tsutsumi S, Aburatani H, Hanaka S, Itakura H, Matsumoto A. Analysis of the comprehensive effects of polyunsaturated fatty acid on mRNA expression using a gene chip. J. Nutr. Sci. Vitaminol. (Tokyo) 49: 125-132 (2003).
Fukada SI, Morita T, Sugiyama K. Effects of various amino acids on methionine-induced hyperhomocysteinemia in rats. Biosci. Biotechnol. Biochem. 72: 1940-1943 (2008). *
Fukasawa T, Murashima K, Matsumoto I, Hosono A, Ohara H, Nojiri C, Koga J, Kubota H, Kanegae M, Kaminogawa S, Abe K, Kono T. Identification of marker genes for intestinal immunomodulating effect of a fructooligosaccharide by DNA microarray analysis. J. Agric. Food Chem. 55: 3174-3179 (2007). *
Fukata M, Abreu MT. TLR4 signalling in the intestine in health and disease. Biochem. Soc. Trans. 35: 1473-1478 (2007). *
Fukatsu K, Moriya T, Ikezawa F, Maeshima Y, Omata J, Yaguchi Y, Okamoto K, Mochizuki H, Hiraide H, Hardy G. Interleukin-7 dose-dependently restores parenteral nutrition-induced gut-associated lymphoid tissue cell loss but does not improve intestinal immunoglobulin A levels. JPEN J. Parenter. Enteral Nutr. 30: 388-393 (2006). *
Fukuda M, Kanauchi O, Araki Y, Andoh A, Mitsuyama K, Takagi K, Toyonaga A, Sata M, Fujiyama Y, Fukuoka M, Matsumoto Y, Bamba T. Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. Int. J. Mol. Med. 9: 65-70 (2002).
Fukuda W, Yamazaki T, Akaogi T, Hayashi H, Kusakabe T, Tsubouchi Y, Kawahito Y, Inoue M, Yoshikawa T. Malnutrition and disease progression in patients with rheumatoid arthritis. Mod. Rheumatol. 15: 104-107 (2005).
Fukuda Y, Matsui T, Suzuki Y, Kanke K, Matsumoto T, Takazoe M, Matsumoto T, Motoya S, Honma T, Sawada K, Yao T, Shimoyama T, Hibi T. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study. J. Gastroenterol. 39: 1158-1164 (2004). *
Fukuda Y, Takazoe M, Sugita A, Kosaka T, Kinjo F, Otani Y, Fujii H, Koganei K, Makiyama K, Nakamura T, Suda T, Yamamoto S, Ashida T, Majima A, Morita N, Murakami K, Oshitani N, Takahama K, Tochihara M, Tsujikawa T, Watanabe M. Oral spherical adsorptive carbon for the treatment of intractable anal fistulas in Crohn's disease: a multicenter, randomized, double-blind, placebo-controlled trial. Am. J. Gastroenterol. 103: 1721-1729 (2008). *
Fukuda Y, Tao Y, Tomita T, Hori K, Fukunaga K, Noguchi T, Hayashi T, Shimoyama T, Tahahashi R. A traditional Japanese medicine mitigates TNBS-induced colitis in rats. Scand. J. Gastroenterol. 41: 1183-1189 (2006). *
Fukunaga K, Hossain Z, Takahashi K. Marine phosphatidylcholine suppresses 1,2-dimethylhydrazine-induced colon carcinogenesis in rats by inducing apoptosis. Nutr. Res. 28: 635-640 (2008). *
Fukushima A, Ohta A, Sakai K, Sakuma K. Expression of calbindin-D9k, VDR and Cdx-2 messenger RNA in the process by which fructooligosaccharides increase calcium absorption in rats. J. Nutr. Sci. Vitaminol. (Tokyo) 51: 426-432 (2005).
Fukushima J, Kamada Y, Matsumoto H, Yoshida Y, Ezaki H, Takemura T, Saji Y, Igura T, Tsutsui S, Kihara S, Funahashi T, Shimomura I, Tamura S, Kiso S, Hayashi N. Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization. Hepatol. Res. 39: 724-738 (2009). *
Fulford A, Scolapio JS, Aranda-Michel J. Parenteral nutrition-associated hepatotoxicity. Nutr. Clin. Pract. 19: 274-283 (2004). *
Funahashi H, Satake M, Hasan S, Sawai H, Newman RA, Reber HA, Hines OJ, Eibl G. Opposing effects of n-6 and n-3 polyunsaturated fatty acids on pancreatic cancer growth. Pancreas 36: 353-362 (2008).
Fundia AF, Cottliar AS, La Motta G, Crivelli A, Gomez JC, Slavutsky IR, Larripa IB. Analysis of genomic instability in adult-onset celiac disease patients by microsatellite instability and loss of heterozygosis. Eur. J. Gastroenterol. Hepatol. 20: 1159-1166 (2008).
Fundia AF, Larripa I, Slavutsky I. Genetic alterations, genomic instability and cancer in celiac disease. Acta Gastroenterol. Latinoam. 39: 55-62 (2009).
Funk JL, Frye JB, Oyarzo JN, Kuscuoglu N, Wilson J, McCaffrey G, Stafford G, Chen G, Lantz RC, Jolad SD, Solyom AM, Kiela PR, Timmermann BN. Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis. Arthritis Rheum. 54: 3452-3464 (2006). *
Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Solyom AM, Timmermann BN. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J. Nat. Prod. 69: 351-355 (2006). *
Furenes EB, Seljeflot I, Solheim S, Hjerkinn EM, Arnesen H. Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease. Scand. J. Clin. Lab. Invest. 68: 177-184 (2008). *
Furuta GT, Forbes D, Boey C, Dupont C, Putnam P, Roy S, Sabra A, Salvatierra A, Yamashiro Y, Husby S; Eosinophilic Gastrointestinal Diseases Working Group. Eosinophilic gastrointestinal diseases (EGIDs). J. Pediatr. Gastroenterol. Nutr. 47: 234-238 (2008). *
Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, Bonis P, Hassall E, Straumann A, Rothenberg ME; Members of the First International Gastrointestinal Eosinophil Research Symposium (FIGERS) Subcommittees. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment sponsored by the American Gastroenterological Association (AGA) Institute and North American Society of Pediatric Gastroenterol. Gastroenterology 133: 1342-1363 (2007). *
Furuya H, Ohkawara S, Nagashima K, Asanuma N, Hino T. Dietary sphingomyelin alleviates experimental inflammatory bowel disease in mice. Int. J. Vitam. Nutr. Res. 78: 41-48 (2008).
Furuzawa-Carballeda J, Munoz-Chable OA, Barrios-Payan J, Hernandez-Pando R. Effect of polymerized-type I collagen in knee osteoarthritis. I. In vitro study. Eur. J. Clin. Invest. 39: 591-597 (2009).
Fustik S, Jacovska T, Spirevska L, Koceva S. Protein-energy malnutrition as first manifestation of cystic fibrosis in infancy. Pediatr. Int. 51: 678-683 (2009). *
Fustik S, Trajkovska M, Jakovska T, Spirevska L, Josifovska T, Koceva S. Screening for liver disease in cystic fibrosis: analysis of clinical and genetic risk factors for its development. Turk. J. Pediatr. 50: 526-532 (2008).
Fyderek K, Strus M, Kowalska-Duplaga K, Gosiewski T, Wedrychowicz A, Jedynak-Wasowicz U, Sladek M, Pieczarkowski S, Adamski P, Kochan P, Heczko PB. Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease. World J. Gastroenterol. 15: 5287-5294 (2009). *
Gabbi C, Kim HJ, Hultenby K, Bouton D, Toresson G, Warner M, Gustafsson JA. Pancreatic exocrine insufficiency in LXRbeta(-/-) mice is associated with a reduction in aquaporin-1 expression. Proc. Natl. Acad. Sci. U.S.A. 105: 15052-15057 (2008). *
Gabler NK, Radcliffe JS, Spencer JD, Webel DM, Spurlock ME. Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal glucose absorption potentially via the acute activation of AMPK. J. Nutr. Biochem. 20: 17-25 (2009). *
Gabler NK, Spencer JD, Webel DM, Spurlock ME. n-3 PUFA attenuate lipopolysaccharide-induced down-regulation of Toll-like receptor 4 expression in porcine adipose tissue but does not alter the expression of other immune modulators. J. Nutr. Biochem. 19: 8-15 (2008). *
Gabler NK, Spencer JD, Webel DM, Spurlock ME. In utero and postnatal exposure to long chain (n-3) PUFA enhances intestinal glucose absorption and energy stores in weanling pigs. J. Nutr. 137: 2351-2358 (2007). *
Gabory A, Attig L, Junien C. Sexual dimorphism in environmental epigenetic programming. Mol. Cell. Endocrinol. 304: 8-18 (2009).
Gabrielsen TO, Hoel PS. Primary biliary cirrhosis associated with coeliac disease and dermatitis herpetiformis. Dermatologica 170: 31-34 (1985).
Gaby AR. Natural remedies for scleroderma. Altern. Med. Rev. 11: 188-195 (2006). *
Gaby AR. Natural approaches to epilepsy. Altern. Med. Rev. 12: 9-24 (2007). *
Gaby AR. Nutritional approaches to prevention and treatment of gallstones. Altern. Med. Rev. 14: 258-267 (2009). *
Gaddipati K, Yang P. Hepatobiliary complications of parenteral nutrition. Gastroenterologist 4: 98-106 (1996).
Gadewar S, Fasano A. Celiac disease: is the atypical really typical? Summary of the recent national institutes of health consensus conference and latest advances. Curr. Gastroenterol. Rep. 7: 455-461 (2005).
Gaetke LM, Oz HS, de Villiers WJ, Varilek GW, Frederich RC. The leptin defense against wasting is abolished in the IL-2-deficient mouse model of inflammatory bowel disease. J. Nutr. 132: 893-896 (2002). *
Gaia E, Cavalot F, De Giuli P, Emanuelli G. Primary sclerosing cholangitis associated with colonic Crohn disease and marked eosinophilia. Description of a case. Minerva Gastroenterol. Dietol. 37: 59-63 (1991).
Gaiva MH, Couto RC, Oyama LM, Couto GE, Silveira VL, Ribeiro EB, Nascimento CM. Diets rich in polyunsaturated fatty acids: effect on hepatic metabolism in rats. Nutrition 19: 144-149 (2003). *
Gajewska J, Ambroszkiewicz J, Hozyasz KK. Biochemical markers of bone turnover in children with celiac disease on gluten-free diet. Med. Wieku. Rozwoj. IX: 675-683 (2005).
Gajewska J, Ambroszkiewicz J, Hozyasz KK. The impairement of bone formation and resorption in 25-year-old man with neglected celiac disease. Wiad. Lek. 58: 338-341 (2005).
Galan P, Briancon S, Blacher J, Czernichow S, Hercberg S. The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or n-3 PUFA on fatal and non fatal cardiovascular events. Design, methods and participants characteristics. Trials 9: 35 (2008). *
Galandi D, Allgaier HP. Diet therapy in chronic inflammatory bowel disease: results from meta-analysis and randomized controlled trials. Schweiz. Rundsch. Med. Prax. 91: 2041-2049 (2002).
Galgani JE, Uauy RD, Aguirre CA, Diaz EO. Effect of the dietary fat quality on insulin sensitivity. Br. J. Nutr. 100: 471-479 (2008). *
Galhenage SP, Viiala CH, Olynyk JK. Screening for hemochromatosis: patients with liver disease, families, and populations. Curr. Gastroenterol. Rep. 6: 44-51 (2004).
Galicka-Latala D, Zwolinska-Wcislo M, Sosin-Rudnicka L, Rozpondek P. The role of celiac disease and type 1 diabetes coexistance. Is celiac disease responsible for diabetic status? Przegl. Lek. 66: 170-175 (2009).
Galimanis A, Mono ML, Arnold M, Nedeltchev K, Mattle HP. Lifestyle and stroke risk: a review. Curr. Opin. Neurol. 22: 60-68 (2009).
Gallai V, Sarchielli P, Trequattrini A, Franceschini M, Floridi A, Firenze C, Alberti A, Di Benedetto D, Stragliotto E. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J. Neuroimmunol. 56: 143-153 (1995).
Galli C, Marangoni F. n-3 Fatty acids in the Mediterranean diet. Prostaglandins Leukot. Essent. Fatty Acids 75: 129-133 (2006). *
Galli C, Rise P. Fish consumption, omega 3 fatty acids and cardiovascular disease. The science and the clinical trials. Nutr. Health 20: 11-20 (2009).
Galman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis. Gastroenterology 129: 1445-1453 (2005). *
Galvan-Portillo MV, Onate-Ocana LF, Perez-Perez GI, Chen J, Herrera-Goepfert R, Chihu-Amparan L, Flores-Luna L, Mohar-Betancourt A, Lopez-Carrillo L. Dietary folate and vitamin B12 intake before diagnosis decreases gastric cancer mortality risk among susceptible MTHFR 677TT carriers. Nutrition Jul 2 [Epub ahead of print] (2009). *
Galvez J, Rodriguez-Cabezas ME, Zarzuelo A. Effects of dietary fiber on inflammatory bowel disease. Mol. Nutr. Food Res. 49: 601-608 (2005). *
Galvez-Hernandez C, Franklin ME, Villegas-Cabello O, Diaz-Elizondo J, Trevino JM, Salazar-Lopez D. Laparoscopic subtotal colectomy. Results from the Texas Endosurgery Institute. Cir. Cir. 75: 443-448 (2007).
Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin. Endocrinol. (Oxf.) 52: 565-573 (2000). *
Gambino R, Cassader M, Pagano G, Durazzo M, Musso G. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology 45: 1097-1107 (2007). *
Gamble MV, Shang E, Zott RP, Mertz JR, Wolgemuth DJ, Blaner WS. Biochemical properties, tissue expression, and gene structure of a short chain dehydrogenase/ reductase able to catalyze cis-retinol oxidation. J. Lipid Res. 40: 2279-2292 (1999). *
Game X, Malavaud B, Alric L, Mouzin M, Sarramon JP, Rischmann P. Infliximab treatment of Crohn disease ileovesical fistula. Scand. J. Gastroenterol. 38: 1097-1098 (2003). *
Ganapathy P, Moister B, Roon P, Mysona B, Duplantier JN, Dun Y, Moister TV, Farley MJ, Prasad PD, Liu K, Smith SB. Endogenous elevation of homocysteine induces retinal neuron death in the cystathionine-beta-synthase mutant mouse. Invest. Ophthalmol. Vis. Sci. 50: 4460-4470 (2009). *
Gandini S, Raimondi S, Gnagnarella P, Dore JF, Maisonneuve P, Testori A. Vitamin D and skin cancer: a meta-analysis. Eur. J. Cancer 45: 634-641 (2009). *
Gane E, Bergman R, Hutchinson D. Resolution of alcoholic neuropathy following liver transplantation. Liver Transpl. 10: 1545-1548 (2004). *
Gangopadhyay NN, Moldoveanu Z, Stephensen CB. Vitamin A deficiency has different effects on immunoglobulin A production and transport during influenza A infection in BALB/c mice. J. Nutr. 126: 2960-2967 (1996). *
Ganji V, Kafai MR. Demographic, lifestyle, and health characteristic and serum B vitamin status determinants of plasma total homocysteine concentration in the post-folic acid fortification period, 1999-2004. J. Nutr. 139: 345-352 (2009). *
Gant TW, O'Connor CK, Corbitt R, Thorgeirsson U, Thorgeirsson SS. In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. Toxicol. Appl. Pharmacol. 133: 269-276 (1995). *
Gao CM, Tang JH, Cao HX, Ding JH, Wu JZ, Wang J, Liu YT, Li SP, Su P, Matsuo K, Takezaki T, Tajima K. MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women. J. Hum. Genet. 54: 414-418 (2009).
Gao F, Kiesewetter D, Chang L, Ma K, Bell JM, Rapoport SI, Igarashi M. Whole body synthesis-secretion rates of long-chain n-3 polyunsaturated fatty acids from circulating unesterified alpha -linolenic acid in unanesthetized rats. J. Lipid Res. 50: 749-758 (2009). *
Gao F, Kiesewetter D, Chang L, Ma K, Rapoport SI, Igarashi M. Whole-body synthesis-secretion of docosahexaenoic acid from circulating eicosapentaenoic acid in anesthetized rats. J. Lipid Res. 50: 2463-2470 (2009). *
Gao Y, Song LX, Jiang MN, Ge GY, Jia YJ. Effects of traditional Chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. Inflammation 31: 121-132 (2008). *
Gao Z, Yin J, Zhang J, He Q, McGuiness OP, Ye J. Inactivation of NF-kappaB P50 leads to insulin sensitization in liver through post-translational inhibition of P70S6K. J. Biol. Chem. 284: 18368-18376 (2009). *
Garaulet M, Corbalan MD, Madrid JA, Morales E, Baraza JC, Lee YC, Ordovas JM. CLOCK gene is implicated in weight reduction in obese patients participating in a dietary programme based on the Mediterranean diet. Int. J. Obes. (Lond.) Jan 12 [Epub ahead of print] (2010). *
Garaulet M, Lee YC, Shen J, Parnell LD, Arnett DK, Tsai MY, Lai CQ, Ordovas JM. CLOCK genetic variation and metabolic syndrome risk: modulation by monounsaturated fatty acids. Am. J. Clin. Nutr. 90: 1466-1475 (2009). *
Garay CA, Engstrom PF. Chemoprevention of colorectal cancer: dietary and pharmacologic approaches. Oncology (Huntingt.) 13: 89-97 (1999).
Garcia AL, Ruhl R, Herz U, Koebnick C, Schweigert FJ, Worm M. Retinoid- and carotenoid-enriched diets influence the ontogenesis of the immune system in mice. Immunology 110: 180-187 (2003). *
Garcia D, Angel B, Carrasco E, Albala C, Santos JL, Perez-Bravo F. VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile. Diabetes Res. Clin. Pract. 77: 134-140 (2007).
Garcia-Careaga M Jr, Kerner JA Jr. Gastrointestinal manifestations of food allergies in pediatric patients. Nutr. Clin. Pract. 20: 526-535 (2005). *
Garcia-Garcia AB, Gonzalez C, Real JT, Martin de Llano JJ, Gonzalez-Albert V, Civera M, Chaves FJ, Ascaso JF, Carmena R. Influence of microsomal triglyceride transfer protein promoter polymorphism -493 GT on fasting plasma triglyceride values and interaction with treatment response to atorvastatin in subjects with heterozygous familial hypercholesterolaemia. Pharmacogenet. Genomics 15: 211-218 (2005).
Garcia-Rodenas CL, Bergonzelli GE, Nutten S, Schumann A, Cherbut C, Turini M, Ornstein K, Rochat F, Corthesy-Theulaz I. Nutritional approach to restore impaired intestinal barrier function and growth after neonatal stress in rats. J. Pediatr. Gastroenterol. Nutr. 43: 16-24 (2006). *
Garcia-Rojas P, Antaramian A, Gonzalez-Davalos L, Villarroya F, Shimada A, Varela-Echavarria A, Mora O. Induction of PPARgamma and PGC-1alpha by unsaturated fatty acids, retinoic acid, and carotenoids in preadipocytes obtained from bovine white adipose tissue. J. Anim. Sci. Feb 12 [Epub ahead of print] (2010). *
Garcia-Ruiz C, Fernandez-Checa JC. Mitochondrial glutathione: hepatocellular survival-death switch. J. Gastroenterol. Hepatol. 21 Suppl. 3: S3-S6 (2006). *
Garcia-Tevijano ER, Berasain C, Rodriguez JA, Corrales FJ, Arias R, Martin-Duce A, Caballeria J, Mato JM, Avila MA. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. Hypertension 38: 1217-1221 (2001). *
Garcia-Urkia N, Asensio AB, Cano A, Sampron N, Garcia-Arenzana JM, Bachiller P, Aldazabal P, Eizaguirre I. Effect of the administration of cholecystokinin on the cholestasis associated with total parenteral nutrition in experimental short bowel. Cir. Pediatr. 20: 180-182 (2007).
Gardiner JV, Campbell D, Patterson M, Kent A, Ghatei MA, Bloom SR, Bewick GA. The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fat. Gastroenterology Feb 20 [Epub ahead of print] (2010).
Gardiner P, Phillips R, Shaughnessy AF. Herbal and dietary supplement - drug interactions in patients with chronic illnesses. Am. Fam. Physician 77: 73-78 (2008). *
Gardiner P, Woods C, Kemper KJ. Dietary supplement use among health care professionals enrolled in an online curriculum on herbs and dietary supplements. BMC Complement. Altern. Med. 6: 21 (2006). *
Gardmo C, Kotokorpi P, Helander H, Mode A. Transfection of adult primary rat hepatocytes in culture. Biochem. Pharmacol. 69: 1805-1813 (2005). *
Gardner ER, Ahlers CM, Shukla S, Sissung TM, Ockers SB, Price DK, Hamada A, Robey RW, Steinberg SM, Ambudkar SV, Dahut WL, Figg WD. Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival. BJU Int. 102: 1694-1699 (2008).
Garg A, Simha V. Update on dyslipidemia. J. Clin. Endocrinol. Metab. 92: 1581-1589 (2007). *
Gargouri L, Ponsot P, Viala J, Belarbi N, Martinez C, Bellaiche M, Mougenot JF, Hugot JP, Belghiti J, Cezard JP. Recurrent autoimmune pancreatitis in a 10-year-old boy. J. Pediatr. Gastroenterol. Nutr. 48: 374-377 (2009).
Gariballa S. Refeeding syndrome: a potentially fatal condition but remains underdiagnosed and undertreated. Nutrition 24: 604-606 (2008). *
Garman JH, Mulroney SE, Manigrasso M, Flynn E, Maric C. Omega-3 fatty acid rich diet prevents diabetic renal disease. Am. J. Physiol. Renal Physiol. 296: F306-F316 (2009). *
Garrido A, Luque A, Vazquez A, Hernandez JM, Alcantara F, Marquez JL. Primary small bowel neoplasms as a complication of celiac disease. Gastroenterol. Hepatol. 32: 618-621 (2009).
Garrido A, Verdejo C, Marquez JL, Giraldez A, Trigo C, Belda O. Intestinal lymphoma and mesenteric panniculitis: complications of undiagnosed celiac disease. Gastroenterol. Hepatol. 31: 221-224 (2008).
Garsed K, Scott BB. Can oats be taken in a gluten-free diet? A systematic review. Scand. J. Gastroenterol. 42: 171-178 (2007). *
Garthright WE, Archer DL, Kvenberg JE. Estimates of incidence and costs of intestinal infectious diseases in the United States. Public Health Rep. 103: 107-115 (1988).
Garzon L, Ledo A, Cubells E, Saenz P, Vento M. Cholestasis associated with prolonged parenteral nutrition in neonates: the role of ursodeoxycholic acid. An. Pediatr. (Barc.) 70: 547-552 (2009).
Gasbarrini G, Miele L, Malandrino N, Grieco A, Addolorato G, Gasbarrini A, Cammarota G, Bonvicini F. Celiac disease in the 21st century: issues of under- and over-diagnosis. Int. J. Immunopathol. Pharmacol. 22: 1-7 (2009).
Gasper AV, Traka M, Bacon JR, Smith JA, Taylor MA, Hawkey CJ, Barrett DA, Mithen RF. Consuming broccoli does not induce genes associated with xenobiotic metabolism and cell cycle control in human gastric mucosa. J. Nutr. 137: 1718-1724 (2007). *
Gass J, Bethune MT, Siegel M, Spencer A, Khosla C. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology 133: 472-480 (2007). *
Gass J, Vora H, Hofmann AF, Gray GM, Khosla C. Enhancement of dietary protein digestion by conjugated bile acids. Gastroenterology 133: 16-23 (2007). *
Gasser RW. Cholestasis and metabolic bone disease - a clinical review. Wien. Med. Wochenschr. 158: 553-557 (2008). *
Gassull MA. Can nutritional therapy replace pharmacologic therapy in pediatric Crohn's disease? Nat. Clin. Pract. Gastroenterol. Hepatol. 6: 80-81 (2009).
Gassull MA. The role of nutrition in the treatment of inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl. 4: 79-83 (2004). *
Gassull MA. Nutrition and inflammatory bowel disease: its relation to pathophysiology, outcome and therapy. Dig. Dis. 21: 220-227 (2003).
Gassull MA, Cabre E. Nutrition in inflammatory bowel disease. Curr. Opin. Clin. Nutr. Metab. Care 4: 561-569 (2001).
Gassull MA, Mane J, Pedrosa E, Cabre E. Macronutrients and bioactive molecules: is there a specific role in the management of inflammatory bowel disease? JPEN J. Parenter. Enteral Nutr. 29: S179-S183 (2005). *
Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 50: 1087-1093 (2009).
Gatof D, Ahnen D. Primary prevention of colorectal cancer: diet and drugs. Gastroenterol. Clin. North Am. 31: 587-623, xi (2002).
Gattone VH 2nd, Chen NX, Sinders RM, Seifert MF, Duan D, Martin D, Henley C, Moe SM. Calcimimetic inhibits late-stage cyst growth in ADPKD. J. Am. Soc. Nephrol. 20: 1527-1532 (2009).
Gaudel CL, Grimaldi PA. Metabolic functions of peroxisome proliferator-activated receptor beta/delta in skeletal muscle. PPAR Res. 2007: 86394 (2007). *
Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, et al. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol. Biomarkers Prev. 18: 1610-1616 (2009). *
Gaudier E, Michel C, Segain JP, Cherbut C, Hoebler C. The VSL# 3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice. J. Nutr. 135: 2753-2761 (2005). *
Gaudio E, Barbaro B, Alvaro D, Glaser S, Francis H, Franchitto A, Onori P, Ueno Y, Marzioni M, Fava G, Venter J, Reichenbach R, Summers R, Alpini G. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. Am. J. Physiol. Gastrointest. Liver Physiol. 291: G307-G317 (2006). *
Gaudio E, Onori P, Pannarale L, Alvaro D. Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study. Gastroenterology 111: 1118-1124 (1996). *
Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, Evans A, Whitehead AS. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 157: 451-456 (2001).
Gaujoux S, Couchard AC, Al Youssef J, Paquet JC. Ureteral obstruction and Crohn's disease. Gastroenterol. Clin. Biol. 31: 611-613 (2007).
Gautam A, Jain BK, Midha V, Sood A, Sood N. Prevalence of celiac disease among siblings of celiac disease patients. Indian J. Gastroenterol. 25: 233-235 (2006). *
Gautier EL, Huby T, Ouzilleau B, Doucet C, Saint-Charles F, Gremy G, Chapman MJ, Lesnik P. Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice. Arterioscler. Thromb. Vasc. Biol. 27: 1625-1631 (2007). *
Gavin J, Anderson CE, Bremner AR, Beattie RM. Energy intakes of children with Crohn's disease treated with enteral nutrition as primary therapy. J. Hum. Nutr. Diet. 18: 337-342 (2005). *
Gay J, Kokkotou E, O'Brien M, Pothoulakis C, Karalis KP. Corticotropin-releasing hormone deficiency is associated with reduced local inflammation in a mouse model of experimental colitis. Endocrinology 149: 3403-3409 (2008). *
Gayet C, Leray V, Saito M, Siliart B, Nguyen P. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs. Br. J. Nutr. 98: 497-503 (2007). *
Gearing KL, Gottlicher M, Widmark E, Banner CD, Tollet P, Stromstedt M, Rafter JJ, Berge RK, Gustafsson JA. Fatty acid activation of the peroxisome proliferator activated receptor, a member of the nuclear receptor gene superfamily. J. Nutr. 124: 1284S-1288S (1994). *
Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease - a pilot study. Journal of Crohn's and Colitis 3: 8-14 (2009). *
Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am. J. Clin. Nutr. 83: 1526S-1535S (2006). *
Gebhardt T, Lorentz A, Detmer F, Trautwein C, Bektas H, Manns MP, Bischoff SC. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1. Gut 54: 928-934 (2005). *
Geddes K, Philpott DJ. A new role for intestinal alkaline phosphatase in gut barrier maintenance. Gastroenterology 135: 8-12 (2008). *
Gee MI, Grace MG, Wensel RH, Sherbaniuk RW, Thomson AB. Nutritional status of gastroenterology outpatients: comparison of inflammatory bowel disease with functional disorders. J. Am. Diet. Assoc. 85: 1591-1599 (1985).
Geelen A, Schouten JM, Kamphuis C, Stam BE, Burema J, Renkema JM, Bakker EJ, Van't Veer P, Kampman E. Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies. Am. J. Epidemiol. 166: 1116-1125 (2007). *
Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am. J. Clin. Nutr. 67: 919-926 (1998). *
Geerling BJ, Badart-Smook A, van Deursen C, van Houwelingen AC, Russel MG, Stockbrugger RW, Brummer RJ. Nutritional supplementation with n-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm. Bowel Dis. 6: 77-84 (2000). *
Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrugger RW, Brummer RJ. Diet as a risk factor for the development of ulcerative colitis. Am. J. Gastroenterol. 95: 1008-1013 (2000). *
Gehrig KA, Dinulos JG. Acrodermatitis due to nutritional deficiency. Curr. Opin. Pediatr. Dec 3 [Epub ahead of print] (2009).
Geier A, Dietrich CG, Gerloff T, Haendly J, Kullak-Ublick GA, Stieger B, Meier PJ, Matern S, Gartung C. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat. Biochim. Biophys. Acta 1609: 87-94 (2003). *
Geier A, Dietrich CG, Grote T, Beuers U, Prufer T, Fraunberger P, Matern S, Gartung C, Gerbes AL, Bilzer M. Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat. J. Hepatol. 43: 1021-1030 (2005). *
Geier A, Dietrich CG, Lammert F, Orth T, Mayet WJ, Matern S, Gartung C. Regulation of organic anion transporters in a new rat model of acute and chronic cholangitis resembling human primary sclerosing cholangitis. J. Hepatol. 36: 718-724 (2002). *
Geier A, Dietrich CG, Trauner M, Gartung C. Extrahepatic cholestasis downregulates Oatp1 by TNF-alpha signalling without affecting Oatp2 and Oatp4 expression and sodium-independent bile salt uptake in rat liver. Liver Int. 27: 1056-1065 (2007). *
Geier A, Dietrich CG, Voigt S, Ananthanarayanan M, Lammert F, Schmitz A, Trauner M, Wasmuth HE, Boraschi D, Balasubramaniyan N, Suchy FJ, Matern S, Gartung C. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G831-G841 (2005). *
Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, Kullak-Ublick GA, Lorenzen J, Matern S, Gartung C. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38: 345-354 (2003). *
Geier A, Gartung C, Dietrich CG, Lammert F, Wasmuth HE, Matern S. Diagnosis of cholestatic disorders. Med. Klin. (Munich) 98: 499-509 (2003).
Geier A, Gartung C, Dietrich CG, Wasmuth HE, Reinartz P, Matern S. Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC. World J. Gastroenterol. 9: 2681-2685 (2003). *
Geier A, Gartung C, Theurl I, Weiss G, Lammert F, Dietrich CG, Weiskirchen R, Zoller H, Hermanns B, Matern S. Occult celiac disease prevents penetrance of hemochromatosis. World J. Gastroenterol. 11: 3323-3326 (2005). *
Geier A, Kim SK, Gerloff T, Dietrich CG, Lammert F, Karpen SJ, Stieger B, Meier PJ, Matern S, Gartung C. Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. J. Hepatol. 37: 198-205 (2002). *
Geier A, Martin IV, Dietrich CG, Balasubramaniyan N, Strauch S, Suchy FJ, Gartung C, Trautwein C, Ananthanarayanan M. Hepatocyte nuclear factor 4alpha is a central transactivator of the mouse Ntcp gene. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G226-G233 (2008). *
Geier A, Mertens PR, Gerloff T, Dietrich CG, En-Nia A, Kullak-Ublick GA, Karpen SJ, Matern S, Gartung C. Constitutive rat multidrug-resistance protein 2 gene transcription is down-regulated by Y-box protein 1. Biochem. Biophys. Res. Commun. 309: 612-618 (2003). *
Geier A, Reugels M, Weiskirchen R, Wasmuth HE, Dietrich CG, Siewert E, Gartung C, Lorenzen J, Bosserhoff AK, Brugmann M, Gressner AM, Matern S, Lammert F. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver Int. 24: 285-294 (2004). *
Geier A, Wagner M, Dietrich CG, Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim. Biophys. Acta 1773: 283-308 (2007). *
Geier A, Zollner G, Dietrich CG, Wagner M, Fickert P, Denk H, van Rooijen N, Matern S, Gartung C, Trauner M. Cytokine-independent repression of rodent Ntcp in obstructive cholestasis. Hepatology 41: 470-477 (2005). *
Geier MS, Torok VA, Allison GE, Ophel-Keller K, Gibson RA, Munday C, Hughes RJ. Dietary omega-3 polyunsaturated fatty acid does not influence the intestinal microbial communities of broiler chickens. Poult. Sci. 88: 2399-2405 (2009).
Gekara NO, Dietrich N, Lyszkiewicz M, Lienenklaus S, Weiss S. Signals triggered by a bacterial pore-forming toxin contribute to Toll-like receptor redundancy in Gram-positive bacterial recognition. J. Infect. Dis. 199: 124-133 (2009). *
Gelfond D, Fasano A. Celiac disease in the pediatric population. Pediatr. Ann. 35: 275-279 (2006).
Gelinas R, Labarthe F, Bouchard B, Janie MD, Guy C, Young ME, Des Rosiers C. Alterations in carbohydrate metabolism and its regulation in PPAR alpha null mouse hearts. Am. J. Physiol. Heart Circ. Physiol. 294: H1571-H1580 (2008). *
Gelli A, Al-Shaiba N, Espejo F. The costs and cost-efficiency of providing food through schools in areas of high food insecurity. Food Nutr. Bull. 30: 68-76 (2009).
Gelling RW, Yan W, Al-Noori S, Pardini A, Morton GJ, Ogimoto K, Schwartz MW, Dempsey PJ. Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice. Endocrinology 149: 6053-6064 (2008). *
Gelman L, Fruchart JC, Auwerx J. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer. Cell. Mol. Life Sci. 55: 932-943 (1999). *
Gelsi E, Ruitord F, Saint-Paul MC, Filippi J, Arab K, Hebuterne X. Association of Budd-Chiari syndrome with a coeliac disease in patient native from North Africa. Gastroenterol. Clin. Biol. 28: 903-905 (2004).
Gemmel K, Santry HP, Prachand VN, Alverdy JC. Vitamin D deficiency in preoperative bariatric surgery patients. Surg. Obes. Relat. Dis. 5: 54-59 (2009).
Genkinger JM, Platz EA, Hoffman SC, Strickland P, Huang HY, Comstock GW, Helzlsouer KJ. C47T polymorphism in manganese superoxide dismutase (MnSOD), antioxidant intake and survival. Mech. Ageing Dev. 127: 371-377 (2006).
Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, La Villa G, Laffi G. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J. Hepatol. 30: 639-645 (1999). *
Genton L, Kudsk KA, Reese SR, Ikeda S. Enteral feeding preserves gut Th-2 cytokines despite mucosal cellular adhesion molecule-1 blockade. JPEN J. Parenter. Enteral Nutr. 29: 44-47 (2005). *
Genuis SJ. To sea or not to sea: benefits and risks of gestational fish consumption. Reprod. Toxicol. 26: 81-85 (2008).
Genuis SJ, Bouchard TP. Celiac disease presenting as autism. J. Child. Neurol. 25: 114-119 (2010).
Genuis SJ, Schwalfenberg GK. Time for an oil check: the role of essential omega-3 fatty acids in maternal and pediatric health. J. Perinatol. 26: 359-365 (2006).
Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors. J. Hand Surg. [Br.] 29: 423-426 (2004).
George J, Ganesh HK, Acharya S, Bandgar TR, Shivane V, Karvat A, Bhatia SJ, Shah S, Menon PS, Shah N. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J. Gastroenterol. 15: 3516-3522 (2009). *
Geppert J, Kraft V, Demmelmair H, Koletzko B. Docosahexaenoic acid supplementation in vegetarians effectively increases omega-3 index: a randomized trial. Lipids 40: 807-814 (2005).
Geppert J, Kraft V, Demmelmair H, Koletzko B. Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidaemic vegetarians: a randomised trial. Br. J. Nutr. 95: 779-786 (2006). *
Geppert J, Min Y, Neville M, Lowy C, Ghebremeskel K. Gender-specific fatty acid profiles in platelet phosphatidyl-choline and -ethanolamine. Prostaglandins Leukot. Essent. Fatty Acids Oct 16 [Epub ahead of print] (2009). *
Geraldine M, Stephanie D, Benedicte L, Isabelle D, Monique L, Sylvie V. DHA enhances the noradrenaline release by SH-SY5Y cells. Neurochem. Int. Sep 18 [Epub ahead of print] (2009).
Gerard-Boncompain M, Claudel JP, Gaussorgues P, Salord F, Sirodot M, Chevallier M, Robert D. Hepatic cytolytic and cholestatic changes related to a change of lipid emulsions in four long-term parenteral nutrition patients with short bowel. JPEN J. Parenter. Enteral Nutr. 16: 78-83 (1992).
Gerasimidis K, McGrogan P, Hassan K, Edwards CA. Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 27: 155-165 (2008). *
Gerber DA, Green M, Jaffe R, Greenberg D, Mazariegos G, Reyes J. Cryptosporidial infections after solid organ transplantation in children. Pediatr. Transplant. 4: 50-55 (2000).
Gercek A, Yildirim O, Konya D, Bozkurt S, Ozgen S, Kilic T, Sav A, Pamir N. Effects of parenteral fish-oil emulsion (omegaven) on cutaneous wound healing in rats treated with dexamethasone. JPEN J. Parenter. Enteral Nutr. 31: 161-166 (2007). *
German JB, Roberts MA, Watkins SM. Genomics and metabolomics as markers for the interaction of diet and health: lessons from lipids. J. Nutr. 133: 2078S-2083S (2003). *
Germano M, Meleleo D, Montorfano G, Adorni L, Negroni M, Berra B, Rizzo AM. Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD). Nutr. Neurosci. 10: 1-9 (2007).
Gero L. Treatment of nephrotic syndrome in the adult. Orv. Hetil. 147: 2313-2318 (2006).
Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, Lindor KD, Kaplan MM, Vierling JM, USA PBC Epidemiology Group. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 42: 1194-1202 (2005). *
Gershwin ME, Van de Water J, Leung P, Ansari AA, Coppel RL. The pathobiology and the cause of primary biliary cirrhosis. Falk Symposium 135. Immmunological diseases of liver and gut. Prague (Czech Republic). p. 36-37. September 12 - 13 (2003). *
Gershwin ME, Van de WaterJ, Leung P, Ansari AA, Coppel RL. Primary biliary cirrhosis: from induction through destruction. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper�s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 18. October 15-16 (2003). *
Gerster H. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int. J. Vitam. Nutr. Res. 68: 159-173 (1998).
Gertler A. Development of leptin antagonists and their potential use in experimental biology and medicine. Trends Endocrinol. 17: 372-378 (2006). *
Gertsch J. Anti-inflammatory cannabinoids in diet: towards a better understanding of CB(2) receptor action? Commun. Integr. Biol. 1: 26-28 (2008).
Gervois P, Torra IP, Fruchart JC, Staels B. Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin. Chem. Lab. Med. 38: 3-11 (2000).
Gessendorfer B, Koehler P, Wieser H. Preparation and characterization of enzymatically hydrolyzed prolamins from wheat, rye, and barley as references for the immunochemical quantitation of partially hydrolyzed gluten. Anal. Bioanal. Chem. 395: 1721-1728 (2009). *
Ghadimi D, Vrese MD, Heller KJ, Schrezenmeir J. Effect of natural commensal-origin DNA on Toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells. Inflamm. Bowel Dis. 16: 410-427 (2010).
Ghafoorunissa, Ibrahim A, Rajkumar L, Acharya V. Dietary (n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J. Nutr. 135: 2634-2638 (2005). *
Ghany MG, Doo EC. Antiviral resistance and hepatitis B therapy. Hepatology 49: S174-S184 (2009).
Gharib AM, Thomasson D, Li KC. Molecular imaging of hepatocellular carcinoma. Gastroenterology 127 (5 Suppl. 2): S153-S158 (2004). *
Ghavami S, Hashemi M, Kadkhoda K, Alavian SM, Bay GH, Los M. Apoptosis in liver diseases - detection and therapeutic applications. Med. Sci. Monit. 11: RA337-RA345 (2005). *
Ghenimi Rahab N, Benamevieux MC, Biran M, Pallet V, Higueret P, Gallis JL. Vitamin A deficiency in rats induces anatomic and metabolic changes comparable with those of neurodegenerative disorders. J. Nutr. 139: 696-702 (2009). *
Ghezzi A, Zaffaroni M. Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol. Sci. 22 Suppl. 2: S117-S122 (2001).
Ghidini B, Bellaiche M, Berrebi D, Viala J, Hugot JP, Mougenot JF, Munck A, Peuchmaur M, Cezard JP. Cytomegalovirus colitis in children with inflammatory bowel disease. Gut 55: 582-583 (2006). *
Ghosh A. Obesity measures, metabolic profiles and dietary fatty acids in lean and obese postmenopausal diabetic Asian Indian women. Anthropol. Anz. 67: 83-93 (2009).
Ghosh C, Baker JA, Moysich KB, Rivera R, Brasure JR, McCann SE. Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutr. Cancer 60: 331-341 (2008).
Ghosh D, Skinner MA, Laing WA. Pharmacogenomics and nutrigenomics: synergies and differences. Eur. J. Clin. Nutr. 61: 567-574 (2007). *
Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn�s and Ulcerative Colitis Associations (EFCCA) patient survey. Journal of Crohn's and Colitis 1: 10-20 (2007).
Ghosh-Choudhury T, Mandal CC, Woodruff K, St Clair P, Fernandes G, Choudhury GG, Ghosh-Choudhury N. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res. Treat. 118: 213-228 (2009). *
Ghoshal UC, Shukla A. Malnutrition in inflammatory bowel disease patients in northern India: frequency and factors influencing its development. Trop. Gastroenterol. 29: 95-97 (2008).
Giacco R, Cuomo V, Vessby B, Uusitupa M, Hermansen K, Meyer BJ, Riccardi G, Rivellese AA; KANWU Study Group. Fish oil, insulin sensitivity, insulin secretion and glucose tolerance in healthy people: is there any effect of fish oil supplementation in relation to the type of background diet and habitual dietary intake of n-6 and n-3 fatty acids? Nutr. Metab. Cardiovasc. Dis. 17: 572-580 (2007).
Giacconi R, Bonfigli AR, Testa R, Sirolla C, Cipriano C, Marra M, Muti E, Malavolta M, Costarelli L, Piacenza F, Tesei S, Mocchegiani E. +647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol. Genet. Metab. 94: 98-104 (2008). *
Giacconi R, Caruso C, Malavolta M, Lio D, Balistreri CR, Scola L, Candore G, Muti E, Mocchegiani E. Pro-inflammatory genetic background and zinc status in old atherosclerotic subjects. Ageing Res. Rev. 7: 306-318 (2008).
Giacconi R, Cipriano C, Muti E, Costarelli L, Malavolta M, Caruso C, Lio D, Mocchegiani E. Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients. Biogerontology 7: 347-356 (2006). *
Giacconi R, Cipriano C, Muti E, Costarelli L, Maurizio C, Saba V, Gasparini N, Malavolta M, Mocchegiani E. Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc. Biogerontology 6: 407-413 (2005). *
Giacosa A, Rondanelli M. Fish oil and treatment of cancer cachexia. Genes Nutr. 3: 25-28 (2008). *
Giaginis C, Tsantili-Kakoulidou A, Theocharis S. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism. Fundam. Clin. Pharmacol. 21: 231-244 (2007). *
Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005. Immunol. Rev. 204: 232-249 (2005). *
Gianfrani C, Levings MK, Sartirana C, Mazzarella G, Barba G, Zanzi D, Camarca A, Iaquinto G, Giardullo N, Auricchio S, Troncone R, Roncarolo MG. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J. Immunol. 177: 4178-4186 (2006). *
Gianfrani C, Siciliano RA, Facchiano AM, Camarca A, Mazzeo MF, Costantini S, Salvati VM, Maurano F, Mazzarella G, Iaquinto G, Bergamo P, Rossi M. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 133: 780-789 (2007). *
Gianfrani C, Troncone R, La Cava A. Autoimmunity and celiac disease. Mini. Rev. Med. Chem. 8: 129-134 (2008).
Giannini S, Martes C. Anemia in inflammatory bowel disease. Minerva Gastroenterol. Dietol. 52: 275-291 (2006).
Gianotti L. Nutrition and infections. Surg. Infect. (Larchmt.) 7 Suppl.2: s29-s32 (2006).
Giarnieri E, Giorgetti GD, Mazzetti di Pietralata M. Role of coeliac disease in the Helicobacter pylori infection. Minerva Gastroenterol. Dietol. 45: 1-4 (1999).
Gibbons DL, Haque SF, Copestake SL, Wells JW, Noble A, Smith AL, Hayday AC. Suppression of airway inflammation by a natural acute infection of the intestinal epithelium. Mucosal Immunol. 2: 144-155 (2009). *
Gibbons T, Fuchs GJ. Chronic enteropathy: clinical aspects. Nestle Nutr. Workshop Ser. Pediatr. Program 59: 89-104 (2007).
Gibbons TE, Sayed K, Fuchs GJ. Massive pan-gastrointestinal bleeding following cocaine use. World J. Pediatr. 5: 149-151 (2009). *
Gibbs RA, Rymer C, Givens DI. Postgraduate symposium. Long-chain n-3 PUFA: intakes in the UK and the potential of a chicken meat prototype to increase them. Proc. Nutr. Soc. Dec 3 [Epub ahead of print] (2009). *
Gibelli NE, Tannuri U, Pinho-Apezzato ML, Tannuri AC, Maksoud-Filho JG, Andrade WC, Velhote MC, Santos MM, Ayoub AA, Marques da Silva M. Sirolimus in pediatric liver transplantation: a single-center experience. Transplant. Proc. 41: 901-903 (2009). *
Gibson GR, Macfarlane GT, Cummings JH. Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. Gut 34: 437-439 (1993). *
Gibson PR. Overview of inflammatory bowel disease in Australia in the last 50 years. J. Gastroenterol. Hepatol. 24 Suppl. 3: S63-S68 (2009). *
Gibson PR, Iser J. Flammatory bowel disease. Aust. Fam. Physician 34: 233-237 (2005).
Gibson PR, Shepherd SJ. Personal view: food for thought - western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment. Pharmacol. Ther. 21: 1399-1409 (2005). *
Gibson RJ. Gut microbiome and intestinal mucositis: a new challenge for researchers. Cancer Biol. Ther. Mar 14 [Epub ahead of print] (2009).
Gibson RS. Zinc: the missing link in combating micronutrient malnutrition in developing countries. Proc. Nutr. Soc. 65: 51-60 (2006). *
Gieger C, Geistlinger L, Altmaier E, Hrabe de Angelis M, Kronenberg F, Meitinger T, Mewes HW, Wichmann HE, Weinberger KM, Adamski J, Illig T, Suhre K. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet. 4: e1000282 (2008). *
Gil A. Polyunsaturated fatty acids and inflammatory diseases. Biomed. Pharmacother. 56: 388-396 (2002).
Gil A, Bengmark S. Advanced glycation and lipoxidation end products - amplifiers of inflammation: the role of food. Nutr. Hosp. 22: 625-640 (2007).
Gilad LA, Tirosh O, Schwartz B. Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells. J. Endocrinol. 191: 387-398 (2006). *
Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand. J. Gastroenterol. 22: 1009-1024 (1987).
Gilby KL, Jans J, McIntyre DC. Chronic omega-3 supplementation in seizure-prone versus seizure-resistant rat strains: a cautionary tale. Neuroscience 163: 750-758 (2009).
Gill HK, Wu GY. Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer? World J. Gastroenterol. 12: 345-353 (2006). *
Gill S, Sinicrope FA. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure? Semin. Oncol. 32: 24-34 (2005). *
Gill TS, Karantana A, Rees J, Pandey S, Dixon AR. Laparoscopic proctocolectomy with restorative ileal-anal pouch. Colorectal Dis. 6: 458-461 (2004). *
Gillam M, Noto A, Zahradka P, Taylor CG. Improved n-3 fatty acid status does not modulate insulin resistance in fa/fa Zucker rats. Prostaglandins Leukot. Essent. Fatty Acids 81: 331-339 (2009). *
Gillett HR, Arnott ID, McIntyre M, Campbell S, Dahele A, Priest M, Jackson R, Ghosh S. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 122: 800-805 (2002). *
Gillett HR, Cauch-Dudek K, Jenny E, Heathcote EJ, Freeman HJ. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis. Can. J. Gastroenterol. 14: 672-675 (2000). *
Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues JF, Touchon J, Vellas B; MAPT Study Group. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Alzheimers Dement. 5: 114-121 (2009).
Gilman J, Shanahan F, Cashman KD. Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use. Eur. J. Clin. Nutr. 60: 889-896 (2006). *
Gilman J, Shanahan F, Cashman KD. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis. Aliment. Pharmacol. Ther. 23: 1007-1016 (2006). *
Gilroy R, Sudan D. Liver and small bowel transplantation: therapeutic alternatives for the treatment of liver disease and intestinal failure. Semin. Liver Dis. 20: 437-450 (2000). *
Ginsberg A, Stahl Z, Leventhal A. Omega-3 fatty acids: the science and the beliefs. Harefuah. 148: 114-120, 138 (2009).
Ginsburg PM, Bayless TM. Managing functional disturbances in patients with inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 8: 211-221 (2005).
Gionchetti P, Lammers KM, Rizzello F, Campieri M. Probiotics and barrier function in colitis. Gut 54: 898-900 (2005). *
Gionchetti P, Rizzello F, Campieri M. Probiotics in gastroenterology. Curr. Opin. Gastroenterol. 18: 235-239 (2002).
Giorgetti GM, Tursi A, Brandimarte G, Anemona L. Small bowel adenocarcinoma as first presentation of coeliac disease. Minerva Gastroenterol. Dietol. 48: 347-350 (2002).
Giorgetti GM, Tursi A, Iani C, Arciprete F, Brandimarte G, Capria A, Fontana L. Assessment of autonomic function in untreated adult coeliac disease. World J. Gastroenterol. 10: 2715-2718 (2004). *
Giovannini M, Verduci E, Salvatici E, Fiori L, Riva E. Phenylketonuria: dietary and therapeutic challenges. J. Inherit. Metab. Dis. 30: 145-152 (2007). *
Giovannucci E. The epidemiology of vitamin D and colorectal cancer: recent findings. Curr. Opin. Gastroenterol. 22: 24-29 (2006).
Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J. Nutr. 132: 2350S-2355S (2002). *
Giovannucci E, Chen J, Smith-Warner SA, Rimm EB, Fuchs CS, Palomeque C, Willett WC, Hunter DJ. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev. 12: 970-979 (2003). *
Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 168: 1174-1180 (2008). *
Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res. 54: 2390-2397 (1994). *
Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency. J. Pediatr. Gastroenterol. Nutr. 45: 433-437 (2007). *
Giovenale D, Meazza C, Cardinale GM, Sposito M, Mastrangelo C, Messini B, Citro G, Delvecchio M, Di Maio S, Bozzola M. The prevalence of growth hormone deficiency and celiac disease in short children. Clin. Med. Res. 4: 180-183 (2006). *
Girard H, Butler LM, Villeneuve L, Millikan RC, Sinha R, Sandler RS, Guillemette C. UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans. Mutat. Res. 644: 56-63 (2008).
Girard H, Thibaudeau J, Court MH, Fortier LC, Villeneuve L, Caron P, Hao Q, von Moltke LL, Greenblatt DJ, Guillemette C. UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver. Hepatology 42: 448-457 (2005). *
Gisondi P, Del Giglio M, Di Francesco V, Zamboni M, Girolomoni G. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. Am. J. Clin. Nutr. 88: 1242-1247 (2008). *
Gisondi P, Fantuzzi F, Malerba M, Girolomoni G. Folic acid in general medicine and dermatology. J. Dermatolog. Treat. 18: 138-146 (2007).
Giugliano D, Ceriello A, Esposito K. The effects of diet on inflammation emphasis on the metabolic syndrome. J. Am. Coll. Cardiol. 48: 677-685 (2006). *
Giuliano G, Tavazza R, Diretto G, Beyer P, Taylor MA. Metabolic engineering of carotenoid biosynthesis in plants. Trends Biotechnol. 26: 139-145 (2008). *
Glanemann B, Schonenbrucher H, Bridger N, Abdulmawjood A, Neiger R, Bulte M. Detection of Mycobacterium avium subspecies paratuberculosis-specific DNA by PCR in intestinal biopsies of dogs. J. Vet. Intern. Med. 22: 1090-1094 (2008).
Glaser C, Heinrich J, Koletzko B. Role of FADS1 and FADS2 polymorphisms in polyunsaturated fatty acid metabolism. Metabolism Dec 30 [Epub ahead of print] (2009). *
Glasscoe CA, Quittner AL. Psychological interventions for people with cystic fibrosis and their families. Cochrane Database Syst. Rev. 3: CD003148 (2008). *
Glatzle J, Beckert S, Kasparek MS, Mueller MH, Mayer P, Meile T, Konigsrainer A, Steurer W. Olive oil is more potent than fish oil to reduce septic pulmonary dysfunctions in rats. Langenbecks Arch. Surg. 392: 323-329 (2007). *
Glatzle J, Kasparek MS, Mueller MH, Binder F, Meile T, Kreis ME, Konigsrainer A, Steurer W. Enteral immunonutrition during sepsis prevents pulmonary dysfunction in a rat model. J. Gastrointest. Surg. 11: 719-724 (2007). *
Glauert HP, Tharappel JC, Lu Z, Stemm D, Banerjee S, Chan LS, Lee EY, Lehmler HJ, Robertson LW, Spear BT. Role of oxidative stress in the promoting activities of PCBs. Environ. Toxicol. Pharmacol. 25: 247-250 (2008). *
Glenville M. Nutritional supplements in pregnancy: commercial push or evidence based? Curr. Opin. Obstet. Gynecol. 18: 642-647 (2006).
Glew RH, Wold RS, Herbein JH, Wark WA, Martinez MA, Vanderjagt DJ. Low docosahexaenoic acid in the diet and milk of women in New Mexico. J. Am. Diet. Assoc. 108: 1693-1699 (2008). *
Gloerich J, van den Brink DM, Ruiter JP, van Vlies N, Vaz FM, Wanders RJ, Ferdinandusse S. Metabolism of phytol to phytanic acid in the mouse and the role of PPARalpha in its regulation. J. Lipid Res. 48: 77-85 (2007). *
Gloro R, Hourmand-Ollivier I, Mosquet B, Mosquet L, Rousselot P, Salame E, Piquet MA, Dao T. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur. J. Gastroenterol. Hepatol. 17: 1135-1137 (2005).
Gluud C, Brok J, Gong Y, Koretz RL. Hepatology may have problems with putative surrogate outcome measures. J. Hepatol. 46: 734-742 (2007). *
Gnerre C, Schuster GU, Roth A, Handschin C, Johansson L, Looser R, Parini P, Podvinec M, Robertsson K, Gustafsson JA, Meyer UA. LXR deficiency and cholesterol feeding affect expression and phenobarbital mediated induction of cytochromes P450 in mouse liver. J. Lipid Res. 46: 1633-1642 (2005). *
Gnoni GV, Priore P, Geelen MJ, Siculella L. The mitochondrial citrate carrier: metabolic role and regulation of its activity and expression. IUBMB Life 61: 987-994 (2009).
Gobbetti M, Giuseppe Rizzello C, Di Cagno R, De Angelis M. Sourdough lactobacilli and celiac disease. Food Microbiol. 24: 187-196 (2007). *
Godart B, Beau P, Benchellal Z, Bumsel F, Metman ET. Ulcerative colitis associated with haemorrhagic enteritis: successful treatment with infliximab. Gastroenterol. Clin. Biol. 31: 88-90 (2007).
Goddard CJ, Gillett HR. Complications of coeliac disease: are all patients at risk? Postgrad. Med. J. 82: 705-712 (2006). *
Godeiro-Junior Cde O, Felicio AC, Barsottini OG, Gabbai AA. Cerebellar degeneration and immune thrombocytopenic purpura associated with human immunodeficiency virus infection (HIV). Arq. Neuropsiquiatr. 65: 1010-1011 (2007). *
Goel A, Chiu H, Felton J, Palmer JP, Brooks-Worrell B. T cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta cell lesion in phenotypic type 2 diabetes. Diabetes 56: 2110-2115 (2007). *
Goel NK, McBane RD, Kamath PS. Cardiomyopathy associated with celiac disease. Mayo Clin. Proc. 80: 674-676 (2005). *
Goel R, Boylan B, Gruman L, Newman PJ, North PE, Newman DK. The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet induced-steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1205-G1214 (2007). *
Goerres MS, Meijer JWR, Wahab PJ, Kerckhaert JAM, Groenen PJTA, Van Krieken JHJM, Mulder CJJ. Azathioprine and prednisone combination therapy in refractory Coeliac disease. Aliment. Pharmacol. Ther. 18: 487-494 (2003). *
Goh C, Banerjee K. Prevalence of coeliac disease in children and adolescents with type 1 diabetes mellitus in a clinic based population. Postgrad. Med. J. 83: 132-136 (2007). *
Goh J, O'Morain CA. Review article: nutrition and adult inflammatory bowel disease. Aliment. Pharmacol. Ther. 17: 307-320 (2003). *
Goh K, Xiao SD. Inflammatory bowel disease: a survey of the epidemiology in Asia. J. Dig. Dis. 10: 1-6 (2009). *
Gokce S, Suoglu OD, Celtik C, Aydogan A, Sokucu S. Cystic fibrosis and hypoelectrolytemia. Pediatr. Emerg. Care 23: 760 (2007).
Gold BD. Epidemiology and management of gastro-oesophageal reflux in children. Aliment. Pharmacol. Ther. 19 Suppl. 1: 22-27 (2004).
Goldbart AD, Cohen AD, Weitzman D, Tal A. Effects of rehabilitation winter camps at the Dead Sea on European cystic fibrosis patients. Isr. Med. Assoc. J. 9: 806-809 (2007). *
Goldberg RF, Austen WG Jr, Zhang X, Munene G, Mostafa G, Biswas S, McCormack M, Eberlin KR, Nguyen JT, Tatlidede HS, Warren HS, Narisawa S, Millan JL, Hodin RA. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc. Natl. Acad. Sci. U.S.A. 105: 3551-3556 (2008). *
Goldbohm RA, van den Brandt PA, van 't Veer P, Brants HA, Dorant E, Sturmans F, Hermus RJ. A prospective cohort study on the relation between meat consumption and the risk of colon cancer. Cancer Res. 54: 718-723 (1994). *
Goldiner I, van der Velde AE, Vandenberghe KE, van Wijland MA, Halpern Z, Gilat T, Konikoff FM, Veldman RJ, Groen AK. ABCA1-dependent but ApoA-I-independent cholesterol efflux mediated by fatty acid-bile acid conjugates (FABACs). Biochem. J. 396: 529-536 (2006). *
Goldman AS. The immune system in human milk and the developing infant. Breastfeed. Med. 2: 195-204 (2007).
Goldring CE, Kitteringham NR, Elsby R, Randle LE, Clement YN, Williams DP, McMahon M, Hayes JD, Itoh K, Yamamoto M, Park BK. Activation of hepatic Nrf2 in vivo by acetaminophen in CD-1 mice. Hepatology 39: 1267-1276 (2004). *
Goldstein DB, Need AC, Singh R, Sisodiya SM. Potential genetic causes of heterogeneity of treatment effects. Am. J. Med. 120: S21-S25 (2007). *
Goldstein ES, Rubin PH. Endoscopic therapy for inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 6: 237-243 (2003).
Goldstein NS. Non-gluten sensitivity-related small bowel villous flattening with increased intraepithelial lymphocytes: not all that flattens is celiac sprue. Am. J. Clin. Pathol. 121: 546-550 (2004). *
Golfetto I, McGready R, Ghebremeskel K, Min Y, Dubowitz L, Nosten F, Drury P, Simpson JA, Arunjerdja R, Crawford MA. Fatty acid composition of milk of refugee Karen and urban Korean mothers. Is the level of DHA in breast milk of Western women compromised by high intake of saturated fat and linoleic acid? Nutr. Health 18: 319-332 (2007).
Gollan JL. Morbus Wilson. Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper�s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 91-92. October 17 - 19 (2003). *
Gombart AF. The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 4: 1151-1165 (2009). *
Gomez FE, Cassis-Nosthas L, Morales-De-Leon JC, Bourges H. Detection and recognition thresholds to the 4 basic tastes in Mexican patients with primary Sjogren's syndrome. Eur. J. Clin. Nutr. 58: 629-636 (2004). *
Gomez FE, Lan J, Kang W, Ueno C, Kudsk KA. Parenteral nutrition and fasting reduces mucosal addressin cellular adhesion molecule-1 (MAdCAM-1) mRNA in Peyer's patches of mice. JPEN J. Parenter. Enteral Nutr. 31: 47-52 (2007). *
Gomez M, Sanz-Gonzalez SM, Nabah YN, Lamana A, Sanchez-Madrid F, Andres V. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69. Cardiovasc. Res. 81: 197-205 (2009).
Gomez R, Lago F, Gomez-Reino J, Dieguez C, Gualillo O. Adipokines in the skeleton: influence on cartilage function and joint degenerative diseases. J. Mol. Endocrinol. 43: 11-18 (2009). *
Goncalves M, D'Almeida V, Guerra-Shinohara EM, Galdieri LC, Len CA, Hilario MO. Homocysteine and lipid profile in children with juvenile idiopathic arthritis. Pediatr. Rheumatol. Online J. 5: 2 (2007). *
Gonda TA, Khan SU, Cheng J, Lewis SK, Rubin M, Green PH. Association of intussusception and celiac disease in adults. Dig. Dis. Sci. Dec 24 [Epub ahead of print] (2009). *
Gong JF, Niu LY, Wei XW, Zhu WM, Li N, Li JS. Therapeutic effects of combined enteral nutrition with Tripterygium Wilfordii Polyglycosidium in remission induction of active adult Crohn's disease. Zhonghua Wai Ke Za Zhi 47: 1213-1217 (2009).
Gong Z, Holly EA, Wang F, Chan JM, Bracci PM. Intake of fatty acids and antioxidants and pancreatic cancer in a large population-based case-control study in the San Francisco Bay Area. Int. J. Cancer Jan 26 [Epub ahead of print] (2010). *
Gong Z, Huang C, Sheng X, Zhang Y, Li Q, Wang MW, Peng L, Zang YQ. The role of tanshinone IIA in the treatment of obesity through peroxisome proliferator-activated receptor gamma antagonism. Endocrinology 150: 104-113 (2009). *
Gong Z, Yan S, Zhang P, Huang Y, Wang L. Effects of S-adenosylmethionine on liver methionine metabolism and steatosis with ethanol-induced liver injury in rats. Hepatol. Int. 2: 346-352 (2008). *
Gonzalez S, Huerta JM, Fernandez S, Patterson AM, Lasheras C. The relationship between dietary lipids and cognitive performance in an elderly population. Int. J. Food Sci. Nutr. Dec 14 [Epub ahead of print] (2009). *
Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J. Gastroenterol. 15: 4653-4658 (2009). *
Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M, Abad-Lacruz A, Cabre E, Acero D, Figa M, Guilera M, Humbert P, de Leon R, et al. Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis. Am. J. Gastroenterol. 88: 227-232 (1993).
Gonzalez-Perez O, Moy-Lopez NA, Guzmsn-Muniz J. Alpha-tocopherol and alpha-lipoic acid. An antioxidant synergy with potential for preventive medicine. Rev. Invest. Clin. 60: 58-67 (2008).
Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E, Titos E, Martinez-Clemente M, Lopez-Parra M, Arroyo V, Claria J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 23: 1946-1957 (2009). *
Gonzalez-Periz A, Planaguma A, Gronert K, Miquel R, Lopez-Parra M, Titos E, Horrillo R, Ferre N, Deulofeu R, Arroyo V, Rodes J, Claria J. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 20: 2537-2539 (2006). *
Goodman BP, Mistry DH, Pasha SF, Bosch PE. Copper deficiency myeloneuropathy due to occult celiac disease. Neurologist 15: 355-356 (2009).
Goodman DS. Overview of current knowledge of metabolism of vitamin A and carotenoids. J. Natl. Cancer Inst. 73: 1375-1379 (1984).
Goodnight W, Newman R; for the Society of Maternal-Fetal Medicine. Optimal nutrition for improved twin pregnancy outcome. Obstet. Gynecol. 114: 1121-1134 (2009).
Goodwin B, Gauthier KC, Umetani M, Watson MA, Lochansky MI, Collins JL, Leitersdorf E, Mangelsdorf DJ, Kliewer SA, Repa JJ. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc. Natl. Acad. Sci. U.S.A. 100: 223-228 (2003). *
Goodwin B, Moore JT. CAR: detailing new models. Trends Pharmacol. Sci. 25: 437-441 (2004). *
Gopal DV, Pfau PR, Lucey MR. Endoscopic management of biliary complications after orthotopic liver transplantation. Curr. Treat. Options Gastroenterol. 6: 509-515 (2003).
Gorard DA, Hunt JB, Payne-James JJ, Palmer KR, Rees RG, Clark ML, Farthing MJ, Misiewicz JJ, Silk DB. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 34: 1198-1202 (1993). *
Gorbach SL. Probiotics in the third millennium. Dig. Liver Dis. 34 Suppl. 2: S2-S7 (2002).
Gordon Bell J, Miller D, Macdonald DJ, Mackinlay EE, Dick JR, Cheseldine S, Boyle RM, Graham C, O'Hare AE. The fatty acid compositions of erythrocyte and plasma polar lipids in children with autism, developmental delay or typically developing controls and the effect of fish oil intake. Br. J. Nutr. Dec 9 [Epub ahead of print] (2009). *
Gordon CM, Anderson EJ, Herlyn K, Hubbard JL, Pizzo A, Gelbard R, Lapey A, Merkel PA. Nutrient status of adults with cystic fibrosis. J. Am. Diet. Assoc. 107: 2114-2119 (2007). *
Gordon CM, Feldman HA, Sinclair L, Williams AL, Kleinman PK, Perez-Rossello J, Cox JE. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch. Pediatr. Adolesc. Med. 162: 505-512 (2008).
Gore DC, Chinkes DL, Wolf SE, Sanford AP, Herndon DN, Wolfe RR. Quantification of protein metabolism in vivo for skin, wound, and muscle in severe burn patients. JPEN J. Parenter. Enteral Nutr. 30: 331-338 (2006). *
Gorgun J, Portyanko A, Marakhouski Y, Cherstvoy E. Tissue transglutaminase expression in celiac mucosa: an immunohistochemical study. Virchows Arch. 455: 363-373 (2009). *
Gorgun OV, Portianko AS. Collagenous sprue: a case description. Klin. Med. (Mosk.) 85: 70-72 (2007).
Goswami R, Mondal AM, Tomar N, Ray D, Chattopadhyay P, Gupta N, Sreenivas V. Presence of 25(OH)D deficiency and its effect on vitamin D receptor mRNA expression. Eur. J. Clin. Nutr. 63: 446-449 (2009). *
Goto S, Okada N, Kaneko A, Isemura M. Different effects of all-trans-retinoic acid on phorbol ester-stimulated and phytohemagglutinin-stimulated interleukin-2 expression in human T-cell lymphoma HUT-78 cells. Cell Struct. Funct. 33: 13-19 (2008). *
Gotteland M, Lopez M, Munoz C, Saez R, Altshiller H, Llorens P, Brunser O. Local and systemic liberation of proinflammatory cytokines in ulcerative colitis. Dig. Dis. Sci. 44: 830-835 (1999). *
Gottrand F. Long-chain polyunsaturated fatty acids influence the immune system of infants. J. Nutr. 138: 1807S-1812S (2008). *
Gotua M, Lomidze N, Dolidze N, Gotua T. IgE-mediated food hypersensitivity disorders. Georgian Med. News 157: 39-44 (2008).
Gould KA, Strecker TE, Hansen KK, Bynote KK, Peterson KA, Shull JD. Genetic mapping of loci controlling diethylstilbestrol-induced thymic atrophy in the Brown Norway rat. Mamm. Genome 17: 451-464 (2006). *
Goulet O, Joly F, Corriol O, Colomb-Jung V. Some new insights in intestinal failure-associated liver disease. Curr. Opin. Organ Transplant. 14: 256-261 (2009).
Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology 130: S16-S28 (2006). *
Gounarides JS, Korach-Andre M, Killary K, Argentieri G, Turner O, Laurent D. Effect of dexamethasone on glucose tolerance and fat metabolism in a diet-induced obesity mouse model. Endocrinology 149: 758-766 (2008). *
Gove ME, Pini M, Fayad R, Cabay RJ, Fantuzzi G. Adiponectin deficiency modulates adhesion molecules expression and cytokine production but does not affect disease severity in the transfer model of colitis. Cytokine 47: 119-125 (2009).
Gove ME, Rhodes DH, Pini M, van Baal JW, Sennello JA, Fayad R, Cabay RJ, Myers MG Jr, Fantuzzi G. Role of leptin receptor-induced STAT3 signaling in modulation of intestinal and hepatic inflammation in mice. J. Leukoc. Biol. 85: 491-496 (2009). *
Govers MJ, Van der Meet R. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut 34: 365-370 (1993). *
Gowani SA, Shoukat S, Taqui AM, Hanif HM, Rawasia WF, Qadri Z, Dhakam SH. Secondary prevention of heart disease - knowledge among cardiologists and omega-3 fatty acid prescribing behaviors in Karachi, Pakistan. BMC Cardiovasc. Disord. 9: 4 (2009). *
Goyal S, Gupta P, Ryan CM, Kazlas M, Noviski N, Sheridan RL. Toxic epidermal necrolysis in children: medical, surgical, and ophthalmologic considerations. J. Burn Care Res. 30: 437-449 (2009).
Goyenechea E, Collins LJ, Parra D, Abete I, Crujeiras AB, O'Dell SD, Mart�nez JA. The -11391 G/A polymorphism of the adiponectin gene promoter is associated with metabolic syndrome traits and the outcome of an energy-restricted diet in obese subjects. Horm. Metab. Res. 41: 55-61 (2009).
Goyenechea E, Dolores Parra M, Alfredo Martinez J. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms. Br. J. Nutr. 96: 965-972 (2006). *
Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP. Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am. J. Clin. Nutr. 84: 44-53 (2006). *
Goyette P, Lefebvre C, Ng A, Brant SR, Cho JH, Duerr RH, Silverberg MS, Taylor KD, Latiano A, Aumais G, Deslandres C, Jobin G, Annese V, Daly MJ, Xavier RJ, Rioux JD. Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol. 1: 131-138 (2008). *
Goytain A, Quamme GA. Functional characterization of human SLC41A1, a Mg2+ transporter with similarity to prokaryotic MgtE Mg2+ transporters. Physiol. Genomics 21: 337-342 (2005). *
Goytain A, Quamme GA. Functional characterization of the human solute carrier, SLC41A2. Biochem. Biophys. Res. Commun. 330: 701-705 (2005). *
Gozdzik J, Cofta S, Piorunek T, Batura-Gabryel H, Kosicki J. Relationship between nutritional status and pulmonary function in adult cystic fibrosis patients. J. Physiol. Pharmacol. 59 Suppl. 6: 253-260 (2008).
Gozdzik J, Majka-Sumner L, Cofta S, Nowicka A, Piorunek T, Batura-Gabryel H. Challenges in care of adult CF patients - the specialist cystic fibrosis team. Rocz. Akad. Med. Bialymst. 50 Suppl. 1: 42-45 (2005).
Gracey M, Houghton M, Thomas J. Deoxycholate depresses small-intestinal enzyme activity. Gut 16: 53-56 (1975). *
Gracia MC. A possible cause and corresponding treatment for inflammatory, auto-immune or auto-aggressive diseases. Med. Hypotheses 69: 395-402 (2007).
Gradelet S, Astorg P, Pineau T, Canivenc MC, Siess MH, Leclerc J, Lesca P. Ah receptor-dependent CYP1A induction by two carotenoids, canthaxanthin and beta-apo-8'-carotenal, with no affinity for the TCDD binding site. Biochem. Pharmacol. 54: 307-315 (1997). *
Gradelet S, Leclerc J, Siess MH, Astorg PO. beta-Apo-8'-carotenal, but not beta-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 26: 909-919 (1996).
Graff GR, Maguiness K, McNamara J, Morton R, Boyd D, Beckmann K, Bennett D. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period � Clin. Ther. 32: 89-103 (2010).
Graham RC, Burke A, Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J. Pediatr. Gastroenterol. Nutr. Jul 28 [Epub ahead of print] (2009).
Graham S, Courtois P, Malaisse WJ, Rozing J, Scott FW, Mowat AM. Enteropathy precedes type 1 diabetes in the BB rat. Gut 53: 1437-1444 (2004). *
Gramlich L, Taft AK. Acute pancreatitis: practical considerations in nutrition support. Curr. Gastroenterol. Rep. 9: 323-328 (2007).
Granado-Lorencio F, Herrero-Barbudo C, Olmedilla-Alonso B, Blanco-Navarro I, Perez-Sacristan B. Hypocarotenemia after bariatric surgery: a preliminary study. Obes. Surg. 19: 879-882 (2009).
Granados S, Quiles JL, Gil A, Ramifrez-Tortosa MC. Dietary lipids and cancer. Nutr. Hosp. 21 Suppl. 2: 42-52, 44-54 (2006).
Granell R, Heron J, Lewis S, Smith GD, Sterne JA, Henderson J. The association between mother and child MTHFR C677T polymorphisms, dietary folate intake and childhood atopy in a population-based, longitudinal birth cohort. Clin. Exp. Allergy 38: 320-328 (2008). *
Granito A, Zauli D, Muratori P, Muratori L, Grassi A, Bortolotti R, Petrolini N, Veronesi L, Gionchetti P, Bianchi FB, Volta U. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment. Pharmacol. Ther. 21: 881-887 (2005). *
Grant WB. Epidemiology of disease risks in relation to vitamin D insufficiency. Prog. Biophys. Mol. Biol. 92: 65-79 (2006). *
Grant WB. Hypothesis: ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. Photochem. Photobiol. 84: 356-365 (2008).
Grant WB. Re: Prospective study of vitamin D and cancer mortality in the United States. J. Natl. Cancer Inst. 100: 826 (2008). *
Grant WB. Does vitamin D reduce the risk of dementia? J. Alzheimers Dis. 17: 151-159 (2009).
Grant WB, Cross HS, Garland CF, Gorham ED, Moan J, Peterlik M, Porojnicu AC, Reichrath J, Zittermann A. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog. Biophys. Mol. Biol. 99: 104-113 (2009). *
Grant WB, Garland CF. The health benefits of vitamin D greatly outweigh the health risks. Bioessays 30: 506-507 (2008). *
Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review. Altern. Med. Rev. 10: 94-111 (2005). *
Grant WB, Strange RC, Garland CF. Sunshine is good medicine. The health benefits of ultraviolet-B induced vitamin D production. J. Cosmet. Dermatol. 2: 86-98 (2003).
Grau T, Bonet A, Rubio M, Mateo D, Farre M, Acosta JA, Blesa A, Montejo JC, Garcia de Lorenzo A, Mesejo A. Liver dysfunction associated with artificial nutrition in critically ill patients. Crit. Care 11: R10 (2007). *
Graziani G, D'Argenio G, Tuccillo C, Loguercio C, Ritieni A, Morisco F, Del Vecchio Blanco C, Fogliano V, Romano M. Apple polyphenol extracts prevent damage to human gastric epithelial cells in vitro and to rat gastric mucosa in vivo. Gut 54: 193-200 (2005). *
Green CD, Jump DB, Olson LK. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover. Endocrinology 150: 2637-2645 (2009). *
Green CJ, Mountford V, Hamilton H, Kettlewell MG, Travis SP. A 15-year audit of home parenteral nutrition provision at the John Radcliffe Hospital, Oxford. QJM 101: 365-369 (2008).
Green JT, Liu Z, Bazinet RP. Brain phospholipid arachidonic acid half lives are not altered following 15 weeks of n-3 polyunsaturated fatty acid adequate or deprived diet. J. Lipid Res. Aug 6 [Epub ahead of print] (2009). *
Green P, Anyakoha N, Yadid G, Gispan-Herman I, Nicolaou A. Arachidonic acid-containing phosphatidylcholine species are increased in selected brain regions of a depressive animal model: implications for pathophysiology. Prostaglandins Leukot. Essent. Fatty Acids 80: 213-220 (2009). *
Green PH, Jabri B. Celiac disease. Annu. Rev. Med. 57: 207-221 (2006). *
Green PH, Rostami K, Marsh MN. Diagnosis of coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19: 389-400 (2005).
Green R. Indicators for assessing folate and vitamin B12 status and for monitoring the efficacy of intervention strategies. Food Nutr. Bull. 29: S52-S63 (2008).
Green S. PPAR: a mediator of peroxisome proliferator action. Mutat. Res. 333: 101-109 (1995).
Green TJ, Skeaff CM, McMahon JA, Venn BJ, Williams SM, Devlin AM, Innis SM. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations. Br. J. Nutr. Jan 21 [Epub ahead of print] (2010). *
Greenberg JA, Bell SJ, Ausdal WV. Omega-3 fatty acid supplementation during pregnancy. Rev. Obstet. Gynecol. 1: 162-169 (2008).
Greenberg L. Case management implications of celiac disease. Prof. Case Manag. 13: 211-217 (2008).
Greenberg PD, Cello JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13: 348-354 (1996).
Greene MT, Whitington PF. Outcomes in pediatric autoimmune hepatitis. Curr. Gastroenterol. Rep. 11: 248-251 (2009).
Greenlee H, Kwan ML, Ergas IJ, Sherman KJ, Krathwohl SE, Bonnell C, Lee MM, Kushi LH. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways study. Breast Cancer Res. Treat. 117: 653-665 (2009).
Greenwald P, Kelloff GJ, Boone CW, McDonald SS. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol. Biomarkers Prev. 4: 691-702 (1995). *
Greer JB, Lynch HT, Brand RE. Hereditary pancreatic cancer: a clinical perspective. Best Pract. Res. Clin. Gastroenterol. 23: 159-170 (2009).
Greer JB, Whitcomb DC. Role of BRCA1/2 mutations in pancreatic cancer. Gut 56: 601-605 (2007). *
Greer JB, Whitcomb DC, Brand RE. Genetic predisposition to pancreatic cancer: a brief review. Am. J. Gastroenterol. 102: 2564-2569 (2007). *
Greer RM, Buntain HM, Lewindon PJ, Wainwright CE, Potter JM, Wong JC, Francis PW, Batch JA, Bell SC. Vitamin A levels in patients with CF are influenced by the inflammatory response. J. Cyst. Fibros. 3: 143-149 (2004).
Greger DL, Blum JW. Effects of dexamethasone on mRNA abundance of nuclear receptors and hepatic nuclear receptor target genes in neonatal calves. J. Anim. Physiol. Anim. Nutr. (Berl.) 91: 62-67 (2007). *
Greger DL, Gropp F, Morel C, Sauter S, Blum JW. Nuclear receptor and target gene mRNA abundance in duodenum and colon of dogs with chronic enteropathies. Domest. Anim. Endocrinol. 31: 327-329 (2006). *
Greger DL, Philipona C, Blum JW. Ontogeny of mRNA abundance of nuclear receptors and nuclear receptor target genes in young cattle. Domest. Anim. Endocrinol. 31: 76-87 (2006). *
Gregor JI, Heukamp I, Kilian M, Kiewert C, Schimke I, Kristiansen G, Walz MK, Jacobi CA, Wenger FA. Does enteral nutrition of dietary polyunsaturated fatty acids promote oxidative stress and tumour growth in ductal pancreatic cancer? Experimental trial in Syrian Hamster. Prostaglandins Leukot. Essent. Fatty Acids 74: 67-74 (2006). *
Gregory JF 3rd, Quinlivan EP. In vivo kinetics of folate metabolism. Annu. Rev. Nutr. 22: 199-220 (2002). *
Gregus Z, Fekete T, Halaszi E, Gyurasics A, Klaassen CD. Effects of fibrates on the glycine conjugation of benzoic acid in rats. Drug Metab. Dispos. 26: 1082-1088 (1998). *
Greifer MK, Markowitz JF. Update in the treatment of paediatric ulcerative colitis. Expert Opin. Pharmacother. 7: 1907-1918 (2006).
Gremlich S, Nolan C, Roduit R, Burcelin R, Peyot ML, Delghingaro-Augusto V, Desvergne B, Michalik L, Prentki M, Wahli W. Pancreatic islet adaptation to fasting is dependent on PPARalpha transcriptional up-regulation of fatty acid oxidation. Endocrinology 146: 375-382 (2005). *
Grendell JH. Genetic factors in pancreatitis. Curr. Gastroenterol. Rep. 5: 105-109 (2003).
Grenier E, Schwalm Maupas F, Beaulieu JF, Seidman EG, Delvin E, Sane AT, Tremblay E, Garofalo C, Levy E. Effect of retinoic acid on cell proliferation and differentiation as well as on lipid synthesis, lipoprotein secretion and apolipoprotein biogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1178-G1189 (2007). *
Griel AE, Cao Y, Bagshaw DD, Cifelli AM, Holub B, Kris-Etherton PM. A macadamia nut-rich diet reduces total and LDL-cholesterol in mildly hypercholesterolemic men and women. J. Nutr. 138: 761-767 (2008). *
Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL. An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr. J. 6: 2 (2007). *
Griffin A, Baraho-Hassan D, McSorley SJ. Successful treatment of bacterial infection hinders development of acquired immunity. J. Immunol. 183: 1263-1270 (2009).
Griffin BA. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr. Opin. Lipidol. 19: 57-62 (2008).
Griffin IJ, Kim SC, Hicks PD, Liang LK, Abrams SA. Zinc metabolism in adolescents with Crohn's disease. Pediatr. Res. 56: 235-239 (2004). *
Griffin MD, Sanders TA, Davies IG, Morgan LM, Millward DJ, Lewis F, Slaughter S, Cooper JA, Miller GJ, Griffin BA. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am. J. Clin. Nutr. 84: 1290-1298 (2006). *
Griffiths AM. Enteral feeding in inflammatory bowel disease. Curr. Opin. Clin. Nutr. Metab. Care 9: 314-318 (2006).
Griffiths AM. Anti-TNF therapies have eliminated the need for steroids in pediatric Crohn's disease: con. Why use a drug with an unknown long-term safety profile if more established therapies will be effective? Inflamm. Bowel Dis. 7: 342-344 (2001). *
Griffiths AM. Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently? Dig. Dis. 27: 404-411 (2009).
Griffiths AM. Enteral nutrition in the management of Crohn's disease. JPEN J. Parenter. Enteral Nutr. 29: S108-S117 (2005). *
Grimble GK. Dietary nucleotides and gut mucosal defence. Gut 35: S46-S51 (1994). *
Grimble RF. Nutritional modulation of immune function. Proc. Nutr. Soc. 60: 389-397 (2001). *
Grimble RF. Immunonutrition. Curr. Opin. Gastroenterol. 21: 216-222 (2005).
Grimble RF, Howell WM, O'Reilly G, Turner SJ, Markovic O, Hirrell S, East JM, Calder PC. The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am. J. Clin. Nutr. 76: 454-459 (2002). *
Grimble RF, Tappia PS. Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids. Z. Ernahrungswiss 37 Suppl. 1: 57-65 (1998).
Grimes DS. Are statins analogues of vitamin D? Lancet 368: 83-86 (2006). *
Grimm H, Mayer K, Mayser P, Eigenbrodt E. Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Br. J. Nutr. 87 Suppl. 1: S59-S67 (2002). *
Grimminger F, Fuhrer D, Papavassilis C, Schlotzer E, Mayer K, Heuer KU, Kiss L, Walmrath D, Piberhofer S, Lubbecke F, et al. Influence of intravenous n-3 lipid supplementation on fatty acid profiles and lipid mediator generation in a patient with severe ulcerative colitis. Eur. J. Clin. Invest. 23: 706-715 (1993).
Grimstein C, Choi YK, Satoh M, Lu Y, Wang X, Campbell-Thompson M, Song S. Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis. J. Gene Med. 12: 35-44 (2010).
Grintal B, Champeil-Potokar G, Lavialle M, Vancassel S, Breton S, Denis I. Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid. Neurochem. Int. 54: 535-543 (2009).
Grivceva Stardelova K, Misevska P, Zdravkovska M, Trajkov D, Serafimoski V. Total parenteral nutrition in treatment of patients with inflammatory bowel disease. Prilozi. 29: 21-43 (2008).
Grober J, Zaghini I, Fujii H, Jones SA, Kliewer SA, Willson TM, Ono T, Besnard P. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J. Biol. Chem. 274: 29749-29754 (1999). *
Groen A, Kunne C, Oude Elferink RP. Increased serum concentrations of secondary bile salts during cholate feeding are due to coprophagy. A study with wild-type and Atp8b1-deficient mice. Mol. Pharm. 3: 756-761 (2006). *
Groen AK. The emerging role of bile acids as integrators of intermediary metabolism. J. Hepatol. 45: 337-338 (2006). *
Groen AK, Oude Elferink RP, Verkade HJ, Kuipers F. The ins and outs of reverse cholesterol transport. Ann. Med. 36: 135-145 (2004).
Grogan PM, Katz JS. Inflammatory myopathies. Curr. Treat. Options Neurol. 6: 155-161 (2004).
Grompe M. The pathophysiology and treatment of hereditary tyrosinemia type 1. Semin. Liver Dis. 21: 563-571 (2001).
Gronlund J, Nanto-Salonen K, Venetoklis J, Holmberg RL, Heinonen A, Stahlberg MR. Poor cognitive development and abdominal pain: Wilson's disease. Scand. J. Gastroenterol. 41: 361-364 (2006). *
Gronowitz E, Lorentzon M, Ohlsson C, Mellstrom D, Strandvik B. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis. Br. J. Nutr. 99: 160-167 (2008). *
Groschwitz KR, Ahrens R, Osterfeld H, Gurish MF, Han X, �brink M, Finkelman FD, Pejler G, Hogan SP. Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. Dec 16 [Epub ahead of print] (2009). *
Grosse SD, Boyle CA, Botkin JR, Comeau AM, Kharrazi M, Rosenfeld M, Wilfond BS; CDC. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm. Rep. 53 (RR-13): 1-36 (2004).
Grossman AB, Baldassano RN. Specific considerations in the treatment of pediatric inflammatory bowel disease. Expert Rev. Gastroenterol. Hepatol. 2: 105-124 (2008).
Grossman AB, Mamula P. What is the optimal management approach for pediatric patients with severe ulcerative colitis? Nat. Clin. Pract. Gastroenterol. Hepatol. 5: 542-543 (2008).
Grossman AB, Noble AJ, Mamula P, Baldassano RN. Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger. Inflamm. Bowel Dis. 14: 750-755 (2008). *
Grossman G. Neurological complications of coeliac disease: what is the evidence? Pract. Neurol. 8: 77-89 (2008).
Gruenwald J, Graubaum HJ, Hansen K, Grube B. Efficacy and tolerability of a combination of Lyprinol and high concentrations of EPA and DHA in inflammatory rheumatoid disorders. Adv. Ther. 21: 197-201 (2004).
Grummer MA, Erdman JW Jr. Effect of chronic alcohol consumption and moderate fat diet on vitamin A status in rats fed either vitamin a or beta-carotene. J. Nutr. 113: 350-364 (1983). *
Grun F, Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147: S50-S55 (2006). *
Grun F, Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev. Endocr. Metab. Disord. 8: 161-171 (2007). *
Grungreiff K, Abicht K, Kluge M, Presser HJ, Franke D, Kleine FD, Klauck S, Diete U. Clinical studies on zinc in chronic liver diseases. Z. Gastroenterol. 26: 409-415 (1988).
Grungreiff K, Reinhold D. Liver cirrhosis and "liver" diabetes mellitus are linked by zinc deficiency. Med. Hypotheses 64: 316-317 (2005).
Gruy-Kapral C, Little KH, Fordtran JS, Meziere TL, Hagey LR, Hofmann AF. Conjugated bile acid replacement therapy for short-bowel syndrome. Gastroenterology 116: 15-21 (1999). *
Grzenda-Adamek Z, Przybyszewska K. Celiac disease in a girl with congenital chloride diarrhea: coincidence of 2 diarrheal disorders. J. Pediatr. Gastroenterol. Nutr. 47: 504-506 (2008). *
Grzymislawski M, Derc K, Sobieska M, Wiktorowicz K. Microheterogeneity of acute phase proteins in patients with ulcerative colitis. World J. Gastroenterol. 12: 5191-5195 (2006). *
Gualdrini U, Coraglio M, Filippa L, Masciangioli G, Gutierrez A, Lumi C, Graziano A. Long term functional outcomes after ileoanal pouch in patients with and without postoperative complications. Acta Gastroenterol. Latinoam. 37: 143-149 (2007).
Gualdrini UA, Sambuelli A, Barugel M, Gutierrez A, Avila KC. Prevention of colorectal cancer. Acta Gastroenterol. Latinoam. 35: 104-140 (2005).
Guan X, Karpen HE, Stephens J, Bukowski JT, Niu S, Zhang G, Stoll B, Finegold MJ, Holst JJ, Hadsell DL, Nichols BL, Burrin DG. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130: 150-164 (2006). *
Guan Y. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease. Minerva Urol. Nefrol. 54: 65-79 (2002).
Guandalini S. Probiotics for children: use in diarrhea. J. Clin. Gastroenterol. 40: 244-248 (2006).
Guandalini S. The influence of gluten: weaning recommendations for healthy children and children at risk for celiac disease. Nestle Nutr. Workshop Ser. Pediatr. Program 60: 139-155 (2007).
Guandalini S. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. J. Pediatr. Gastroenterol. Nutr. 41: 366-367 (2005). *
Guandalini S, Gokhale R. Update on immunologic basis of celiac disease. Curr. Opin. Gastroenterol. 17: 545-550 (2001).
Guandalini S, Gokhale R. Update on immunologic basis of celiac disease. Curr. Opin. Gastroenterol. 18: 95-100 (2002).
Guarner F. Studies with inulin-type fructans on intestinal infections, permeability, and inflammation. J. Nutr. 137: 2568S-2571S (2007). *
Guarner F, Casellas F, Borruel N, Antol�n M, Videla S, Vilaseca J, Malagelada JR. Role of microecology in chronic inflammatory bowel diseases. Eur. J. Clin. Nutr. 56 Suppl. 4: S34-S38 (2002). *
Guarner F, Vilaseca J, Malagelada JR. Dietary manipulation in experimental inflammatory bowel disease. Agents Actions Spec. No.: C10-C14 (1992).
Guarnieri G, Biolo G, Zanetti M, Barazzoni R. Chronic systemic inflammation in uremia: potential therapeutic approaches. Semin. Nephrol. 24: 441-445 (2004).
Gubern C, Lopez-Bermejo A, Biarnes J, Vendrell J, Ricart W, Fernandez-Real JM. Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes 55: 216-224 (2006). *
Gudbrandsen OA, Rodr�guez E, Wergedahl H, M�rk S, Reseland JE, Skorve J, Palou A, Berge RK. Trans-10, cis-12-conjugated linoleic acid reduces the hepatic triacylglycerol content and the leptin mRNA level in adipose tissue in obese Zucker fa/fa rats. Br. J. Nutr. 102: 803-815 (2009). *
Gudjonsdottir AH, Nilsson S, Naluai AT, Ek J, Amundsen SS, Wahlstrom J, Ascher H. Association between genotypes and phenotypes in doeliac disease. J. Pediatr. Gastroenterol. Nutr. 49: 165-169 (2009).
Gueant JL, Gueant-Rodriguez RM, Gastin IA, Cornejo-Garcia JA, Viola M, Barbaud A, Mertes PM, Blanca M, Romano A. Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity. Curr. Pharm. Des. 14: 2770-2777 (2008).
Gueant JL, Xiaohong L, Ortiou S, Gerard P, Shue S, Namour F. The association between plasma homocysteine and holo-transcobalamin and the transcobalamin 776C->G polymorphism is influenced by folate in the absence of supplementation and fortified diet. Am. J. Clin. Nutr. 83: 171-172 (2006). *
Gueant-Rodriguez RM, Gueant JL, Debard R, Thirion S, Hong LX, Bronowicki JP, Namour F, Chabi NW, Sanni A, Anello G, Bosco P, Romano C, Amouzou E, Arrieta HR, Sanchez BE, Romano A, Herbeth B, Guilland JC, Mutchinick OM. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am. J. Clin. Nutr. 83: 701-707 (2006). *
Guebre-Egziabher F, Rabasa-Lhoret R, Bonnet F, Bastard JP, Desage M, Skilton MR, Vidal H, Laville M. Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects. Eur. J. Clin. Nutr. 62: 1287-1293 (2008). *
Guerre-Millo M, Rouault C, Poulain P, Andre J, Poitout V, Peters JM, Gonzalez FJ, Fruchart JC, Reach G, Staels B. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50: 2809-2814 (2001). *
Guerreiro CS, Carmona B, Goncalves S, Carolino E, Fidalgo P, Brito M, Leitao CN, Cravo M. Risk of colorectal cancer associated with the C677T polymorphism in 5,10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients. Am. J. Clin. Nutr. 88: 1413-1418 (2008). *
Guerreiro CS, Cravo ML, Brito M, Vidal PM, Fidalgo PO, Leitao CN. The D1822V APC polymorphism interacts with fat, calcium, and fiber intakes in modulating the risk of colorectal cancer in Portuguese persons. Am. J. Clin. Nutr. 85: 1592-1597 (2007). *
Guerreiro CS, Ferreira P, Tavares L, Santos PM, Neves M, Brito M, Cravo M. Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in Crohn's disease. Am. J. Gastroenterol. 104: 2241-2249 (2009). *
Guevel MR, Sirot V, Volatier JL, Leblanc JC. A risk-benefit analysis of French high fish consumption: a QALY approach. Risk Anal. 28: 37-48 (2008). *
Guglielmi FW, Boggio-Bertinet D, Federico A, Forte GB, Guglielmi A, Loguercio C, Mazzuoli S, Merli M, Palmo A, Panella C, Pironi L, Francavilla A. Total parenteral nutrition-related gastroenterological complications. Dig. Liver Dis. 38: 623-642 (2006).
Guglielmi FW, Regano N, Mazzuoli S, Fregnan S, Leogrande G, Guglielmi A, Merli M, Pironi L, Penco JM, Francavilla A. Cholestasis induced by total parenteral nutrition. Clin. Liver Dis. 12: 97-110 (2008).
Guichelaar MM, Kendall R, Malinchoc M, Hay JE. Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl. 12: 1390-1402 (2006). *
Guidetti M, Sforzini A, Bersani G, Corsini C, Grossi G, Zolezzi C, Fasano C, Pironi L. Vitamin A and vitamin E isoforms stability and peroxidation potential of all-in-one admixtures for parenteral nutrition. Int. J. Vitam. Nutr. Res. 78: 156-166 (2008).
Guilbault C, Martin P, Houle D, Boghdady ML, Guiot MC, Marion D, Radzioch D. Cystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection technique. Lab. Anim. 39: 336-352 (2005).
Guilford WG, Matz ME. The nutritional management of gastrointestinal tract disorders in companion animals. N. Z. Vet. J. 51: 284-291 (2003).
Guillen MD, Goicoechea E. Toxic oxygenated alpha,beta-unsaturated aldehydes and their study in foods: a review. Crit. Rev. Food Sci. Nutr. 48: 119-136 (2008).
Guillot M, Amiour M, El Hachem C, Harchaoui S, Ribault V, Paris C. Macrolides, Pseudomonas aeruginosa and cystic fibrosis. Arch. Pediatr. 13 Suppl. 1: S48-S50 (2006).
Guizy M, David M, Arias C, Zhang L, Cofan M, Ruiz-Gutierrez V, Ros E, Lillo MP, Martens JR, Valenzuela C. Modulation of the atrial specific Kv1.5 channel by the n-3 polyunsaturated fatty acid, alpha-linolenic acid. J. Mol. Cell. Cardiol. 44: 323-335 (2008). *
Guja C, Guja L, Nutland S, Rance H, Sebastien M, Todd JA, Ionescu-Tirgoviste C. Type 1 diabetes genetic susceptibility encoded by HLA DQB1 genes in Romania. J. Cell. Mol. Med. 8: 249-256 (2004). *
Guja C, Guja L, Nutland S, Rance H, Todd JA, Ionescu-Tirgoviste C. Strong association of insulin gene INS-VNTR polymorphisms with type 1 diabetes in the Romanian population. Rom. J. Intern. Med. 42: 313-323 (2004).
Guja C, Marshall S, Welsh K, Merriman M, Smith A, Todd JA, Ionescu-Tirgoviste C. The study of CTLA-4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population. J. Cell. Mol. Med. 6: 75-81 (2002). *
Gukovsky I, Lugea A, Shahsahebi M, Cheng JH, Hong PP, Jung YJ, Deng QG, French BA, Lungo W, French SW, Tsukamoto H, Pandol SJ. A rat model reproducing key pathologic responses of alcoholic chronic pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 294: G68-G79 (2008). *
Gulcan M, Ozen A, Karatepe HO, Gulcu D, Vitrinel A. Impact of H. pylori on growth: is the infection or mucosal disease related to growth impairment? Dig. Dis. Sci. Jan 29 [Epub ahead of print] (2010). *
Gullett N, Rossi P, Kucuk O, Johnstone PA. Cancer-induced cachexia: a guide for the oncologist. J. Soc. Integr. Oncol. 7: 155-169 (2009).
Gumpricht E, Dahl R, Devereaux MW, Sokol RJ. Beta-carotene prevents bile acid-induced cytotoxicity in the rat hepatocyte: evidence for an antioxidant and anti-apoptotic role of beta-carotene in vitro. Pediatr. Res. 55: 814-821 (2004). *
Gunerhan Y, Koksal N, Sahin UY, Uzun MA, Eksioglu-Demiralp E. Effect of preoperative immunonutrition and other nutrition models on cellular immune parameters. World J. Gastroenterol. 15: 467-472 (2009). *
Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, Urabe A. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 14: 144-150 (2009). *
Gunnarsdottir I, Tomasson H, Kiely M, Martinez JA, Bandarra NM, Morais MG, Thorsdottir I. Inclusion of fish or fish oil in weight-loss diets for young adults: effects on blood lipids. Int. J. Obes. (Lond.) 32: 1105-1112 (2008). *
Gunnarsson O, Indriethason OS, Franzson L, Halldorsdottir E, Sigurethsson G. Vitamin-D homeostasis amongst adult Icelandic population. Laeknabladid. 90: 29-36 (2004).
Gunsar C, Melek M, Karaca I, Sencan A, Mir E, Ortac R, Canan O. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study. Hepatogastroenterology 49: 497-500 (2002).
Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB Jr, Kliewer SA, Gonzalez FJ, Sinal CJ. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 278: 45062-45071 (2003). *
Guo W, Xie W, Lei T, Hamilton JA. Eicosapentaenoic acid, but not oleic acid, stimulates beta-oxidation in adipocytes. Lipids 40: 815-821 (2005).
Gupta N, Khera S, Vempati RP, Sharma R, Bijlani RL. Effect of yoga based lifestyle intervention on state and trait anxiety. Indian J. Physiol. Pharmacol. 50: 41-47 (2006).
Gupta P, Gokhale R, Kirschner BS. 6-Mercaptopurine metabolite levels in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 33: 450-454 (2001). *
Gupta S, Kuhnisch J, Mustafa A, Lhotak S, Schlachterman A, Slifker MJ, Klein-Szanto A, High KA, Austin RC, Kruger WD. Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J. 23: 883-893 (2009). *
Gupta S, Pandak WM, Hylemon PB. LXR alpha is the dominant regulator of CYP7A1 transcription. Biochem. Biophys. Res. Commun. 293: 338-343 (2002). *
Gupta S, Todd Stravitz R, Pandak WM, Muller M, Reno Vlahcevic Z, Hylemon PB. Regulation of multidrug resistance 2 P-glycoprotein expression by bile salts in rats and in primary cultures of rat hepatocytes. Hepatology 32: 341-347 (2000). *
Gupta SK, Fitzgerald JF, Croffie JM, Pfefferkorn MD, Molleston JP, Corkins MR. Comparison of serological markers of inflammatory bowel disease with clinical diagnosis in children. Inflamm. Bowel Dis. 10: 240-244 (2004). *
Gupta T, Mandot A, Desai D, Abraham P, Joshi A. Celiac crisis with hypokalemic paralysis in a young lady. Indian J. Gastroenterol. 25: 259-260 (2006). *
Gupte AA, Bomhoff GL, Morris JK, Gorres BK, Geiger PC. Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high fat-fed rats. J. Appl. Physiol. 106: 1425-1434 (2009). *
Gupte AR, Draganov PV. Eosinophilic esophagitis. World J. Gastroenterol. 15: 17-24 (2009). *
Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 118: e197-e201 (2006). *
Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 121: e678-e686 (2008). *
Guri AJ, Hontecillas R, Bassaganya-Riera J. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome. J. Nutrigenet. Nutrigenomics 1: 126-135 (2008).
Gursoy S, Guven K, Kula M, Canoz O, Yurci A, Unluhizarci K, Ozbakir O, Yucesoy M. Subclinical alveolar involvement in ulcerative colitis. Inflamm. Bowel Dis. 11: 372-375 (2005). *
Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Gastineau DA, Dietz AB. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro. Oncol. Feb 23 [Epub ahead of print] (2010).
Gustafsson JA. Seeking ligands for lonely orphan receptors. Science 284: 1285-1286 (1999). *
Gustafsson JA. Steroids and the scientist. Mol. Endocrinol. 19: 1412-1417 (2005). *
Gustot T, Lemmers A, Moreno C, Nagy N, Quertinmont E, Nicaise C, Franchimont D, Louis H, Deviere J, Le Moine O. Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43: 989-1000 (2006). *
Gutgesell A, Ringseis R, Brandsch C, Stangl GI, Hirche F, Eder K. Peroxisome proliferator-activated receptor alpha and enzymes of carnitine biosynthesis in the liver are down-regulated during lactation in rats. Metabolism 58: 226-232 (2009). *
Gutierrez A, Ratliff EP, Andres AM, Huang X, McKeehan WL, Davis RA. Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4. Arterioscler. Thromb. Vasc. Biol. 26: 301-306 (2006).
Gutt CN, Brinkmann L, Mehrabi A, Fonouni H, Muller-Stich BP, Vetter G, Stein JM, Schemmer P, Buchler MW. Dietary omega-3-polyunsaturated fatty acids prevent the development of metastases of colon carcinoma in rat liver. Eur. J. Nutr. 46: 279-285 (2007). *
Guttormsen V, Lovik A, Bye A, Bratlie J, Morkrid L, Lundin KE. No induction of anti-avenin IgA by oats in adult, diet-treated coeliac disease. Scand. J. Gastroenterol. 43: 161-165 (2008). *
Guzman M, Lo Verme J, Fu J, Oveisi F, Blazquez C, Piomelli D. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J. Biol. Chem. 279: 27849-27854 (2004). *
Guzy C, Schirbel A, Paclik D, Wiedenmann B, Dignass A, Sturm A. Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro. Eur. J. Nutr. 48: 12-21 (2009). *
Gwyn K, Sinicrope FA. Chemoprevention of colorectal cancer. Am. J. Gastroenterol. 97: 13-21 (2002). *
Gyamfi MA, Damjanov I, French S, Wan YJ. The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury. Biochem. Pharmacol. 75: 981-995 (2008). *
Gyamfi MA, He L, French SW, Damjanov I, Wan YJ. Hepatocyte retinoid X receptor alpha-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury. J. Pharmacol. Exp. Ther. 324: 443-453 (2008). *
Gylling H, Hallikainen M, Nissinen MJ, Miettinen TA. The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins. Clin. Nutr. Aug 25 [Epub ahead of print] (2009).
Ha CL, Woodward B. Depression in the quantity of intestinal secretory IgA and in the expression of the polymeric immunoglobulin receptor in caloric deficiency of the weanling mouse. Lab. Invest. 78: 1255-1266 (1998).
Haag M. Essential fatty acids and the brain. Can. J. Psychiatry 48: 195-203 (2003).
Haas L, McClain C, Varilek G. Complementary and alternative medicine and gastrointestinal diseases. Curr. Opin. Gastroenterol. 16: 188-196 (2000).
Haase H, Rink L. Functional significance of zinc-related signaling pathways in immune cells. Annu. Rev. Nutr. 29: 133-152 (2009). *
Haber B, Ferreira CT, Aw M, Bezerra J, Sturm E, Thompson R, D'Agostino D, McKiernan P; Cholestasis Working Group. Cholestasis: current issues and plan for the future. J. Pediatr. Gastroenterol. Nutr. 47: 220-224 (2008). *
Haber BA, Erlichman J, Thayu M, Flake AW, Rand EB. Successful revision of portoenterostomy in an infant with biliary atresia. J. Pediatr. Surg. 41: e1-e3 (2006).
Habermann N, Christian B, Luckas B, Pool-Zobel BL, Lund EK, Glei M. Effects of fatty acids on metabolism and cell growth of human colon cell lines of different transformation state. Biofactors 35: 460-467 (2009).
Habermann N, Lund EK, Pool-Zobel BL, Glei M. Modulation of gene expression in eicosapentaenoic acid and docosahexaenoic acid treated human colon adenoma cells. Genes Nutr. 4: 73-76 (2009). *
Habermann N, Schon A, Lund EK, Glei M. Fish fatty acids alter markers of apoptosis in colorectal adenoma and adenocarcinoma cell lines but fish consumption has no impact on apoptosis-induction ex vivo. Apoptosis Jan 28 [Epub ahead of print] (2010). *
Habior A, Lewartowska A, Orlowska J, Zych W, Sankowska M, Bauer A, Butruk E. Association of coeliac disease with primary biliary cirrhosis in Poland. Eur. J. Gastroenterol. Hepatol. 15: 159-164 (2003).
Haboubi NY, Jones S. Influence of dietary factors on the clinical course of inflammatory bowel disease. Gut 54: 567 (2005). *
Haboubi NY, Taylor S, Jones S. Coeliac disease and oats: a systematic review. Postgrad. Med. J. 82: 672-678 (2006). *
Hachem SB, Mooradian AD. Familial dyslipidaemias: an overview of genetics, pathophysiology and management. Drugs 66: 1949-1969 (2006).
Hachisu Y, Okamura S, Tanaka H, Tanaka Y, Morita K, Kudo T, Iida T, Kawamura O, Kusano M, Mori M. Crohn's disease complicating psoas abscess treated by drainage and infliximab administration. Nippon Shokakibyo Gakkai Zasshi 106: 1364-1369 (2009).
Hacquebard M, Portois L, Malaisse WJ, Carpentier YA. The metabolic syndrome of omega3-depleted rats. V. Intestinal phospholipid omega6 fatty acids. Int. J. Mol. Med. 24: 867-875 (2009).
Haddad Y, Vallerand D, Brault A, Haddad PS. Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis. Evid. Based Complement. Alternat. Med. Nov 1 [Epub ahead of print] (2009).
Haderslev KV, Tjellesen L, Haderslev PH, Staun M. Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. JPEN J. Parenter. Enteral Nutr. 28: 289-294 (2004). *
Hadithi M, von Blomberg BM, Crusius JB, Bloemena E, Kostense PJ, Meijer JW, Mulder CJ, Stehouwer CD, Pena AS. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann. Intern. Med. 147: 294-302 (2007). *
Hadjiliadis D. Special considerations for patients with cystic fibrosis undergoing lung transplantation. Chest 131: 1224-1231 (2007). *
Hadjiyanni I, Li KK, Drucker DJ. Glucagon like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the non obese diabetic mouse. Endocrinology 150: 592-599 (2009). *
Hadley KB, Ryan AS, Nelson EB, Salem N. An assessment of dietary docosahexaenoic acid requirements for brain accretion and turnover during early childhood. World Rev. Nutr. Diet. 99: 97-104 (2009).
Hadziselimovic F, Geneto R, Buser M. Celiac disease, pregnancy, small for gestational age: role of extravillous trophoblast. Fetal Pediatr. Pathol. 26: 125-134 (2007).
Hafkamp AM, Havinga R, Sinaasappel M, Verkade HJ. Effective oral treatment of unconjugated hyperbilirubinemia in Gunn rats. Hepatology 41: 526-534 (2005). *
Hafstad AD, Khalid AM, Hagve M, Lund T, Larsen TS, Severson DL, Clarke K, Berge RK, Aasum E. Cardiac PPARalpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischemic functional loss. Cardiovasc. Res. 83: 519-526 (2009).
Hagege AA. Management of the patient with chronic coronary artery disease. Rev. Prat. 58: 1541-1548 (2008).
Hagen KB, Byfuglien MG, Falzon L, Olsen SU, Smedslund G. Dietary interventions for rheumatoid arthritis. Cochrane Database Syst. Rev. 1: CD006400 (2009).
Hagerty BP, Schaap FG, Hermann M, Krenn B, Eder C, Dorfmeister B, Stangl H, Patsch W, Strobl W. Changes in hepatic ApoAV expression are not required for the rapid triglyceride lowering effect of fish oil diet in rats. Horm. Metab. Res. 40: 69-71 (2008).
Hages M, Pietrzik K. Assessment of the folate supply in children with regard to cobalamin and iron maintenance. 3: Modification of the supply status by various diseases. Int. J. Vitam. Nutr. Res. 55: 287-294 (1985).
Hagfors L, Nilsson I, Skoldstam L, Johansson G. Fat intake and composition of fatty acids in serum phospholipids in a randomized, controlled, Mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr. Metab. (Lond.) 2: 26 (2005). *
Hagi A, Nakayama M, Miura Y, Yagasaki K. Effects of a fish oil-based emulsion on rat hepatoma cell invasion in culture. Nutrition 23: 871-877 (2007). *
Hagiwara S, Iwasaka H, Shingu C, Noguchi T. Effect of enteral vs. parenteral nutrition on inflammation and cardiac function in a rat model of endotoxin-induced sepsis. Shock 30: 280-284 (2008). *
Hagopian WA, Lernmark A, Rewers MJ, Simell OG, She JX, Ziegler AG, Krischer JP, Akolkar B. TEDDY-The Environmental Determinants of Diabetes in the Young: an observational clinical trial. Ann. N. Y. Acad. Sci. 1079: 320-326 (2006). *
Hague T, Andrews PL, Barker J, Naughton DP. Dietary chelators as antioxidant enzyme mimetics: implications for dietary intervention in neurodegenerative diseases. Behav. Pharmacol. 17: 425-430 (2006).
Haines ML, P Anderson R, Gibson PR. Systematic review: the evidence base for long term management of celiac disease. Aliment. Pharmacol. Ther. 28: 1042-1066 (2008). *
Hait EJ, Barendse RM, Arnold JH, Valim C, Sands BE, Korzenik JR, Fishman LN. Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J. Pediatr. Gastroenterol. Nutr. 48: 61-65 (2009). *
Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J. Food and nutrient intake in relation to mental wellbeing. Nutr. J. 3: 14 (2004). *
Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J. Is low dietary intake of omega-3 fatty acids associated with depression? Am. J. Psychiatry 161: 567-569 (2004). *
Halac U, Alvarez F. Hepatitis: new hope for difficult cases of autoimmune hepatitis. Nat. Rev. Gastroenterol. Hepatol. 6: 629-630 (2009).
Halac U, Dhaybi RA, Powell J, Soglio DB, Alvarez F. Unusual association between autoimmune hepatitis and severe pyoderma gangrenosum. J. Pediatr. Gastroenterol. Nutr. Jul 8 [Epub ahead of print] (2009).
Halevy O, Arazi Y, Melamed D, Friedman A, Sklan D. Retinoic acid receptor-alpha gene expression is modulated by dietary vitamin A and by retinoic acid in chicken T lymphocytes. J. Nutr. 124: 2139-2146 (1994). *
Halfdanarson TR, Litzow MR, Murray JA. Hematological manifestations of celiac disease. Blood 109: 412-421 (2007). *
Halfvarson J, Jess T, Magnuson A, Montgomery SM, Orholm M, Tysk C, Binder V, Jarnerot G. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population. Inflamm. Bowel Dis. 12: 925-933 (2006). *
Halilbasic E, Fickert P, Foirotto R , Marschall HU, Moustafa T, Fuchsbichler A, Gumhold J, Silbert D, Langner C, Maitra U, Denk H , Strazzabosco M, Trauner M. Side-chain-modification critically determines the physiologic and therapeutic properties of 24-nor-ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice and isolated bile duct units. Falk Symposium 165: XX International Bile Acid Meeting. Bile Acid Biology and Therapeutic Actions. June 13-14, 2008, Amsterdam, Netherlands, p. 55 (2008). *
Halilbasic E, Fickert P, Fuchbichler A , Langner C, Gumhold J, Silbert D, Maitra U, Zatloukal K, Denk H, Trauner M. Taurine-conjugation critically determines the therapeutic effectiveness of 24-nor-ursodeoxycholic acid (norUDCA) in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. J. Hepatol. 46: S51 (2007). *
Halilbasic E, Fiorotto R, Fickert P, Marschall HU, Moustafa T, Spirli C, Fuchsbichler A, Gumhold J, Silbert D, Zatloukal K, Langner C, Maitra U, Denk H, Hofmann AF, Strazzabosco M, Trauner M. Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice. Hepatology 49: 1972-1981 (2009). *
Hall DA, Parsons J, Benke T. Paroxysmal nonkinesigenic dystonia and celiac disease. Mov. Disord. 22: 708-710 (2007).
Hall JA, Jha S, Skinner MM, Cherian G. Maternal dietary n-3 fatty acids alter immune cell fatty acid composition and leukotriene production in growing chicks. Prostaglandins Leukot. Essent. Fatty Acids 76: 19-28 (2007). *
Hall JA, Picton RA, Skinner MM, Jewell DE, Wander RC. The (n-3) fatty acid dose, independent of the (n-6) to (n-3) fatty acid ratio, affects the plasma fatty acid profile of normal dogs. J. Nutr. 136: 2338-2344 (2006). *
Hall NJ, Rubin G, Charnock A. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment. Pharmacol. Ther. 30: 315-330 (2009). *
Hall PM. Preventing kidney stones: calcium restriction not warranted. Cleve. Clin. J. Med. 69: 885-888 (2002).
Hall RP 3rd, Benbenisty KM, Mickle C, Takeuchi F, Streilein RD. Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten. J. Invest. Dermatol. 127: 2158-2165 (2007). *
Hall RP 3rd, Owen S, Smith A, Keough M, Bagheri B, Church P, Streilein R. TCR Vbeta expression in the small bowel of patients with dermatitis herpetiformis and gluten sensitive enteropathy. Limited expression in dermatitis herpetiformis and treated asymptomatic gluten sensitive enteropathy. Exp. Dermatol. 9: 275-282 (2000).
Hall RP 3rd, Smith AD, Streilein RD. Increased production of IL-4 by gut T-cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten-sensitive enteropathy. Dig. Dis. Sci. 45: 2036-2043 (2000). *
Hall WL. Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function. Nutr. Res. Rev. 22: 18-38 (2009).
Hallahan B, Hibbeln JR, Davis JM, Garland MR. Omega-3 fatty acid supplementation in patients with recurrent self-harm: single-centre double-blind randomised controlled trial. Br. J. Psychiatry 190: 118-122 (2007). *
Hallberg H, Stahlberg D, Akerlund JE. Ileal pouch-anal anastomosis (IPAA): functional outcome after postoperative pelvic sepsis. A prospective study of 100 patients. Int. J. Colorectal Dis. 20: 529-533 (2005). *
Haller CA, Markowitz J. IBD in children: lessons for adults. Curr. Gastroenterol. Rep. 9: 528-532 (2007).
Haller D. Intestinal epithelial cell signalling and host-derived negative regulators under chronic inflammation: to be or not to be activated determines the balance towards commensal bacteria. Neurogastroenterol. Motil. 18: 184-199 (2006).
Haller D, Antoine JM, Bengmark S, Enck P, Rijkers GT, Lenoir-Wijnkoop I. Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J. Nutr. Jan 27 [Epub ahead of print] (2010).
Haller D, Bode C, Hammes WP, Pfeifer AM, Schiffrin EJ, Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47: 79-87 (2000). *
Hallert C, Bjorck I, Nyman M, Pousette A, Granno C, Svensson H. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm. Bowel Dis. 9: 116-121 (2003). *
Hallert C, Svensson M, Tholstrup J, Hultberg B. Clinical trial: B vitamins improve health in coeliac patients living on a gluten-free diet. Aliment. Pharmacol. Ther. 29: 811-816 (2009). *
Halliwell B. Antioxidants in human health and disease. Annu. Rev. Nutr. 16: 33-50 (1996). *
Hallows KR, Mount PF, Pastor-Soler NM, Power DA. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am. J. Physiol. Renal Physiol. Feb 24 [Epub ahead of print] (2010).
Halpert A, Dalton CB, Palsson O, Morris C, Hu Y, Bangdiwala S, Hankins J, Norton N, Drossman D. What patients know about irritable bowel syndrome (IBS) and what they would like to know. National survey on patient educational needs in IBS and development and validation of the patient educational needs questionnaire (PEQ). Am. J. Gastroenterol. 102: 1972-1982 (2007). *
Halsted CH. Nutrition and alcoholic liver disease. Semin. Liver Dis. 24: 289-304 (2004).
Halsted CH, Villanueva JA, Devlin AM. Folate deficiency, methionine metabolism, and alcoholic liver disease. Alcohol 27: 169-172 (2002). *
Halsted CH, Villanueva JA, Devlin AM, Niemela O, Parkkila S, Garrow TA, Wallock LM, Shigenaga MK, Melnyk S, James SJ. Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proc. Natl. Acad. Sci. U.S.A. 99: 10072-10077 (2002). *
Haluzik MM, Lacinova Z, Dolinkova M, Haluzikova D, Housa D, Horinek A, Vernerova Z, Kumstyrova T, Haluzik M. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels. Endocrinology 147: 4517-4524 (2006). *
Halvorsen B, Staff AC, Ligaarden S, Prydz K, Kolset SO. Lithocholic acid and sulphated lithocholic acid differ in the ability to promote matrix metalloproteinase secretion in the human colon cancer cell line CaCo-2. Biochem. J. 349: 189-193 (2000). *
Hamada T, Egashira N, Nishizono S, Tomoyori H, Nakagiri H, Imaizumi K, Ikeda I. Lymphatic absorption and deposition of various plant sterols in stroke-prone spontaneously hypertensive rats, a strain having a mutation in ATP binding cassette transporter G5. Lipids 42: 241-248 (2007).
Hamada Y. Diabetes and bone health. The relationship between insulin resistance and bone metabolism. Clin. Calcium 19: 1269-1274 (2009).
Hamady ZZ, Scott N, Farrar MD, Lodge PJ, Holland KT, Whitehead TR, Carding SR. Xylan regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus. Gut Sep 7 [Epub ahead of print] (2009).
Hamai H, Keyserman F, Quittell LM, Worgall TS. Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling. J. Lipid Res. 50: 1101-1108 (2009). *
Hamano K, Atsumi S, Hayashi M, Tanuma N, Uchiyama A. Clinical characteristics of ulcerative colitis in four patients with severe motor and intellectual disabilities. No To Hattatsu 39: 214-218 (2007).
Hamaoui E, Hamaoui M. Nutritional assessment and support during pregnancy. Gastroenterol. Clin. North Am. 32: 59-121, v (2003). *
Hamilton C, Seidner DL. Metabolic bone disease and parenteral nutrition. Curr. Gastroenterol. Rep. 6: 335-341 (2004).
Hamilton FA. Health care in minority patients with IBD. Am. J. Gastroenterol. 102: 1350-1351 (2007). *
Hamilton JA, Hillard CJ, Spector AA, Watkins PA. Brain uptake and utilization of fatty acids, lipids and lipoproteins: application to neurological disorders. J. Mol. Neurosci. 33: 2-11 (2007).
Hamilton SR. Targeted therapy of cancer: new roles for pathologists in colorectal cancer. Mod. Pathol. 21 Suppl. 2: S23-S30 (2008).
Hamlin JN, Bloodworth RA, Cardona ST. Regulation of phenylacetic acid degradation genes of Burkholderia cenocepacia K56-2. BMC Microbiol. 9: 222 (2009). *
Hamm CM, Reimers MA, McCullough CK, Gorbe EB, Lu J, Gu CC, Li E, Dieckgraefe BK, Gong Q, Stappenbeck TS, Stone CD, Dietz DW, Hunt SR. NOD2 status and human ileal gene expression. Inflamm. Bowel Dis. Feb 12 [Epub ahead of print] (2010). *
Hammami S, Ghedira Besbes L, Hadded S, Chouchane S, Ben Meriem C, Gueddiche MN. Co-occurrence pulmonary haemosiderosis with coeliac disease in child. Respir. Med. 102: 935-936 (2008).
Hammamieh R, Chakraborty N, Miller SA, Waddy E, Barmada M, Das R, Peel SA, Day AA, Jett M. Differential effects of omega-3 and omega-6 fatty acids on gene expression in breast cancer cells. Breast Cancer Res. Treat. 101: 7-16 (2007). *
Hammana I, Coderre L, Potvin S, Costa M, Berthiaume Y, Lavoie A, Chiasson JL, Levy E, Rabasa-Lhoret R. Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study. J. Cyst. Fibros. 8: 128-134 (2009).
Hammana I, Malet A, Costa M, Brochiero E, Berthiaume Y, Potvin S, Chiasson JL, Coderre L, Rabasa-Lhoret R. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis. Diabetes Metab. 33: 213-219 (2007). *
Hammana I, Potvin S, Tardif A, Berthiaume Y, Coderre L, Rabasa-Lhoret R. Validation of insulin secretion indices in cystic fibrosis patients. J. Cyst. Fibros. 8: 378-381 (2009).
Hammer KD, Hillwig ML, Neighbors JD, Sim YJ, Kohut ML, Wiemer DF, Wurtele ES, Birt DF. Pseudohypericin is necessary for the light-activated inhibition of prostaglandin E2 pathways by a 4 component system mimicking an Hypericum perforatum fraction. Phytochemistry 69: 2354-2362 (2008). *
Hammond BG, Lemen JK, Ahmed G, Miller KD, Kirkpatrick J, Fleeman T. Safety assessment of SDA soybean oil: results of a 28-day gavage study and a 90-day/one generation reproduction feeding study in rats. Regul. Toxicol. Pharmacol. 52: 311-323 (2008).
Hammond BR Jr, Wooten BR, Snodderly DM. Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vision Res. 36: 3003-3009 (1996).
Han DY, Fraser AG, Dryland P, Ferguson LR. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand. Mutat. Res. Sep 11 [Epub ahead of print] (2009).
Han J, Colditz GA, Hunter DJ. Polymorphisms in the MTHFR and VDR genes and skin cancer risk. Carcinogenesis 28: 390-397 (2007). *
Han J, Zhou X, He W, Huang Z, Gotto AM Jr, Hajjar DP. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression: a new SREBP1 dependent mechanism. J. Biol. Chem. 283: 2129-2138 (2008). *
Han S, Sun X, Ritzenthaler JD, Roman J. Fish oil inhibits human lung carcinoma cell growth by suppressing integrin-linked kinase. Mol. Cancer Res. 7: 108-117 (2009). *
Han SH, Lee OY, Eun CS, Roh BJ, Sohn W, Baeg SS, Yoon BC, Choi HS. A case of protein-losing enteropathy associated with small bowel villous atrophy. Korean J. Gastroenterol. 49: 31-36 (2007).
Han W, Mercenier A, Ait-Belgnaoui A, Pavan S, Lamine F, van Swam II, Kleerebezem M, Salvador-Cartier C, Hisbergues M, Bueno L, Theodorou V, Fioramonti J. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm. Bowel Dis. 12: 1044-1052 (2006). *
Han X, Uchida K, Jurickova I, Koch D, Willson T, Samson C, Bonkowski E, Trauernicht A, Kim MO, Tomer G, Dubinsky M, Plevy S, Kugathsan S, Trapnell BC, Denson LA. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology 136: 1261-1271.e3 (2009). *
Hanauer SB. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis. Aliment. Pharmacol. Ther. 24 Suppl. 3: 37-40 (2006). *
Hanauer SB. Natalizumab, anti-IL-12, alicaforsen, plasmapheresis, protease inhibitors, phosphodiesterase inhibitors (past). Inflamm. Bowel Dis. 12 Suppl. 3: S7-S8 (2006).
Hanauer SB. New biologicals for inflammatory bowel disease. Gastroenterology & Hepatology Annual Review Vol. 1, June 2006, p. 67-71 (2006). *
Hanauer SB. Medical therapy for ulcerative colitis. Curr. Opin. Gastroenterol. 16: 324-328 (2000).
Hanauer SB. Turning traditional treatment strategies on their heads: current evidence for "step-up" versus "top-down". Rev. Gastroenterol. Disord. 7 Suppl. 2: S17-S22 (2007).
Hanauer SB. Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk? Gut 56: 1181-1183 (2007). *
Hanauer SB. Review article: evolving concepts in treatment and disease modification in ulcerative colitis. Aliment. Pharmacol. Ther. 27 Suppl. 1: 15-21 (2008).
Hanauer SB. The role of loperamide in gastrointestinal disorders. Rev. Gastroenterol. Disord. 8: 15-20 (2008).
Hanauer SB. Positioning biologic agents in the treatment of Crohn's disease. Inflamm. Bowel Dis. 15: 1570-1582 (2009).
Hanauer SB. Medical management of Crohn's disease: treatment algorithms 2009. Dig. Dis. 27: 536-541 (2009).
Hanauer SB. Update on medical management of inflammatory bowel disease: ulcerative colitis. Rev. Gastroenterol. Disord. 1: 169-176 (2001). *
Hanauer SB. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies. Rev. Gastroenterol. Disord. 4 Suppl. 3: S18-S24 (2004). *
Hanauer SB. Assessing the risk of lymphomas in inflammatory bowel disease. Rev. Gastroenterol. Disord. 3: 50-51 (2003). *
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359: 1541-1549 (2002). *
Hanauer SB, Present DH. The state of the art in the management of inflammatory bowel disease. Rev. Gastroenterol. Disord. 3: 81-92 (2003). *
Hanauer SB, Present DH, Wolf JL, Jones WK, Marts SA. The state of the art in the management of inflammatory bowel disease. Based on the proceedings of a roundtable held December 12-13, 2001. Clinician 20: 1-31 (2002). *
Hanauer SB, Sandborn WJ. Refining the role of TNF antagonists for Crohn's disease. Rev. Gastroenterol. Disord. 7 Suppl. 1: S1-S2 (2007).
Hanauer SB, Sparrow M. COLAL-PRED Alizyme. Curr. Opin. Investig. Drugs 5: 1192-1197 (2004).
Hanbauer I, Rivero-Covelo I, Maloku E, Baca A, Hu Q, Hibbeln JR, Davis JM. The decrease of n-3 fatty acid energy percentage in an equicaloric diet fed to B6C3Fe mice for three generations elicits obesity. Cardiovasc. Psychiatry Neurol. 2009: 867041 (2009).
Hance KW, Rogers CJ, Hursting SD, Greiner JW. Combination of physical activity, nutrition, or other metabolic factors and vaccine response. Front. Biosci. 12: 4997-5029 (2007).
Hanck C, Schneider A, Whitcomb DC. Genetic polymorphisms in alcoholic pancreatitis. Best Pract. Res. Clin. Gastroenterol. 17: 613-623 (2003).
Hancock CR, Han DH, Chen M, Terada S, Yasuda T, Wright DC, Holloszy JO. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc. Natl. Acad. Sci. U.S.A. 105: 7815-7820 (2008). *
Hancock R, Koren G. Celiac disease during pregnancy. Can. Fam. Physician 50: 1361-1363 (2004).
Handelsman B, Bonorris G, Marks JW, Schoenfield LJ. Enrichment of bile with tauroursodeoxycholic acid and biliary cholesterol saturation in hamsters. Am. J. Physiol. 243: G424-G427 (1982).
Hanebutt FL, Demmelmair H, Schiessl B, Larque E, Koletzko B. Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin. Nutr. 27: 685-693 (2008).
Hanje AJ, Fortune B, Song M, Hill D, McClain C. The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutr. Clin. Pract. 21: 255-272 (2006). *
Hankard R, Munck A, Navarro J. Nutrition and growth in cystic fibrosis. Horm. Res. 58 Suppl. 1: 16-20 (2002).
Hankey GL, Holmes GK. Coeliac disease in the elderly. Gut 35: 65-67 (1994). *
Hanna MK, Kudsk KA. Nutritional and pharmacological enhancement of gut-associated lymphoid tissue. Can. J. Gastroenterol. 14 Suppl. D: 145D-151D (2000).
Hanniman EA, Lambert G, McCarthy TC, Sinal CJ. Loss of functional farnesoid X-receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice. J. Lipid Res. 46: 2595-2604 (2005). *
Hannon TS, Dimeglio LA, Pfefferkorn MD, Denne SC. Acute effects of enteral nutrition on protein turnover in adolescents with Crohn disease. Pediatr. Res. 61: 356-360 (2007). *
Hansen D, Brock-Jacobsen B, Lund E, Bjorn C, Hansen LP, Nielsen C, Fenger C, Lillevang ST, Husby S. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years' follow-up. Diabetes Care 29: 2452-2456 (2006). *
Hansen D, Brock-Jacobsen B, Lund E, Bjorn C, Hansen LP, Nielsen C, Fenger C, Lillevang ST, Husby S. Prevalence of coeliac disease (CD) in children with type 1 diabetes (T1D). Ugeskr. Laeger. 169: 2029-2032 (2007).
Hansen GH, Niels-Christiansen LL, Immerdal L, Nystrom BT, Danielsen EM. Intestinal alkaline phosphatase: selective endocytosis from the enterocyte brush border during fat absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G1325-G1332 (2007). *
Hansen HS, Artmann A. Endocannabinoids and nutrition. J. Neuroendocrinol. 20 Suppl. 1: 94-99 (2008).
Hansen RA, Harris MA, Pluhar GE, Motta T, Brevard S, Ogilvie GK, Fettman MJ, Allen KG. Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease. J. Nutr. Biochem. 19: 101-108 (2008). *
Hansen SN, Harris WS. New evidence for the cardiovascular benefits of long chain omega-3 fatty acids. Curr. Atheroscler. Rep. 9: 434-440 (2007).
Hansmann G, Wagner RA, Schellong S, de Jesus Perez VA, Urashima T, Wang L, Sheikh AY, Suen RS, Stewart DJ, Rabinovitch M. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation 115: 1275-1284 (2007). *
Hao J, Shen W, Yu G, Jia H, Li X, Feng Z, Wang Y, Weber P, Wertz K, Sharman E, Liu J. Hydroxytyrosol promotes mitochondrial biogenesis and mitochondrial function in 3T3-L1 adipocytes. J. Nutr. Biochem. Jul 1 [Epub ahead of print] (2009). *
Harach HR, Ceballos GA. Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model. Endocr. Pathol. 19: 209-220 (2008).
Harada LM, Amigo L, Cazita PM, Salerno AG, Rigotti AA, Quintao EC, Oliveira HC. CETP expression enhances liver HDL-cholesteryl ester uptake but does not alter VLDL and biliary lipid secretion. Atherosclerosis 191: 313-318 (2007).
Harada M, Strnad P, Resurreccion EZ, Ku NO, Omary MB. Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation. Hepatology 45: 88-96 (2007). *
Harada N, Kusuyama A, Morishima M, Okada K, Takahashi A, Nakaya Y. Bezafibrate improves bacterial lipopolysaccharide-induced dyslipidemia and anorexia in rats. Metabolism 56: 517-522 (2007). *
Harano Y, Yasui K, Toyama T, Nakajima T, Mitsuyoshi H, Mimani M, Hirasawa T, Itoh Y, Okanoue T. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. Liver Int. 26: 613-620 (2006). *
Harbige LS. Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proc. Nutr. Soc. 57: 555-562 (1998). *
Harbige LS. Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38: 323-341 (2003).
Hardin DS, Adams-Huet B, Brown D, Chatfield B, Dyson M, Ferkol T, Howenstine M, Prestidge C, Royce F, Rice J, Seilheimer DK, Steelman J, Shepherd R. Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis - results of a multicenter randomized controlled trial. J. Clin. Endocrinol. Metab. 91: 4925-4929 (2006). *
Harding SV, Adegoke OA, Fraser KG, Marliss EB, Chevalier S, Kimball SR, Jefferson LS, Wykes LJ. Maintaining adequate nutrition, not probiotic administration, prevents growth stunting and maintains skeletal muscle protein synthesis rates in a piglet model of colitis. Pediatr. Res. Nov 25 [Epub ahead of print] (2009).
Hardison WG, Grundy SM. Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption. Gastroenterology 87: 130-135 (1984).
Hardman WE. (n-3) Fatty acids and cancer therapy. J. Nutr. 134: 3427S-3430S (2004). *
Hardy G. Manganese in parenteral nutrition: who, when, and why should we supplement? Gastroenterology 137: S29-S35 (2009). *
Hardy G, Puzovic M. Formulation, stability, and administration of parenteral nutrition with new lipid emulsions. Nutr. Clin. Pract. 24: 616-625 (2009). *
Harissi-Dagher M, Khan BF, Schaumberg DA, Dohlman CH. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea 26: 564-568 (2007).
Harjes CE, Rocheford TR, Bai L, Brutnell TP, Kandianis CB, Sowinski SG, Stapleton AE, Vallabhaneni R, Williams M, Wurtzel ET, Yan J, Buckler ES. Natural genetic variation in lycopene epsilon cyclase tapped for maize biofortification. Science 319: 330-333 (2008). *
Harle L, Brown T, Laheru D, Dobs AS. Omega-3 fatty acids for the treatment of cancer cachexia: issues in designing clinical trials of dietary supplements. J. Altern. Complement. Med. 11: 1039-1046 (2005).
Harms B, Bremner AR, Mulligan J, Fairhurst J, Griffiths DM, Salmon T, Beattie RM. Crohn's disease post-cardiac transplantation presenting with severe growth failure and delayed onset of puberty. Pediatr. Allergy Immunol. 15: 186-189 (2004). *
Harnack K, Andersen G, Somoza V. Quantitation of alpha-linolenic acid elongation to eicosapentaenoic and docosahexaenoic acid as affected by the ratio of n6/n3 fatty acids. Nutr. Metab. (Lond.) 6: 8 (2009). *
Harpavat M, Greenspan SL, O'Brien C, Chang CC, Bowen A, Keljo DJ. Altered bone mass in children at diagnosis of Crohn disease: a pilot study. J. Pediatr. Gastroenterol. Nutr. 40: 295-300 (2005). *
Harpavat M, Keljo DJ, Regueiro MD. Metabolic bone disease in inflammatory bowel disease. J. Clin. Gastroenterol. 38: 218-224 (2004).
Harpaz N, Schiano T, Ruf AE, Shukla D, Tao Y, Fishbein TM, Sauter BV, Gondolesi GE. Early and frequent histological recurrence of Crohn's disease in small intestinal allografts. Transplantation 80: 1667-1670 (2005).
Harper CR, Edwards MJ, Defilipis AP, Jacobson TA. Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans. J. Nutr. 136: 83-87 (2006). *
Harper E, Moses H, Lagrange A. Occult celiac disease presenting as epilepsy and MRI changes that responded to gluten-free diet. Neurology 68: 533-534 (2007).
Harper JW, Holleran SF, Ramakrishnan R, Bhagat G, Green PH. Anemia in celiac disease is multifactorial in etiology. Am. J. Hematol. 82: 996-1000 (2007). *
Harrell LE, Hanauer SB. Mesalamine derivatives in the treatment of Crohn's disease. Gastroenterol. Clin. North Am. 33: 303-317 (2004).
Harrell LE, Rubin DT, Hanauer SB. Fever and right upper quadrant pain in a pregnant woman at 30 weeks' gestation. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 113-116 (2004). *
Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 26: 1197-1203 (1985). *
Harrington WW, S Britt C, G Wilson J, O Milliken N, G Binz J, C Lobe D, R Oliver W, C Lewis M, M Ignar D. The effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan agonists on body weight, body mass, and serum lipid profiles in diet-induced obese AKR/J mice. PPAR Res. 2007: 97125 (2007). *
Harris JE, Lammerding AM. Crohn's disease and Mycobacterium avium subsp. paratuberculosis: current issues. J. Food Prot. 64: 2103-2110 (2001).
Harris KM, Fasano A, Mann DL. Monocytes differentiated with IL-15 support Th17 and Th1 responses to wheat gliadin: implications for celiac disease. Clin. Immunol. Feb 10 [Epub ahead of print] (2010). *
Harris W. Omega-6 and omega-3 fatty acids: partners in prevention. Curr. Opin. Clin. Nutr. Metab. Care 13: 125-129 (2010).
Harris WS. The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses. Curr. Atheroscler. Rep. 8: 453-459 (2006).
Harris WS. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol. Res. 55: 217-223 (2007). *
Harris WS. The omega-3 index as a risk factor for coronary heart disease. Am. J. Clin. Nutr. 87: 1997S-2002S (2008). *
Harris WS. Does treatment with eicosapentaenoic acid prevent major coronary events in patients with hypercholesterolemia? Nat. Clin. Pract. Cardiovasc. Med. 4: 532-533 (2007).
Harris WS, Dirienzo MA, Sands SA, George C, Jones PG, Eapen AK. Stearidonic acid increases the red blood cell and heart eicosapentaenoic acid content in dogs. Lipids 42: 325-333 (2007).
Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr. Atheroscler. Rep. 10: 503-509 (2008).
Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197: 12-24 (2008).
Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, Cunnane SC, Holden JM, Klurfeld DM, Morris MC, Whelan J. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J. Nutr. 139: 804S-819S (2009). *
Harris WS, Thomas RM. Biological variability of blood omega-3 biomarkers. Clin. Biochem. Sep 2 [Epub ahead of print] (2009). *
Harrison J, Hanauer SB. Medical treatment of Crohn's disease. Gastroenterol. Clin. North Am. 31: 167-184, x (2002).
Harrison J, McKiernan J, Neuberger JM. A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl. Int. 10: 369-374 (1997).
Harrison MS, Wehbi M, Obideen K. Celiac disease: more common than you think. Cleve. Clin. J. Med. 74: 209-215 (2007). *
Harrison SA. Non-alcoholic steatohepatitis. Preface. Clin. Liver Dis. 13: xiii-xiv (2009). *
Harrison SA, Day CP. Benefits of lifestyle modification in NAFLD. Gut 56: 1760-1769 (2007). *
Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology 49: 80-86 (2009). *
Harrison-Findik DD, Klein E, Evans J, Gollan J. Regulation of liver hepcidin expression by alcohol in vivo does not involve Kupffer cell activation or TNF-alpha signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G112-G118 (2009). *
Harsha WT, Kalandarova E, McNutt P, Irwin R, Noel J. Nutritional supplementation with transforming growth factor-beta, glutamine, and short chain fatty acids minimizes methotrexate-induced injury. J. Pediatr. Gastroenterol. Nutr. 42: 53-58 (2006). *
Hart AR, Eaden J, Barnett S, de Bono AM, Mayberry JF. Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme. J. Epidemiol. Community Health 52: 818-820 (1998). *
Hart AR, Luben R, Olsen A, Tjonneland A, Linseisen J, Nagel G, Berglund G, Lindgren S, Grip O, Key T, Appleby P, Bergmann MM, Boeing H, Hallmans G, Danielsson A, Palmqvist R, Sjodin H, Hagglund G, Overvad K, Palli D, Masala G, Riboli E, Kennedy H, et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion 77: 57-64 (2008). *
Hart AR; The IBD in EPIC Study Investigators. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis - a European prospective cohort study. Gut 58: 1606-1611 (2009). *
Hartkorn A, Hoffmann F, Ajamieh H, Vogel S, Heilmann J, Gerbes AL, Vollmar AM, Zahler S. Antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury. J. Nat. Prod. 72: 1741-1747 (2009).
Hartl WH, Jauch KW, Parhofer K, Rittler P; Working group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine. Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11. Ger. Med. Sci. 7: Doc17 (2009).
Hartman C, Berkowitz D, Weiss B, Shaoul R, Levine A, Adiv OE, Shapira R, Fradkin A, Wilschanski M, Tamir A, Shamir R. Nutritional supplementation with polymeric diet enriched with transforming growth factor-beta 2 for children with Crohn's disease. Isr. Med. Assoc. J. 10: 503-507 (2008). *
Hartman C, Eliakim R, Shamir R. Nutritional status and nutritional therapy in inflammatory bowel diseases. World J. Gastroenterol. 15: 2570-2578 (2009). *
Hartman C, Eliakim R, Shamir R. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease. Isr. Med. Assoc. J. 6: 221-226 (2004). *
Hartman HB, Gardell SJ, Petucci CJ, Wang S, Krueger JA, Evans MJ. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR-/- and apoE-/- mice. J. Lipid Res. 50: 1090-1100 (2009). *
Hartman HB, Lai K, Evans MJ. Loss of small heterodimer partner expression in the liver protects against dyslipidemia. J. Lipid Res. 50: 193-203 (2009). *
Hartog A, Leenders I, van der Kraan PM, Garssen J. Anti-inflammatory effects of orally ingested lactoferrin and glycine in different zymosan-induced inflammation models: evidence for synergistic activity. Int. Immunopharmacol. 7: 1784-1792 (2007).
Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 368: 1795-1809 (2006). *
Hartweg J, Farmer AJ, Holman RR, Neil HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia 50: 250-258 (2007). *
Hartweg J, Farmer AJ, Perera R, Holman RR, Neil HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia 50: 1593-1602 (2007). *
Hartweg J, Perera R, Montori V, Dinneen S, Neil H, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 1: CD003205 (2008). *
Hartwich J, Malec MM, Partyka L, Perez-Martinez P, Marin C, Lopez-Miranda J, Tierney AC, Monagle JM, Roche HM, Defoort C, Wolkow P, Dembinska-Kiec A. The effect of the plasma n-3/n-6 polyunsaturated fatty acid ratio on the dietary LDL phenotype transformation - insights from the LIPGENE study. Clin. Nutr. 28: 510-515 (2009).
Haruta I, Hashimoto E, Shibata N, Kato Y, Kobayashi M, Shiratori K. Lipoteichoic acid may affect the pathogenesis of PBC-like bile duct damage and might be involved in systemic multifocal epithelial inflammations in chronic colitis-harboring TCRalpha-/-xAIM-/- mice. Autoimmunity 40: 372-379 (2007). *
Harzallah F, Daoud I, Bouzid C, Oueslati A, Kanoun F, Slimane H. Celiac disease revealed by hypocalcemia complicating total thyroidectomy: a case report. Ann. Endocrinol. (Paris) 67: 357-359 (2006).
Haseeb A, Iliyas M, Chakrabarti S, Farooqui AA, Naik SR, Ghosh S, Suragani M, Ehtesham NZ. Single-nucleotide polymorphisms in peroxisome proliferator-activated receptor gamma and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population. J. Biosci. 34: 405-414 (2009). *
Hasenboehler E, Williams A, Leinhase I, Morgan SJ, Smith WR, Moore EE, Stahel PF. Metabolic changes after polytrauma: an imperative for early nutritional support. World J. Emerg. Surg. 1: 29 (2006). *
Hashem RM, Mahmoud MF, El-Moselhy MA, Soliman HM. Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis. Eur. J. Gastroenterol. Hepatol. 20: 995-1001 (2008).
Hashimoto K, Cohen RN, Yamada M, Markan KR, Monden T, Satoh T, Mori M, Wondisford FE. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J. Biol. Chem. 281: 295-302 (2006). *
Hashimoto M, Hossain S, Shido O. Docosahexaenoic acid but not eicosapentaenoic acid withstands dietary cholesterol-induced decreases in platelet membrane fluidity. Mol. Cell. Biochem. 293: 1-8 (2006). *
Hashimoto T, Shimizu N, Kimura T, Takahashi Y, Ide T. Polyunsaturated fats attenuate the dietary phytol-induced increase in hepatic fatty acid oxidation in mice. J. Nutr. 136: 882-886 (2006). *
Hasio AC, Chen JJ, Chung WL, Su HM. Effect of brain DHA levels on cytoskeleton expression. Asia Pac. J. Clin. Nutr. 17 Suppl. 1: 158-161 (2008).
Haskey N, Dahl WJ. Synbiotic therapy: a promising new adjunctive therapy for ulcerative colitis. Nutr. Rev. 64: 132-138 (2006).
Hasler WL. Lysine as a serotonin receptor antagonist: using the diet to modulate gut function. Gastroenterology 127: 1004-1006 (2004). *
Hassan IR, Gronert K. Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J. Immunol. 182: 3223-3232 (2009).
Hassanali Z, Ametaj B, Field CJ, Proctor SD, Vine DF. Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat. Diabetes Obes. Metab. Nov 16 [Epub ahead of print] (2009).
Hatano E, Tanaka A, Kanazawa A, Tsuyuki S, Tsunekawa S, Iwata S, Takahashi R, Chance B, Yamaoka Y. Inhibition of tumor necrosis factor-induced apoptosis in transgenic mouse liver expressing creatine kinase. Liver Int. 24: 384-393 (2004). *
Hatch EE, Nelson JW, Stahlhut RW, Webster TF. Association of endocrine disruptors and obesity: perspectives from epidemiological studies. Int. J. Androl. Jan 22 [Epub ahead of print] (2010).
Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell. Mol. Life Sci. 65: 1631-1652 (2008). *
Hattingh Z, Walsh CM, Bester CJ, Oguntibeju OO. An analysis of dietary micronutrient intakes in two age groups of black South African women. West Indian Med. J. 57: 431-437 (2008).
Hatzoglou M, Lamers W, Bosch F, Wynshaw-Boris A, Clapp DW, Hanson RW. Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase. J. Biol. Chem. 265: 17285-17293 (1990). *
Hauenschild A, Bretzel RG, Schnell-Kretschmer H, Kloer HU, Hardt PD, Ewald N. Successful treatment of severe hypertriglyceridemia with a formula diet rich in omega-3 fatty acids and medium-chain triglycerides. Ann. Nutr. Metab. 56: 170-175 (2010).
Haug A, Hostmark AT, Harstad OM. Bovine milk in human nutrition - a review. Lipids Health Dis. 6: 25 (2007). *
Haugaard SB, Madsbad S, Hoy CE, Vaag A. Dietary intervention increases n-3 long-chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity. Clin. Endocrinol. (Oxf.) 64: 169-178 (2006). *
Haugaard SB, Vaag A, Mu H, Madsbad S. Skeletal muscle structural lipids improve during weight-maintenance after a very low calorie dietary intervention. Lipids Health Dis. 8: 34 (2009). *
Haugen BR, Jensen DR, Sharma V, Pulawa LK, Hays WR, Krezel W, Chambon P, Eckel RH. Retinoid X receptor gamma-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet. Endocrinology 145: 3679-3685 (2004). *
Haugen F, Drevon CA. Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 148: 5478-5486 (2007). *
Haugen M, Brantsaeter AL, Alexander J, Meltzer HM. Dietary supplements contribute substantially to the total nutrient intake in pregnant Norwegian women. Ann. Nutr. Metab. 52: 272-280 (2008). *
Hauser R, Duty S, Godfrey-Bailey L, Calafat AM. Medications as a source of human exposure to phthalates. Environ. Health Perspect. 112: 751-753 (2004). *
Hauser W, Dietz N, Grandt D, Steder-Neukamm U, Janke KH, Stein U, Stallmach A. Validation of the inflammatory bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis. Z. Gastroenterol. 42: 131-139 (2004).
Hauser W, Dietz N, Steder-Neukamm U, Janke KH, Stallmach A. Biopsychosocial determinants of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis. Inflamm. Bowel Dis. 10: 399-407 (2004). *
Hauser W, Gold J, Stein J, Caspary WF, Stallmach A. Health-related quality of life in adult coeliac disease in Germany: results of a national survey. Eur. J. Gastroenterol. Hepatol. 18: 747-754 (2006).
Hauser W, Musial F, Caspary WF, Stein J, Stallmach A. Predictors of irritable bowel-type symptoms and healthcare-seeking behavior among adults with celiac disease. Psychosom. Med. 69: 370-376 (2007).
Hauser W, Stallmach A, Caspary WF, Stein J. Predictors of reduced health-related quality of life in adults with coeliac disease. Aliment. Pharmacol. Ther. 25: 569-578 (2007). *
Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh JC, Slater S, Jurutka PW. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr. Rev. 66: S98-S112 (2008). *
Haussmann J, Sekar A. Chronic urticaria: a cutaneous manifestation of celiac disease. Can. J. Gastroenterol. 20: 291-293 (2006). *
Hauzeur JP, Malaise M, Gangji V. Osteonecrosis in inflammatory bowel diseases: a review of the literature. Acta Gastroenterol. Belg. 72: 327-334 (2009).
Havermans T, Colpaert K, Vanharen L, Dupont LJ. Health related quality of life in cystic fibrosis: to work or not to work? J. Cyst. Fibros. 8: 218-223 (2009).
Havrda DE, Rathbun S, Scheid D. A case report of warfarin resistance due to azathioprine and review of the literature. Pharmacotherapy 21: 355-357 (2001).
Hawrelak JA, Myers SP. The causes of intestinal dysbiosis: a review. Altern. Med. Rev. 9: 180-197 (2004). *
Hawryluk EB, English JC 3rd. Female adolescent hair disorders. J. Pediatr. Adolesc. Gynecol. 22: 271-281 (2009).
Hawthorne KM, Abrams SA, Heird WC. Docosahexaenoic acid (DHA) supplementation of orange juice increases plasma phospholipid DHA content of children. J. Am. Diet. Assoc. 109: 708-712 (2009). *
Hay JE, Wiesner RH, Shorter RG, LaRusso NF, Baldus WP. Primary sclerosing cholangitis and celiac disease. A novel association. Ann. Intern. Med. 109: 713-717 (1988).
Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc. Nutr. Soc. 59: 531-535 (2000). *
Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell. Mol. Biol. (Noisy-le-grand) 49: 277-300 (2003).
He H, Yang D, Ma L, Luo Z, Ma S, Feng X, Cao T, Yan Z, Liu D, Tepel M, Zhu Z. Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways. Hypertension Feb 22 [Epub ahead of print] (2010).
He K. Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease - eat fish or take fish oil supplement? Prog. Cardiovasc. Dis. 52: 95-114 (2009).
He K, Liu K, Daviglus ML, Jenny NS, Mayer-Davis E, Jiang R, Steffen L, Siscovick D, Tsai M, Herrington D. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of inflammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am. J. Cardiol. 103: 1238-1243 (2009).
He K, Liu K, Daviglus ML, Mayer-Davis E, Jenny NS, Jiang R, Ouyang P, Steffen LM, Siscovick D, Wu C, Barr RG, Tsai M, Burke GL. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am. J. Clin. Nutr. 88: 1111-1118 (2008). *
He W. PPARgamma2 polymorphism and human health. PPAR Res. 2009: 849538 (2009). *
Head K, Jurenka JS. Inflammatory bowel disease part II: Crohn's disease - pathophysiology and conventional and alternative treatment options. Altern. Med. Rev. 9: 360-401 (2004). *
Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics 121: 703-710 (2008). *
Healy E, Newell L, Howarth P, Friedmann PS. Control of salicylate intolerance with fish oils. Br. J. Dermatol. 159: 1368-1369 (2008). *
Heap GA, van Heel DA. Genetics and pathogenesis of coeliac disease. Semin. Immunol. 21: 346-354 (2009). *
Heath ML, Sidbury R. Cutaneous manifestations of nutritional deficiency. Curr. Opin. Pediatr. 18: 417-422 (2006).
Heath RB, Karpe F, Milne RW, Burdge GC, Wootton S, Frayn KN. Dietary fatty acids make a rapid and substantial contribution to VLDL-triacylglycerol in the fed state. Am. J. Physiol. Endocrinol. Metab. 292: E732-E739 (2007). *
Hebbachi AM, Knight BL, Wiggins D, Patel DD, Gibbons GF. Peroxisome proliferator-activated receptor alpha-deficiency abolishes the response of lipogenic gene expression to re-feeding: restoration of the normal response by activation of liver X receptor alpha. J. Biol. Chem. 283: 4866-4876 (2008). *
Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J. Postgrad. Med. 50: 145-149 (2004). *
Hebuterne X, Filippi J, Al-Jaouni R, Schneider S. Nutritional consequences and nutrition therapy in Crohn's disease. Gastroenterol. Clin. Biol. 33S3: S235-S244 (2009).
Hebuterne X, Wang XD, Johnson EJ, Krinsky NI, Russell RM. Intestinal absorption and metabolism of 9-cis-beta-carotene in vivo: biosynthesis of 9-cis-retinoic acid. J. Lipid Res. 36: 1264-1273 (1995). *
Hebuterne X, Wang XD, Smith DE, Tang G, Russell RM. In vivo biosynthesis of retinoic acid from beta-carotene involves and excentric cleavage pathway in ferret intestine. J. Lipid Res. 37: 482-492 (1996). *
Hecht GA. Inflammatory bowel disease - live transmission. N. Engl. J. Med. 358: 528-530 (2008). *
Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology (Bethesda) 20: 125-133 (2005). *
Hedin C, Whelan K, Lindsay JO. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc. Nutr. Soc. 66: 307-315 (2007). *
Hedlund M, Padler-Karavani V, Varki NM, Varki A. Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression. Proc. Natl. Acad. Sci. U.S.A. 105: 18936-18941 (2008). *
Hegazi RA, Mady HH, Melhem MF, Sepulveda AR, Mohi M, Kandil HM. Celecoxib and rofecoxib potentiate chronic colitis and premalignant changes in interleukin 10 knockout mice. Inflamm. Bowel Dis. 9: 230-236 (2003). *
Hegazi RA, Saad RS, Mady H, Matarese LE, O'keefe S, Kandil HM. Dietary fatty acids modulate chronic colitis, colitis-associated colon neoplasia and COX-2 expression in IL-10 knockout mice. Nutrition 22: 275-282 (2006). *
Hegele RA, Robinson JF. ABC transporters and sterol absorption. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5: 31-37 (2005).
Heid IM, Vollmert C, Kronenberg F, Huth C, Ankerst DP, Luchner A, Hinney A, Bronner G, Wichmann HE, Illig T, Doring A, Hebebrand J. Association of the MC4R V103I polymorphism with the metabolic syndrome: the KORA study. Obesity (Silver Spring) 16: 369-376 (2008). *
Heier A, Sonne C, Grone A, Leifsson PS, Dietz R, Born EW, Bacciarini LN. An immunohistochemical study of retinol-binding protein (RBP) in livers of free-living polar bears (Ursus maritimus) from east Greenland. J. Zoo. Wildl. Med. 36: 440-446 (2005).
Heikkinen S, Auwerx J, Argmann CA. PPARgamma in human and mouse physiology. Biochim. Biophys. Acta 1771: 999-1013 (2007). *
Heilbronn LK, Campbell LV. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr. Pharm. Des. 14: 1225-1230 (2008).
Heim D, Wege H. Hepatic stem and progenitor cells in liver diseases and hepatocarcinogenesis. Minerva Gastroenterol. Dietol. 55: 111-121 (2009).
Heimburger DC. Localized deficiencies of folic acid in aerodigestive tissues. Ann. N. Y. Acad. Sci. 669: 87-95 (1992). *
Heimerl S, Moehle C, Zahn A, Boettcher A, Stremmel W, Langmann T, Schmitz G. Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. Biochim. Biophys. Acta 1762: 341-350 (2006). *
Hein GJ, Bernasconi AM, Montanaro MA, Pellon-Maison M, Finarelli G, Chicco A, Lombardo YB, Brenner RR. Nuclear receptors and hepatic lipidogenic enzymes response to a dyslipidemic sucrose rich diet and its revertion by fish oil n-3 polyunsaturated fatty acids. Am. J. Physiol. Endocrinol. Metab. Dec 1 [Epub ahead of print] (2009). *
Heine RG. Pathophysiology, diagnosis and treatment of food protein-induced gastrointestinal diseases. Curr. Opin. Allergy Clin. Immunol. 4: 221-229 (2004).
Heine RG. Eosinophilic esophagitis in children with celiac disease: new diagnostic and therapeutic dilemmas. J. Gastroenterol. Hepatol. 23: 993-994 (2008). *
Heine RG, Tang ML. Dietary approaches to the prevention of food allergy. Curr. Opin. Clin. Nutr. Metab. Care 11: 320-328 (2008).
Heininger K. A unifying hypothesis of Alzheimer's disease. III. Risk factors. Hum. Psychopharmacol. 15: 1-70 (2000).
Heinrichs SC. Dietary omega-3 fatty acid supplementation for optimizing neuronal structure and function. Mol. Nutr. Food Res. Jan 28 [Epub ahead of print] (2010). *
Heinz C, Steuhl KP, Meller D. Corneal perforation associated with vitamin A deficiency. Ophthalmologe 101: 614-617 (2004).
Heird WC. Omega-3 long-chain polyunsaturated fatty acids in older children. J. Pediatr. 150: 457-459 (2007). *
Heird WC, Lapillonne A. The role of essential fatty acids in development. Annu. Rev. Nutr. 25: 549-571 (2005). *
Hekmatdoost A, Feizabadi MM, Djazayery A, Mirshafiey A, Eshraghian MR, Yeganeh SM, Sedaghat R, Jacobson K. The effect of dietary oils on cecal microflora in experimental colitis in mice. Indian J. Gastroenterol. 27: 186-189 (2008). *
Hela S, Nihel M, Faten L, Monia F, Jalel B, Azza F, Slaheddine S. Osteoporosis and Crohn's disease. Joint Bone Spine 72: 403-407 (2005). *
Helland IB, Smith L, Blomen B, Saarem K, Saugstad OD, Drevon CA. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 122: e472-e479 (2008). *
Heller A, Koch T, Schmeck J, van Ackern K. Lipid mediators in inflammatory disorders. Drugs 55: 487-496 (1998).
Heller AR. Pharmaconutrition with omega-3 fatty acids: status quo and further perspectives. Mini. Rev. Med. Chem. 8: 107-115 (2008).
Heller AR, Rossel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, Zimmermann T, Koch T. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int. J. Cancer 111: 611-616 (2004). *
Heller AR, Rossler S, Litz RJ, Stehr SN, Heller SC, Koch R, Koch T. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit. Care Med. 34: 972-979 (2006).
Heller AR, Theilen HJ, Koch T. Fish or chips? News Physiol. Sci. 18: 50-54 (2003). *
Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, Jones K, Koehn SL, Lok VM, Aikawa E, Moore KJ, Luster AD, Gerszten RE. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113: 2301-2312 (2006).
Heller J, Kristeleit H, Brensing KA, Woitas RP, Spengler U, Sauerbruch T. Nitrite and nitrate levels in patients with cirrhosis of the liver: influence of kidney function and fasting state. Scand. J. Gastroenterol. 34: 297-302 (1999). *
Hellquist A, Jarvinen TM, Koskenmies S, Zucchelli M, Orsmark-Pietras C, Berglind L, Panelius J, Hasan T, Julkunen H, D'Amato M, Saarialho-Kere U, Kere J. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus. J. Rheumatol. 36: 1631-1638 (2009).
Hellquist A, Zucchelli M, Lindgren CM, Saarialho-Kere U, Jarvinen TM, Koskenmies S, Julkunen H, Onkamo P, Skoog T, Panelius J, Raisanen-Sokolowski A, Hasan T, Widen E, Gunnarson I, Svenungsson E, Padyukov L, Assadi G, Berglind L, Makela VV, et al. Identification of MAMDC1 as a candidate susceptibility gene for systemic lupus erythematosus (SLE). PLoS One 4: e8037 (2009). *
Helmersson J, Arnlov J, Larsson A, Basu S. Low dietary intake of beta-carotene, alpha-tocopherol and ascorbic acid is associated with increased inflammatory and oxidative stress status in a Swedish cohort. Br. J. Nutr. 101: 1775-1782 (2009). *
Helms S. Celiac disease and gluten-associated diseases. Altern. Med. Rev. 10: 172-192 (2005). *
Hendriks HF. Retinoid (vitamin A) metabolism. Eur. J. Clin. Nutr. 50 Suppl. 3: S2-S6 (1996).